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Colic ins and microcins are proteinaceous antimicrobial agents produced by members of 
the Enterobacteriaceae which are active against other members of this family. Colicin 
24 is a novel bacteriocin produced by a uropathogenic strain of Escherichia coli isolated 
at Christchurch Hospital. Through detailed genetic analysis of the DNA encoding this 
toxin and assaying the toxic activity, colicin 24 was re-classified as microcin 24 and has 
been shown to have a similar genetic organisation to that of colicin V and a novel mode 
of activity. 
The region of DNA encoding microcin 24 was subcloned from pGOB34 into 
pBR322 generating pGOB18 (5.44kb). Mutagenesis, DNA sequencing and trans-
complementation identified two regions with high sequence similarity and functional 
homology to the ColV transporters CvaA and CvaB. The insert DNA of pGOB 18 was 
sequenced in both directions and has been found to contain 5267bp encoding five open 
reading frames, mdbA, mtft, mtjS, mtfA and mtjB, forming three operons mdbA, 
mtftlmtjS and mtfAlmtjB all of which were transcribed in the same direction. The 
predicted protein products of all the open reading frames except mtjB were confirmed by 
expressing the genes in minicells. Further mutagenesis and trans-complementation has 
identified mdbA as a cis acting positive regulatory gene with sequence similarity to the 
histone-like proteins. The mtft and mtjS genes were confirmed as the Mcc24 immunity 
gene and the Mcc24 structural gene respectively. The genes mtfA and mtjB were found 
to encode the transport proteins homologous to CvaA and CvaB respectively, with mtjB 
encoding a protein which is a member of the ABC family of bacterial transporters. 
Transport also requires the TolC outer membrane protein. Analysis of the mtjS DNA 
sequence has identified a double glycine leader sequence, making MtfS the second 
microcin after ColV to belong to this class of peptide antibiotics. Experimental 
evidence suggested that unlike CoIV, Mcc24 is inactive within the producing cell, 
however both toxins require the ABC transporter for post-translational modification of 
the pre-peptide. 
The regulation ofMcc24 synthesis is controlled by the interaction between (i, 
Fur, and MdbA, encoded by the mdbA gene. Analysis of the promoter sequences has 
identified putative regions of DNA bending which might facilitate the binding of as and 
MdbA. A Fur-box with good sequence similarity to the consensus Fur-box has been 
identified in the mtjI/mtjS promoter and is the proposed site for Fur binding. 
v 
The activity spectrum of Mcc24 is restricted to enteric bacteria and SernA, the 
MccE492 receptor, is also required as the receptor for Mcc24. Extracts of Mcc24 have 
been found to degrade both linearised and covalently closed circular DNA in vitro. The 
activity is absent in extracts from mtjS - strains, suggesting that Mcc24 inhibits the 
growth of sensitive cells by degrading DNA. The effect of Mcc24 expression on the 
virulence of E. coli was tested using the embryo lethality assay, however unlike ColV 
which increases the virulence of strains, the expression of Mcc24 did not appear to have 
a significant effect on E. coli virulence in this system. 
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CHAPTER 1. 
INTRODUCTION. 
The ability of one organism to inhibit the growth of another by the production of an 
antibiotic substance is a phenomenon seen widely among prokaryotic species. The term 
antibiotic refers to substances produced by one organism which are harmful to other 
organisms (Davies, 1990). Hopwood (1978) defined "true" antibiotics as small, non-
typical compounds which are active against a wide range of organisms. These 
inhibitory substances are secondary metabolites produced by multi-enzyme processes, 
after the cessation of cellular growth (Kleinkauf and van Dohren 1987). Antibiotics are 
thought to playa natural role in biological interactions, where one microorganism 
inhibits the growth of other microorganisms in nutrient limiting environments (Martin 
and Demain, 1980; Hansen, 1993). Davies (1990) has argued that the antibiotic 
property of these substances might result from an original function as effectors or 
cofactors in the primeval translation machinery. It is proposed that secondary 
metabolites are primitive molecules, exerting their antibiotic activity through 
interactions with conserved sites on cellular macromolecules, for example ribosomes. 
Bacteriocins are a class of antibiotic which differ from the classical antibiotics in 
that they are proteinaceous and are active against closely related species. Bacteriocins 
can be defined as bacterial peptide or protein antibiotics which are ribosomaUy made or 
derived from gene-encoded precursor peptides and toward which the producing strain 
possesses a self-protection mechanism (Sahl, 1994; Jack, 1995). Hopwood (1978) 
defines the difference between bacteriocins and true antibiotics as genetic - Bacteriocins 
are the products of single genes, whereas true antibiotics are not encoded by single 
genes but are the products of multi-enzyme pathways. 
Four groups ofbacteriocins have so far been identified. Colicins and microcins 
are produced by members of the Enterobacteriaceae, in particular Escherichia coli (E. 
coli) (Reviewed by Pugsley, 1984a and b; Kolter and Moreno, 1992). Gram-positive 
bacteria produce Bacteriocin-Like Inhibitory Substances (BLlS) and lantibiotics which 
have been the subject of extensive reviews (Tagg et al., 1976; SaW, 1992; Tagg, 1992; 
Hansen, 1993; Sahl, 1994; Jack et al., 1995). Colicin V was the first bacteriocin to be 
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identified, when Gratia described a biologically active factor produced by E. coli V 
which inhibited the growth of E. coli ~ (Gratia, 1925; Fredericq et al., 1949). The early 
perception of bacteriocin production was typified by the high molecular weight, narrow 
spectrum of activity, receptor-mediated binding to sensitive cells and production 
through lethal biosynthesis, which is characteristic of colicin expression. More recently 
microcins, BLIS (non-Ianthionine containing bacteriocins) and lantibiotics have been 
identified and are similar to colicins in that they are proteinaceous. They have however 
been classified separately due to a wide activity spectrum, their small size, heat stability, 
high degree of modifications and non-inducible synthesis (Tagg et al., 1976; Jack et al., 
1995; Kolter and Moreno, 1992). 
The production and activity ofmicrocins, BLIS and lantibiotics is a multi-step 
process in both gram-negative and gram-positive bacteria (Figure 1). The producing 
organism must be able to synthesise the bacteriocin, which involves transcription of the 
structural gene, translation to form the 'prepeptide, post-translational modification and 
processing by cleavage of the N-terminalleader sequence to form the active molecule. 
Once produced, the cell must be able to protect itself from the bacteriocidal action of the 
bacteriocin and export the active peptide out of the cell. The bacteriocin must then be 
able to exert its biological activity on target cells by first interacting with the cell surface 
and then gaining access to the target site (Kolter and Moreno, 1992). 
1.1 BACTERIOCINS PRODUCED BY ESCHERICHIA COLI. 
1.1.1 COLICINS. 
All colicins have three common functional domains and molecular weights ranging 
from 29kDa to 75kDa (Braun et al., 1994). The catalytic domain is represented by the 
C-terminaI25% of the molecule which is also involved in interactions with the specific 
immunity protein, whereas the hydrophobic N-terminaI25% is involved in the 
translocation ofthe colicin across the cell membrane. The receptor binding domain is 
located in the central region of the colicin molecule (Konisky, 1982). Colicin activity 
can be seen as a single hit phenomenon where one colicin molecule is enough to kill a 
single sensitive cell (Hardy, 1975) however, not all colicin-receptor interactions lead to 
cell death (Pugsley, 1984a). 
Mode of action. 
Colicins are classified by their mode of action and have been divided into various 
subgroups (Konisky, 1982; Pugsley, 1984a; Luria and Suit, 1986; Braun et al., 1994). 
Pore forming colicins (Colicins A, B, E1, la, lb, K, N, S8, 5, 10). 
The majority of colicins kill sensitive cells by forming pores in the cytoplasmic 
membrane, destroying the cell's membrane potential and causing efflux of intracellular 
K+ and inorganic phosphates (Lakey et al., 1994). Alignment of the C-terminal catalytic 
domain has revealed some similarity between these colic ins and in particular a long 
hydrophobic sequence which forms a membrane-spanning hydrophobic hairpin (Pattus, 
1990). The membrane inserted state of colicin A has been studied in great depth and 
was found to be in a "penknife" configuration with the hydrophobic helices 8 and 9 
running parallel to the membrane (Lakey et al., 1992; Lakey et al., 1994). For colicin 
E 1 however, it has been proposed that helices 8 and 9 are perpendicular to the 
membrane (Palmer and Merril, 1994). 
'a'gel of 
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I structural gene I 
Figure 1. Diagram of the steps involved in peptide antibiotic production and action in gram~ 
negative bacteria. Abbreviations are: OM, outer membrane; 1M, inner membrane (From Kolter and 
Moreno 1992). 
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En don ucleases. 
Colicins with endodeoxyribonucelease activity ( colicins E2, E7, E8, E9) kill sensitive 
cells through the nonspecific degradation of chromosomal DNA. Extensive sequence 
similarity has been found among these colicins (Toba et ai., 1988). 
Colicins E3, E4, E6 and cloacin DF13 all possess endoribonuclease activity. 
Cell death is caused by the inhibition of protein synthesis, brought about by an 
endonucleolytic break that cleaves a 49 nucleotide fragment from the 3'-OH end of the 
16sRJ\JA molecule within the 30s ribosomal subunit. It also appears that the 50s 
ribosomal subunit plays a role in the activity of these colicins (Luria and Suit, 1986). 
Extensive protein homology is found in the catalytic domains of these colicins (de Graaf 
and Oudega, 1986) but not between these and the endodeoxyribonuclease colicins 
(Pugsley, 1984a; Cole et ai., 1985). 
Inhibition of peptidoglycan biosynthesis. 
Colicin M is the only colicin known to inhibit peptidoglycan biosynthesis through the 
inhibition ofbactoprenyl-P carrier lipid regeneration (Harkness and OlschHiger, 1991). 
The active site in sensitive cells is only accessible to colicin M from the periplasmic 
side of the inner membrane (OlschHiger, 1991). 
Other mechanisms. 
Both colic ins D and E5 inhibit protein synthesis but possibly by a different mechanism 
than RJ\Jase activity. The mechanism of activity for colicins G and H is unknown. 
Genetics. 
The genes for colicin activity, immunity and release are encoded on plasmids (Hardy, 
1975; Luria and Suit, 1986), with the exception of colicin L, a chromosomally-encoded 
colicin produced by Serratia marcescens JF246 (Pugsley, 1984a). Two groups of Col 
plasmids have been distinguished and individual colicins are encoded on one type, never 
both. Group I Col plasmids are multicopy plasmids with a molecular weight of 3 x 106_ 
6x106, whereas group II Col plasmids are large, often conjugative, low copy number 
plasmids with a molecular weight of between 7x107_12x107 (Luria and Suit, 1986). 
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Three genes have been identified among the group I Col plasmids which encode 
the structural, immunity and lysis proteins. The genetic arrangement of these genes is 
similar for all colicins (Figure 2) and transcription is under the control of an inducible 
promoter lying upstream of the structural gene. The immunity gene of pore forming 
colicins is transcribed from its own promoter in the opposite direction to that of the 
structural and lysis genes. As a result, transcription of the lysis gene is inhibited, 
causing a build up of cytoplasmic colicin prior to release (Pugsley, 1984a; Luria and 
Suit, 1986; Braun et al., 1994). 
The release of colicins encoded by group I Col plasmids is a lethal process for 
the producing cells, resulting in partial lysis of the culture and semi-selective release of 
the colicin from the producing cells. Killing of the producing cells and activation of 
phospholipase A are induced by the lysis protein, a small lipoprotein encoded by the 
lysis gene (de Graafand Oudega, 1986; Lazdunski et al., 1988; Lakey et al., 1994). 
Lysis proteins are translated with a 17-19 amino acid signal sequence and share 
extensive sequence similarity to each other (Cavard and Oudega, 1992). The activation 
of phospholipase A by the lysis protein may play an important role in the release of the 
colicin through destabilisation of the cell membrane (Pugsley, 1984a; de Graaf and 
Oudega, 1986). The mechanism of colicin release encoded by group II Col plasmids is 
unclear since they do not encode lysis proteins and are inefficiently released (Pugsley, 
1984a). 
Colicin specific immunity genes are also encoded on Col plasmids and form the 
basis on which novel colicins are identified from new E. coli isolates (Pugsley, 1985). 
By definition, immunity is the property by which colicinogenic cells are not killed by 
the particular colicin that they produce (Jakes and Lazdunski, 1992). 
The immunity protein for endonuclease-acting colic ins is made in a 
stoichiometric 1: 1 proportion to that of the colicin, protecting the cell by binding to the 
catalytic domain of the colicin (Pugsley, 1984a). Commonality in amino acid sequence 
has been found among the immunity proteins of enzymatic colicins regardless of their 
DNase or RNase activity (de Graafand Oudega, 1986). The exact nature of the 
interaction between the immunity protein and catalytic domain remains unclear, 
however the colicins remain bound to their respective immunity proteins upon release 
and are dissociated after binding to the receptors on a target cell (Jakes and Lazdunski, 
1992). 
Immunity to pore forming colicins functions through the direct interaction of the 
immunity protein with the pore forming domain of the respective colicin at the cell 
membrane, resulting in the prevention of pore formation (Geli and Lazdunski, 1992). 
The immunity protein is only required to protect the producing cell from external colicin 
since the transmembrane potential is the opposite of that required for colicin activity 
(Jakes and Lazdunski, 1991). The addition of excess extracellular colicin results in a 
phenomenon called immunity breakdown (Konisky, 1982, Pugsley, 1984b), whereby 
insufficient immunity protein exists to bind all of the colicin molecules within the cell 
membrane (Lakey et ai., 1994). Classification of immunity proteins is based on the 
number of transmembrane domains, resulting in the proper protein topology. The first 
group has four transmembrane domains typified by the ColA immunity protein and the 
second, like the ColE1 immunity protein, has three transmembrane domains (Geli and 
Lazdunski, 1992). 
p 
pore-forming 
colicin 
col imm lys 
p 
Tl 12 
nuclease ~I ~~J colicin 
col imm lys 
Figure 2. Genetic organisation of colicin operons. col, colicin structural gene; imm, colicin immunity 
gene; lys, colicin lysis gene; P, promoter; T, transcription terminator (From Cavard and Oudega, 1992). 
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Colicin production is a highly inducible process controlled by the SOS response, 
a system that regulates gene expression after DNA damage through the relief ofLexA 
repression by the RecA protease mediated proteolytic cleavage of LexA (Braun et al., 
1994). Once repression is removed amplification of colicin synthesis by several orders 
of magnitude occurs (Luria and Suit, 1986), with only a small proportion of cells in a 
population expressing the colicin genes thereby maximising selection against non 
plasmid bearing cells (Lakey et al., 1994). Binding sites for the LexA repressor are 
found within the structural gene promoter of all colicins regulating the expression of the 
structural, immunity and lysis genes (Luria and Suit, 1986; de Graaf and Oudega, 1986). 
Immunity genes which are transcribed in the opposite orientation to that of the structural 
gene are not SOS regulated and have their own weak promoter (Braun et al., 1994). 
Catabolite repression may also playa role in the regulation of colicin expression 
(Pugsley, 1984a). 
Receptor binding and translocation. 
The activity spectrum of a particular colicin is defined by the distribution of specific 
receptors on sensitive cells. This interaction is an energy independent, trypsin sensitive 
process. Different colicins may share the same receptor, recognising the same or 
different receptor domains (Pugsley, 1984a). Colicin receptors also have normal 
physiological roles in the life of the cell. Many serve as nutrient uptake receptors such 
as ButB, the receptor for the E colicins which also is involved in vitamin B12 uptake and 
FepA (colicin B) or Cir (colicins Ia and Ib) which are involved in iron-enterochelin 
binding and iron accumulation, respectively (Pugsley, 1984a). The dependence of 
colicins on receptors which are required for normal cellular activities has been proposed 
as a method by which continued selective pressure has maintained the presence of the 
receptor required for colicin uptake (Konisky, 1982). 
Once bound to the receptor, an energy dependent translocation of the colicin to a 
trypsin inaccessible state can occur by two pathways, classifying colicins into two 
groups dependent on which pathway is used. Mutations in genes in either pathway 
result in colicin tolerance in the mutant strain (Pugsley, 1984a). TonB, the product of 
the tonB gene, is an energy transducer, coupling energy to the active transport of iron 
siderophores and vitamin B12 (Postle, 1990; Kadner, 1990) and defines the translocation 
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of the group B colicins (B, la, lb, M, D). Proteins and their receptors which utilise 
TonB all contain a sequence at their N-terminus designated the "TonB box" which is the 
site of interaction with TonB (Braun et al., 1994). Group A colicins (E1, E2, E3, A, K, 
L, DF13, N, S4) are defined by utilising the products of the tolQRAB genes for 
translocation by an energy independent process. Colicin is an exception since it 
strictly requires TolC and not TolB (Braun et al., 1994). The talA gene product is 
analogous to TonB, however the specific role of the tal genes is unknown except they 
playa role in the import of certain biologically active macromolecules (Webster, 1991). 
Colicins which use this pathway contain a glycine rich N-terminal region not found in 
their receptors which has been designated the "ToIA box" (Pilsl andBraun, 1995). 
Two recently studied colicins have been found to utilise components of both the 
Ton and Tol systems. Colicins 5 and 10 both bind to the Tsx protein, the receptor for 
colicin K which utilises the Tol system, however colicins 5 and lOuse the TonB system 
(Bradley and Howard, 1992; Pilsl and Braun, 1995). Colicin 10 is the first colicin to 
require both TonB and TolC for translocation (Pilsl and Braun, 1995). 
1.1.2 MICROCINS. 
Asensio et ai. (1976) were the first to identify a class oflow molecular weight 
antibiotics, produced by enteric bacteria isolated from the faeces of newborn infants, 
which could inhibit the growth of related microorganisms. These antibiotics were able 
to diffuse through cellophane, inhibit the growth of an indicator bacterium and were 
found to be soluble in methanol-water (5:1) and thermostable. The generic name 
"microcin" was proposed to differentiate these antibiotics from colicins. 
Microcins are low molecular weight «10 kDa) ribosomally synthesised peptide 
antibiotics, produced by diverse members of the Enterobacteriaceae and are active 
against E. coli and other enteric bacteria. Like colicins, the microcins are proteinaceous, 
except for MccA15 which is a methionine analogue (Aguilar et al., 1982) and are 
produced in association with a specific immunity protein. Microcin production 
however, is not SOS inducible but occurs at the start of stationary phase growth. 
Synthesis is non-lethal for the producing strain and requires a dedicated export system 
for secretion (Reviewed by Baquero and Moreno, 1984; Kolter and Moreno, 1992). 
Uptake and translocation into sensitive cells, as with the colicins, is receptor mediated 
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(Pugsley, 1984a). The microcin structural, immunity and export genes are encoded on 
plasmids (Baquero et al., 1978), with the exception of MccH47 which is chromosomally 
encoded (Lavifia, 1990). Unlinked chromosomal genes are also known to be involved 
with the post-translation modification and export of microcins (Kolter and Moreno, 
1992). 
Microcin classification was standardised by Baquero and Moreno (1984). Based 
on cross immunity tests between producing strains, five phenotypic groups (I-V) were 
established. Microcin types A-E were then proposed for the activities related to the 
plasmids found in the phenotypic groups I-V, with type A microcins inhibiting 
metabolic enzymes, type B microcins inhibiting DNA replication, type C microcins 
affecting protein synthesis and type D microcins impairing the cells energy system 
(Table 1). Subsequently a type H microcin has been identified but the mechanism of 
action is unknown (Lavifia, 1990). 
Survey of microcins: Genetics, activity and regulation. 
The emphasis of this survey will be on CoIV, MccB 17 and MccC7 because of their 
relevance to the current work. 
Colicin V. 
Historically this toxin has been classified as a colicin. However, genetic and functional 
analysis has shown that ColV is a small peptide, the synthesis of which is not SOS-
inducible and the release of which is by a dedicated export system. These 
characteristics have meant that ColV is now considered a microcin (Fath et al., 1992). 
Many similarities have also been found between ColV and the non-Ianthionine 
containing bacteriocins produced by gram-positive bacteria (Havarstein et al., 1994). 
The biological activity of ColV is directed against the cell membrane of 
sensitive cells, disrupting the membrane potential (Yang and Konisky, 1984), however 
not through the formation of channels (Fath et al., 1991). ColV synthesis and uptake is 
iron regulated. Transcriptional regulation of the ColV genes is controlled by the Fur 
repressor encoded by the fur gene; increased ColV production occurs when iron 
availability is low and derepression in iron rich media occurs infur mutants. Uptake of 
ColV into sensitive cells requires the Cir protein as the outer membrane receptor and 
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TonB which is responsible for translocation of the toxin. Both genes are also involved 
in iron accumulation (Chehade and Braun, 1988). 
Table 1. Classification and activity of known microcins. 
Mode of action 
Dissipation of proton motive 
force 
Microcin* 
ColV 
MccE492 
MccD140 
MccD15 
Inhibition of cell division Mcc25 
Disruption of DNA biosynthesis MccD93 
Inhibition of DNA replication MccB 17 
Blockage of protein biosynthesis MccA15, MccA93 and 
MccA136 
MccC7 
Prevention of precursor inclusion MccC51 
(DNA, RNA, protein) 
Unknown 
Unknown 
Unknown 
Unknown 
Nonspecific nuclease 
MccH47 
MccB2 and MccB27 
MccRSl 
MccJ 
Mcc24 
Reference. 
Yang and Konisky, 1984 
de Lorenzo and Pugsley, 1985 
Duro et al., 1979 
Aguilar et al., 1983 
Salomon and Farias, 1992 
Martinez and Perez-Diaz, 1986 
Herrero and Moreno, 1986; 
Vizan et al., 1991 
Aguilar et al., 1982; Perez-Diaz 
and Clowes, 1980 
Garcia-Bustos et al., 1985 
Kurepina et al., 1993 
Lavrna et al., 1990 
Basyuk et al., 1994 
Kurepina et al., 1992 
Martin, 1994; Kippenberger, 
1996 
This work 
*Group classification is specified by the letter after Mcc. All strains producing group A microcins also 
produce a group D microcin, encoded by a different plasmid (Baquero and Moreno, 1984). 
The genes encoding ColV production, immunity and export are encoded on a number of 
large, conjugative plasmids which have been associated with the pathogenicity of E. coli 
(Reviewed by Waters and Crosa, 1991). Frick et aZ. (1981) were the first to clone the 
structural and immunity genes in a 900bp fragment from pCo1V-B188 however, this 
fragment failed to produce extracellular ColV. The complete genetic region was cloned 
from pColV -K30 into pBR322 by Gilson et al. (1987). Through mutagenesis and 
complementation, the cloned 9.4kb HindUI-San fragment was found to encode four 
genes within a 4.4kb region: cvaC, the structural gene; evi, encoding specific immunity; 
cvaA!cvaB required for extracellular secretion ofthe toxin. Sequence analysis revealed 
that the four genes form two converging operons comprised of cvaC!cvi and cvaA!cvaB 
(Gilson et al., 1990; Figure 3). 
Cvi. 
The Cvi protein is a 78 amino acid inner membrane protein which is sufficient for ColV 
specific immunity (Fath et al., 1992). Cytoplasmic ColV is not bacteriocidal to the 
producing cell, therefore the role of Cvi is to protect the producing cells from ColV 
molecules interacting with the inner membrane from the periplasmic side (Zhang et al., 
1995). 
CvaC. 
The ColV protein, CvaC, was visualised by SDS-PAGE as a 6kDa protein (Gilson et aZ., 
1987). Sequence analysis ofthe cvaC gene has predicted a 103 residue protein with a 
molecular mass of 1O.304kDa (Gilson et al., 1990), indicating that ColV might be 
subject to post-translational modification. Processing of CvaC involves the cleavage of 
the 15 N-terminal amino acids, termed the leader sequence or double glycine type leader 
peptide, resulting in an 88 amino acid mature peptide with bacteriocidal activity (Fath et 
al., 1994; Havarstein et al., 1994). The leader peptide is required for signal sequence-
independent export of CoIV, involving the transport proteins CvaA and CvaB (Zhang et 
aZ., 1995). Fath et aZ. (1994) identified the C-terminal region as possessing the 
bacteriocidal activity which was retained after SDS-PAGE resulting in an active band of 
5.8kDa. It has been suggested that further non-covalent modifications of the ColV 
peptide occur after cleavage, resulting in a possible metalloprotein with iron (Fath et aZ., 
1994), or a possible disulphide bridge between the C-tenninal cysteine residues at 
positions 91 and 102 (Havarstein et al., 1994). The increased stability ofthe protein 
after either modification results in an unusual mobility under SDS-PAGE and the low 
estimation of molecular mass by this method. 
The leader peptide of pre-ColV shares many similar features with non-
lanthionine containing bacteriocins and some lantibiotics produced gram-positive 
bacteria, making ColV the first gram-negative bacteriocin to fit into this group. Protein 
sequence alignment has revealed many features common to this class of bacteriocin: (a) 
a cleaved leader sequence of 15-12 amino acids; (b) N-tenninal sequence of'Met-
(Lys/Arg); (c) a predicted a-helical structure over most of the leader sequence; (d) a 
negatively charged region in the middle of the leader sequence; (e) a predicted tum 
starting 1-3 residues from the cleavage site which is proposed to expose the cleavage 
site to the protease; (f) cleavage following a Gly-Gly pair; (g) processing results in a 
small bacteriocin of between 43-88 amino acids; (h) export ofthe bacteriocin via an 
ABC transport complex (path et al., 1994; Havarstein et al., 1994). 
Export a/ColicinV' CvaA, CvaB and TalC 
The extracellular secretion of ColV is a signal sequence independent process requiring 
the products of three genes, cvaA, cvaB and the chromosomally encoded gene talC, 
which together form a dedicated export complex (Gilson et al., 1990; Figure 3), Zhang 
et al. (1995) have shown that a small amount of active ColV is present in the periplasm 
during export. Pre-ColV was found to be very unstable in the absence of CvaA and 
CvaB, with CvaB being an absolute requirement for processing. 
CvaA is a member of the membrane fusion protein (MFP) family which are 
accessory proteins required in gram-negative bacteria when the substrate is exported 
across both membranes (Dinh et al., 1994). It has been speculated that MFP proteins 
may fonn bridges between the two membranes (Skvirsky et at., 1995). DNA 
sequencing and mini cell protein analysis has identified two fonns of CvaA, a full length 
413 amino acid protein (47kDa) and a truncated 256 amino acid (27kDa) protein 
designated CvaA *, the result of a translational restart at the in-frame methionine codons 
at positions 156 and 160 (Gilson et at., 1990). CvaA is an inner membrane protein, 
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anchored to the membrane by a single N-terminal domain while the majority of the 
protein is located in the periplasm (Skvirsky et al., 1995). 
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DNA sequence analysis of cvaB, revealed that CvaB is a member of the MDR-
like (Multiple Drug Resistance) or ABC transporter (ATP Binding Cassette) family of 
proteins (Gilson et al., 1990), characterised by a highly conserved ATP-binding domain 
at the C-terminus end of the protein. These proteins hydrolyse A TP to provide the 
energy for active transport of the substrate (Fath and Kolter, 1993). CvaB is a 698 
amino acid (78kDa), integral inner membrane protein containing six transmembrane 
domains between residues 179-438 (Gilson et al., 1990; Fath et al., 1992). The 
cytoplasmic C-terminal domain shares the highest sequence similarity with other ABC 
transporters and contains the ATP binding fold consisting of an A and B site (Fath et al., 
1992). Functional complementation between the exporters CvaAB, HylBD (a-
hemolysin) and PrtDEF (Erwinia protease) has been demonstrated. ColV was able to be 
exported by HylBD and PrtDEF in the'absence ofCvaAB but at a lower efficiency. 
Complementation was not reciprocal and hemolysin was unable to be exported by 
CvaAB or PrtDEF. Differences in signal specificity for CvaC was also found between 
the CvaAB and HylBD export systems (Fath et al., 1991). 
TolC is a minor outer membrane protein, first identified as being required for the 
excretion of a-hemolysin (Wandersman and Delepelaire, 1990). Gilson et al. (1990) 
found that TolC was also required for ColV secretion. Export was reduced in tolC 
mutants and could be restored by the transformation of plasmids encoding the tolC 
gene. 
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Figure 3. Molecular biology of colicin V. A. Genetic organisation of the colicin V operons (From 
Gilson et al., 1990). Amino acids (a.a.). B. The current model for colicin V production, export, 
immunity and activity (From Fath et al., 1992). 
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Microcin B17. 
Microcin B 1 7 was the first peptide antibiotic shown to inhibit a type II DNA 
topoisomerase. The primary effect of this microcin is to inhibit DNA elongation by 
blocking DNA gyrase at the replication fork, trapping an enzyme-DNA cleavable 
complex. This results in a double stranded cleavage of the DNA mediated by DNA 
gyrase, inducing the SOS repair system and causing massive DNA degradation (Herrero 
and Moreno, 1986; Vizful et al., 1991; Hernandez-Chico et al., 1992). 
The genes encoding MccB 17 were first cloned from the 70kb conjugative 
plasmid pMccB 17 (pRYC17) to a 5.1kb fragment (San Millan et al.,1985a). 
Complementation of Tn5 mutants within this region revealed four loci, termed 
mcbABCD, which were essential for MccB 17 production (San Millan et al., 1985b) and 
DNA sequencing and transcriptional analysis identified three promoters (Genilloud et 
al., 1989). Analysis of the region downstream of mcbD located three more genes, 
mcbEFG (Figure 4). It was found that immunity to endogenous MccB17 occurred by 
two mechanisms. Firstly, the genes mcbEF encoded an export complex which rapidly 
exported active MccB 17 out of the producing celL Sequence analysis indicated that 
McbF was a member of the ABC family oftransport proteins. The specific immunity to 
endogenous MccB 17 was provided by the product of the mcbG gene (Garrido et al., 
1988). Herrero et ai. (1986) found that immunity due to McbG does not neutralise the 
toxic activity, but rather prevents the subsequent events leading to cell death after the 
inhibition of DNA synthesis, but before DNA degradation begins. Recently, Baquero et 
al. (1995) have described a chromosomal gene, sbmC, which when cloned into a high 
copy vector results in high levels of resistance to exogenous MccB 17. Induction of 
sbmC is controlled by SOS regulation and stationary phase growth. It is suggested that 
SbmC recognises and sequesters MccB 17 in a reversible way since it confers resistance 
and blocks MccH17 export from producing cells. 
The structural gene for MccB 17 was identified as mcbA, encoding a 69 amino 
acid primary translation product. This product is subject to post-translational 
modification and processing prior to export, resulting in an active microcin of 43 amino 
acids, of which 23 were glycine residues (Davagnino et al., 1986). Two mechanisms of 
post-translational modification were determined for the maturation of MccB 17 (Figure 
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Sa). The 69 amino acid pre-MccB17 peptide is first modified and folded, a process 
controlled by McbBCD (Yorgey et al., 1993). Chemical modification of four cysteine 
and four serine residues resulting in four thiazole and four oxazole rings which in turn 
fold to produce two aromatic heterocycles (Bayer et al., 1993; Yorgey et al., 1994). 
This proMccB17 form is biologically active but is unable to be exported out of the cell 
(Rodriguez-Sainz et al., 1990). The final processing step involves the removal of the 
first 23 N-terminal amino acids, termed the leader peptide, to produce the active 
MccB17. Rodriguez-Sainz et al. (1990) identified a chromosomal gene at 96 minutes 
on the E. coli chromosome map, called pmbA, which encoded the cytoplasmic peptidase 
responsible for the cleavage. Once exported, MccB 17 gains entry into sensitive cells 
through binding to OmpF, an outer membrane protein. Translocation into the cell is 
mediated by SbmA, an inner membrane protein encoded by sbmA (Lavina et al., 1986; 
Liu,1994). 
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Figure 4. Organisation ofthe microcin B17 genetic system (From Moreno et al., 1992). 
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Expression of MccB 17 occurs as the cell enters stationary phase growth and is 
regulated by several chromosomally encoded genes (Figure 6; Hernandez-Chico et al., 
1986; Kolter and Moreno, 1992). Growth phase regulation ofmcbABCDEFG 
transcription is controlled from the promoter P mcb located upstream of mcbA. Two non-
regulated promoters have also been found within mcbC, one promoting low level 
expression of mcbD and the other directing transcription in the opposite direction to that 
ofP mcb (Hernandez-Chico et al., 1982; Genilloud et al., 1989). Growth phase dependent 
activation ofP mcb was found to be controlled by the transcription activator OmpR 
(Hernandez-Chico et al., 1982; Hernandez-Chico et al., 1986). The IHF protein, 
encoded by the chromosomal genes himA and himD also activates transcription from 
P mcb, possibly through DNA bending (Moreno et al., 1992). Negative regulation of 
MccB 17 expression is mediated by the products of the chromosomally encoded genes 
mprA (del Castillo et al., 1990) and bglY (hns) encoding the histone like protein H-NS 
(Moreno et al., 1992). 
Pmcb 
GG 89 
37.6 20 27.5 67.6 69 73.6 815.5 \:/< 
Pmcc 
Figure 6. EschericMu coli chromosomal genes regulating P mcb and P mcc' (+) indicates activation of 
promoter; (-) inhibition of promoter. The dashed line indicates that the Pmcc is clearly inhibited only in 
the presence of many copies of mprA. Numbers under the genes indicate their location on the genetic 
map (From Moreno et al., 1992). 
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Microcin C7. 
Microcin C7 is a linear heptapeptide which inhibits cellular protein synthesis. The 
genes for MccC7 are encoded on a 43kb plasmid pMccC7 (Garcia-Bustos et al., 1984; 
Garcia-Bustos et al., 1985). Novoa et al. (1986) cloned two adjacent HindIII fragments 
from pMccC7 which encoded production and immunity. Complementation analysis 
identified four DNA regions named a, ~,y and 3, all of which were transcribed in the 
same direction and all necessary for microcin production. The gene meeA was 
identified as the gene encoding MccC7 and contained a 21 bp coding sequence for the 
seven amino acids ofthe microcin (Gonzalez-Pastor et al., 1994). Chemical analysis of 
MccC7 revealed that the peptide was subject to post-translational modification at the N 
and C termini. The N-terminus possessed a N-formyl group whereas the C-terminus 
contained an aspartic acid residue, the product of deamidation of the DNA-encoded 
arginine, connected via an amide to a modified nucleotide (5' adenylic acid) (Guijarro et 
al., 1995). Experiments showed that the peptide was the biologically active portion of 
the molecule and the C-terminal substituent has a role in transport of MccC7 into 
sensitive cells. 
Gonzales-Pastor et al. (1995) have recently sequenced the entire MccC7 coding 
region and identified six clustered genes responsible for MccC7 production and 
immunity, mceABCDE and meeF (Figure 7A). Transcription of the meeABCDE operon 
was initiated from the promoter P mcc (meep) whereas meeF was transcribed from its own 
promoter in the opposite direction. Immunity to MccC7 was mediated by MccC, 
responsible for rapid export ofMccC7, MccE which appeared to be a cytosolic protein 
and possibly acetylated the antibiotic target on the ribosome, and MccF which appeared 
to sequester MccC7 in the periplasm. Post-translational modification of proMccC7 was 
proposed to be mediated by MccB and MccD, with MccB responsible for the C-terminal 
adenylation (Figure 7B). 
Expression ofMccC7 occurs as the cells enter stationary phase (Figure 5). Diaz-
Guerra et al. (1989) found that growth phase dependent transcription from P mcc was 
controlled by the appR gene, also called katF or rpoS. AppR was not required for 
expression but ensured full expression from the promoter (Moreno et al., 1992). 
Expression of MccC7 was also found to be subject to catabolic activation through the 
activity of the CRP protein (cAMP receptor protein) (Moreno et al., 1992). 
Microcin E492. 
Microcin E492 is a 6kDa hydrophobic protein, produced by a faecal isolate of Klebsiella 
pneumoniae and is active against E. coli, Klebsiella, Salmonella, Citrobacter, 
Enterobacter and Erwinia species but not Shigella, Proteus, Serratia or Pseudomonas 
species (de Lorenzo, 1984). Sensitive cells are killed by the depolarisation of the 
cytoplasmic membrane through the formation of cation selective channels (de Lorenzo 
and Pugsley, 1985; Lagos et al., 1993). Uptake of MccE492 requires the tonB and exbB 
genes as well as the product of the sernA gene, which function as the outer membrane 
receptor (Pugsley et al., 1986). Little is known about the genetics of MccE492 
production. The genes may be located on the chromosome or on a large non-
mobilisable plasmid. The two visible plasmids within the strain were found not to 
encode MccE492 production (de Lorenzo and Pugsley, 1985). 
Microcin H47. 
Microcin H47 is the first microcin whose genetic system has been found to reside on the 
chromosome of producing cells. Produced by a naturally occuring isolate, E. coli H47, 
this microcin is active against E. coli, Salmonella, Enterobacter, Shigella, Klebsiella 
and Proteus species but not against gram-positive species. The genes encoding 
MccH47 were found to reside on a 10kb ehromosomal fragment (Lavina et al., 1990; 
Lavina and Gaggero, 1992). Complementation analysis has revealed that six genes are 
required for production, mchA-F, with mchABCD being required for production and 
mchEF for export. The immunity gene, mchI lies in a 750bp fragment upstream of 
mchB. An unusual feature is a 3kb silent region between mchA and mchB. Mutations 
and deletions within this region do not seem to alter microcin production, however a 
gene mchSl has been identified within this region which encodes a 43.5kDa protein. 
Similarities between mchE and cvaA have been found since both encode two translation 
products (Gaggero et at., 1993). 
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Figure 7. Genetic organisation and production of microcin C7. A. Structure of MccC7 genetic 
system. ORFI indicates the open-reading frame that encodes the primary structure ofMccC7 (From 
Moreno et al., 1992 and Gonzales-Pastor et al., 1995). B. Model for MccC7 production and immunity. 
The gene products MccA to F are indicated by A to F respectively. Rcp designates a presumed MccC7-
specific receptor on the inner membrane (1M); OmpF is an E. coli porin on the outer membrane (OM) 
shown to be involved in MccC7 uptake (From Gonzales-Pastor et al., 1995). 
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MicrocinsA15,A93 andA136. 
Microcins A15, A93 and A136 are plasmid encoded and produced by E. coli strains 
LP15, LP93 and LP136 respectively. It is thought that these microcins are the same 
since E. coli LP15, LP93 and LP136 have cross-immunity to each other, and E. coli 
LP15 and LP93 share the same 3.9-Md plasmid and E. coli LP136 possesses a plasmid 
with 2.4-Md of homology to the 3 .9-Md plasmid (Perez-Diaz and Clowes, 1980). These 
three microcins all inhibit protein synthesis in sensitive cells. The mechanism of 
MccA15 action has been studied and was found to inhibit the enzyme homoserine-O-
transsuccinylase, an enzyme involved with L-methionine biosynthesis (Aguilar et al., 
1982). 
Microcin C51. 
Microcin C51 is a novel rnicrocin pr04uced by a faecal isolate of E. coli which inhibits a 
wide range of gram-negative species and some gram-positive species by preventing 
incorporation of RNA, DNA and protein precursors (Kurepina et ai., 1993). The genes 
coding for MccC51 production and immunity reside on a 38kb conjugative plasmid and 
at least three genes are required for production ofMccC51 and two for immunity 
(Kurepina et al., 1993). The structure of MccC51 is very similar to that of MccC7, both 
sharing the same heptapeptide and cross immunity. Metlitskaya et al. (1995) have 
suggested that MccC51 contains an asparagine linked with nebularin-5'-monophoshate 
at the C-terminus, however their interpretation of the data has been disputed, with the 
suggestion that MccC51 and MccC7 may in fact be the same (Guijarro et ai., 1995). 
The chromosomally encoded ompR gene has been found to be required for MccC51 
synthesis (Kurepina et al., 1993). 
Microcin 25 
Microcin 25 is a plasmid encoded microcin which interferes with cell division resulting 
in the filamentation of sensitive cells. The activity spectrum of Mcc25 is restricted to E. 
coli, Salmonella and Shigella. Analysis of the amino acid composition has revealed that 
Mcc25 is made up of20 amino acids (2.lkDa) of which five are glycine. The molecule 
is hydrophobic with a blocked N-terminus (Salom6n and Farias, 1992). Induction of 
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Mcc25 synthesis occurs at the start of stationary phase growth and is regulated by iron 
however, this regulation appears to be independent of the Fur repressor (Salomon and 
Farias, 1994). The uptake ofMcc25 shares many features with other colicins and 
microcins including the receptor, FhuA, a multifunctional outer-membrane receptor for 
ferrichrome which is also the receptor for CoIM, ExbBD and TonB for translocation 
into the cell and the sbmA gene product which is also required for MccB 17 uptake 
(Salomon and Farias, 1993 and 1995). 
Type D Microcins. 
Three microcins belong to this group; MccD15, MccD93 and MccD140. It has been 
proposed that MccD15 and MccD93 are the same or very similar and are closely related 
to MccD140. Differences in their reported modes of action have meant that biochemical 
evaluation is needed to clarifY their relatedness (Martinez and Perez-Diaz, 1986). 
Microcin D93 is a small hydrophilic peptide with a molecular weight of less than 
1kDa. Sensitive strains treated with MccD93 suffer a reduction in the rate of DNA 
biosynthesis, an effect increased in recA strains. Sensitivity to MccD93 is found among 
E. coli, Proteus, Citrobacter and Pseudomonas species (Martinez and Perez-Diaz, 
1986). Production and immunity of MccD93 is encoded on a 5.5kb nonconjugative 
plasmid, pMccD93. Cloning of the determinants for microcin production has revealed a 
2.3kb region which encoded MccD93 production but only has low levels of immunity, 
suggesting that not all of the immunity determinants were cloned. The small size of this 
region implies a more simple genetic arrangement than that found in other microcin 
genetic systems (Martinez and Perez-Diaz, 1990). 
MccD15 is a 500 dalton polar peptide encoded by a 3.7 Md conjugative plasmid 
(Aguilar et al., 1982). Both MccD15 and MccD140 target the inner membrane of 
sensitive cells, disrupting the proton motive force (Aguilar et ai., 1982; Duro et ai., 
1979). 
Microcin R51 
Microcin R51 is a plasmid encoded microcin produced by Citrobacter R51 which is 
active against a wide variety of gram-negative and gram-positive species (Kurepina et 
al.,1990). A 5kb fragment was found to encode microcin production and immunity 
with full immunity requiring 4.6kb and partial immunity 1.9kb (Kurepina et al., 1992). 
Microcins E2 and E27. 
Microcin B2 production and immunity are encoded on a 4.2kb and l.4kb DNA fragment 
respectively. A 5kb fragment was found to be necessary for MccB27 production and 
immunity as well as the product of the ompR gene. Susceptibility to both microcins was 
increased when the sensitive cells were recA- and lexA- (Basyuk et ai., 1994). 
Microcin J. 
Microcin J is a novel plasmid-encoded microcin produced by the uropathogenic E. coli 
isolate 2687. Cloning and mutagenesis has identified a 2.8kb stretch of DNA essential 
for MccJ production. Three complementation groups have been found and a possible 5 
polypeptides identified by SDS-PAGE (Martin, 1994). DNA sequencing of this region 
has revealed at least three proteins with no apparent sequence similarity to known 
proteins. A further 2.2kb of sequence contiguous with the 2.8kb region has identified a 
51kDa protein with sequence similarity to the MDR-like family of exporters. 
Transposon insertions into this region were found to render producing cells sensitive to 
MccJ (Kippenberger, 1996). 
1.1.3 ECOLOGICAL ROLE OF COLICINS AND MICROCINS. 
Escherichia coli is a ubiquitous organism in the intestine and is also a pathogen of 
several body systems, especially those involving mucosal surfaces. The role that 
colicins and microcins play in the ecology of E. coli is thought to be one of providing an 
advantage to the producing strain, thus defending the ecological niche against invading 
E. coli with the same nutrient requirements (Braun et ai., 1994). It has been suggested 
that colicins do not have a role in intestinal ecology due to the high activity of intestinal 
proteolytic enzymes (de Lorenzo and Aguilar, 1984). Colicins may however act outside 
the intestinal tract, for example in faeces, ensuring numerical dominance of the 
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producing strain resulting in a greater chance of faecal to oral transmission (Pugsley, 
1984b). Microcins on the other hand may be of ecological significance due to their 
temperature and pH resistance (de Lorenzo and Aguilar, 1984). There is evidence to 
suggest that microcins are produced and remain active in the intestinal tract, since 
microcin-like compounds have been found in faecal samples (Baquero and Moreno, 
1984). 
Hardy (1975) identified three approaches to define the ecological role of colicins 
and microcins:(a) the use of gnotobiotic animals; (b) studies into bacterial succession; 
(c) comparisons between pathogenic and intestinal isolates. 
Studies using gnotobiotic mice and pigs have both indicated that Cot bacteria 
predominate over cor bacteria, but it was found that the selective advantage was due to 
the Col factor and not through the killing of sensitive cells (Hardy, 1975). 
The succession of intestinal bacteria has been studied in humans, mice and pigs. 
By dividing the bacterial species into resident strains, which survive in the intestine for 
several months, and transient strains, those retained for only a few days, it was found 
that resident bacteria were more likely to be Col+ (Hardy, 1975). Experiments using 
mixed cultures of Klebsiella pneumoniae (MccE492) and intestinal E. coli have shown 
that the production and excretion of microcin results in a prevalence of the Klebsiella 
pneumoniae, since Mcc- Klebsiella had no effect. The production of a microcin 
antagonistic substance indicated that the relationship between microcin production and 
predominance was not a simple one (de Lorenzo et al., 1984). Studies into the intestinal 
flora of newborn infants have found that in five out of seven episodes of strain 
disappearance, the displaced strain was sensitive to the microcin produced by the new 
strain. In mice, E. coli containing pMccB 17 were found to be 100 times more prevalent 
in faeces and lasted longer in the gut of the mice (Baquero and Moreno, 1984). 
One of the best areas of evidence for the ecological significance of colicins and 
microcins is the high frequency of producing strains among natural populations 
(pugsley, 1984b), and in particular the correlation between colicinogenicity and 
pathogenicity. Many studies have shown the high frequency of colicinogenicity among 
both pathogenic and non-pathogenic bacteria (Table 2). E. coli of human origin are 
more likely to be Col+ than E. coli of animal origin (Riley and Gordon, 1992). Among 
pathogenic isolates an association between colicinogenicity and pathogenesis has been 
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detennined (Smith, 1974; Smith and Huggins, 1976; Achtman et al., 1983; O'Brien et 
al., 1996). It has been shown that colicins remain active in vivo since activity was found 
in the blood of mice after subcutaneous injection with producing strains, and in the urine 
of mice suffering from a urinary tract infection (UTI) (Hardy, 1975). Among human 
UTI isolates, colicinogenicity was found to be correlated with symptomatic infections 
rather than asymptomatic infections (O'Brien et al., 1996). 
Table 2. Bacteriocin production among E. coli from pathogenic and non-pathogenic 
populations. 
Smith, 1974 Bacteraemia: Human 21.0 18.40 
Bovine 25.0 41.7b 
Sheep 25.0 25.0b 
Chicken 15.4 66.7b 
Asensio et al., 1976 Human (H) na 15.0 
Baquero et al., 1978 Human (H) na 10.0 
Davies et al., 1981 Human: Faeces 31.4 13.6b 
UTI Urine(HO) 43.0 26.2b 
UTI Urine(NH) 40.9 20.0b 
Septicaemia Blood 51.0 31.6b 
Waalwijk et al., 1982 Uropathogenic 30.4 na 
Achtman et al., 1983 Human (D) 51.0 na 
Riley and Gordon, 1992 BCOR collection 35 na 
Khme1 et al., 1993 Human (H) na 1.2 
O'Brienetal., 1996 Human: UTI 42.6 4.55 
a Isolates from healthy (H) individuals or diseased (D) individuals. b Only colicin V tested for. 
Bacteriocins not tested for is denoted "na". Patients were hospitalised (HO) or non-hospitalised (NH). 
UTI: urinary tract infection isolate. 
Chapter 1, Introduction, 27 
Colicin V and virulence. 
To date only one E. coli bacteriocin, colicin V, has been directly associated with 
pathogenicity (Smith, 1974; Smith and Huggins, 1976; Davies, 1981; Achtman et al., 
1983). Conjugal transfer of the Col plasmid to avirulent strains was found to result in 
an increase in virulence, with loss of the plasmid returning the strain to its original state 
(Smith, 1974; Smith and Huggins, 1976). In order to determine if ColV itself caused 
the increase in virulence observed in many studies, Quakenbush and Falkow (1979) 
created Tn5 mutants which abolished ColV production. The strains carrying the mutant 
plasmids still produced high mortality rates in mice, similar to those containing the wild 
type plasmids, suggesting that ColV itself does not playa role in virulence, but that 
other factors closely linked to the ColV genes in the plasmid may be responsible for the 
increase in virulence. More recently, it has been shown that ColV does have a direct 
role in virulence. Wooley et al. (1994) showed that avirulent strains transformed with 
the recombinant ColV plasmid pHKl1, caused a significantly higher rate of mortality in 
chicken embryos compared to ColV- derivatives. 
Colicin V associated virulence factors. 
Several virulence factors have been found to be encoded by ColV plasmids (Fernandez-
Beros et al., 1990; Waters and Crosa, 1991). Adhesion, the specific binding of bacteria 
to epithelial cells at the site of attachment, is a prerequisite for colonisation (Reid and 
Sobel, 1987). Adherence to mouse intestinal epithelial cells has been found to increase 
when strains possess the plasmid pCo1V-H247 (Clancey and Savage, 1981), however 
this adhesion was not related to the expression of the F-pili (Darken and Savage., 1987). 
The conjugative pili have also been shown to increase cell surface hydrophobicity, the 
non-specific physiochemical attachment of bacteria to epithelial cell surfaces (Waters 
and Crosa, 1991). 
Increased serum resistance is another property associated with ColV plasmids. 
Nilus and Savage (1984) identified three plasm ids out of eight which encoded serum 
resistance. Resistance was associated with the plasmid transfer system but not solely 
dependent on plasmid transfer. A loci for serum resistance called iss (increased §erum 
§urvival) has been cloned from pCoIV,I-K94 and was found to be closely linked to the 
Chapter 1. Introduction. 28 
ColV genes (Binns et ai., 1979). Conjugative plasmids also encode a property called 
surface exclusion, in which the strains carrying the plasmid have a reduced ability to act 
as recipients if the donor harbours a closely related conjugative plasmid (Achtman et ai., 
1977). One of the genes responsible for this property, traT, has been found to have a 
role in serum resistance (Moll et al., 1980; Binns et ai., 1982). It has been suggested 
that TraT interferes with the formation of complement complexes, possibly at the 
junction sites between the inner and outer membrane (Binns et ai., 1982). Both the fraT 
and iss genes are highly correlated with serum resistance and ColV production among 
clinical isolates (Montenegro et ai., 1985; Fernandez-Beros et ai., 1990). 
The aerobactin-mediated iron assimilation system is one of the best recognised 
ColV associated virulence factors encoded on ColV plasmids (Warner et ai., 1981; 
Waters and Crosa, 1986). Williams (1979) was the first to identify the association, 
since ColV plasmids were found to confer a selective advantage to host bacteria in 
experimental infections which was reversible in conditions of excess iron. By the 
generation of ColV and aerobactin mutants and screening for the other activity, it was 
shown that iron uptake was independent of Col V synthesis (Williams and Warner, 
1980). The aerobactin genes have also been identified in the chromosome of clinical 
isolates, but lack the conserved upstream region found in the plasmid encoded system 
(Valvano and Crosa, 1984; Bindereifand Neilands, 1985; Valvano et ai., 1986). 
1.2 ABC TRANSPORTERS: STRUCTURE AND ROLE IN BACTERIOCIN 
TRANSPORT. 
ABC transporters comprise a superfamily of transport proteins which utilise the energy 
from ATP hydrolysis to transport their specific substrate across the cell membrane. 
These transporters are found among prokaryotic organisms, both gram-positive and 
gram-negative bacteria and among eukaryotes (Higgins, 1992). Members of this family 
are defined by the possession of a highly conserved ATP-binding domain (Higgins et 
al., 1986; Fath and Kolter, 1993). 
A common feature of ABC transporters is the basic domain structure which is 
conserved in all examples found to date (Higgins et ai., 1986). Four domains have been 
identified of which two are hydrophobic membrane spanning domains (MSD) and two 
are cytoplasmic, containing the ATP-binding cassette (ABC). The transporter functions 
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either as a homodimer, with the ABC and MSD on the same polypeptide, or as a 
heterodimer where these domains reside on separate polypeptides (Higgins, 1992; Fath 
and Kolter, 1993). Phenotypic analysis has shown that the ABC superfamily has 
originated from a shared common ancestor, with the earliest divergence giving rise to 
two subfamilies, one comprised ofhomodimers and the other ofheterodimers (Fath and 
Kolter, 1993). 
Membrane Spanning Domain. 
The MSD forms six transmembrane segments with three extracellular and two 
intracellular loops, resulting in each ABC transporter having twelve membrane spanning 
segments. The cytoplasmic loops are thought to interact with the ABC domain (Pearce 
et al., 1992). Two transporters, MalF and HisQM, have been found to have only five 
transmembrane domains (Higgins, 1992). 
ATP binding domain. 
The ABC domain is approximately 200 amino acids long, located at the cytoplasmic C-
terminus at the end of an a-helix. Two motifs, the A and B sites or Walker motifs, have 
been identified which form an ATP-binding pocket. Residues GXGKST are proposed 
to form a tum, bringing the lysine residue into close proximity to the phosphates in the 
Mg2+ -ATP. The aspartic acid in the B site is in close spatial proximity to the A site and 
may interact with the Mg2+ molecule (Walker et al., 1982). The domain contains a 
highly folded core, with loops extending and interacting with other components of the 
transporter, coupling the energy from ATP hydrolysis to transport via conformational 
change. Loops 2 and 3 have been identified as the most likely to be involved in 
conformational change transduction, since mutations in these loops prevent transport 
without altering ATP binding and hydrolysis (Hyde et al., 1990). A linker peptide, 
LSGGQ, which is central to the transmission of the ATP-dependent conformational 
change has also been found between the A and B sites (Koronakis et al., 1995). By 
using the HylB transporter, the specific ABC transporter for a-hemolysin, Koronakis et 
al. (1995) have identified specific amino acids in the A, B and linker sequences which 
when substituted, disrupted energy translocation through loss of ATP hydrolysis but not 
binding. Substitutions KS05 to I in the A site and D630 to H in the B site resulted in the 
loss of ATPase activity and the loss of export functions respectively, where as 
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substitutions S607 to Nand G609 to D in the linker peptide resulted in the loss of export 
and ATPase activity but not A TP binding. 
Types of ABC transporters. 
ABC transporters have a high degree of specificity for their substrates which include 
sugars, peptides, inorganic ions, amino acids, oligopeptides, polysaccharides and 
proteins (Higgins, 1992). The superfamily can be divided into three families based on 
differences in sources and function (Reviewed by Fath and Kolter, 1993). 
Bacterial importers. 
Bacterial ABC importers, or periplasmic permeases, form a multi subunit import system, 
where the MSD and ABC domains reside on different polypeptides (Doige and Ames, 
1993; Fath and Koiter, 1993). In prokaryotes, a periplasmic receptor protein is required 
to bind the substrate in the periplasm and present it to the import complex (Doige and 
Ames, 1993). 
Eukaryotic transporters. 
Eukaryotic ABC transporters have the ABC and MSD domains on the same 
polypeptide. There is a tandem repeat of the basic structure and no requirement for 
other subunits. Many eukaryotic transporters are of medical significance, for example 
the p-glycoprotein, responsible for multiple drug resistance in tumour cells when over 
expressed (Endicott and Ling, 1989) and the CFTR protein which is defective in cystic 
fibrosis patients (Riordan et at., 1989). 
Bacterial transporters. 
The bacterial ABC transporters are involved in signal sequence independent export of 
substrates out of the cell. They have the basic domain structure previously described, 
with the ABC and MSD domains residing on the same or different polypeptides. 
Complementation between ABC transporters has been shown in several studies, with 
varying efficiency of export depending on the ABC transporter used (Guzzo et at., 
1991; Fath et at., 1991; Binet and Wandersman, 1995). Discrimination of substrates has 
been found to be a function of the ABC transporter (Binet and Wandersman, 1995). 
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Accessory proteins have been identified in gram-negative bacteria which are 
required when the secreted product is destined for immediate release. These proteins 
have been defined as belonging to the membrane fusion protein family (MFP) and 
function to connect the inner and outer membranes (Dinh et ai., 1994). The genes 
encoding MFPs are linked to the ABC transporter genes (Fath and Kolter, 1993). With 
a few exceptions MFPs have a uniform size of 422 residues ±13% and have similar 
structures. The N-terminal region is hydrophilic, followed by 20 hydrophobic residues, 
forming an anchor in the inner membrane. Residues 150-318 are also hydrophilic, 
forming a central periplasmic domain. A hydrophobic C-terminal domain comprising 
residues 319-420 forms a highly conserved outer membrane domain. Phylogenetic 
grouping has been found to correlate with substrate specificity indicating a direct 
interaction between the MFP and substrate (Dinh et ai., 1994). 
Outer membrane proteins have also been identified, the genes of which may be 
linked (Letoffe et ai., 1990) or distinct'from the export genes (Wandersman and 
Delepelaire, 1990). A direct interaction between the MFP and outer membrane protein 
has been found, resulting in the direct passage of the substrate from the cytoplasm to the 
extracellular medium (Binet and Wandersman, 1995). Lipopolysaccharide biosynthesis 
is required for ABC mediated transport, possibly by ensuring the correct incorporation 
of outermembrane proteins in the cell envelope (Wandersman and Lettofe, 1993). 
The substrates exported by bacterial ABC transporters can be divided into non-
protein, protein and peptides (Fath and Kolter, 1993). Non-protein substrates include 
lipophilic drugs, antibiotics, and polysaccharides. No accessory proteins or outer 
membrane proteins are required since these products are not exported directly to the 
extracellular medium (Fath and Kolter, 1993). 
The export signal of protein substrates resides in the C-terminal 60-150 residues, 
such as found with coli a-hemolysin (Kenny et ai., 1992) and Erwinia chrysanthemi 
proteases (Delepelaire and Wandersman, 1991). A glycine rich region, GGXGXD, 
close to the C-terminus is repeated six to nine times and may have a role in presenting 
the signal to the exporter (Wandersman, 1992). 
Peptide transporters export ribosomally encoded bacteriocins produced by gram-
positive and gram-negative bacteria. The export signal for these bacteriocins is located 
in the N-terminal30 amino acids and shares a high degree of similarity. The term 
"double glycine leader peptide", has been given to these export signals since cleavage of 
the leader peptide occurs after two glycine residues (Hlvarstein et ai.) 1994). ABC 
exporters for peptide antibiotics have been found to have a N-terminal extension of 100-
150 residues compared with other ABC transporters, which is responsible for the 
proteolytic cleavage of the leader sequence (Figure 8; Havarstein et ai., 1995). The 
glycine residue at the -2 position appears to be central in the recognition and cleavage of 
the leader peptide (Gilson et ai., 1990; Havarstein et ai., 1995). A model has been 
proposed in which the two proteolytic domains of the homodimer each bind a 
bacteriocin precursor. Hydrolysis of two A TP molecules results in a conformational 
change giving rise to cleavage and export of the bacteriocin (Havarstein et ai., 1995). 
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Figure 8. A model predicting the domain organisation of the new family of bacteriocin ABC 
transporters. Represented is an ABC transporter monomer, however these transporters probably 
function as homodimers. Consequently each transport complex contains two proteolytic domains, 12 
membrane-spanning seqments and two ATP-binding domains (From Havarstein et al., 1995). 
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1.3 REGULATION OF BACTERIOCIN PRODUCTION. 
1.3.1 SYNTHESIS DURING STATIONARY PHASE. 
The synthesis of microcins is not inducible and seems to occur as the cells enter 
stationary phase (Kolter and Moreno, 1992). Starvation or stationary phase is defined as 
the phase when there is no detectable increase in cell numbers within a culture. This is a 
metabolically less active, more resistant state which allows the bacteria to survive in 
nutrient limiting environments and rapidly resume growth when nutrients are available 
(Reviewed by Seigele and Kolter, 1992; Kolter et at., 1993). 
Many global physiological and morphological changes occur during the entry of 
cells into stationary phase resulting in a variety of specifIC genes being transcribed. The 
promoter specificity of the RNA polymerase holoenzyme !3!3'u2a or Ea (HeImann and 
Chamberlin, 1988) can be altered by r~placing a 70, the sigma factor required for gene 
expression during exponential growth, with alternative sigma factors in response to 
environmental signals. During the transition into stationary phase, 30 or more genes are 
expressed which are required for long term survival in a nutrient deficient medium 
(McCann et at., 1991). The transcription of these genes is controlled by as (a38) the 
stationary phase sigma factor, encoded by the rpoS gene, which has been previously 
known as nul', appR, csi-2, abrD, and katF (Loewen and Hengge-Aronis, 1994). 
Mulvey and Loewen (1989) first sequenced rpoS (kat};) and determined an open reading 
frame of 1086 bp, with two potential transcription start sites and strong protein 
similarity to a70, suggesting that rpoS may function as a sigma factor. Loewen et at. 
(1993) identified the ATG at +37 as the transcriptional starting point resulting in a 342 
amino acid protein (38 kDa). Further sequence comparisons between a 70, as and 
alternative sigma factors has identified a highly conserved region (region 2) involved in 
core binding, DNA melting and recognition of the -10 promoter sequence and a 
conserved C-terminal region (region 4) which recognises -35 promoter sequences 
(Lonetto et al., 1992). Biochemical evidence that as can function as a sigma factor 
binding RNA polymerase came from Nguyen et al. (1993) who were able to cosediment 
RNA polymerase and as in a glycerol density gradient. 
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The recognition of different promoters by RNA polymerase is essential for the 
expression of genes required for survival in stationary phase. Both Ea70 and Eas are 
found to recognise very similar promoter sequences and in some cases can regulate the 
expression of the same gene (Tanaka et al., 1993). The determination of a -10 and -35 
consensus promoter sequence for as binding has proved difficult (Loewen and Hengge-
Aronis, 1994). A -10 hexamer, TATACT, has been determined for as.dependent 
promoters, but can also be recognised by Ea70 (Tanaka et al., 1995), reflecting the 
similarity in their recognition domain, region 2.4 (Lonetto et al., 1992). Unlike a70 
however, as does not recognise a consensus -35 hexameric sequence, but requires 
additional sequences downstream of position -17 (Tanaka et al., 1995). Some -35 
promoter determinants are still required since changing the T to C found in the a 70 _ 
dependent -35 hexamer of the proU promoter has been found to allow recognition by 
as, whereas a change in the as -dependent -35 promoter sequence of osmYfrom C to T 
resulted in recognition of the promoter'by a 70 and decreased binding of as (Wise et al., 
1996). DNA bending has been proposed as a mechanism to increase the strength of a s_ 
dependent promoters, thus compensating for the absence of a well defined promoter 
sequence (Espinosa-Urgel and Tormo, 1993). Promoters containing "gearbox 
sequences" are another class of growth rate dependent promoters but are as -independent 
(Vincente et al., 1991). MccB 17 expression is growth phase dependent, however 
transcription from P mcb, which contains a gearbox sequence, is a 70 -dependent 
(Bohannonetal., 1991). 
The level of as within the cell is tightly controlled and increases during entry to 
stationary phase to approximately 30% that of a 70 (Jishage and Ishihama, 1995). One 
promoter is responsible for the majority of rpoS transcription (Lange et al., 1995) and 
corresponds to the P2 promoter determined by Takayanagi et al. (1994). Regulation of 
as occurs at three levels, transcription, translation and protein stability (Lange and 
Hengge-Aronis, 1994), with transcription stimulated in response to 3' -5'-
bispyrophosphate (ppGpp) (Gentry, 1993) and inhibited by cAMP-CRP (Lange and 
Hengge-Aronis 1991). During exponential growth, transcription of rpoS has been found 
to be high, however translation is induced dramatically during the transition to 
stationary phase implying post-transcriptional regulation of as levels (McCann et 
al.,1993; Loewen et al., 1993). The secondary structure of the rpoSmRNA has a long 
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and branched stem and loop structure in which the translation initiation sequence is 
paired with a downstream region preventing translation. Stabilisation of the mRNA, 
resulting in translation, requires the involvement of proteins specific for environmental 
signals (Lange and Hengge-Aronis, 1994). Protein stability is growth phase dependent 
and increases upon the onset of starvation. The ClpXP protease has been implicated in 
the instability of as during exponential phase, however stability in stationary phase is 
not due to a decrease in ClpXP concentration suggesting another protein maybe 
involved (Schweder et al., 1996). A response regulator encoded by the rssB gene, has 
been identified by Muffler et al. (1996) which is essential for as turnover. 
as is part of a global regulatory system modulating gene expression in response 
to environmental signals such as temperature and osmolarity. Other factors such as 
cAMP-CRP, Lrp, IHF and H-NS act independently or in combinations to regulate a s_ 
dependent genes, fine tuning gene expression (Lange et aI., 1993; Loewen and Hengge-
Aronis, 1994). Virulence has also been found to be as regulated. The plasmid encoded 
spvRABCD genes are highly conserved among non-typhoidal Salmonella serovars and 
are required for survival within phagosomes (Fang et al., 1992; Guiney et al., 1995). 
Mutations in rpoS reduce the transcription of spvR, the regulator of spvABCD, resulting 
in reduced virulence. Complementation using cloned rpoS restored virulence through 
increasing spvR transcription. It was also thought that rpoS also regulates chromosomal 
genes required for virulence (Kowarz et al., 1994). 
1.3.2 HISTONE-LIKE PROTEINS. 
The bistone-like nucleoid §tructural protein (H-NS or HI) is a heat stable, neutral 
protein which is highly conserved in enterobacterial species and functions as a 
homodimer in binding double stranded DNA. Along with the protein HU, H-NS forms 
the structural component of the bacterial nucleoid (Reviewed by Drlica and Rouviere-
Yaniv, 1987; Higgins et al., 1990; Ussery et al., 1994). The gene encoding H-NS, hns, 
is chromosomally encoded and has been identified as osmZ, bglY, drdX,pilG and virR 
in several studies (Ussery et ai., 1994). A single copy of hns was mapped to 27 minutes 
on the E. coli chromosome (Pon et ai., 1988). Mutations in hns are found to be highly 
pleiotrophic, affecting the expression of apparently unrelated plasmid and chromosomal 
genes, indicating that H-NS is involved in gene regulation (Higgins et al., 1990). 
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Spassky et al. (1984) identified species ofH-NS, a, b and c which exist in varying ratios 
depending on growth conditions. The level of hns transcription is maximal at mid-
logarithmic phase and no significant accumulation ofH-NS occurs during stationary 
phase (Free and Dorman, 1995). 
Many genes are regulated by H-NS, including the cold shock regulon (La Teana 
et al., 1991) and osmoregulated genes (Higgins et al., 1988), as well as virulence genes 
in Shigellaflexneri and E. coli (Dorman et al., 1990; Tobe et al., 1993; Colonna et al., 
1995) and ribosomal RNA synthesis (Tippner et ai., 1994). H-NS alters gene 
expression by functing as a regulator or as a passive structural component of the 
nucleoid (Ussery et at., 1994), inducing changes in the topology of DNA (Hulton et al., 
1990). Yamada et ai. (1991) were the first to identify H-NS as a trans acting 
transcriptional regulator by analysing H-NS deletion mutants by 2D-gel electrophoresis 
and finding the induction of at least 21 genes. Further studies by Ueguchi and Mizuno 
(1993) using the proU promoter identified H-NS as a transcriptional repressor, binding 
to target promoters and inhibiting an early step(s) of transcription initiation by a direct 
mechanism rather than through alteration of the supercoiled state of the promoter. The 
cAMP-CRP complex has been found to act as an antirepressor for H-NS-dependent 
transcriptional repression (Forsman et at., 1992). Although H-NS acts primarily as a 
transcriptional repressor, in some instances however, the level of some proteins 
decreases in an hns mutant implying that H-NS is functioning as a transcriptional 
activator (Yamada et ai., 1991). The precise mechanism of transcriptional activation 
has yet to be identified (Ussery et ai., 1994). 
DNA bending has been shown to be a mechanism which affects gene 
transcription through changing or determining the affinity of regulatory proteins, 
whether activators or repressors, to cognate sites in the neighbourhood of the RNA 
polymerase binding site (Perez-Martin et ai., 1994). The sites of DNA curvature most 
often occur in AT rich regions upstream or down stream of the transcription initiation 
site (Travers and Klug, 1987; Crothers et at., 1990). Owen-Hughs et at. (1992) 
identified sequences downstreanl of the proU promoter as the site ofH-NS contact. 
This region of curved DNA could be replaced by heterologous curved DNA, indicating 
that H-NS recognises and binds to a structural motif, thereby preventing RNA 
polymerase binding and hence transcription initiation. H -NS binding sites have been 
shown to correspond with RNA polymerase and CRP binding sites (Rim sky and 
Spassky, 1990). By placing a 5A6A motif in front of the laeZ gene, Zuber et aZ. (1994) 
were also able to show that H-NS binds to curved DNA sequences and represses 
transcription. The hns promoter also contains a region of curved DNA which binds H-
NS resulting in autoregulation of hns transcription (Ueguchi et aZ., 1993; Falconi et al., 
1993). Autoregulation controls H-NS concentration in response to growth rate therefore 
adjusting the nucleoid in response to environmental conditions (Dersch et al., 1993). 
Blockage of DNA synthesis has been found to shut-down hns transcription, therefore 
autoregulation also matches H-NS synthesis to the demands of DNA synthesis, 
maintaining a relatively constant H-NS-DNA ratio (Free and Dorman, 1995). 
Recently H-NS has been identified as a component of the rpoS global network, 
with at least 21 as -dependent genes derepressed in an hns' background (Barth et al., 
1995). Three classes of as -dependent genes have been determined with respect to the 
effect of H-NS (Barth et al., 1995). Class I genes, typified by osmY, are no longer 
affected by hns· mutations in an rpoS· background, suggesting that H-NS has an indirect 
effect on gene expression through regulation of rpoS. Yamashino et al. (1995) have 
shown that H-NS is involved in post-transcriptional regulation of as. In hns::neo 
mutants there was a 10 fold increase of as at mid-logarithmic phase. This increase was 
not due to increased transcription of rpoS, but rather due to increased translational 
efficiency of rpoS mRNA and as stability. It was thought that H -NS affects the 
translation efficiency through negatively regulating a gene which encodes a factor 
involved in rpoS mRNA translation or by directly binding the mRNA. Increased 
stability of as could occur through H-NS repressing the transcription of a gene encoding 
a factor responsible for as stability. Class II genes, for example the MccC7 genes 
(Moreno et al., 1992), are more strongly expressed in hn:;;" rpoS backgrounds than in 
rpaS· alone. It is possible that H-NS can bind these genes directly. In the hns· rpoS 
background, gene expression is modulated by a70 however, in a wild type strain, only as 
can overcome H-NS repression. Expression from the MccB 17 promoter P mcb is also 
increased in a bgIY(hns) mutants (Moreno et aZ., 1992), however transcription is a 70 
dependent (Bohannon et al., 1991). Class III genes, for example esiD and esiE, are 
weakly increased in hns mutants during exponential growth and seem to require H-NS 
as a positive factor for stationary phase growth as well as an additional factor besides 
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cl. Expression from the MccB 17 promoter P mcb would appear to fall into this category 
since transcription is increased in bglY (hns) mutants and requires ompR as a positive 
activator (Moreno et al., 1992) however, transcription is a 70 dependent (Bohannon et 
al., 1991). 
Other DNA-binding proteins. 
Alternative histone-like proteins have been identified in E. coli and Yersinia 
enterocolitica. StpA is a second H-NS-like protein in E. coli which appears to be a 
molecular backup for H-NS. StpA also regulates gene expression independently ofH-
NS, possibly through superior binding to RNA (Zhang and Belfort, 1992; Zhang et al., 
1996). The ymoA gene of Y enterocolitica, encodes a histone-like protein which 
modulates expression of thermoregulated virulence factors. The predicted protein 
sequence encoded by ymoA however has no significant similarity to other known 
histone-like proteins (Comelis et al., 1991). 
Two other histone-like proteins are also found in E. coli, but unlike HU and H-
NS which bind DNA non-specifically, IHF and FIS both bind DNA in a site-specific 
fashion (Reviewed by Drlica and Rouviere-Yaniv, 1987; Schmid, 1990; Freundlich et 
al., 1992; Goosen and van de Putle, 1995). The integration host factor, IHF, was first 
identified as being involved in the site specific recombination of phage A. Now the 
involvement ofIHF in a wide variety of physiological activities (Friedman, 1988) and 
transcriptional regulation, including transcription from the MccB 17 promoter P mcb 
(Moreno et al., 1992) is well recognised. IHF is a 21.8 kDa protein encoded by himA 
and himD and functions as aheterodimer, binding approximately 40 bp of DNA around 
a 13 bp consensus sequence resulting in DNA bending (Goosen and van de Putle, 1995). 
The consensus sequence is located within the AT rich promoter regions ofIHF 
regulated promoters (Goodrich et al., 1990; Harrington, 1992). Transcription from 
himA and himD increases as the cells enter stationary phase and is controlled by as, 
ppGpp and IHF (Aviv et al., 1994). IHF affects transcription through both passive and 
active mechanisms by being a component of the bacterial nucleoid or through acting as 
a positive or negative regulator of gene expression (Goosen and van de Putle, 1995). 
Because IHF binds bent DNA, it is postulated that H-NS and IHF might alter DNA 
supercoiling resulting in fine tuning of gene expression (Goosen and van de Pude, 
1995). 
1.3.3 IRON REGULATION. 
The ferric uptake regulation protein, Fur, is the central regulator of gene expression for 
all genes involved in iron uptake in E. coli (reviewed by Bagg and Neilands, 1987, 
Silver and Walderhaug, 1992; Guerinot, 1994). Other genes not related to iron 
metabolism are also Fur regulated including carbon utilisation pathways (Bagg and 
Neilands, 1987) and virulence gene expression (reviewed by Litwin and Calderwood, 
1993) such as Shiga-like toxin production (Calderwood and Mekalanos, 1987 and 1988) 
and ColV production and uptake (Chehade and Braun, 1988). Fur homologs have been 
identified in other gram-negative bacteria including pathogens, with greater than 50% 
identity found between Fur proteins at the amino acid level (Ochsner et al., 1995). 
The Fur protein, encoded byfur., is a 148 amino acid protein which functions as 
a transcriptional repressor, requiring activation by a divalent heavy metal ion. In vivo 
Fur binds to Fe2+, however other divalent ions such as Mn2+, C02+ Cd2+and Zn2+ have 
also been shown to bind Fur (Bagg and Neilands, 1987). The histidine residues 31, 32 
and 131 have been implicated in ion binding (Saito et al., 1991). Fur regulated 
repression also functions as part of the global regulatory network, fine tuning gene 
expression to environmental signals, as seen in E. coli manganese superoxide dismutase 
expression, where two positive and four negative regulators function to control gene 
expression (Compan and Touati, 1993). 
Functioning as a dimer, Fur represses transcription through binding to a specific 
sequence located within the promoters of Fur regulated genes includingfur itself. The 
"Fur-box", first identified in the aerobactin operon (de Lorenzo et al., 1987; Bagg and 
Neilands, 1987), is a 19bp dyad repeat containing the sequence 5' -TCATT -3' as a 
complement in both halves of the repeat (Calderwood and Mekalanos, 1988). 
Visualisation of the Fur-DNA interaction indicates that Fur wraps around the DNA 
fragment, partially or totally covering it, resulting in rigidification of the DNA and 
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polymerisation of Fur (Le Cam et al., 1994), therefore preventing transcription by 
inhibiting RNA polymerase binding. Repression is relieved in iron limiting 
environments since Fur alone cannot bind DNA without the presence of a divalent ion, 
and so Fur dissociates from the promoter allowing RNA polymerase to bind (Litwin and 
Calderwood, 1993). 
1.4 MICROCIN 24. 
Microcin 24 is produced by a uropathogenic E. coli strain, 2424, isolated from a patient 
with pyelonephritis at Christchurch Hospital. Previously classified as colicin 24, this 
bacteriocin was found to be novel by using cross-immunity tests against the colicin 
reference collection (Pugsley and Oudega, 1987). Activity was found against all of the 
colicin or microcin producing strains as well as against Salmonella typhimurium 
(O'Brien and Mahanty, 1994). 
The genes encoding Mcc24 reside on a 43.54 kb plasmid, p24-2. Mutagenesis 
has identified two consecutive BcoRl fragments that contain the Mcc24 genes (Figure 
9). Failure to restore a Mcc24+ phenotype in mutant strains by lysing with chloroform 
vapour, a technique previously used to identify transport mutants in the study of ColV 
(Gilson et al., 1987), did not allow complementation groups to be determined. In order 
to clone the Mcc24 genes, an extra BamHI site within mini-Tn} 0 was utilised from a 
mutant with a Mcc24+ phenotype (Figure 9, no 24). The resulting pBR322 clone, 
pGOB34, contained 25.14 kb of insert DNA (O'Brien and Mahanty, 1994). 
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Figure 9. Restrictiou map of p24-2, mini-TnlO mutants and pGOB34. (From O'Brien and Mahanty, 
1994) A. Restriction map ofp24-2. Restriction enzymes B, BamHI; EcoRI; H HindIlI; P, PstI; S, 
SaIL B. Location of mini-Tn1 0 insertions in plasmid p24-2 resulting in various Mcc24 phenotypes. 
Microcin phenotypes: normal, 24; increased, 18-20; reduced 21-23; minus, I-II and 14-17. C. 
Restriction map of pGOB34. Cloning utilised a unique BamH! site in mutant 24 present in mini-Tn10 
resulting in a 25.l4kb fragment being cloned into pBR322. 
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1.5 AIMS OF THIS STUDY. 
Colicins and microcins are the two classes ofbacteriocins produced by E. coli and are 
often produced by pathogenic E. coli strains, however the specific role that these toxins 
play in pathogenicity is unclear. Of the colicins and microcins studied to date, the 
majority are produced by strains isolated in Europe and the USA with only three 
rnicrocins, ColV, MccB 17 and MccC7 having been studied in detail. 
Because of the unique nature of Mcc24 and the strong bacteriocidal activity this 
toxin displayed against other enteric pathogens, this study aimed to elucidate the 
molecular mechanisms of Mcc24 production, immunity, transport and activity in order 
to further understand the role that microcins play in bacterial pathogenicity. The 
specific objectives ofthis study were: 
1. To subclone the Mcc24 encoding genetic region to the smallest possible DNA 
fragment which retained all ofthe Mcc24 activity and regulation. 
2. Identify the number of genes involved in Mcc24 production, immunity and 
transport through mutagenesis and complementation, utilising lacZ fusions to determine 
the number and location of the promoters regulating transcription of the Mcc24 genes. 
3. Obtain the complete nucleotide sequence of the Mcc24 encoding region and 
confirm the open reading frames through mutagenesis, complementation and protein 
analysis using E. coli maxicells or mini cells. 
4. Identify mechanisms ofMcc24 regulation. 
5. Extract Mcc24 from spent culture supernatants in order to elucidate the 
mechanism of action against target cells. 
6. Test the activity of Mcc24 against known human pathogens and assay microcin 
producing clones for toxicity using an animal model. 
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CHAPTER 2. 
MATERIALS AND METHODS. 
2.1 BACTERIAL STRAINS, BACTERIOPHAGES AND PLASMIDS. 
Bacterial strains, bacteriophages and plasmids used in this study are listed in Table 4. 
2.2 BUFFERS AND MEDIA. 
Buffers and solutions used in this study were prepared as described in Appendix 1. 
Media used in this study were prepared as described in Appendix 2. 
2.2.1 ANTIBIOTICS AND SUPPLEMENTS. 
Antibiotics and supplements were added to agar plates or to overnight liquid cultures as 
stated in Table 3. 
Table 3. Antibiotics and Supplements. 
Antibiotic or supplement Abbreviation Concentration 
Ampicillin Amp SO or 100mglml 
Chloramphenicol Cm 30mg/ml 
Gentamycin Gent 30mglml 
Kanamycin Kan SOmg/ml 
Nalidixic acid Nal 30mglml 
Rifampicin Rif SO - lS0mglml 
Spectinomycin Spec SOmglml 
Streptomycin Strep SOmglml 
Tetracycline Tet lSmglml 
Isopropyl-~-D-thio-galactopyranoside IPTG O.SmM 
S-bromo-4-chloro-3- indoyl-~-D- X-Gal 30mglml 
galactopyranoside 
0-N itropheny l-P-D-galactopyranoside ONPG O.gmg/ml 
Sodium pyrophosphate Napp L2SmM 
2,2' -dipyridyl O.lmM 
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Table 4. Bacterial Strains, Bacteriophages and Plasmids. 
or Plasmid 
Escherichia coli 
BzBlO13 Fep mutation FepA Resistance-ColB ColD Pugsley and Oudega, 1987 
BzB1030 butB mutation Resistance-ColA ColE1 Co1E2-E9 Pugsley and Oudega, 1987 
BzB1190 tsx mutation Resistance-ColK Pugsley and Oudega, 1987 
BzBlI92 tonB- Pugsley and Oudega, 1987 
BzB2101 (pCoIA-CA31 CoiA+ eaa cat cal) Pugsley and Oudega, 1987 
BzB2104 (pCoIE1-K53 ColEl+ ceaA ceiA eelA) Pugsley and Oudega, 1987 
CSH26 pColV-K30::TnlO TetR ColV+ * 
DHIOB F- araD139 I:.(ara, leu)7697 /)./acX74 galU Grant et al., 1990 
galK merA l:.(mrr-hsdRMS-mcrBC) rpsL dol' 
~80dlacZI:.M15 endAI nupG reeA1 
DF1 rspl (tnpA CmR) Wang et al., 1993a; 1993b 
GC4468 F l:./aeUl69 rpsl/ur' Compan and Touati, 1993 
GC4468 /ur+ (pCoIV-K30::TnlO TetR ColVl This study 
GC4468 fur + (P24-2: :mini-Tnl 0 # Mcc24i ) This study 
GC4468 I:.fur: :kan Compan and Touati, 1993 
GC4468 I:.filr::kan (pCoIV-K30::TnlO TetR ColV+) This study 
GC4468 I:.filr::kan (p24-2::mini-TnlO # Mcc24l This study 
GC7442 F his trpE tolC: :Tn5 ColV leaky Gilson et al., 1990 
GC7459 tolC: :Tnl 0 ColV tight Gilson et al., 1990 
JM246 eys- * 
JM246 cys- Mcc24 R 'This study 
K802 met- * 
K802 met- Mcc24R This study 
L392 (ZK127) supE44 supF58 hsdR514 galK2 gal122 metB1 Murray et al., 1977 
hpR55laeYl 
LE392 metB1 Mcc24R This study 
MC4100 F- araD139 b.(lacl PO ZYA-argF) U169 Casadaban, 1976 
rpsL thi recA-56 
MC4100 Mcc24R This study 
MC4100 reeA-56 (PHK11 ColV+ AmpR) Gilson et al., 1987 
N3002 cys- * 
N3002 cys- Mcc24 R This study 
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Table 4. Continued. 
Strain, Phage 
or Plasmid 
PAP308 
PAP702 
PAP710 
PAP1402 
PB2480 
P678-54T 
W31l0 
W3110 
ZB3 
ZK126 (ZK353) 
ZK126 
ZK126 
ZKl26 
ZK762 
71-18 
2424 
2424 
2686 
Other 
K. pneumoniae 
S. typhimurium L T2 
Hospital pathogens 
Bacteriophage 
Lambda NK1316 
Lambda NK1323 
Lambda NK1205 
Genotype or description 
ompF mutation Resistance-ColA CoIN 
Tolerance-CoIE2-E9 ColK CoIL CoIS4 mccC7 
mccB17 
ompA mutation Tolerance-ColK ColL 
semA::Tn5 Tolerance-E492 
ompR::Tn5 Resistance-ColA CoLN 
Tolerance-CoIE2-E9 ColK CoIL CoIS4 ColB18 
F- thr 1 leu6 lac Yl supE44 tonAZl T sR 080' 
F thr leu thi supE lac Y tonA gal mal xyl ara mtl 
min 
Ecoli K-12 F-Iambda" StrepR 
(p24-2::mini-TnlO KanR #24 Mcc24+) StrepR 
ZK126 rpoS(IS insert) A(bolA::lacZ) lysogen 
KanR 
Slip" Streps F- Rit 
(pJC10 Mcct) 
(pCoIV-K30::mini-TnIO TetR ColV+) 
(pHKll ColV+ AmpR) 
MC4100 pcnB80 zad::TnlO 
supE thi /).(lac-proAB) F' [proAB+ lacfl 
lacZllM15] 
(p24-12 AmpR CmR StrepR TetR SpecR Mcc24+) 
NaIR Hospital pyelonephritis isolate 
(p24-2 Mcc24+) NaIR 
Mcct Hospital pyelonephritis isolate 
RYC472 MccE492+ 
Pathogen reference strains. Table 9. 
1.8 kb mini-TnlO 103 KanR 
2.9 kb mini-Tnl 0 104 TetR 
4.9 kb mini-TnlO 112 KanR lacZ 
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Reference 
Pugsley and Oudega, 1987 
Pugsley and Oudega, 1987 
Pugsley and Oudega, 1987 
Pugsley and Oudega, 1987 
Berquist,P. 
Meagher et al., 1977 
* 
O'Brien, 1992 
'" 
Kolter, R. 
Martin, 1994 
This study 
This study 
Lopilato et al., 1986 
Messing et al., 1977 
O'Brien and Mahanty, 1994 
O'Brien and Mahanty, 1994 
Martin, 1994 
Pugsley and Oudega, 1987 
'" 
Christchurch Hospital 
Kleckner et al., 1991 
Kleckner et al., 1991 
Kleckner el al., 1991 
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Table 4. Continued. 
Strain, Phage 
or plasmid 
pACYCl84 
pBluescript 
pBR322 
pCoIV-K30::TnIO 
pDELTAl 
pGOB34 
pGOB9 
pGOBl1 
pGOB18 
pGOB 18: :mini-TtiJO 
pGOB181 
pGOBlSl ::mini-
TnlO 
pGOB200 
pGOB341 
pGOB342 
pGOB343 
pGOB420 
pGOB42t 
pGOB423 
pGAl85 
Genotype or description 
CmRTetR 
SK+AmpR 
AmpRTetR 
ColV+Te{ 
R R R I Amp Kan Tet strA sacB acZ' 
R + Amp Mcc24 
6.12kb Sau3AI fragment in pBR322, Amp R 
Mcc24+ 
6.72kb Sal/3AI fragment in pBR322, Amp R 
Mcc24+ 
5.25kb Sau3AI fragment in pBR322, Amp R 
. Mcc24+ 
Insertions with various Mcc24 phenotypes, KanR 
1.913kb EcoRl fragment in pBR322, AmpR 
Mcc24-
Insertions with various Mcc24 phenotypes, TetR 
7.65kb EcoRl/SaIl fragment in pUClS, AmpR 
Mcc24-
9.3kb BamHI/EcoRI fragment in pBR322, AmpR 
Mcc24-
4.5kb and 4.2kb EcoRl fragments in pUCt8, 
R + Amp Mcc24 
7.86 kb SaniHindIII fragment in pBR322, AmpR 
Mcc24-
4.5kb and 4.2kb EcoRl fragments in pUCt8, 
R + Amp Mcc24 
4.2kb EcoRl fragment in pucts, AmpR Mcc24-
4.5kb EcoRl fragment in pUCtS, AmpR Mcc24-
5.267kb insert + 3.99kb (pBR322) BamHI/EcoRl 
fr' R R R + agment ill pDELTAl, Amp Kan Tet Mcc24 
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Reference 
Chang and Cohen, 1978 
Short et al., 1988 
Bolivar et al., 1977 
Gilson et a1., 1987 
Wang et al., 1993a; 1993b 
O'Brien and Mahanty, 1994 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Table 4. Continued. 
Strain, Phage 
or plasmid 
pGA185 
pGA813 
pGA813 
pGA851 
pGA851 
pGSK813 
pHK11 
pHK22 
pHK22::Tn5 #6 
pLOB8 
pLOB21 
pLOB421 
pLOB813 
pLOB813: :mini-
TnlO 
pLY21 
pNK2882 
pUC18 
pYlE 1 0 
p24-2 
* 
Genotype or description 
Deletion derivatives, 33 KanK/StrepK, various 
phenotypes 
1.913kb insert + 0.28kb pBR322 EeoRIlSalJ 
fragment in pDELTAI, AmpR KanR TetR Mcc24" 
Deletion derivatives, 19 TetRISucR and 11 
KanR;StrepR, various phenotypes 
3.36kb EeoRI fragment in pDELTA1, AmpR 
KanRTe{ Mcc24" 
Deletion derivatives, 14 TetR/SucR and 14 
KanR/StrepR, various phenotypes 
1.913kb insert + 0.28 kb pBR322 EcoRIlSalI 
fragment in pBluescript, AmpR Mcc24" 
r.+.+ + + 1 + R 
evaL eVI cvaA evaB Co Y ,Amp 
evaC+ evt evaA+ evaB+ COIY+,CmR 
ColV"CmRKanR 
3.7kb Sau3AI fragment in pACYCI84, CmR 
Mcc24" 
l.3kb Sau3AI fragment in pACYC184, CmR 
Mcc24" 
4.2kb EeoRI fragment in pACYCI84, CmR 
Mcc24" 
1.913kb BamHI fragment in pACYCI84, CmR 
Mcc24" 
Insertions with various Mcc24 phenotypes, TetR 
evaC+ evt evaAK Cm R 
tnpA ATS transposase TetR 
AmpR 
Mcc24+ 
Laboratory Collection. 
Reference 
This study 
This study 
This study 
This study 
This study 
This study 
Gilson et al.,1987 
Gilson et al., 1987 
Gilson et al., 1987 
This study 
This study 
This study 
This study 
This study 
Gilson et al., 1990 
Kleckner et al., 1991 
Yanisch-Perron et al., 1985 
Shum, 1992 
O'Brien and Mahanty, 1994 
. , 
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2.3. BACTERIOLOGICAL METHODS. 
2.3.1 CULTURE CONDITIONS. 
Bacterial cultures were incubated at 37°C unless otherwise stated. Strains used in the 
experiments outlined in Results 3.6.1 were incubated at the appropriate temperature of 
each organism . 
Exponential Cultures. 
A 1 :50 dilution of a bacterial overnight culture was made in LB broth (50-1 OOml). The 
culture was vigorously shaken at the required temperature for 2-3 hours until the culture 
reached an OD6oo of 0.4. 
Overnight Cultures. 
A single bacterial colony was resuspended in 3ml LB broth containing antibiotics when 
required and shaken at the appropriate temperature overnight. When required the cells 
were pelleted by centrifugation (6000rpm, 5min, 4°C). An overnight culture was 
assumed to contain approximately lxl 09 cells/ml (Kleckner et ai., 1991). 
2.3.2 ANTIBIOTIC RESISTANCE. 
Plate assay. 
Bacterial strains were subcultured on the appropriate antibiotic plate in order produce 
single colonies. Discrete colonies on the second and third streaks denoted resistance. 
Serial dilution. 
A loopful of bacteria was resuspended in 100/-11 ofLB in a microtitre wel1. Serial 
dilutions of 10"2, 10-4 and 10-6 were made in LB broth to a final volume of 100/-11. A 5/-11 
sample from each dilution was spotted onto the appropriate antibiotic plates. After 
drying, the plates were incubated at overnight and growth at 10-2, 10-4 or 10-6 was taken 
to denote antibiotic resistance. 
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2.3.3 COLICIN AND MICROCIN PRODUCTION (Pugsley and Oudega, 1987). 
Plate overlays were performed using a 3ml aliquot of molten H-top agar inoculated with 
an overnight culture of E. coli MC4100 (1001l1) unless otherwise stated. 
Patch Test. 
Post-incubation. 
A M63 plate was overlayed and after 20 minutes, the test strains were toothpicked onto 
the lawn and the plates incubated for 8-14 hours. Bacteriocin production was scored 
visually, based on the distance between the colony edge and the edge ofthe clearing 
zone (1=<0.5rnrn; 2=0.5-lmm; 3=1-2.5rnrn; 4=2.5-5rnrn; 5=>5rnrn). 
Pre-incubation. 
In some instances it was necessary to pre-incubate the test strains after spreading 100111 
of LB broth over a M63 plate to provide a limited nutrient source. The test strains were 
then toothpicked onto the plate. After 0vernight incubation at 30°C, the plate was 
overlayed with H-top agar seeded with coli MC4100 and incubated for 8-14 hours. 
Overlay Test. 
The test colonies were toothpicked onto a M63 plate and grown as described for the 
patch test with pre-incubation. The plate was exposed to chloroform vapour for 20 
minutes and then left open to allow the residual chloroform to evaporate. A 5ml aliquot 
of molten H-top agar seeded with indicator bacteria was used for the overlay and the 
plate incubated as previously described. 
Cross-streak Test. 
Using a sterile toothpick or loop, a bacteriocin-producing strain was streaked down the 
centre of a M63 plate and incubated for 48 hours. The test strains were streaked at right 
angles up to the edge of the producing strain streak and incubated overnight. Inhibition 
of growth near the junction between producing and test strains denoted sensitivity of the 
test strain to the bacteriocin. 
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Cellophane test. 
Pre-incubation. 
Cellophane filters were cut to fit into a petri dish and sterilised under UV light for 5 
minutes on each surface. A filter was placed on a M63 plate and the test strains 
toothpicked onto the surface ofthe cellophane and incubated overnight. The following 
day the filter was removed and 5ml of molten H-top agar seeded with indicator bacteria 
was poured onto the plate and the plate incubated for 8 hours. 
Post-incubation. 
The test strains were grown as previously described for the patch test with pre-
incubation. A cellophane filter was placed over the colonies and 3ml of molten H-Top 
agar seeded with indicator bacteria gently was poured over the plate, followed by an 8 
hour incubation. 
2.3.4 GENERATION OF SPONTANEOUS MICROCIN 24 RESISTANT 
MUTANTS. 
The strain from which spontaneous mutants were to be derived was used to seed 3ml H-
Top agar and poured over a M63 agar plate. Colonies of MC4100(pGOBl 8) were 
spotted onto the lawn and the plate incubated for 12-24 hours. Any colonies that 
appeared within the microcin halo surrounding MC41 OO(pGOB 18) were collected, 
purified and retested for microcin resistance using the patch test. 
Amino acid uptake. 
Overnight cultures of two Mcc24R mutants were grown in LB broth and a loopful 
streaked for single colonies on M63 agar and M63 agar supplemented with methionine 
(20Ilg/ml) or cysteine (20llg/ml). Modification to this method involved harvesting the 
cells from 1ml of overnight culture, washing the cells in Ix M63 salts and resuspending 
-2 -4 -5 
the pellet in 1ml of Ix M63 salts. Serial dilutions of 10 ,10 and 10 were made and a 
10111 aliquot from each was plated on a M63 agar and M63 agar with amino acid 
supplements. After an overnight incubation the plates were examined for growth. 
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2.4 DNA MANIPULATION AND CLONING TECHNIQUES. 
All centrifugation steps involving DNA preparation were performed at 12000rpm for 5 
minutes at 4°C unless otherwise stated. When required, enzymes were inactivated by 
heating at 75°C for 10 minutes. 
2.4.1 ALKALINE EXTRACTION OF PLASMID DNA. 
(Derivedfrom Birnboim and Dofy, 1979). 
A 1.5ml aliquot of bacterial overnight culture was poured into an eppendorf tube and the 
cells pelleted by centrifugation. The supernatant was removed by suction and the pellet 
resuspended in 100J-ll of Solution I. After a five minute incubation on ice, 200J-ll of 
Solution II was added and mixed gently until the solution became viscous and clear. 
After a further 10 minute incubation on ice, 150J-l1 of Solution III was added and the 
tube mixed thoroughly to break up the precipitate. The tube was incubated on ice for 
one hour, the precipitate pelleted by centrifugation and the supernatant poured off into a 
new tube. Sometimes a second centrifugation was necessary to obtain a clean lysate. 
The DNA was precipitated using 250J-ll of cold isopropanol and placed on ice 
for 30 minutes. Once pelleted, washed with Iml of 70% ethanol and air dried, the DNA 
was dissolved in 200J-ll of O.3M sodium acetate (PH 4.8), and 400J-ll of cold 100% 
ethanol added. The DNA was precipitated at -80°C for 10 minutes and pelleted by 
centrifugation. Aspriration was used to remove the supernatant and a second spin in a 
microfuge performed to remove any remaining liquid, after which the DNA pellet was 
dissolved in 30J-l1 TE. 
2.4.2 MODIFIED ALKALINE EXTRACTION OF PLASMID DNA 
(Kennedy, 1988. A modified version of Birnboim and Dofy, 1979; Ish-Borowicz and 
Burke, 1981). 
The same solutions and volumes as in the above procedure were used. After Solutions I 
and II the tube was incubated at room temperature for five minutes. Following the 
addition of Solution III, the tube was placed on ice for a further five minutes and the 
precipitate pelleted by centrifugation. The supernatant was transferred to a new tube 
and 1ml of room temperature 100% ethanol was added. After two minutes at room 
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temperature, the DNA was pelleted by centrifugation (l2,000rpm, lOmin, 2S0C), the 
supernatant removed by aspiration and the pellet washed with 400fll room temperature 
70% ethanol. Once dried, the pellet was dissolved in 30-S0fll of sterile distilled water. 
2.4.3 LARGE SCALE PLASMID DNA PREPARATION - Lithium Chloride 
Method (Sambrook et at, 1989). 
Bacterial cultures were grown overnight in 100ml ofLB broth with the appropriate 
antibiotics and then pelleted by centrifugation (4000rpm, 10min, 4°C) in a 50ml Sorval 
tube. The pellet was resuspended in Sml of Solution I, followed by 10mi of Solution II 
and the tube was gently rolled until the solution became viscous and clear. After S 
minutes at room temperature, Sml of Solution III was added and the solution thoroughly 
mixed to break up the precipitate. The precipitate was pelleted by centrifugation 
(lOOOOrpm, 20min, 4°C) and the supernatant strained through sterile muslin into a fresh 
tube. 
The DNA was precipitated from the supernatant by adding an equal volume of 
cold isopropanol and placing the tube on ice for 10 minutes. Once pelleted by 
centrifugation (2500rpm, 10min, 4°C) and the supernatant removed by suction, the 
DNA was dissolved in 1ml ofTE and then transferred to a lOml centrifuge tube where 
an equal volume of SM LiCI was added. After 10 minutes on ice, the precipitate was 
removed by centrifugation and the supernatant transferred into a clean tube. The DNA 
was precipitated with cold isopropanol, pelleted and dissolved in O.4ml ofTE. After 
transferring the supernatant to an eppendorftube, 2fll of RNase A (lOmg/ml) was added 
and the tube incubated at 37°C for 15 minutes. The DNA was precipitated by adding 
SOOfll of2.SM NaC1I20% PEG and placing the tube at -20°C for 10 minutes. Once 
pelleted and dried, the DNA was dissolved in 250fll ofTE. 
Contaminants were extracted from the DNA using an equal volume of 
phenol:isoanlyl alchohol (24:1) and chloroform, followed by two chloroform extractions 
to remove any remaining phenol. The DNA was precipitated using ethanol (Methods 
2.4.4) and pelleted by centrifugation. If no precipitate could be seen the sample was left 
at -20°C overnight before the DNA was centrifuged. Once the supernatant was 
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discarded, the pellet was washed with Iml of 70% ethanol, vacuum dried and dissolved 
in 200f,t1 of sterile distilled water. 
2.4.4 ETHANOL PRECIPITATION OF DNA. 
1110 volume of 3M sodium acetate (PH 4.8) was added to the DNA sample 
followed by 2 volumes of 100% ethanol. After 10 minutes at _80°C the DNA was 
pelleted by centrifugation, the supernatant removed and the pellet was redissolved in an 
appropriate volume of sterile glass distilled water or TE. 
2.4.5 RESTRICTION DIGESTION OF DNA. 
Restriction digestions were carried out using the manufacturers' recommended 
conditions and buffers. Typically, reactions were carried out in 10-20f,t1 volumes and 
incubated for 4 hours or overnight. For double digestions, the most suitable buffer for 
the two enzymes was used. In some cases the enzyme with the lowest salt requirement 
was incubated first, then the second enzyme and more salt were added and the 
incubation continued at the appropriate temperature. 
2.4.6 GEL ELECTROPHORESIS. 
Agarose dissolved in Ix TAE buffer was used for gel electrophoresis. The agarose 
content varied between 0.5-1.5% depending on the size of the fragment of interest. 
Ethidium bromide (0.5/-Lg/ml) was used to stain the gels for 20 minutes, followed by 
destaining in water for 5-10 minutes if required. DNA bands were visualised using a 
Sigma T2210 UV Transilluminator (302nm). 
2.4.7 RNaseA TREATMENT OF DNA FOR GEL ELECTROPHORESIS. 
Loading buffer containing RNaseA (l0/-Lg/ml) was added to the DNA and the sample 
was incubated at 37°C for 5 minutes before loading onto the agarose gel. Treatment 
after gel electrophoresis could be achieved by soaking the gel in RNaseA solution 
(lOf,tg/ml in 1xTAE) at 37°C for 15 minutes. 
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2.4.8 ELUTION OF DNA FRAGMENTS FROM AGAROSE GELS: MODIFIED 
SPIN-DOWN METHOD (He et at, 1992). 
A 1ml Gilson blue tip was cut, the end plugged with glass wool and then placed inside 
an eppendorf tube. DNA fragments were separated by electrophoresis and the gel 
stained briefly in fresh ethidium bromide. The DNA fragment was visualised using a 
UV transilluminator, excised from the gel using a razor blade and placed onto a piece of 
Whatman 3MM paper to reduce the volume of eluted DNA solution. Once placed 
inside the blue tip, the eppendorftube was centrifuged (6000rpm, 2min) and the eluted 
DNA collected. The DNA fragment was then used directly in further manipulations or 
ethanol precipitated to concentrate the sample before further use. 
2.4.9 DEPHOSPHORYLATION OF LINEARISED PLASMID DNA USING 
CALF INTESTINAL ALKALINE PHOSPHATASE (CIP) (Sambrook et aI., 1989). 
Following restriction digestion of DNA (lJlg), the restriction enzymes were inactivated 
by heating and the DNA was precipitatedwith ethanol. The DNA was dissolved in 90JlI 
lOmM Tris (pH 8.3) and 10Jll of lOx CIP dephosphorylation buffer added along with 
1 Jll of CIP. After a one hour incubation at 37°C, EDT A (SmM) was added and the CIP 
was heat inactivated. The DNA was extracted once with phenol:chloroform (1: 1) and 
once with chloroform followed by ethanol precipitation. Centrifugation was used to 
pellet the DNA, which was then resuspended in 10 JlI of sterile glass distilled water. The 
DNA concentration was determined by electrophoresis. 
2.4.10 PARTIAL DIGESTION OF DNA WITH RESTRICTION 
ENDONUCLEASES (Ausubel et aI., 1989). 
Partial digestion was used to clone segments of DNA where the desired restriction site 
were represented many times within the fragment. A 100111 reaction mixture containing 
DNA (3Jlg) in Ix restriction buffer was prepared and divided into five microfuge tubes 
so that tube one contained 4SJlI, tube two 20Jl1, tube three lSJl1 and tubes four and five 
10Jll each. The restriction enzyme (S units) was added to tube one, and a 20111 and Sill 
aliquot was transferred to tubes two and four respectively. A lSIl1 and 5111 aliquot from 
tube two was then transferred to tubes three and five respectively. All the tubes were 
incubated at 37°C for 15 minutes and the reaction stopped heat inactivating the enzyme. 
The extent of digestion was checked by gel electrophoresis using a IOfll sample from 
each reaction. The remaining digest was then ligated to the appropriately digested 
vector using T4 DNA Ligase in Ix Ligation Buffer. 
2.4.11 LIGATION OF DNA. 
Ligation was performed in a total volume of20J.!1 with 4fll ofBRL 5x Ligation 
Buffer. As a common practice, a 3: 1 insert to vector ratio was used. Before the DNA 
was added to the ligation reaction, the restriction enzyme was heat inactivated. One unit 
of BRL T4 Ligase was used for each ligation and the reaction mix incubated at 16°C or 
room temperature overnight. The ligation efficiency was checked by gel 
electrophoresis. 
2.4.12 ELECTROPORATION. 
Preparation of Competent Cells. 
An exponential culture ofMC4100 was grown in 200ml ofLB broth, using 2ml of an 
overnight LB broth culture as the inoculum. The culture was shaken at 37°C until the 
cells reached an OD6oo of 0.5-0.8. After chilling the culture on ice for 30 minutes, the 
cells were collected by centrifugation (4000rpm, 15min, 4°C), suspended in 200ml of 
high quality distilled water and placed on ice 30 minutes. This step was repeated and 
the pellet suspended in 100ml. Again the cells were collected by centrifugation and the 
pellet resuspended in 4ml of ice cold 10% glycerol. After a 30 minute incubation on ice 
and a final centrifugation step, the pellet was suspended in 400J.!1 of ice cold 10% 
glycerol and 40J.!1 aliquots were either used immediately or stored at _80°C until 
required. When required, frozen cells were first thawed on ice. 
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Electroporation. 
Sterile electroporation cuvettes (0.2cm gap) and the chamber slide were chilled on ice 
and the Biorad Gene Pulser set to 25MF and 250kV and the Pulse Controller set to 
2000hms. Approximately 100ng of DNA was added to the thawed competent cells and 
the mixture left on ice for one minute. The mixture was transferred to the chilled 
cuvette which was then placed into the chamber slide. Once the chamber slide was 
placed into the electroporation chamber the sample was pulsed once. A 1ml aliquot of 
SOC media was added immediately to the sample and the supension transferred to an 
eppendorftube. The cells were elaborated in the eppendorftube at 37°C for 1-2 hours 
and a 200JlI aliquot was then plated on an LB+antibiotics plate. After harvesting the 
cells by centrifugation, the cells were resuspended in 200JlI ofLB broth and equally 
spread onto two LB+antibiotic plates. The plates were then incubated overnight. 
2.4.13 ELECTROPORATION OF LIGATED DNA INTO BACTERIA 
(Zabarovsky and Winberg, 1990). 
Ligation was performed in a 20JlI volume as previously described. Potassium acetate 
(PH 8.0) was added to a final concentration of 0.25M along with 2.5 volumes of 100% 
ethanoL Precipitates were allowed to form at -20°C for two hours and the DNA pelleted 
by centrifugation. After two rinses with 70% ethanol, the pellet was redissolved in 5JlI 
sterile distilled water. A 1-2Jll aliquot was then used in the electroporation step as 
previously described. 
2.4.14 PREPARATION OF COMPETENT CELLS. 
Exponentially grown cells were harvested by centrifugation and the supernatant 
removed. The cells were suspended in cold Solution I (1/2 the original volume) and 
placed on ice for 20 minutes. This step was repeated and the pellet suspended in cold 
Solution II (1/4 the original volume) and placed on ice. Following centrifugation and 
removal of the supernatant, the pellet was gently suspended in cold Solution II (1/15 the 
original volume). After 30 minutes on ice, 200JlI aliquots of cells were used 
immediately or stored at -80°C, after the addition of7JlI of 99.5% dimethyl sulfoxide. 
2.4.15 TRANSFORMATION. 
Approximately 100-200ng of DNA was added to thawed competent cells and gently 
mixed. After 30 minutes on ice, the mixture was transferred to a 42°C heating block for 
2 minutes and then placed on ice immediately. The cells were elaborated and plated on 
LB+antibiotic plates as previously described (Methods 2.4.12). 
2.4.16 NESTED DELETIONS OF CLONED DNA. 
Nested deletions of cloned DNA were generated using the Deletion FactoryTM System 
(Life Technologies, 8378SA). The DNA fragment of interest was cloned into the 
deletion vector pDEL TA 1 using the techniques previously described and electroporated 
into E. coli DH1 OB. Transformants were selected on LB+ X-gal+ Tet+Kan plates, with 
white colonies denoting clones. Single colonies were then cultured in 2ml 
LB+ Tet+Kan, the plasmid DNA extracted and the correct insert verified by restriction 
digestion and agarose gel electrophoresis. The correct plasmid was transformed into 
E.coli DF1 which could provide the transposase gene in trans. After transformants were 
selected on LB+Tet+Kan+Cmplates, five colonies were transferred to a flask containing 
2ml LB+Cm+Tet and five to a flask containing 2ml LB+Cm+Kan. After an overnight 
incubation, plasmid DNA was extracted from each culture and an aliquot checked by gel 
electrophoresis. The DNA was diluted 1\10-1\20 and 1111 electroporated into DHIOB 
with selection on LB+Tet+Sucrose (Cm+Tet) and LB+Kan+Strep (Cm+Kan). 
Resulting transformants were purified and the plasmid DNA examined by restriction 
digestion and agarose gel electrophoresis to determine the size of the deletion. Deleted 
plasmids with the desired sized inserts were then chosen for further analysis by DNA 
sequencing. 
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2.5 MUTAGENESIS. 
2.5.1 MUTAGENESIS USING ALTERED TARGET SPECIFICITY MINI-TNIO 
DERIVATIVES (Kleckner et at, 1991). 
Preparation of High Titre Phage. 
Phage stock was diluted to 10-6 and IOOIlI added to 3ml of molten H-Top agar, seeded 
with IOOIlI ofPB2480 overnight culture (grown in TBMM containing 0.2% maltose). 
The H-Top agar was poured over a Tryptone plate, left to set and the plate incubated 
overnight. 
Using a Pasteur pipette, a single plaque was removed from the Tryptone plate 
and added to a 100ml flask containing 10ml LB broth+0.01mM MgS04 and 100fll of a 
PB2480 overnight culture. The flask was shaken vigorously at 37°C for 4-S hours until 
lysis had occured, 10 drops of chlorofonn were added and the flask shaken and left to 
settle. The cellular debris were removed by centrifugation (6000rpm, lOmin, 4°C) and 
the supernatant poured into McCartney bottles to be stored at 4°C after adding S drops 
of chloroform. 
Determining Phage Titre. 
-8 
A 2111 aliquot of phage stock was diluted in a series of IOO-fold dilutions to 10 . An LB 
plate was overlayed with PB2480 and IOll1 from each dilution spotted onto the lawn. 
After drying, the plate was incubated overnight and the number of plaques in each 
dilution counted. Phage titre = number of plaques x dilution x volume correction. 
Transduction of mini-Tnl OKano 
An overnight culture of the bacteria to be mutated when grown in 5ml TBMM with the 
appropriate antibiotics was estimated to contain approximately lxl09 cells/ml. Once 
harvested by centrifugation, the cells were suspended in TBMM (1110 the original 
volume) to give a final concentration of lxlOlO cells/ml. Aliquots of lOO1l1 were placed 
into five eppendorftubes and phage stock added to a m.oj of 0.3. The mixture was 
incubated at 2SoC for 15 minutes and then at 37°C for 15 minutes. Unadsorbed phage 
were removed by washing the culture in Sml ofLB broth containing 50mM sodium 
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citrate and the cells collected by centrifugation. The cells were suspended in 3ml ofLB 
broth containing 50mM sodium citrate and incubated at 37°C. After 90 minutes, 200111 
of cells were plated out on a LB+Kan+Napp plate and the remaining culture pelleted by 
centrifugation. Once the supernatant was removed, the pellet was suspended in 1ml of 
LB broth and lOO1l1 aliquots spread onto each of three LB+Kan+Napp plates. After an 
overnight incubation, the colonies were resuspended in 3ml ofLB broth and the 
suspension used as the starting material for plasmid DNA extraction. Mini-Tnl 0 
insertions into plasmids were then selected by electroporating the plasmid DNA into E. 
coli MC4lO0. 
2.5.2 GENERATION OF TRANSLATIONAL FUSIONS (Kleckner et at, 1991). 
Translational fusions between lacZ' and the target gene were created using the 4.9kb 
mini-Tnl OlacZ' KanRderivative 112 carried on A NK1205 (Kleckner et al., 1991). The 
strain carrying the plasmid of interest was first transfOlmed with pNK2882 (tnpA TetR) 
using electoporation to provide the transposase function in trans. The preparation of a 
high titre lysate and the transduction of A NK1205 was performed as previously 
described in Methods 2.5.1. A 1 III aliquot of plasmid DNA from each pool was 
electroporated into MC4100 and plated on LB+Amp+Kan+X-gal+IPTG plates. The 
resulting transformants were then screened for microcin production, p-galactosidase 
activity and sensitivity to tetracycline. 
2.5.3 DETERMINING GENE EXPRESSION BY p-GALACTOSIDASE 
ACTIVITY (Miller 1972; Sambrook et aI., 1989). 
An overnight culture was grown in Ix A medium containing 0.4% glucose, Illg/ml 
vitamin BI> ImM MgS04 and the appropriate antibiotic. The next day the culture was 
diluted 1 :50 in the same medium, grown until it reached an A600 of 0.4 and then placed 
on ice. A IOOlli aliquot of culture was added to 900111 of Z buffer and two drops of 
chloroform and one drop of 0.1 % SDS were added. After 10 seconds vortexing, the 
lysed culture was equilibrated to 30°C for 10 minutes and then 200lli ONPG in A 
medium (4mg/ml) was added. In cases where low levels of p-galactosidase activity 
were expected, 500111 of culture and 500lli of Z buffer was used. The reaction sample 
was left until a yellow colour developed, the reaction was then stopped by adding 500111 
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of 1M Na2C03 and the time in minutes recorded. The A600 of the culture and the A 420 
and AS50 of the reaction sample were determined using a LKB Ultraspec II and the units 
of ~-galactosidase activity calculated. The AS50 reading was ignored if the reaction 
sample was centrifuged prior to reading. 
2.6. DNA SEQUENCING OF DOUBLE STRANDED DNA TEMPLATES. 
DNA sequencing of double stranded templates was performed using the dideoxy chain 
termination method (Sanger et al., 1977). Sequence reactions were carried out with 
[35 S]dATPaS (Amersham, S11304) using the T7 Sequencing™ Kit (Pharmacia 
Biotech, 27-1682-01 ). 
2.6.1 TEMPLATE PREPARATION (Modification to T7 Sequencing manual). 
A single bacterial colony containing the nested deletion was used to inoculate 10ml 
2x YT media with the appropriate antibiotic and incubated overnight. The cells were 
harvested by centrifugation and resuspended in 1ml Solution 1. After 10 minutes at 
room temperature, 1 ml of Solution II was added followed by a further 10 minute 
incubation. Solution III (lml) was then added and the tubes placed on ice for 10 
minutes. The precipitate was pelleted by centrifugation and the supernatant drained 
through nappy liner. An equal volume of cold isopropanol was added to the sample and 
the mixture left at room temperature for five minutes. The DNA was pelleted by 
centrifugation (12000rpm, 4°C, 1Ornin.), the supernatant removed by aspiration and the 
pellet resuspended in 200).11 distilled water. RNA was removed by adding 20).11 RNase 
A (20mg\ml) and incubating at 37°C for 20 minutes. Two phenol! chloroform 
extractions followed by a chloroform extraction were then performed and the DNA 
ethanol precipitated. The DNA was dissolved in 50).11 distilled water and a 1).11 aliquot 
was digested with the appropriate restriction enzyme and analysed by agarose gel 
electrophoresis. If required 0.5).11 RNase A was then added. 
2.6.2 PRIMER ANNEALING. 
Template DNA (2)lg) was added to 8)l12M NaOH and the volume adjusted to 40)l1 with 
sterile distilled water. After vortexing and brief centrifugation, the DNA was incubated 
at room temperature for 10 minutes, 7)l1 of 3M sodium acetate, 4)l1 distilled water and 
120)l1100% ethanol were added and the solution left at -20°C overnight. The DNA was 
collected by centrifugation, washed in Iml 70% ethanol and spun for a further 10 
minutes. Once the supernatant was removed by aspiration and the pellet dried under 
vacuum, the DNA was dissolved in 9)l1 distilled water, 3)l1 primer (lOmg/ml) and 2)l1 
annealing buffer. After vortexing and pulse centrifugation the template was incubated 
at 65°C for five minutes, 37°C for ten minutes and room temperature for at least 5 
minutes. If the template was not going to be used immediately it was stored at _20°C. 
2.6.3 LABELLING AND TERMINATION REACTIONS. 
Prior to labelling the templates, four microfuge tubes were labelled A, C, G, T and 2.5)l1 
of the appropriate termination mix (short reaction) added. T7 DNA polymerase was 
diluted to 1.6units/)l1 and 2)l1 added to the annealed template plus 3)l1 of labelling mix-
dATP and 0.5-1)l1 [a-35S]dATPaS. After 5 minutes at room temperature, 4.5)l1 was 
removed and added to each of the four termination mix tubes followed by a 5 minute 
incubation at 37°C. A 5)l1 aliquot of stop buffer was added to each tube and the tubes 
heated to 85°C for 20 minutes prior to electrophoresis. 
2.6.4 ELECTROPHORESIS AND AUTORADIOGRAPHY. 
The LKB 2010 Macrophor sequencing system was used to make and run the sequencing 
gels. Sequencing gels (6% acrylamide, 0.2mm) were poured using the LKB 2010-001 
macromould gel casting unit. Pre-electrophoresis of the gel was performed for 30 
minutes at 2000 volts. After heating the sequencing reactions, 0.5-1)l1 was loaded into 
the appropriate well and the gel run at 1500-2000 volts for 2.5-3 hours. The remaining 
sample was stored at _20°C and if required for another gel, was heated to 85°C for five 
minutes prior to electrophoresis. 
Once electrophoresis was completed, the notched plate with the gel attached 
was carefully removed from the thermostatic plate and placed in 10% acetic acid for 20 
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minutes and dried at 65°C for 60 minutes. After leaving the plate to cool, Hyperpaper 
(Amersham RPN1804) was cut to size and placed emulsion side down on the gel. A 
second glass plate was placed on top, clamped and the sandwich was put in a light-proof 
box for 16-20 hours to expose the Hyperpaper. The Hyperpaper was developed in Agfa 
G 150 Developer for 3 minutes, washed in water for 2 minutes and the image fixed in 
Agfa Fixer for 5 minutes. 
2.7. PROTEIN ANALYSIS USING SDS-PAGE. 
2.7.1 SDS-PAGE (Modification of Laemmli, 1970). 
Denaturing protein gels were made according to Hoefer Scientific Instruments, Sturdier 
Slab Gel Electrophoresis Unit instructions. All buffers and gel formulae are given in 
Appendix 1. 
The resolving gel was prepared as described and poured between two, 150mm 
glass plates set 1.5mm apart. To aid polymerisation, water-saturated butanol was placed 
on top of the resolving gel. After polymerisation and removal of the butanol, the 
interface was rinsed with distilled water, the stacking gel was poured and the well 
former inserted. The gel was left to set for one hour, attached to a vertical 
electrophoresis box and the reservoirs filled with Tank: Buffer. Between 50-1 00~1 of 
sample was loaded into each well and electrophoresis performed at 20mA through the 
stacking gel and then 30-40mA until the Bromphenol Blue dye front reached the bottom 
of the geL 
The gel was stained in Coomassie Brilliant Blue (R-250) for 2-4 hours and 
destained in Solution 1 overnight prior to further treatment if required. Destain Solution 
2 could also be used for the overnight soak. 
2.7.2 SDS-PAGE OF RADIOACTIVELY LABELLED PROTEINS. 
The gel was prepared as previously described with the plates set 0.75mm apart. After 
electrophoresis, the gel was stained in Commassie Blue for 2 hours, destained for 2 
hours and then soaked overnight in pre drying solution (3% glycerol, 40% methanol, 
10% acetic acid). After a 30 minute wash in distilled water, the gel was placed in 
AmplifyTM (Amersham) for 30 minutes and then placed in distilled water. The gel was 
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vacuum dried onto Whatrnan 3MM at 600 e for 2-3 hours using a Model 443 Slab drier 
(Bio Rad) and then placed in an autoradiography cassette containing an intensifying 
screen. 
Autoradiography. 
Amersham Hyperfilrn-MP was cut to size and placed in the cassette with the dried gel 
" 0 
and exposed at -80 e for 2-7 days. The film was developed in Agfa G 150 Developer 
for five minutes, rinsed in water for two minutes and then fixed in Agfa Fixer for eight 
minutes. After a final wash under running water the film was left to dry. 
2.7.3 SDS-PAGE MAXIMISED FOR SMALL PROTEINS (Thomas and 
Kornberg, 1978). 
Visualisation of small peptides was maximised using the method of Thomas and 
Kornberg 1978. The procedure is the same as that described in Methods 2.7.2 with the 
following modifications: an 18% polyacrylamide separating gel and 3% stacking gel 
were used; the concentration of Tris buffer in the separating gel was raised to 0.75M; the 
ratio N,N'-methylene bisacrylamide:acrylamide was lowered to 0.15:30; the electrode 
buffer was changed to 50mM Tris, 0.38M glycine and 0.1 % (w/v) SDS. 
The resolving gel was prepared as described in Appendix 1 and the gel poured 
to a depth of 10-15cm and a width ofO.75rnrn. The gel was covered with water-
saturated butanol and left to set, after which the butanol was replaced with 0.1 % SDS 
and the gel left for approximately one hour. The stacking gel was prepared as described 
(Appendix 1), the well forming comb inserted to a depth of half the stacking gel and the 
gel left to set for 30 minutes. 
The samples were applied to the gel and electrophoresis was performed at a 
constant current of 30rnA until the dye ran off the end of the gel after approximately 
five hours. Staining, drying and autoradiography were performed as previously 
TM 
described (Methods 2.7.2). The Storm 840 PhosphorImager (Molecular Dynamics) 
was used as an alternative to normal autoradiography. A dried gel was wrapped in 
clingwrap, placed in a phosphor screen cassette and exposed for 3-7 days. The 
phosphorimager was then used to read the image from the phosphorscreen. 
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7.4 SILVER STAINING OF SDS-PAGE GELS. 
The SDS-PAGE gel was washed with agitation in Wash Solution 1 for 30 minutes. 
After a 15 minute wash in distilled water, the previous step was repeated using Wash 
Solution 2. Distilled water was used to rinse the gel for 10 min, fresh distilled water 
added and the rinse repeated. The gel was left agitating in distilled water overnight. 
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Fresh stain was made and the gel stained for 10 minutes while being agitated. 
The gel was washed in distilled water for 5 minutes and the wash repeated 3 times. 
Fresh developer was prepared and the gel soaked with agitation until the protein bands 
were visible, then the gel was quickly placed in fixer solution. Leaving the gel in fixer 
solution overnight enhanced the contrast of the protein bands. 
2.8. EXPRESSION OF PLASMID ENCODED PROTEINS. 
2.8.1 MINICELL ANALYSIS OF PLASMID ENCODED PROTEINS 
(Clark-Curtiss and Curtiss Ill, 1983; Rodriguez and Tait, 1983). 
Preparation of E. coli mini-cells. 
The minicell producing strain E. coli P678-54T was made competent for electroporation 
as previously described and transformed with the desired plasmids. DNA was prepared 
from the transformants by alkaline extraction and the presence of the correct plasmid 
was confirmed by restriction digestion and electrophoresis. 
Plasmid-containing minicells were prepared by differential rate centrifugation 
through sucrose gradients. A 20% sucrose solution was made in M63 salts and 35ml 
aliquots were frozen at _80°C for 1-2 hours in 50ml centrifuge tubes. Prior to use, the 
tubes were thawed overnight at 4°C to form the gradient. 
A 300ml culture of the plasmid containing minicell strain was grown overnight 
in LB broth containing the appropriate antibiotics until it reached an OD6oo 0.8 - 1.2. 
The vegetative cells were collected by centrifugation (2000rpm, lOmin, 4°C) and the 
supernatant containing the minicells was poured off into a new tube. A small amount of 
the remaining supernatant was gently pipetted over the vegetative pellet to remove any 
mini cells and the liquid added to the initial supernatant fraction. The minicells were 
harvested by centrifugation (lO,OOOrpm, lOmin, 4°C), the supernatant was poured off 
and the pellet resuspended in 2ml BSG buffer. Once resuspended the cells were gently 
pipetted onto the surface of the sucrose gradient and the tubes spun for 10 minutes 
(5000rpm, 10°C) using a swing out rotor. The top half of the minicell band, 5-10rnl, 
was removed and added to an equal volume ofBSG buffer. After re-centrifugation 
(10,000rpm, 10min 4°C), the cells were resuspended in 2ml B S G buffer and loaded onto 
a second sucrose gradient and centrifuged as before. After harvesting the top half of the 
mini cell band and resedimentation as previously described, the pellet was resuspended 
in 10ml BSG buffer. The OD600 of the minicells were measured, the cells pelleted by 
centrifugation and the pellet resuspended in M63/30% glycerol to give an OD600 2.0. 
The cells were stored in 100J-L1 aliquots at -80°C until required. To test for vegetative 
cell contamination, a 10111 aliquot of cells was spread on a LB plate containing the 
appropriate antibiotics and incubated overnight. Fewer than 1000 colonies per 10J-LI was 
considered an acceptable level of contamination. 
Labelling and electrophoresis of plasmid-encoded proteins. 
Each 100J-Ll aliquot of frozen minicells were thawed on ice for 20 minutes and 900111 of 
M63labelling buffer added. The cells were incubated in a 25ml flask for 30 minutes 
and 2J-Ll of 35S-methionine/cysteine (20mCi/rnl, PRO-MIX, Arnersham SJQ0079) was 
added. After a further 40 minutes incubation, the cells were pelleted in a microfuge 
tube by centrifugation (12,000rpm, 2min, 4°C) and resuspended in 60J-LI Storage Buffer. 
The labelled minicells were stored at -20°C until required. Labelled minicells were 
thawed on ice and 60J-LI of2x Treatment Buffer added. The samples were placed in a 
boiling water bath for 3 minutes, and a 60J-LI aliquot was analysed by SDS-PAGE as 
previously described (Methods 2.7.2). 
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2.8.2 MAXICELLANALYSIS OF PLASMID ENCODED PROTEINS (modified 
from Pritchard and Holland, 1985). 
UV -irradiation dose test. 
Individuall0ml cultures of MC4100recA-56 and MC4100(pBR322) were made in M63 
medium+antibiotics from a 111 OOth dilution of a M63 overnight culture and grown at 
o 
37 C to an absorbance (450nm) of 0.50. A LTVC-515 Ultraviolet Multilinker 
(UltraLum, 254nm) was used to irradiate Iml aliquots of culture at 100, 136, 150,200, 
-2 -8 
250, 300, 400 and 500llJcm . The cells were diluted by factors of 10 down to 10 and 
IOll1 spots of each dilution were dried onto LB plates and incubated overnight. The 
smallest LTV dose which prevented growth of both MC4100 and MC4100(PBR322) was 
used to generate maxi-cells. 
Generation of maxi-cells. 
The plasmids to be analysed were first electroporated into MC4100recA-56 and the 
presence of the plasmids confirmed by DNA extraction and restriction analysis. A 3ml 
culture of the plasmid-containing MC4100 strain was grown in M63 
medium+antibiotics overnight, and a 111 OOth dilution used to seed 10ml of 
M63+antibiotics+AAA-meticys. The culture was grown to an absorbance (450nm) of 
0.5 and 3.5ml placed in a sterile petrie dish. The cells were irradiated with LTV 
-2 (200IlJcm ) and placed in a foil covered sterile flask. A IOll1 aliquot was plated onto a 
LB plate, wrapped in foil and incubated overnight to indicate the effectiveness of 
irradiating the cells. The culture was incubated with agitation for one hour, D-
cycloserine (lOOllg/ml) was added and the culture incubated overnight. A 100111 aliquot 
of cells was then plated onto a LB plate to show the number of viable cells. 
Labelling and electrophoresis of plasmid encoded proteins. 
o 
A 0.5ml aliquot of cells was harvested by centrifugation (6000rpm, 4 C, 10m in) washed 
twice with 0.5ml lxM63 salts and resuspended in 200111 M63 medium+O.4% 
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glucose+AAA-met/cys. Following a one hour incubation, S-methionine/cysteine 
(PRO-MIX, 20mCi/ml) was added to a concentration of20-40llCi/ml. The cells were 
incubated for 15-30 minutes, after which IOll1 of both methionine (2mg/ml) and 
cysteine (2mg/ml) were added and the cells incubated for five minutes. The cells were 
harvested, washed twice with lxM63 salts and resuspended in 30fll TE. An equal 
volume of 2x Treatment Buffer was added and the tube placed in a boiling water bath 
for five minutes prior to electrophoresis. Samples (20-30fll) were analysed by SDS-
o 
PAGE maximised for small proteins (Methods 2.7.3), or frozen at -20 C until required. 
2.9 MICROCIN EXTRACTION TECHNIQUES. 
The microcin titre in all supernatants and extracts was estimated using the critical 
dilution method (Methods, 2.10.1). At the end of each extraction procedure, protein 
profiles were determined using SDS-PAGE (Methods 2.7.1). 
2.9.1 EXPRESSION OF MICROCIN 24 USING MITOMYCIN C (Pugsley and 
Oudega 1987). 
An exponential culture of E. coli MC41 OO(pGOB 18) in LB broth was grown with 
aeration until it reached an OD600 of 0.2. Mitomycin C was added to a concentration of 
0.5Jlg/ml and the culture shaken for 2-5 hours. The supernatant was collected after two 
centrifugation steps (IOOOOrpm, 1 Omin, 4°C). EDTA and sodium azide were added to a 
final concentration of SmM and 0.02% (w/v) respectively and the supernatant stored at 
4°C. The supernatant was either used for various extraction procedures, concentrated in 
a vacuum centrifuge (Jouan, RCIO.IO), or acetone precipitated. 
Protein profiles were determined by SDS-PAGE after 2x Treatment Buffer was 
added to the samples in a ratio of 1: 1. Once placed in a boiling water bath for 90 
seconds, the samples were loaded into the gel. 
2.9.2 EXPRESSION OF MICROCIN 24 USING M63 MEDIUM. 
An overnight culture ofMC4IOO(pGOBI8) was grown in M63 medium+Amp and 
diluted 11100 into 2x SOOml ofthe same medium. The culture was grown to stationary 
phase (6-8 hours), chloroform added and the cells removed by centrifugation 
o (ll,OOOrpm, 10 min, 4 C). Mcc24 was extracted by one of the methods described 
(Methods 2.9.3-2.9.7) and the microcin titre estimated. 
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2.9.3 ACETONE PRECIPITATION OF MICROCIN 24 EXTRACTS (Pugsley 
and Oudega, 1987). 
Two volumes of ice cold acetone were added one volume at a time, to prepared 
o 
microcin extracts or spent supernatants, and the solution frozen at -80 C for 15 minutes. 
o 
The protein was collected by centrifugation (11,000rpm, 10 min, 4 C), the acetone 
removed by aspiration and the pellet dried in a vacuum desicator. The protein pellet 
was redissolved in an appropriate buffer and assayed for microcin activity and the 
protein profile determined. 
2.9.4 AMMONIUM SULPHATE PRECIPITATION (Englard and SeYler, 1990). 
Production of Mcc24 from a 50ml culture was induced using mitomycin C and the 
supernatant used for precipitation. Ammonium sulphate was added to the supernatant to 
o 
a saturation of 25%, stired at 0 C until dissolved and left to sit for 15 min. The 
o 
precipitate was collected by centrifugation (12,000rpm, 0 C, 10 min) and the 
supernatant decanted to form the starting material for the next fraction. Ammonium 
SUlphate was added to final saturations of 40%, 50%, 60% 80% and 100% and the 
procedure repeated each time. The precipitate collected after each fractionation was 
redissolved in 3ml of 50mM KH2P04 buffer, acetone precipitated and redissolved in 
200111 of phosphate buffer. Microcin titers and protein profiles were determined as 
previously described. 
2.9.5 BULK PREPARATION OF MICROCIN 24 BY FILTRATION THROUGH 
NITROCELLULOSE (Pugsley and Oudega, 1987). 
The production of Mcc24 was induced using M63 broth cultures (Methods 2.9.2). After 
the removal of cellular material by centrifugation, each 400ml supernatant was filtered 
under vacuum through two nitrocellulose filters (0.22I1m, Millipore) using a Buchner 
funnel. The filters were washed in a McCartney bottle with 8 ml of Wash Buffer and 
then transferred to another bottle containing 8m} of Elution Buffer. After vortexing, the 
filters were removed and the protein precipitated using acetone. The protein pellet was 
dissolved in 1ml of Wash buffer after being air dried. Activity and protein profiles of 
the extract were then determined. 
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2.9.6 GEL FILTRATION OF CRUDE MICROCIN 24 EXTRACT (Pltarmacia 
Gel Filtration Handbook). 
Preparation of Column. 
Sephadex G-100 (15g) was soaked in excess buffer for 24 hours. Gas was removed 
from the Sephadex G-100 under vacuum and the matrix gently poured into a SR25 
column (Pharmacia) to a height of 30cm. After equilibriating the gel with three column 
volumes of buffer, the gel was calibrated using 500j.l1 of Blue Dextran dye. The 
miniscus of the dye was allowed to enter the column, the dye washed through the 
column with excess buffer and collected using a measuring cylinder. The void volumn, 
(V 0)' was determined as the volume of buffer passing through the column when the 
Blue Dextran was first washed out. Blue Dextran was removed from the column by 2 
column volumes of buffer. 
Fractionation. 
Mcc24 extracts were prepared from LB broth cultures (Methods 2.9.1) and concentrated 
to 1-2ml by acteone precipitation. Sucrose was added to the sample giving a final 
concentration of20%. The volume of Mcc24 extract loaded onto the column did not 
exceed 1-5% of the bed volume. The buffer was run to just above the top of the gel, 
then 2ml of crude extract was added to the column using a Pasteur pipette and being 
careful to not disturb the top of the column. Buffer was added to the column, the 
TM TM 
column attached to a UA-5 Absorbance Detector (280nm, ISCO) and Foxy 
Fraction Collector (ISCO) and the buffer passed through the column overnight at a flow 
TM 
rate of 600j.ll/min using a TRlS Peristaltic Pump (ISCO). Fractions containing 
4.125ml (75 drops) were collect after one Vo volume had passed through the column 
and the fractions concentrated to 1ml using a vacuum centrifuge (Jouan, RCIO.IO). 
Column Storage. 
After the samples were collected, the column was washed with one volume of O.2M 
NaOH and then two volumes of buffer. The column was stored in buffer containing 
0.02% sodium azide. Before further use, the column was washed with 2 volumes of 
buffer. 
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Sample Assay. 
A 3JlI aliquot from each fraction was spotted onto a lawn ofMC4100 and the plate 
incubated for 4-8 hours. Clear zones in the lawn denoted Mcc24 activity in those 
samples. Protein profiles of active fractions were examined using SDS-PAGE. 
TM 
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2.9.7 ION EXCHANGE CHROMATOGRAPHY (HiTrap Instruction Manual, 
Pilarmacia). 
Microcin 24 extracts were prepared as described (Methods 2.9.1) and the supernatant 
was placed into sterile dialysis tubing and dialysed against the desired buffer for 12-24 
o 
hours at 4 C with at least two changes of buffer. The dialysed supernatant was 
transfered to a McCamey bottle and assayed for activity. 
The anion exchange column (Q) or the cation exchange column (SP) were 
attached to a peristaltic pump and prepared by washing with five column volumes of 
Start buffer, five column volumes of Elution buffer and a further five column volumes 
of Start buffer at a flow rate of 1mllmin. The dialysed sample was applied to the 
column using the peristaltic pump and the eluate collected. The column was then 
washed with five column volumes of Start buffer, the eluate collected and the protein 
extracted with three column volumes of Elution buffer. The eluate at each step was 
precipitated with acetone, the precipitate dissolved in 100Jll of Start buffer and microcin 
activity tested using the critical dilution method (Methods, 2.10.1). The protein profile 
of each fraction was determined by SDS-PAGE. 
The columns were cleaned with five column volumes of Elution buffer 
followed by Start buffer and stored in 20% ethanollO.2M sodium acetate (SP) or 20% 
ethanol (Q). 
2.10 MICROCIN 24 ACTIVITY TECHNIQUES. 
2.10.1 ESTIMATION OF MICROCIN TITRE - CRITICAL DILUTION METHOD 
(Mayr-Harting et al, 1972). 
The microcin titre of supernatants or concentrated eAiracts was estimated by making 
doubling dilutions in O.lM phosphate buffer (PH 7.4) down to 1:1024. A MAplate was 
overlayed as previously described (Methods 2.3.3) and a 5JlI aliquot from each dilution 
was spotted onto the lawn and the plate incubated overnight. The microcin titre was the 
reciprocal of the last dilution giving a clear zone of inhibition. The units for microcin 
titre are Arbitrary Units (A.D.) per millilitre. 
2.10.2 MICROCIN ACTIVITY AFTER SDS-PAGE (Fath et al, 1994). 
Mcc24 extracts were prepared and analysed by SDS-PAGE after the samples were 
o 
heated to 42 C for 15 minutes before loading onto the gel. The gel was divided into two 
equal halves and samples run in both halves. One half of the gel was silver stained and 
the other half was soaked in Ix M63 medium for 1-2 hours. The gel which was soaked 
was placed on a MA plate and overlayed with MC41 00 in H-Top agar. Microcin 
activity was determined by looking for inhibition ofMC4100 growth. 
2.10.3 EFFECT OF CHLOROFORM ON MICROCIN 24 ACTIVITY. 
An overnight culture ofMC4100(pGQB18) was grown in LB broth and 100/l1 placed 
into each of four microfuge tubes. Into three of the tubes was added either 10JlI 
chloroform, S/ll mitomycin C (O.l/lg/ml) or 10/l1 chloroform + S/ll mitomycin C and 
the fourth tube kept as a control. The cells were incubated for one hour and then 
o 
harvested by centrifugation (13,OOOrpm, 4 C, 10 min). A 20/l1 aliquot of the 
supernatant was placed onto a lawn of MC41 00, dried and microcin activity scored after 
o 
4-6 hours incubation at 37 C. 
2.10.4 PROTEINASES OR RNase TREATMENT OF MICROCIN 24. 
Circular paper filters (lcm diameter) were soaked in Proteinase K (lmg/ml) or RNase A 
(lOmg/m!) solutions. The filters were placed on a M63 plate and overlayed with 4m1 of 
H-Top agar seeded with 100/l1 of MC4 100. Colonies ofMC4100(pGOB18) were 
toothpicked onto, or at various distances from the filters, and the plates incubated 
overnight. An absence of a halo around MC41 OO(pGOB 18) on the MC41 00 lawn was 
seen as inhibition of Mcc24 activity by Proteinase K or RNase A. 
2.10.5 TIME SERIES FOR MICROCIN 24 ACTIVITY. 
An overnight culture of MC41 00 was grown in M63 medium, diluted 11100 and grown 
until the culture reached an OD600 of 0.2. The Mcc24 extract was prepared from 3x 
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400ml M63 medium cultures using nitrocellulose extraction (Methods 2.9.S) and the 
protein dissolved in 7S0fll of SOmM Phosphate Buffer (PH 7.4). A SOfll aliquot of cells 
was placed in each of six eppendorf tubes and SOfll of microcin extract was added. The 
tubes were incubated for 0, IS, 30, 60, 120 and 360 minutes with one tube at each time 
point removed. The cells were harvested by centrifugation, resuspended in SOfll LB 
-8 
broth and diluted by factors often to 10 . After spotting lOfll from each dilution onto 
an LB plate, the cells were grown overnight, colonies counted and cell concentrations 
determined. The activity of the microcin extract was also determined using the critical 
dilution method. 
2.10.7 EFFECT OF MICROCIN 24 ON AMINO ACID UPTAKE (Pugsley and 
Oudega, 1987). 
An overnight culture of MC4100 was grown in M63 medium, diluted 11100 in M63 
medium and grown until early exponential phase (OD600 0.1 - 0.2). The cells were 
harvested by centrifugation, washed twice with Ix M63 salts and resuspended in Ix 
M63 salts + Cm (2Sflg/ml) to an OD6oo of 1.0. Aliquots of Iml were kept on ice for up 
o 
to two hours before use. Prior to use the cells were warmed to 37 C in a water bath. 
Doubling dilutions of microcin extracts were added to the cells giving dilutions from 
35 
114 to 1164, 2fll of S-methionine/cysteine (PRO-MIX, 20mCi/ml) added and tubes 
incubated. MC4100 without microcin extract was used as the control. After 1, S, 10 
and 20 minutes a IOOfll aliquot from each tube was removed, added to 900fll of TE and 
filtered through a 0.2flm nitrocellulose filter. The filters were washed in Ix M63 salts 
o 
and pinned to a polystyrene board. After drying at 37 C, the filters were placed in a 
scintillation vial, Sm1 of scintillation liquid added and the counts per minute (cpm) 
measured in a Wallac 1410 Liquid Scintillation Counter (Pharmacia). 
A modification to this method was made by using a 1/8 dilution ofMcc24 
extract and removing 102fll of culture at the various time points. A 2fll aliquot was 
-2 -4 -6 
diluted to 10 , 10 and 10 and IOfll from each dilution was plated on an LB plate to 
determine cell concentration. The cells in the remaining IOOfll were pelleted by 
centrifugation and the supernatant transferred to a clean eppendorf tube with 1 ml of 
scintillation fluid. The pellet was redissolved in 1 OOfll TE, the cells harvested and 
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redissolved in Iml of scintillation fluid. The cpm of the cells and supematant was 
measured as described previously. 
2.10.8 NUCLEASE ACTIVITY ASSAY (Pugsley and Oudega, 1987). 
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The Mcc24 extract was prepared (Methods 2.9.5) and the protein pellet dissolved in 
111 OOOth the original volume of phosphate buffer. A 2111 aliquot of the extract was 
mixed with 21lg of A, HindUI cut DNA or uncut pBR322 DNA and Reaction Buffer to 
o 
give a final volume of 20111. The mixture was incubated at 37 C and at various time 
points 4111 removed and mixed with 16111 of Dilution Buffer. The samples were 
immediately heated in a boiling water bath for two minutes and then placed on ice. At 
the end of the experiment the samples were analysed by agarose gel electrophoresis in a 
0.6% agarose gel. 
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CHAPTER 3. 
RESULTS. 
3.1 ANALYSIS OF THE MICROCIN 24 ENCODING GENETIC REGION. 
3.1.1 GENERATION OF MICROCIN 24 ENCODING DERIVATIVES. 
Previously, a 25.14kb fragment from the Mcc24 encoding plasmid p24-2 had been 
cloned into pBR322 producing the recombinant plasmid pGOB34 (Figure 9). To further 
analyse the Mcc24 genes located on this fragment, it was first necessary to reduce the 
size of the DNA fragment encoding Mcc24 production, immunity and export. 
Derivatives of pGOB34 were generated and then tested for microcin production and 
immunity using both the patch and overlay tests (Methods 2.3.3; Figure 10). Digestion 
of pGOB34 with EcoRl or SalI followed by self ligation generated the Mcc' Imm 
clones pGOB341 and pGOB343 respectively. Linearised pGOB34 (HindUI cut) was 
subjected to partial digestion with EcoRI (2.5 units, Figure 11) and ligated to EcoRI 
digested pUC18 producing the clone pGOB342 (8.7 kb insert, Mcc+). Re-ligation of 
EcoRI cut pGOB342 resulted in the 8.7 kb insert being ligated to pUC18 in the opposite 
orientation to that ofpGOB342, producing pGOB420 as well as two other deletion 
derivatives pGOB421 (4.2kb insert, Mcc· Imm) and pGOB423 (4.5kb insert, Mcc' 
Imm +). Digestion of pGOB420 with SalI followed by re-ligation generated pGOB200 
(Mcc· Imm+). The insert from pGOB421 was transferred to pACYC184 by digestion of 
both with EcoRI followed by ligation and the resulting recombinant plasmid named 
pLOB421. 
In order to reduce the insert DNA size and because of the lack of suitable 
restriction sites for cloning, mini-Tnl 0 was used to create extra restriction sites in 
pGOB420 without disrupting Mcc24 expression. The 'A suppressing strain E. coli 
W3110 was first transformed with pGOB420 and then infected with 'ANK1316 as 
described (Methods 2.5.1). Transductants were selected on LB+Amp+Kan+Napp plates 
and their DNA electroporated into MC41 00 to select for plasmid insertions. A total of 
44 transformants were obtained and tested for microcin production using the patch test. 
Twenty four showed a microcin positive phenotype and 12 were selected for further 
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analysis. Restriction mapping identified four plasmids that contained the mini-Tnl 0 
insert in a suitable position to allow further cloning experiments. Utilisation of the extra 
BamHI sites provided by mini-Tnl 0 during to generate appropriate fragments for 
cloning, failed to produce a suitable Mcc24+ recombinant plasmid. 
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Figure 10. Restriction maps and phenotypes of pGOB34 derivatives. Derivatives ofpGOB34 were 
tested for Mcc24 activity using the patch and overlay tests. Mcc24 immunity was determined using the 
patch test using recombinant plasmid-bearing E. coli strains as the lawn bacteria. Restriction enzymes B, 
BamHI; EcoRI; H HindlII; P, PstI; S, SalI (Modified from O'Brien and Mahanty, 1994). 
Cha[?ler 1. Results. 
kb 1 2 3 4 5 6 7 8 9 10 
23.1 
9.4 
6.6 
4.4 
2.3 
2.0 
0.56 .~ 
Fig ure 11. Eco RI partial digestion of linea rised pGOB34. Partial diges tions Llsing EcoRI were 
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performeu after linearisation of pGOBJ4 by /Iil/ul!! uigestion. Gel electrophoresis uS ling ,\ 1.2%, agarose 
gel W~IS useu to analyse the uigestions. Lanes: I, Lambua HinuIII stanuard; 2, pGOB34 lineariseu by 
HindlII uigestion; 3, pGOB34 lIinullUEcoRI complete uigest; 4, EcoRI .5 units; 5, EcoRI 2.5 units:. b, 
E·coRI l.b7 units; 7, EcoRI 1 . .25 units: 8, Ec()RI 0.83 units; 9, EcoRI 0.56 units; 10, Ec'uRl 0.28 units. 
The second approach to reduce the Mcc24 encoding region was partial digestion 
of pGOB420 with Sau3AI (0 .67 units) and ligation to BumHI cut pBR322. After 
ovemight incubation at 37°C, each transtormation pla1\' was covered in a lawn of cells, 
with small clearing zones occuring in the lawn. Using a binocular microscope, the 
bacterial colony at the centre of each clearing zone was collccted, purified and Mcc24 
activity confirmed using the patch test. Twenty Mcc24 1- strains were chosen from which 
the plasmid DNA was prepared and analyscd by restriction analysis. A number of 
recombinant plasmids were identified (Figure 12A), of which pGOB 18 was found to 
contain the smallest DNA insert and became the subject of further investigation. l\ 
deletion derivative of pGOB 18 was generated by EcoRI digestion and rdigation of the 
DNA. The resulting plasmid, pGOB 181, contained a 2.01 kb insert and failed to 
produce microcin in the patch test but did show immunity to Mcc24 (Figure 128). 
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In order to determine the presence of complementation groups, as had been 
previously demonstrated in studies on ColV (Gilson et al., 1987), an attempt was made 
to transfer the pGOB18 insert DNA into pACYC184. Partial digestion ofpGOB18 
DNA linearised by HindIII was performed using Sau3AI (0.11 units), followed by 
ligation to BamHI cut pACYC184. Two recombinant plasmids, pLOB21 and pLOB8, 
were generated. coli MC4100 harbouring each derivative were determined to be 
deficient for Mcc24 production and immunity (Figure 12B). Because the constructs 
contained portions of the pGOB18 insert that may contain genes of interest, the 
constructs were stored for future use. 
3.1.2 MINI-TnlOlac KANR MUTAGENESIS OF pGOB18. 
Having established the restriction map and phenotype of pGOB 18, the recombinant 
plasmid encoding the genes for Mcc24 expression, it was then necessary to determine 
the boundaries of the Mcc24 genes by mini-TnlO mutagenesis. Mini-TnlOlacZKanR 
was used because this would generate translational fusions, allowing the position of the 
Mcc24 promoter(s) and the direction of transcription to be determined. 
MC41 OO(pGOB 18) was first transformed with pNK2882 to provide the transposase 
function in trans. Mutagenesis using A NK1205 was performed as described (Methods 
2.5.2) and the plasmid DNA from the transductants was then electroporated into 
MC4100 and analysed for plasmid insertions. A total of91 transformants were obtained 
and then screened for tetracycline sensitivity, indicating the loss of pNK2882, ~­
galactosidase activity and Mcc24 production. A total of 12 dark blue Mcc24-, 8 light 
blue Mcc24- and 6 Mcc24RED (both blue and white) were chosen and their insert position 
was mapped (Figure 13A). The level of ~-galactosidase activity was determined for all 
of the mutants. Results showe that the activity from the light blue mutants (transcribing 
right to left) was negligible (Figure 13B). This indicated that only transcription from 
left to right (Figure 13A) generated active ~-galactosidase fusions which suggested the 
presence of two or three promoters, all transcribing from left to right. 
Chloroform was used to identify insertions in transport genes as observed 
previously with ColV (Gilson, et al., 1987). Treatment of Mcc24- mutants with 
chloroform using the overlay test failed to show microcin activity. 
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Figure 12. Further derivatives encompassing the microcin 24 encoding region. A. Derivatives of 
pGOB420 generated by Sau3AI partial digestion. B. Recombinant plasmids derived from pGOBlS. 
Restriction enzymes: B, BamHI; E, EcoRl; R, EcoRV; P, Pst!; S, san; Sa, Sau3AI. 
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Figure 13. Mutagenesis ofpGOB18 using mini-TnIO/ac. A. Location of mini-Tnl OlaeZ' insertions 
within pGOBI8. Vertical arrows denote position of insert and horizontal arrows denote the direction of 
transcription of LacZ. All mutants were Mcc24 - except R 1-R8 (R, Mcc24RED) Key: B, BamHI; E, EeoRl, 
P, PstI; R, EeoRV; S, SalI; Sa, Sau 3AI. B. Microcin 24 production and f)-galactosidase activity of 
pGOB18::mini-TnlOlae mutants. Mutants with a reduced microcin phenotype are designated "R". Each 
sample was tested twice with two readings per test. The average OD420, ODS50 and OD600 was used to 
calculate the activity of f)-galactosidase (Miller units). Full activity was defmed as 1000 Miller units 
(Miller, 1972). 
Before detelDlining the complete DNA sequence of the pGOB 18 insel1 DNA, it 
was fIrst necessary to obtain some information on the genes involved in Mcc24 
production. Utilising the primer MKBGALl, which binds within the first 120bp of 
lacZ, it was possible to derive DNA sequence from the end of the pGOBI8::mini-TnlO 
insertions #9, 14, 18 and R7. These insertions were chosen because they represented the 
entire Mcc24 encoding region. DNA sequence was obtained by the Center for Gene 
Technology (University of Otago) and sent to the Blast Server in order to identify 
similarities to other DNA and protein sequences in the data bank. DNA and protein 
sequence similarity to regions of the ColV transporter CvaA was found in insertions #18 
and 9, and to regions of the ColV transporter CvaB in insertion #14. Insertion #R7 did 
not show any significant sequence similarity to known bacteriocins or bacteriocin 
related genes (Figure 14). 
3.1.3 TRANS-COMPLEMENTATION BETWEEN pGOB18::MINI-TIl10lac 
MUTANTS AND THE COLICIN V TRANSPORT GENES. 
DNA sequence analysis had identified a degree of sequence similarity between the ColV 
transporters CvaAB and regions encoded by pGOB 18, therefore trans-complementation 
was used to determine whether transport functions encoded by pGOB 18 were 
homologous to CvaAB. The pBR322 compatible pACYC 184 derived plasmids pHK22-
6(cvaAB+ cvaC-) and pLY21 (cvaAB- cvaC+) were transfolDled into E. coli MC4100 
harbouring either pGOB 18: :mini-Tnl Olac #9, 14, 18 or R 7, and transformants spread on 
two LB+ Amp+Cm+Kan plates to select for the complementing plasmids. Fifty 
transformants from each were screened for microcin expression by complementation 
using the patch and overlay tests (Figure 15) and the plasmid profiles of representatives 
checked by gel electrophoresis (Data not shown). Expression of Mcc24 occurred when 
insertions #9,18 and 14 were complemented with pHK22-6, identifying these insertions 
as being in transport genes. Complementation between insertion #R7/pHK22-6 and 
#R7/pL Y21 produced a slightly increased microcin halo (Imm) and a very clear, 1.5mm 
halo respectively compared to #R7 alone, suggesting that ColV might be expressed by 
#R7/pLY21. 
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Figure 14. DNA sequence analysis ofpGOB18::mini-TnIOillc mutants. A. DNA sequence from 
mini-Tn1 Olae?! mutants. Vertical arrows indicate the position of insertion, horizontal arrows indicate the 
direction of transcription of lacZ. The number of bases sequenced from each mutation are indicated. 
Enzymes: B, BamBI; EeoRl; P, PstI; Rv, EcoRV, S, SalI; Sa, Sau3A I. B. Amino acid sequence 
similarities. The DNA sequences were compared to known sequences using the Blast server. Amino 
acids (aa) 4-153 from mutant #18, aa 1-84 and aa 147-188 from mutant #9 showed 68% identity with aa 
1-50,71% identity with aa 370-397 and 68% identity with aa 336-349 ofCvaA respectively. Amino 
acids 1-162 and aa 167-169 from mutant #14 showed 79% identity with aa 574-627 and 88% identity 
with aa 629-637 of CvaB respectively. Mutant R7 did not show any significant protein similarity to 
known microcins. Horizontal arrows indicate the direction of amino acid reading from mutants. 
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Figu re 15. T rans-complementa tion between pGOB18 inser tions and colicin Y transport proteins. 
Complementation was assayed u ing the patch test on a lawn of E. coli MC41 00. All plasm ids were 
harboured within E. coli MC41 00. Plasmids: pGOB 18:: mini-TnlOlac # I 8, 9, 14 and R7; pL Y21 
(cvaC+); pH K22-6(cvaAB+); A I-A4, complementation between pLY2i /pGOBI8 ::mini-T n l Olac # 18, 9 , 
14 and R7; B I-B4, com plementation between pHK22-6/pGO B 1 8: :min i-T nlOlac #18, 9, 14 and R7 . 
Controls: pGO B 18 (Mcc24+); pHK22(Co IY+); MC4 100. 
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Complementation between inselt ions #9, 14, 18 and R 7 with p YIE 10 a plasmid 
containing the transporter for Serratia entomophila chi tinase, was also attempted 
because pYlE 10 had previously been shown to complement CvaAB- mutants (Shum, 
1992). All transfonnants failed to show any complementation. Complementation 
between pGOB 18 1 (Results 3. 1. 1) and pYlE 10 also fai led to produce Mcc24 indicating 
that p YIElO could not complement the transport functions absent in pGOB 181. 
3.1.4 ANALYSIS OFpGOB18 ENCODED PROTEINS USING MINICELLS. 
Minicells are small anucleate cells produced by specific strains of E. coli. These strains 
contain mutations in the min and mtl genes resulting in unequal division of the cell 
during logarithmic phase growth and the budding off of the small nonviable mini cells 
which can be separated from normal cells using density gradient centrifugation. If the 
parental strain carries a plasmid, some plasmid molecules may segregate into the 
minicells during cell division. Since mini cells contain all the RNA and protein required 
for transcription and translation, incubation with 35S-labelled amino acids (methionine) 
results in the identification of proteins arising from the plasmid encoded genes (Adler et 
al., 1967, Meagher et al., 1977). 
E.coli P678-54T was chosen for the generation of mini cells from plasmid 
containing parental cells. The plasmids to be analysed were first electroporated into 
P678-54T and the presence of the plasmid checked by DNA extraction and restriction 
analysis. Minicells were prepared from strains carrying pBR322 (control), pGOB 18 and 
various pGOB18::mini-TnlOlac insertions #18, 9, 7,21, 14 (Mcc24"), R7 and R2 
(Mcc24RED). At this point in the research it was thought that Mcc24 was in fact a 
colicin so SDS-PAGE was performed to maximise proteins from 20-90 kDa (Figure 16). 
Protein bands were identified with approximate sizes 47kDa, 42kDa, 40kDa and 
19.5kDa. 
3.1.5 DEFINING THE LOCATION OF THE MICROCIN 24 GENES BY 
COMPLEMENTATION. 
In contrast to previous complementation experiments where various pGOB18::mini-
TnlO, Mcc24- insertions were used, plasmid derivatives were complemented with 
pL Y21 (cvaC)and pHK22-6 (cvaAB+) in order identify the location of the Mcc24 
genes. Both pHK22-6 and pLY21 were transformed into 71-18(pGOB421) and 71-
18(pGOB423) with transformants selected on LB+Amp+Cm plates and tested for 
microcin production using the patch test. Positive complementation was observed only 
between pGOB423/pHK22-6 indicating that the structural and immunity region was 
encoded by pGOB423 (Figure 17). 
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Figure 16. Analysis if pGOB18 encoded proteins using minicells. Plasm ids were eleciroporatcd intu 
Ec:n/i P678-54T ~lIld minicells separated from normal cells on a 20'% sucrose gradient by centrifugation 
Plasm id encoded proteins were labelled \v ith 35S-methion inc/cys teinc mix (Prom ix , Amersham) and 
analysed by SDS-PAGE on a 10'~;;J acrylumide gel. Lanes: I, pBR.322; 2, pGU1318; 3-9, pG01318 :mini-
Tn/IJ/uc insertions # 18, #9, #7, #21, #14, #R7 and #R2 respectively. Protein bands: A, 47kDa:. 13, 
42kDa; C, 40kDa; D, 19.:5kDa; E-G , absencc of 47kDa, 40kDa and 19.5kDa proteins respectively. Amp, 
fJ-IaCldIl1aSe 31 kDu and 28kDa; Tet, Tetl{ protein 37kDa (Sanc<Ir el aI., 1919). 
To further define gene boundaries the derivative pGOB 181 was complemented 
with pHK22-6 and pLOB423 (Results 3.1.1), howevl~r complementation was only found 
between pGOB 1811pHK22-6. This result indicated that pGOB 181 encoded the Mcc24 
structural gene and that the EeaRl site located between pGOB 181 and pLOB421 was 
important for Mec 24 expression. When MC41 OO(pGOB 181) was used as a bacterial 
lawn in the patch test, pGOB 18 failed to produce it microcin halo shmving that 
pGOB 181 also encoded the Mcc24 immunity gene. 
G 
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Figure 17. Trans-complementation between microcin 24 and colicin V genes. E.coli 71-
18(pGOB42I ) and 71-18(pGOB423) were transformed with pHK22-6 and pL Y21 . Transfolmants were 
screened for microcin production using the patch test. All plasm ids were harboured within E. coli 
MC4100. Plasmids: pGOB42 I (Mcc24-); pGOB423(Mcc24-); pLY21(cvaC ); pHK22-6(cvaAS+); C I and 
C2, pL Y21 /pGOB421 or pGOB423 respectively; D I and D2, pHK22-6/pGOB42I or pGOB423 
respectively. Controls : pGOB 18(Mcc24+); MC4100; pHK22(CoIY+). 
Previous DNA sequencing analysis and complementation results had indicated 
the presence of two transport genes, therefore the gene boundaries were defined by 
complementation between pLOB8, a subclone of pOOB 18 (Results 3.1.1) and various 
pOOB 18: :mini-Tn] Olae insertions. Plasmid DNA of pLOBS was transformed into 
MC4100 harbouring the pOOBI8::mini-Tnl0 plasmids #7,9,14,18,33 and Rl. 
Complementation was only seen between #IS/pLOB8 and #9/pLOBS resulting in halos 
of 2mm and 1 mm respecti vely, confirming that mutations 18 and 9 are in the same gene 
as indicated by the sequence data. The other mutations are in a second transport gene, 
the start of which lies in the 50bp between mutations 9 and 33 (Figure 18). 
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Figure 18. Defining microcin 24 gene boundaries by trans-complementation. A. Complementation 
between pLOB8 and pGOB18::mini-TnlO/ac mutants. Complementation in trans (+) was indicated by 
the production of a microcin halo. No complementation (-) was indicated by no microcin halo. B. 
Location of the Mcc24 genes as indicated by complementation. Key: B, BamHI; E, EcoRI; R, EcoRV; P, 
PstI; S, SalI; Sa, Sau3AI. 
3.1.6 RECIPROCAL COMPLEMENTATION BETWEEN MICROCIN 24 AND 
COLICIN V TRANSPORT GENES. 
The ability of the ColV transporters CvaA and CvaB to export Mcc24 had been 
previously shown (Results 3.1.3). In order to determine if this complementation could 
be reciprocated, resulting in the export of CoIV, pGOB 18, pGOB 181 and 
pGOB18::mini-TnlOlac mutant R7 were transformed with pHK22-6 and pLY21 and 
bacteriocin production tested using the patch test. ColV activity was tested on lawns of 
MC41 00, MC41 OO(pGOB 18) and MC41 OO(PHKll) in order to distinguish between 
production ofMcc24 and CoIV, since MC4100(pGOB18) would be resistant to Mcc24. 
The export of ColV by the Mcc24 transport system was confirmed since a ColV halo 
was produced by pGOB18/pLY21 and R7/pLY21 on a MC4100(pGOB18) lawn (Figure 
19). 
3.2 DIDEOXYNUCLEOTIDE DNA SEQUENCING. 
3.2.1 CLONING INTO pDELTAI AND pBLUESCRIPT. 
To facilitate the nucleotide sequencing of the Mcc24 genes it was necessary to create 
overlapping nested deletions of the Mcc 24 encoding region using the Deletion 
FactorlM System (BRL Life Technologies). The Mcc24 genetic region was cloned into 
pDEL TA 1, the plasmid used by this nested deletion system, and several constructs 
generated in order to create nested deletions covering the entire insert of pGOB 18 
(Figure 20; Appendix 4). 
Cloning into pDELTAl was unsuccessful at first, however the Mcc24 encoding 
region was sucessfully cloned by digesting pGOB18 and pDELTAl with BamHI and 
EcoRI, followed by ligation and electroporation into E. coli DHI0B. A total of 600 
transformants were obtained of which 350 were white, indicating ligation into the lacZ 
poly linker. A total of 34 were found to produced rnicrocin halos and the plasmids from 
10 colonies were analysed by gel electrophoresis. All plasmids contained the same 
fragment and of these, pGA185, containing all ofpGOB18 cloned into pDELTAl, was 
chosen for further experiments. 
A deletion derivative containing the 3.4 kb fragment encoding most of the 
transport genes was generated from pGA 185 by complete digestion of pGA 185 with 
EcoRI followed by self ligation. The resulting derivative, pGA851, was then used to 
create nested deletions. 
Transfer of the structural and immunity region (1.9 kb) from pGOB 181 to 
pBluescript SK by EcoRI and San digestion followed by ligation, produced the 
derivative pGSK813. The 1.9 kb fragment from pGSK813 was then cloned into 
pDELTAl generating pGA813. 
Figure 19. Reciprocal complementation between microcin 24 and colicin V transport proteins. 
MC4 lOO(pGOB I 8), MC4100(pGOBI81) and MC4100(pGOBI8::mini-TnJOlac #R7) were transformed 
with pHK22-6 and pL Y21. Tranformants were assayed for microcin production using the patch test. A. 
MC4100 lawn, control. B. MC41 OO(pGOB 1 8) lawn, selection for ColV production. C. 
MC41 OO(pHK 11) lawn, selection for Mcc24 production. 
Plasmids: 
pGOB18::mini-TnlOlac #R7 
R7/pLY21 
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pGOBl81 pLY21 
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pHKII 
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Figure 20. Generation of plasmids for DNA Sequencing. The size of each insert DNA is indicated in 
the brackets and vector sizes are not given. Antibiotic resistant markers are derived from vector 
molecules. For restriction maps of plasm ids see Appendix 4. 
3.2.2 CREATION OF NESTED DELETIONS AND NUCLEOTIDE 
SEQUENCING. 
All the sequences generated by nested deletions or primer walking were aligned 
manually (Figure 21). 
Transport region. 
Nested deletions were generated from pDELTAl as described in Methods 2.4.16. 
Nested deletions ofpG~185 were selected by KanR and StrepR, giving deletions which 
would allow sequencing of the sense strand as defined by mini-Tn} Olac mutagenesis 
(Results 3.1.2). A total of 110 separate transformants were tested for microcin 
production and the plasmid from each transformant analysed by gel electrophoresis after 
digestion with HindIII. A total of 33 deletions were selected between 4.5-10.5 kb and 
sequenced using the T7 sequencing primer (Methods 2.6). Alignment showed that there 
were 16 individual sequences which sp.anned 2848 bp of the transport region (Figure 
21), with the remainder being identical deletions or progeny. 
To complete the sequence of the 3.36 kb transport region nested deletions were 
generated from pG~851 in both directions. A total of 62 KanR/StrepR elones 
(complementary strand) were screened for sizes between 5.2 - 8.7 kb and 14 plasmids 
were chosen for sequencing using the T7 primer with seven clones sequenced manually 
and seven sent to a commercial facility (Centre for Gene Research, Otago University). 
Deletions using TetR/SucR (sense strand) were screened for sizes between 4.9 - 8.3 kb. 
A total of 56 clones were screened with 14 chosen for sequencing at a commercial 
facility using the Sp6 primer. 
Structural and immunity region. 
Nested deletions of the structural and immunity region were generated in both directions 
from pG~813. A total of90 clones were selected by TetR/SucR (coding strand) and 
screened by BglII digestion and selection 4.9 - 7.3 kb (Figure 22). Nineteen clones 
were sequenced using the Sp6 primer and the T7 polymerase sequencing kit (Methods 
2.6; Figures 21 and 23). Nested deletions of the complementary strand (KanR/StrepR) 
were selected for sizes between 5.6 - 7.7 kb after digestion with BglII and 11 out of99 
chosen for sequencing at a commercial facility. 
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Primer walking. 
In order to fill gaps in the sequence generated by the nested deletions, several 
pGOB18::mini-TnlOlac mutants (Results 3.1.2) were sequenced using the primers 
MKBGALI and mini-TnlOlacZ' (Appendix 3), and the insert positions presented in 
Table A series of seven primers were also created from various nested deletion 
clones (Appendix 3) and used to prime sequence reactions. 
Table 5. Insertion position ofmini-TnlO in pGOB18::mini-TnlO mutants. 
Mutant Primer Bases inserted between (5',3') 
7 MKBGALl (3930,3931 ) 
8 MKBGALl (4748,4749) 
9 MKBGALl (3063,3064) 
13 MKBGAL1 (2944,2945) 
14 MKBGALl and mini-TnlOlaeZ' (4832,4833) 
18 MKBGALl (2027,2028) 
38 MKBGALl (4052,4053) 
R2 MKBGALl (352,353) 
R3 mini-Tnl a/aeZ' (1447,1448) 
R5 MKBGALI (785,786) 
R7 MKBGALI (794,795) 
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Figure 21. Alignment of DNA sequences obtained from nested deletions and primer walking. A. 
Sequence alignment of structural and immunity region using nested deletions of pG~813. B. Sequence 
alignment of transport region using nested deletion ofpG~185. DNA sequences were obtained using 
various methods: p, primer walking; T, DNA sequencing using Tel deletions; K, DNA sequencing using 
KanR deletions; m, DNA sequencing using pGOB18::mini-TnJO insertions. Genes are indicated in 
shaded boxes and the number ofnucleotides sequenced is indicated by a line. Restriction enzymes: P, 
Pst!; E,EcoRI; R, EcoRV; S, Sal!; Sa, Sau3AI. 

Figure 23. Overlapping DNA sequences generated by pGA813 TetR/SUCR nested deletions. Nested 
deletions ofpGA813 were made using the Deletion FactoryTM System (BRL, Life Technologies). 
Sequencing was perfonned using the T7 polymerase sequencing kit (Phannacia) and fragments run on a 
6% acrylamide gel using the LKB 2010 Macrophor Electrophoresis Unit. Arrows indicate the yo 
transposon end 5'-AAACCCC-3', where the 3'-C is juxtaposed to new sequence. Lanes: 1-4 Deletion 
T28 A C G T; 5-8 Deletion T59 A C G T; 9-12, Deletion T7 A C G T; 13-16, Deletion T76 A C G T. 
Alignment: X, T28~T59; Y, T59~T7; Z, T7~T76. 
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3.2.3 ANALYSIS OF DNA SEQUENCE. 
The full nucleotide sequence of 5267 bp is shown in Figure 24. During sequencing it 
was found that pGOB18 contained an extra piece of DNA from the pUC18 amp gene at 
the 3'-OH end resulting in the retention of the BamHI site (Appendix 4). This piece of 
DNA was obtained from Sau3A digestion of pGOB420 (Results 3.1.1). The clone 
pG~813 was found to contain a duplication of the EcoRl-SalI polylinker fragment from 
pDELTAI at the 5' end (Appendix 4). Analysis of the sequence using DNASIS 
identified five open reading frames which have been called mdbA (Mcc24 DNA 
hinding); mtft (Mcc24 immunity, 279bp); mtjS (Mcc24 §tructural, 270bp); mtfA (Mcc24 
transporter A, 1242bp); mtjB (Mcc24 transporter B, 212Ibp). Three operons have been 
identified, mdbA, mtftlmtfS and mtfAlmtjB. The complete physical map of the pGOB18 
insert DNA coding for Mcc24 expression is presented in Figure 25. DNASIS was also 
used to determine restriction enzyme sites (Appendix 5) and to translate the open 
reading frames determined by sequencing. 
3.2.4 SEQUENCE SIMILARITY COMPARISONS. 
In order to generate sequence comparisons between the proteins encoded by the 
nucleotide sequence presented in Figure 24 and known protein sequences, the BLAST 
Server (BLASTX, Altschul et al., 1990) was used to convert the nucleotide sequence 
into the six possible protein sequences, and compare these with the sequences present in 
the data base. 
The protein encoded by mdbA in reading frame + 1, MdbA, was found to have 
significant sequence identity within residues 15-86 to atnino acids (a.a.) 6-76 of the 
DNA binding H-NS protein from Escherichia coli, Salmonella fyphimurium, Serratia 
marcescens (45-47% identity), Proteus vulgaris (a.a. 6-93,39% identity), Haemophilus 
injluenzae(a.a. 6-65, 37% identity), the E. coli StpA protein (a.a. 3-82,45% identity) 
and the Shigellajlexneri pathogenesis gene kcpA (a.a. 1-48,47% identity) (Appendix 6). 
The mtft gene product was not found to have any similar sequences, however by 
manual comparisons a putative Fur box with high sequence sitnilarity to consensus Fur 
binding sequences was identified in the -35 promoter region of mtjI, indicating that 
Mcc24 expression and/or Mcc24 immunity might be iron regulated (Figure 26). 
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5' 1 GATCACCGCCGTGCAGAACTGGTGATGAATAAACTTTA~ATAAGG~TCCTTCCGGCGTA 
10 RBS mdbA 
61 TGGAAGTACGTCC~TTAAAC~GKGGA~TAATTATGAGCGAACTGACTAAAGAAGATGAA 
METSerGluLeuThrLysGluAspGlu 
121 TACGGCATTATCAGCCGGACTATGATGAATATTCGTTCATTGCGTGTGTTTGCCCGTGAG 
TyrGlyIleIleSerArgThrMETMETAsnIleArgSerLeuArgValPheAlaArgGlu 
181 ATTGATTTTGAGCAGTTGCTCGAAATGCAGGAAAAGCTCAACGTTGTTATTGAAGAACGT 
IleAspPheGluGlnLeuLeuGluMETGlnGluLysLeuAsnValValIleGluGluArg 
241 CGTGAAGATGCTGAACGTGAAGCGGCTGAACGAGCAGAGCGTGAACGGAAACGTCAGGAA 
ArgGluAspAlaGluArgGluAlaAlaGluArgAlaGluArgGluArgLysArgGlnGlu 
301 CTGCTTCAGTTAATCGCCGGAGAGGGGTTCTCACCGGAAGAACTGCTTGGTCTGTCTGAA 
LeuLeuGlnLeuI leAl aGlyGluGlyPheSerProGluGluLeuLeuGlyLeu SerGlu 
361 GAAGCACCAAAATCACGTAAAAAAACGTTACCAAAGCCCCGCCTAAATATCAGTTTGAAG 
GluAla~roLysSerArgLysLysThrLeuProLysProArgLeuAsnIleSerLeuLys 
421 AAAATGGTGAAACGAAATACTGGTCTGGTCGTGGACGTGCGCCAAAACCAATTGCTGAAG 
LysMETValLysArgAsnThrGlyLeuValValAspvalArgGlnAsnGlnLeuLeuLys 
481 CACTGGCAGGTGGTCGTTCTCTTGATGAGTTTCTCATCGAGAAATGATTCTACAGCCCTC 
HisTrpGlnValValValLeuLeuMETSerPheSerSerArgAsnAspSerThrAlaLeu 
541 CTTTTCTCTGGAGGGCTGTACCCTTTAAAGCACACTTGCCAGCCAATCTTGTATAAATGT 
LeuPheSerGlyGlyLeuTyrProLeuLysHisThrCysGlnProIleLeuTyrLysCys 
EcoRV 
601 TATGTTTGAACTGGATATCAAATTTTCGGGCAGAGCTACAGCTCTCGGTAGTCTGACAGA 
TyrVal*** 
661 TTGACTCCAGTTTGTGGTTTCCATGGGGTGGCTGGTACAACAACCGTCGGTTGCTGATCA 
721 GACACGCCACCAACAGATTTATCTGCTGGCCAGTATCTTTTTTTGGGAACTATATCACAA 
(370 35 
781 AAAGATGdTTGATAhTGATTTGCATTATTAAGTATAGTGTAAAAAATTCATGAAGCG~ 
Fur Binding Site 
Figure 24. Continued. 
a
70 10 RBS mEt! 
841 WAAGtTAAC~TGAGTTTTCTTAATTTTGCATTTTCTCCTGTATTCTTCTCCATTAT 
METSerPheLeuAsnPheA1aPheSerProVa1PhePheSer11eMET 
901 GGCGTGTTATTTCATTGTATGGAGAAATAAACGAAACGAATTTGTCTGCAATAGATTGCT 
A1aCysTyrPhe11eVa1TrpArgAsnLysArgAsnG1uPheVa1CysASnArgLeuLeu 
961 ATCAATTATAATAATATCTTTTTTGATATGCTTCATATATCCATGGCTAAATTACAAAAT 
Ser11eI1eI1eI1eSerPheLeuI1eCysPheI1eTyrProTrpLeuAsnTyrLys11e 
1021 CGAAGTTAAATATTATATATTTGAACAGTTTTATCTTTTTTGTTTTTTATCGTCACTCGT 
G1uVa1LysTyrTyr11ePheG1uG1nPheTyrLeuPheCysPheLeuSerSerLeuVa1 
a
7
o-35 a 6 -10 a 7 o-10 RBS mEta 
1081 GGCTG~TGTAAkAAACCTAATTdTATACTWTATAT~TA~ATGTATATGAGAGAG 
A1aVa1Va111eAsnLeu11eVa1TyrPheI1eLeuTyrArgArgCys11e*** 
METTyrMETArgGlu 
1141 TTAGATAGAGAGGAATTAAATTGCGTTGGTGGGGCTGGAGATCCGCTTGCAGATCCTAAT 
LeuAspArgGluGluLeuAsnCysValGlyGlyA1aG1yAspProLeuA1aAspProAsn 
Leader Peptide 
ApaI 
1201 TCCCAAATTGTAAGACAGATAATGTCTAATGCGGCATGGGGCCCGCCTTTGGTGCCAGAG 
SerG1nI1eVa1ArgG1nI1eMETSerAsnA1aA1aTrpGlyProProLeuVa1ProGlu 
1261 CGGTTTAGGGGAATGGCTGTTGGAGCCGCAGGTGGGGTTACGCAGACAGTTCTTCAAGGA 
ArgPheArgG1yMETA1aVa1G1yA1aA1aG1yG1yVa1ThrG1nThrVa1LeuG1nG1y 
NdeI 
1321 GCAGCAGCTCATATGCCGGTTAATGTCCCTATACCTAAAGTTCCGATGGGACCCTCATGG 
A1aA1aA1aHisMETProVa1AsnVa1Pro11eProLysVa1ProMETG1yProSerTrp 
1381 AACGGAAGTAAAGGATAAGATTCATTAAGGTAGAATATTTAACTTTGCTTGGGTGTTATA 
AsnG1ySerLysG1y*** 
1441 TCACTCAGGTAAAGTTATTACTCTATTCATCAGATAATTGGCTAATCTTTTTTAACAAGT 
1501 AATTCTCTATGGTAATCGTGTACAGACACTATAGCTCTCATGGATTTGCTCCCTCTCCTC 
1561 TGATTCTCCCCAGACTGTATTTGTCGTGTAAGTTCGGATAAGGAGAATAGGATCACCTGG 
1621 CGCACTATTTTGAACTCCATCAGTAGCCACATGACCGTTGAAAGAGCCAAAGGGAAGCAA 
1681 CTAAAGCTGTCTGATAAACAAAAAATTTGTAATGGATGCACGAAACCGGGCTGCACTGGT 
1741 TGAATTATTTCCAGTCTAACGACCAATTGTCTATAGAACACCGATTCATAATAATATAAT 
Figure 24. Continued. 
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0-8 _35/0-70 35 
1801 TATTTTTTACCATATCATCAGTCAGTAAGGAAAGAAAAGG~T!TCGCp~GAAGCAACA 
0-8 -10 RBS mEtA EcoRl 
1861 GfATAQAPG~TGAAGTGGTGCGGGCGGGCAGTATTATTGCCGGGAATTCCCCCCTGG 
METLysTrpCysGlyArgAlaValLeuLeuProGlyIleProProTrp 
1921 TTGGTCATATCAGTAAGCGTTTTTTTCTTTATTTCTTTTATAGTTTTTGTTATGGAAGGT 
LeuVal IleSerValSerValPhePhePheIleSerPheI leValPheValMET GluGly 
1981 ACATACACACGCCGCATTAATGTAGAAGGAGAAATCACTACATGGCCCCGACCTGTAAAT 
ThrTyrThrArgArgIleAsnValGluGlyGluIleThrThrTrpProArgProValAsn 
2041 GTCTATTCAGGTGTACAGGGAGTTGTCATAAAACAGTTCGTCACTGAAGGACAAAGAATC 
ValTyrSerGlyValGlnGlyValValIleLysGlnPheValThrGluGlyGlnArgIle 
2101 AAAAAAGGCGACCCAATTTATCTGATTGATGTCAGTAAAAGTACTAGTAGTGGTGTTGTA 
LysLysGlyAspProIleTyrLeuIleAspValSerLysSerThrSerSerGlyValVal 
EcoRV EcoRV 
2161 GGTGATAACAAGCGGCGAGATATCGAAAAGCAACTGTCCCGCATTGGGGATATCATATCC 
GlyAspAsnLysArgArgAspIleGluLysGlnLeuSerArgIleGlyAspIleIleSer 
2221 CGCCTTGAAGAAAATAAAAAAACTACACTACAGACACTGGAAAAACAACGGATTCAGTAC 
ArgLeuGluGluAsnLysLysThrThrLeuGlnThrLeuGluLysGlnArgIleGlnTyr 
2281 TACTCAGCTTTTGAACGTTCGACTGAAATCCTTCGTCGTGCTGAAGAAGGAGTAAAAATA 
TyrSerAlaPheGluArgSerThrGluIleLeuArgArgAlaGluGluGlyValLysIle 
2341 ATGAAAAGTAATATGGATAATTATAAACAATATCAAACGAAAGGACTCATAAACAAAGAC 
METLysSerAsnMETAspAsnTyrLysGlnTyrGlnThrLysGlyLeuIleAsnLysAsp 
2401 CAGTTAACCAACCAGATAGCGTTGTATTATCAGCAGCAAAATAACATATTGAGTCTGAGC 
GlnLeuThrAsnGlnIleAlaLeuTyrTyrGlnGlnGlnAsnAsnIleLeuSerLeuSer 
BstEll 
2461 ACACAAAATGAACAAAACTTATTACAGGTAACCAGTCTGGAAAGCCAGATGCAGACCCTA 
ThrGlnAsnGluGlnAsnLeuLeuGlnValThrSerLeuGluSerGlnMETGlnThrLeu 
Pstl 
2521 GCAGCGGAATTTGACAACCGTATTTATCAGGTGGAACTGCAGCGTTACGAATTACAGAAA 
AlaAlaGluPheAspASnArgIleTyrGlnValGluLeuGlnArgTyrGluLeuGlnLys 
2581 GAGCTGGTTGATACAGATGCTGGAAGAGATATTATTATTCGCGCTTTGTCAGATGGGAAA 
GluLeuValAspThrAspAlaGlyArgAspIleIleIleArgAlaLeuSerAspGlyLys 
Figure 24. Continued. 
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2641 ATTGATTCGTTGAGTGTTACACCGGGGCAGATGGTCAGCGTAGGCGACAGTCTGTTACAA 
IleAspSerLeuSerValThrProGlyGlnMETValSerValGlyAspSerLeuLeuGln 
KpnI 
2701 ATTATTCCAGAAGAAATAAAAAATTACCATCTGATTGTTTGGGTACCCAATAATGCCATA 
IleIleProGluGluIleLySAsnTyrHisLeuIleValTrpValProAsnASnAlaIle 
2761 CCTTATATTTCTGTTGGTGATAACGTTAATGTTCGTTATGAGGCCTTTCCGCCAGGAAAA 
proTyrIleSerValGlyAspAsnValAsnValArgTyrGluAlaPheProProGlyLys 
2821 TTTGGCCAGTTTACAGCAAAAATAATGTTAATATCCAGAACTCCGGCCTCCGCTCAAGAA 
PheGlyGlnPheThrAlaLysIleMETLeuIleSerArgThrProAlaSerAlaGlnGlu 
2881 ATGCAGACCTATCCCGGAGCCCCAAGAAATAATACAGGTGTTTCTGTGCCTTACTACAAA 
METGlnThrTyrproGlyAlaProArgAsnAsnThrGlyValSerValProTyrTyrLys 
2941 ATAGTGCTAAATCCGGAGCAACAAACAATAGAATACGGCGAAAAAAAAATGCCTCTGGAG 
IleValLeuAsnProGluGlnGlnThrIleGluTyrGlyGluLysLysMETProLeuGlu 
3001 AATGGTATGAAAGCACAGAGTACTTTATTTCTGGAAAAGAGGAAAATATACCAGTGGATG 
AsnGlyMETLysAlaGlnSerThrLeuPheLeuGluLysArgLysIleTyrGlnTrpMET 
RBS mftB 
3061 CTATCCCCATTCTATAACATGAAATACAGTGCGGTGGGGC~TGAACAATAACGC 
LeuSerProPheTyrASnMETLysTyrSerAlaValGlyproValAsnGluGln*** 
METAsnAsnAsnAla 
3121 TACCTCCCCCTTAAATACTCTCTTGAACAAACTAGAAATAGGACTACGGCGTCGCATTCC 
ThrSerProLeuAsnThrLeuLeuAsnLysLeuGluIleGlyLeuArgArgArgIlePro 
3181 GGTCGTGCACCAGACTGAATCATCAGAATGTGGGCTGGCCTGTCTGTCGATGATATGTGQ 
ValValHisGlnThrGluSerSerGluCysGlyLeuAlaCysLeuSerMETIleCysGly 
BglI 
3241 CCACTATGGCAGGCATATTGATCTGAGTACTCTGCGTCGCCAGTTTAACCTGTCTGCTCT 
HisTyrGlyArgHisIleAspLeuSerThrLeuArgArgGlnPheAsnLeuSerAlaLeu 
Ava I 
3301 GGGAACAACTCTGGCTGGCATTACAGAAATAGGATCTCAATTGGGTATGGAAACCCGAGC 
GlyThrThrLeuAlaGlyIleThrGluIleGlySerGlnLeuGlyMETGluThrArgAla 
3361 ATTCTCACTGGATCTAAATGAACTCAGTGTTCTGAAGTTGCCCTGCATCCTTCACTGGGA 
PheSerLeuAspLeuAsnGluLeuSerValLeuLysLeuProCysIleLeuHisTrpGlu 
Figure 24. Continued. 
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3421 GTTTAGCCATTTTGTGGTGCTGGTCAGCGTCAGAAAAAATCATTTCGTTCTCCATGATCC 
PheSerHisPheValValLeuValSerValArgLysAsnHisPhevalLeuHisAspPro 
3481 GGCACGAGGACGTAGAACGGTAGGACTTGCTGAGATGTCACAGTGTTTTACCGGTGTCGC 
AlaArgGlyArgArgThrValGlyLeuAlaGluMETSerGlnCysPheThrGlyvalAla 
3541 GCTTGAAGTCTGGCCCGGCACAGAGTTTGTTCAGGAAACCATGAAGAACCGGGTAGTGCT 
LeuGluValTrpProGlyThrGluPheValGlnGluThrMETLysASnArgValValLeu 
BstBI 
3601 TCGAACGCTGTTTCGCAGCATTTATGGTCTCCGGAGTACGTTGACTAAAATTTTTTGCTT 
ArgThrLeuPheArgSerIleTyrGlyLeuArgSerThrLeuThrLysIlePheCysPhe 
3661 TTCACTGGTGATTGAAGCTGTAGGTCTGGTGATACCTGTTGGCACTCAACTGGTGATGGA 
SerLeuValIleGluAlaValGlyLeuValIleProValGlyThrGlnLeuValMETAsp 
PstI 
3721 TCACGCCATTCCTGCAGGAGATCGAGGCCTGCTCTCCCTCATCTGCGTCGGTCTGATGTT 
HisAlaIleProAlaGlyAspArgGlyLeuLeuSerLeuIleCysValGlyLeuMETPhe 
3781 TTTCATCCTGTTGCGCACCGCGGTCAGTATGATTCGCTCATGGTCGTCTTTGGTAATGGA 
PheIleLeuLeuArgThrAlaValSerMETIleArgSerTrpSerSerLeuValMETGlu 
PstI 
3841 AACGCTAATAAACGTGCAGTGGCAGTCGGGGTTGCACCGGCATCTGCTGCAGTTGCCGCT 
ThrLeuIleAsnValGlnTrpGlnSerGlyLeuHisArgHisLeuLeuGlnLeuProLeu 
3901 GGCGTATTTTGAACGGCGAAAGATGGGTGATATTCAGTCCCGCTTCAGTTCTCTTGACAC 
AlaTyrPheGluArgArgLysMETGlyAspIleGlnSerArgPheSerSerLeuAspThr 
3961 ACTGCGTACCACGTTTACAACCAGCGTGGTCGGAGCGATTATGGACAGCATCATGGTTTC 
LeuArgThrThrPheThrThrSerValValGlyAlaIleMETAspSerIleMETValSer 
4021 CGGAGTCCTGGCTATGTTGGTGTTGTACGGTGGGTGGTTGACAACTATTGTGCTGGGTTT 
GlyValLeuAlaMETLeuValLeuTyrGlyGlyTrpLeuThrThrIleValLeuGlyPhe 
4081 CACCATTATATATGTGCTAATTCGTTTACTGACCTATAACTATTATCGCCAGTTGTCGGA 
ThrIleIleTyrValLeuIleArgLeuLeuThrTyrAsnTyrTyrArgGlnLeuSerGlu 
4141 AGAATCCCTGATAAGGGAAGCACGTGCCAGTTCGTATTTTATGGAAACCCTGTACGGAAT 
GluSerLeuIleArgGluAlaArgAlaSerSerTyrPheMETGluThrLeuTyrGlyIle 
4201 AGCCACAATCAAGATGCAGGGAATGGGGGAGCGCAGAGGTCGTCACTGGCTGAATCTGAA 
AlaThrIleLysMETGlnGlyMETGlyGluArgArgGlyArgHisTrpLeuAsnLeuLys 
Figure 24. Continued. 
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4261 GATTGATGCAATCAATACTGGTATAAGGCTTGCCAGGATGGATATGCTTTTCAGTGGGAT 
IleAspAlaIleAsnThrGlyIleArgLeuAlaArgMETAspMETLeuPheSerGlyIle 
4321 TAACACGTTTGTTGCAGCATGTGACCAGGTCGTGATTCTGTGGCTGGGAACTAGCCTGGT 
AsnThrPheValAlaAlaCysAspGlnValValIleLeuTrpLeuGlyThrSerLeuVal 
4381 GATTGACAATCAGATGACCATCGGAATGTTTGTGGCGTTCGGGGTATTCCGCGGGCAATT 
I leAspAsnGlnMETThrIleGlyMETPheValAlaPheGlyValPheArgGlyGlnPhe 
4441 CTCGGACCGTGTTGGTTCCCTGACAAATTTTCTGCTTCAGTTGCGTATGATGAGTCTTCA 
SerAspArgValGlySerLeuThrAsnPheLeuLeuGlnLeuArgMETMETSerLeuHis 
4501 TAATGAACGTATTGCTGATATAGCCATGAACGAGCGGGAAGCCCGGAAGCCTGATACGGC 
AsnGluArgIleAlaAspIleAlaMETAsnGluArgGluAlaArgLysProAspThrAla 
4561 CATGAAAGCCGATATGTATCCGGTAGCACTGGAGACCCAGGACTTGAGCTTCCGTTATGA 
METLysAlaAspMETTyrProValAlaLeuGluThrGlnAspLeuSerPheArgTyrAsp 
4621 CAGTCAGTCTGCTCCCGTTTTCAGCAACCTGAATATCAGTATAAAACCGGGAGAAAGTGT 
SerGlnSerAlaproValPheSerAsnLeuAsnIleSerIleLysProGlyGluSerVal 
4681 GGCAATTACCGGGGCCTCAGGTTCAGGGAAAACCACCCTGATGAAGGTACTGTGTGGGCT 
AlaIleThrGlyAlaSerGlySerGlyLysThrThrLeuMETLysValLeuCysGlyLeu 
A site 
KpnI EcoRV 
4741 GCTTGTACCCGAATCCGGCAGAGTCATGATAGACGGTACCGATATCAGATCGTTGGGGGT 
. ., ........ " ... . 
LeuValProGluSerGlyArgValMETIleAspGlyThrAspIleArgSerLeuGlyVal 
4801 CAATAATTATCACAAAATTATTTCCTGTGTGATGCAAGATGACCGACTGTTTTCAGGCTC 
AsnAsnTyrHisLysIleIleSerCysValMETGlnAspAspArgLeuPheSerGlySer 
4861 GATTAGAGAAAATATTTGCGGTTTCACTGAAAATATTGATGAGGCATGGATGGTGGAATG 
IleArgGluAsnIleCysGlyPheThrGluAsnIleAspGluAlaTrpMETValGluCys 
NheI 
4921 TGCCAGAGCTAGCTTTATTCACGACGTTATCATAAAAATGCCTATGGGTTATGATACACT 
AlaArgAlaSerPheI leHisAspVal IleIleLysMETProMETGlyTyrAsp ThrLeu 
101 
Ava IjXhoI 
4981 GATAGGTGAACTGGGTGAAGGTCTTTCTGGCGGGCAGAAACAGCGAATTTTTATTGCTCG 
IleGlyGluLeuGlyGluGlyLeuSerGlyGlyGlnLysGlnArgIlePheIleAlaArg 
Linker peptide 
Sal I 
5041 AGCGCTTTACCGTCGACCGGGCATTTTATTCATGGATGAGGCCACAAGTGCGCTGGATAC 
AlaLeuTyrArgArgProGlyIleLeuPheMETAspGluAlaThrSerAlaLeuAspThr 
B Site 
Figure 24. Continued. 
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5101 TGAAAGTGAATATTATGTTAATCAGGCGATAAAGCAACTGAATATAACACGAATAATCAT 
GIuSerGIuTyrTyrVaIAsnGInAIaIIeLysGInLeuAsnIIeThrArgIIeIIeIIe 
5161 CGCACACAGAGAAACAACAGTAAAATCAGCCGACAGGATAATTTTACTGGAGGCGCCTGC 
AIaHisArgGIuThrThrVaILysSerAIaAspArgIIeIIeLeuLeuGIuAIaProAla 
Sau3AI 
5221 GAGGATATAACTAAAATAATGATATTTATTACTCAAGGGTAGAGATC 
ArgIIe*** 
102 
Figure 24. The complete nucleotide sequence ofthe microcin 24 encoding region ofpGOB18. All 
restriction enzymes with less than 5 sites are shown, except Sau3AI (13 sites) where only the first and last 
sites are shown indicating the start and end of the nucleotide sequence. The putative start sites of each 
gene product are shown in bold. The putative Fur binding site (Litwin and Calderwood, 1993), leader 
peptide (Hilvarstein et al., 1994), ATP binding sites (Fath and Kolter, 1993) and linker peptide 
(Koronakis et al., 1995) are also shown in bold. The promoter sites indicated await experimental 
evaluation: Ribosome binding sites, RBS; putative (3s dependent promoters, (3s_10 and (35_35; putative 
(370 dependent promoters, (37°_10 and (37°_35. Promoters have been named: PMdb, promoter for mdbA; Ph 
promoter for mtfilmtfS; P2, promoter for mtfS; P AB, promoter for mt/AB. The numbers on the left margins 
refer to nucleotide position. Genbank accession number U47048. 
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Figure 25. Physical map of the microcin 24 encoding region of pGOB18. The genes encoded by the 
5267bp insert ofpGOB18 are shown by boxes. Arrows indicate the direction of transcription with mdbA, 
mtjI/mtfS and mtfAlmtfB forming operons. The predicted number of amino acids and molecular weight in 
kilodaltons (kDa) is shown for each gene product. Promoter sequences were identified by DNA 
sequencing. The promoter PI is thought to control the transcription of both mtjI and mtfS. Restriction 
enzymes: E, EeoR1; P, PstI; R, EeoRV; S, San, Sa, Sau3AI. 
Consensus 
792- GATAATGATTTGCATTATT -810 
5'- GATAATGATAATCATTATC - 3' 
Figure 26. Alignment of the PI promoter Fur-box with the Fur consensus sequence. Fur consensus 
sequence had previously been determined (Litwin and Calderwood, 1993). Lines indicate regions of 
symmetry. Numbers indicate nucleotide position of the Fur box in the DNA sequence (Figure 24). 
61<b 
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Sequence comparisons to the mtfS gene product failed to indicate similarity to 
known bacteriocins, however manual comparisons to ColV identified aN-terminal 
double glycine leader sequence, a common feature of many small proteinaceous toxins 
(Figure 27), suggesting that MtfS might be subject to post-translational modification. 
MYMRELDREElNCVGG 
MRTLTlNElDSVSGG 
lSxxElxxl xGG 
AxxA'Lx'L'LAxxA 
A= conserved hydrophobic amino acids 
conserved hydrophilic amino acids 
A G D P ... MtfS 
A S GR. .. CvaC 
Consensus 
sequence 
Figure 27. Alignment of double glycine leader peptide sequences. The leader peptide of CvaC and the 
consensus sequence had been previously determined (Havarstein et al., 1994). 
The gene product of mtfA, MtfA,was found to have a high degree of sequence 
similarity to the ColV transporter CvaA (71 % identity, Appendix 6). Analysis of the 
mtjB gene product, MtfB, identified high sequence similarity (73% identity, Appendix 
6) to the ColV transporter CvaB and other ATP-binding transport proteins. Analysis of 
the ATP-binding domain in MtfB showed that it was very similar to those in CvaB and 
the ATP-binding consensus sequence (Figure 28). 
A Site 
GASGSGKTTlMKV 
GASGAGKTTlMKV 
GRSGSGKST 
B Site 
IlFMD 
IlFMD 
IlilD 
MtfB (microcin 24) 
CvaB (colicin V) 
Consensus sequence 
Figure 28. Alignment of ATP-binding domains for MtfB, CvaB and the ATP-binding consensus 
sequence. ATP binding domains for CvaB and the consensus sequence had been previously determined 
by Gilson et al., (1990) and Fath and Kolter, (1993) respectively. 
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3.2.4 HYDROPATHIC PROFILES OF pGOB18 OPEN READING FRAMES. 
The hydrophobic force is the force arising from the strong cohesion of a solvent, which 
drives molecules lacking any favourable interactions with water molecules themselves 
from the aqueous phase. For proteins, the native structure will therefore remove the 
greatest number of hydrophobic side chains from exposure to water at the same time as 
removing the least number of hydrophilic residues. Kyte and Doolittle (1982) derived a 
hydropathy scale in which each amino acid was assigned a value reflecting its relative 
hydrophobicity and hydrophilicity, by considering the hydrophobic and hydrophilic 
properties of the 20 amino acid side chains. A computer program utilising a moving 
segment of predetermined length and determining the average hydropathy of the 
segment from the amino terminus to the carboxy terminus was devised. For globular 
proteins it was found that interior portions were represented by regions on the 
hydrophobic side and exterior portions by regions on the hydrophilic side. It was also 
found that for membrane bound proteins, large uninterrupted regions on the 
hydrophobic side of the midpoint line represented portions located in the lipid bilayer. 
As such, this technique has proved very useful in determining the number and location 
of membrane spanning domains in open reading frames identified by DNA sequencing. 
In order to understand the physical characteristics of the proteins encoded by the 
nucleotide sequence, the open reading frames were each SUbjected to hydropathy 
analysis using TGREASE (FASTA; Pearson and Lipman, 1988) and the profiles are 
presented in Figure 29. The most striking feature ofMdbA is a hydrophilic domain 
between residues 40-70. Mtfl appears to consists of a N-terminal hydrophilic domain 
followed by two large hydrophobic domains which are likely to be inserted into the 
cytoplasmic membrane. The pre-MtfS peptide appears to be slightly hydrophobic and 
has a N-terminalleader peptide which is hydrophilic. Both transport proteins give the 
expected profile for proteins involved in ABC mediated transport. MtfA has the 
characteristic hydrophobic N-terminus which may anchor the protein to the inner 
membrane, a hydrophilic central region which could span the periplasmic space and a 
hydrophobic C-terminus which may form the outer membrane domain. The ABC 
transporter, Mtffi, has mUltiple hydrophobic membrane spanning domains. 
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A. 
Hydrophobic Hydropathy profile of MdbA 
10 
B. 
Hydrophobic Hydropathy profile of Mill 
Figure 29. Continued. 
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c. 
Hydrophobic 
Hydropathy profile of pre-MtfS 
Hydrophilic 
10 Arrow indicates leader peptide cleavage site. 90 
D. 
Hydrophobic 
Hydropathy profile of MtfA 
Hydrophilic 
400 
Figure 29. Continued. 
E. 
Hydrophobic Hydropathy profile of MtfB 
A 
L 
Hydrophilic 
50 A IP binding cassette: A site, B site, Linker peptide. 
Figure 29. Hydropathy profiles of pGOB18 open reading frames. The number of amino acids for 
each protein is indicated on the x-axis. 
3.3 FUNCTIONAL ANALYSIS OF mtjS, mt,P AND mdbA. 
3.3.1 DETERMINATION OF GENE FUNCTION. 
B 
On the basis of trans-complementation with cvaAB (Results 3.1.3) mtfA and mtjB had 
been identified as the Mcc24 transport genes, however the functional characterisation of 
the structural and immunity genes had not been determined. DNA sequencing identified 
three open reading frames mtjI, mtjS and mdbA (Figure 25) that were located within the 
region previously determined by complementation to encode the Mcc24 structural and 
immunity genes (Results 3.1.5). 
In order to determine the function of these three open reading frames, the 
TetR/SucR and KanR/StrepR nested deletions obtained from pG~813 (Results 3.2.2) were 
tested for Mcc24 immunity using the streak test against MC41 OO(pGOB 18) on aLB 
plate containing 2,2' -dipyridyl, an iron chelator which is known to induce microcin 
700 
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synthesis. Confirmation of immunity was checked by using the derivative as a lawn in 
the patch test. Mcc 24 activity was tested by trans-complementation with pHK22-6 
(cvaAB+) and assaying for activity using the patch test. Deletions encoding mtfl and 
mtfSwere found to produce and be immune to Mcc24. The derivative T14 failed to 
grow on the M63 test plates during complementation and was re-assayed on LB+2,2'-
dipyridyl overlay plate. A small fuzzy halo was produced on the MC41 00 lawn after 
overnight incubation, suggesting that mtfS encoded Mcc24 activity. 
Phenotype 
Mcc+ Inun+ 
--
K14 
K53 
K52 
K70 
KIO 
Sau3AI EeoRV EeoRI 
o lkb 
T32-----------------------------------------
TI2------------------------------
T25 
TI4-----------------
T5-------
T28------
T59-----
T7----
T76---
++++ 
++++ 
++++ 
++ 
++++ 
+ 
Figure 30. Trans-complementation between pGil813 nested deletions and colicin V transport 
proteins. Nested deletions from pGil813 were complemented with pHK22-6 and screened for microcin 
production using the patch test and microcin immunity using the streak test against MC41 OO(pGOB 18). 
Mcc24 expression scale: + faint halo on LB+2,2' -dipyridyl (O.lmM); ++, 1.5mm halo; ++++, wild type 
expression (2.5mm halo). Immune and immunity deficient derivatives are denoted "+" and "-" 
respectively. Lines represent portion of nucleotide sequence retained after deletion. 
+ 
+ 
+ 
+ 
+ 
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3.3.2 SATURATION MUTAGENESIS USING MINI-TNI0 TET. 
Analysis of pGilS13 deletions indicated that mtjS and mtfl encoded Mcc24 and Mcc24 
specific immunity respectively. To confirm this and to elucidate the role ofmdbA in 
Mcc 24 expression, mini-TnlO tet insertions into mtjS, mtfl and mdbA were to be 
generated in compatible plasmid backgrounds and the resulting phenotype tested by 
trans-complementation. 
A pBR322 based derivative, pGOB lSI, encoding this region had already been 
generated (Figure12B), however it was necessary to produce a compatible pACYClS4 
based derivative. The insert DNA form pGilS13 (Appendix 4) was transferred to 
pACYClS4 by the digesting of both with BamHI and ligation. The resulting derivative, 
pLOBS13 was found to be Mcc24 immune and produced Mcc24 when complemented 
with pHKll-l (data not shown). 
MutagenesisofMC4100(pGOBISl) and MC4100(PLOBSI3) was performed 
using ')..1323 (Methods 2.5.1). In order to identify structural and immunity mutants, a 
2J.LI aliquot of DNA from each ofthe pGOBlSl ::mini-TnlO and pLOBS13::mini-TnlO 
DNA pools was electroporated into MC41 00(pHK22-6) or MC41 OO(pHKII-I) 
respectively. A total of 1000 MC41 00(pHK22-6/pGOB lSI: :mini-Tnl 0) transformants 
were tested for Mcc24 production using the patch test producing 63.1 % Mcc24+, 8.9% 
Mcc24RED and 2S% Mcc24- insertions. Less MC4100(pHKl1-l/pLOBSI3::mini-Tnl0) 
transformants were obtained with 44.9%, 6.2% and 3S.9% of the 272 transformants 
being Mcc24-, Mcc24RED and Mcc24+ respectively. 
The insert positions of 50 Mcc24- and 30 Mcc24RED pGOB181 ::mini-TnlO 
mutants and 40 Mcc24- and 20 Mcc24RED pLOB813::mini-TnlO insertions were 
determined by restriction analysis and gel electrophoresis. A total of 15 independent 
Mcc24- and 5 Mcc24RED inseliions were identified into pGOBISl and 12, Mcc24- and 3 
Mcc24RED insertions identified into pLOB813 (Figure 31). DNA sequencing was used 
to located the exact position ofpGOBlSl insertions # 2, 12, 13, 14, 15 (all Mcc24) and 
pLOBS13 insertions #1,2, II (all Mcc24), Ir and 3r (both Mcc24RED). The insertion 
points in the nucleotide sequence (Figure 24) were located after bases 1162, 1295, 1304, 
133S, 1378,248,833, 1369, 794, and 1032 respectively. By re-testing the microcin 
activity and immunity of the independent mutations, it was found that all of the 
pOOB 181: :mini-Tnl 0 Mcc24 RED mutants were located within the mtft gene or promoter 
producing a Mcc24 sensitive phenotype, whereas all of the Mcc24- mutants were 
inserted within mifSbut were still Mcc24 immune. The pLOB813::mini-TnlO 
insertions produced a similar pattern except the Mcc24- insertions #1 (Mcc24 immune) 
and #2 (Mcc24 sensitive) were located within mdbA and the mtjl promoter region 
respectively (Figure 31). The full phenotype of each mutant is shown in Table 6. 
pGOB181 ::mini-Tnl0 
insertions 
pLOB813::mini-Tnl0 
insertions 
o 
Sou3AI 
r 
1 
1 kb 
1 r 2r 3r 4r 5r 
ri~ n r ruml til I I I 
1 r 2r 2 3r 3 4 5 6 1 8 9 1 0 11 12 
Figure 31. Location of mini-Tn1 0 insertions in plasmids pGOB181 and pLOB813. Individual 
insertions (indicated by arrows) were mapped using EcoRI and EcoRIlHindII digestion followed by 
agarose gel electrophoresis. The insertion points of mutants 2,12, 13, 14, 15 (pGOB181) and 1,2, 11, 
Ir, 3r (pLOB813) were confirmed by sequencing. 
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Table 6. Phenotype of mini-Tnl 0 insertions into pGOB18l and pLOB813. 
pGOB lSI ::mini-Tnl 0 insertions. :QLOB813::mini-TnlO insertions. 
Mcc24 Mcc24 Colony Mcc24 activity Mcc24 Colony 
activity immunity morphology immunity morphology 
+ normal 1 + normal 
2 -a + norma] 2 small 
3 + weak normal 3 -a +w normal 
4 + normal 4 +w normal 
5 -a + normal 5 + normal 
6 - a + normal 6 + normal 
7 -a + normal 7 +w normal 
8 + small 8 + normal 
9 + small 9 + normal 
10 - a + normal 10 + normal 
11 + normal 11 -a + normal 
12 - a + normal 12 +w translucent 
13 -a + nonilal lr 0.5mm translucent 
14 -a + normal 2r 0.5mm normal 
15 + small 3r 0.5mm + small 
translucent 
Ir 0.5mm normal 
2r O.5mm normal 
3r Imm normal 
4r 2mm -b normal 
5r 0.5mm normal 
Positive phenotype denoted "+", negative phenotype denoted "-". Microcin activity tested using the 
patch test on M63 media and LB+ 2,2' -dipyridyl. Normal halo size pGOB 1811pHK22-6, 2.5mm; 
pLOBS13/pHKll-l, 2mm. Cell sizes were determined visually after overnight growth. Immunity was 
tested using cross streak test against MC4100(pGOBIS). 
a Translucent colony on LB + 2,2-dipyridyl plate. b MC41 OO(pGOB 18) produced a small halo (Imm) 
when 4r was used as the bacterial lawn in the patch test compared to nOlmal halo of2.5mm on sensitive 
lawns. W Weak immunity defmed as Mcc24 sensitive when tested using the streak test, but mcc24 
resistant when mutant strain is used as the bacterial lawn in the patch test. 
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3.3.3 IDENTIFICATION OFmdbA, mtffAND mtfS GENE PRODUCTS. 
Analysis of the nucleotide sequence for mdbA, mtjI and mtfS predicted that these genes 
encoded proteins of 19.94, 11,43 and 9.42 kDa respectively (Figure 25), however the 
size of these proteins had not been confirmed by SDS-PAGE. The gene sequence for 
mtfS also indicated the presence of a double glycine leader sequence, implying that MtfS 
would be subject to post-translational modification. In order to confirm these 
predictions, the proteins encoded by wild type gene sequences were labelled with 35S 
methionine/cysteine and compared to the proteins produced by various mini-Tnl 0 
insertions using SDS-PAGE maximised to visualise small proteins. 
Protein analysis using maxie ells. 
The ability of E. coli strains carrying mutations in the major DNA repair genes recA and 
uvrA to synthesize plasmid encoded proteins was first described by Sancar et ai., 1979. 
It was found that irradiating the strain CSH603 (recAl uvrA6 phr-l) stopped synthesis 
of chromosomal DNA but plasmid DNA that did not contain a UV hit was replicated. 
These non-dividing cells termed "maxi cells" were then able to use plasmid DNA as the 
template for transcription resulting in differential labelling of plasmid encoded proteins 
with 35S-1abelled amino acids. Because of the difficulty in maintaining recA uvrA 
strains, E. coli strains carrying a mutation in recA alone have been used to generate 
maxicells (Pritchard and Holland, 1985). Although these strains are less sensitive to 
UV, by increasing the UV dosage and checking the efficiency of irradiation, it was 
possible to generate maxicells with the same efficiency as CSH603. 
In order to analyse the proteins encoded by mdbA, mtjI and mtfS, maxi cells were 
generated from E. coli MC4100 (recA-56) strains containing various Mcc24 plasmids. 
The required UV dosage for the generation ofMC4100 maxicells was determined by 
irradiating both MC4100 and MC4100(pBR322) with increasing doses ofUV (2S4nm) 
and determining viable cell count (Methods 2.8.2). It was found that MC4100(PBR322) 
was more UV sensitive than MC4100 alone (Figure 32) and a dosage of200/lJcm-2 
(2Jm-2) was chosen as the irradiation level for maxicell generation. Maxicells were 
prepared from MC4100 and MC4100 containing pBR322 and pACYC184 as controls as 
well as from MC4100 harbouring pGOBI8, pGOB181 various and pGOBI81::mini-
TnlO insertions, however after several attemps it was not possible to clearly define the 
proteins encoded by mdbA, mtjS and mtflby SDS-PAGE. 
UV survival of maxicells 
-0- MC4100 -I:::. - MC4100(pBR322) 
1e+008 r~--···~-~····-~-····~··--··-·---···--~···~--····----i 
1e+007 
1000000 
100000 
0.1 
o 
I:::. 
\. 
\. 
\ 
\. 
\. 
\0 
,\0 
\ 
\ 
\ 
. 
\ 
M-Q-IZll-IZll--IZll--1Zll 
3 4 
UV dosage (Jm-2) 
Figure 32. UV survival rate of MC4100. Exponential growing cultures (OD450 = 0.5) were irradiated 
with UV (254nm) at doses of 100, 136, 150,200,250, 300,400, 500f!Jcm-2 and the viable cell number 
determined and plotted against UV dose. 
Expression of mdbA, mtjI and mtjS using minicells. 
Because protein expression using maxicells did not produce the desired result, the same 
plasmids that were used in the maxi cell experiment were expressed in the mini cell strain 
P678-54T. Minicells were prepared and labelled as previously described (Methods 
2.8.1) and the proteins analysed in a 18% SDS-PAGE maximised for small proteins 
(Methods 2.7.3). Protein bands were identified with approximate molecular weights of 
44kDa, 40kDa, 20kDa, 11.5kDa, 9.5kDa, and 7.5kDa (Figure 33). 
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Figure 33. Expression of mdbA, mtjl and m~/S using mi nicells. The proteins were label led with "s 
methionine/cysteine (Promix. Amersham) and <lnaiysised by OS-PAGE in a !8% acryi ,lInide gel. 
Lanes: i , pBR322; _, pG B 18 ; 3, pG OB i 81; 4, pGOB J 81 ::mini-Tn I() #_ (mtj5r) , 5, pLOB8 ! ~ ::mini-
Tn/O 3r (mtfT) ; 6, pLOB813::mini-Tn/ O # I (mdb;r); 7, pACYC 184. Protei n bands indicated by 
arrows : A, MdbA climer isomers 44kOa and 40kOa; £3, MdbA monomer 20kOa; C, IVltt1 1 1.5kOa; D, pre-
MtfS 9.5k Da; E, ItfS 7.5kOa . Amp, r3-iactamasc 3 1 kDa and 281;:0a; Tet, TetR protein 3 7kDa (Sancar e ( 
aI. , 1 (79). CAT, ch loramphenicol. acety ltr<1nsfe rase 29.8kOa (I'vlayo el al.. 1988). 
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3.4 ANALYSIS OF MICROCIN 24. 
3.4.1 PLATE ASSAYS FOR MICROCIN 24 ACTIVITY. 
Prior to the analysis of the DNA sequence (Results 3.2.3), Mcc24 was classified as a 
colicin (O'Brien and Mahanty, 1994). In order to confinn the nature of this 
antimicrobial agent, plate assays using an MC41 00 lawn (Methods 2.3.3) were repeated 
to detennine if this antibiotic could pass through cellophane, the classical test for 
microcin activity (Arsensio et al., 1976). The Mcc24 activity produced by 
MC41 OO(pGOB 18) was found to dialyse through cellophane (Figure 34) confinning the 
classification of Mcc24. 
3.4.2 PREPARATION OF MICROCIN 24 EXTRACTS. 
In order to analyse the antibiotic function of Mcc24, it was first necessary to extract 
sufficient protein from producing cells for use in further experiments, so several 
methods were attempted to detennine which would give the best yield of the antibiotic. 
Mcc24 extracts were prepared from LB broth cultures induced with mitomycin C 
(Methods 2.9.1) and protein profiles detennined in a 10 or 12.5% acrylamide gel 
(Methods 2.7.1) because during early trials it was still thought that Mcc24 was a colicin. 
The Mcc24 titre of extracts was determined by the critical dilution test (Methods 
2.10.1 ). 
Gel Filtration. 
The first method attempted for purifying Mcc24 was gel filtration using a Sephadex G-
100 column (Methods 2.9.6). The bed volume and Vo were detennined to be 198cm3 
and 44.5ml respectively. After extraction the protein was precipitated using acetone and 
dissolved in 15ml50mM KH2P04, pH 7.0. A 2ml aliquot of Mcc24 extract (8 AU.lml) 
was applied to the column and fractions concentrated and assayed for activity. Fractions 
21-27 were found to inhibit growth of a MC41 00 lawn and fraction 24 gave the 
strongest activity. SDS-PAGE analysis ofthe fractions in a 12.5% acrylamide gel with 
silver staining showed that fractions 21 and 22 contained 10 bands, fraction 23 
contained 4 bands and fractions 24-27 contained 1 band of between 14 - 90 kDa. The 
total extract contained 16 bands. 
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Figure 34. Plate assays for microcin 24 activity. A. Patch test. Strains: A, MC41 OO(pGOB 18 
Mcc24+); B, MC4100(p24-2 Mcc24+); C, MC4100(pHKll CoIY"); D, MC4100(pCoIY-K30::Tn/O 
CoIY+); E, BzB210 I (pCoIA-CA31 ColA +); F, MC41 00(pBR322); G, MC41 00. B. Cellophane test. A 
0.2f.1I aliquot of overnight culture was placed onto a sterile cellophane filter on a M63 agar plate, 
incubated overnight and the cellophane removed and the plate overlayed. Zones of inhibition were 
identified after overnight incubation. Strains: A, MC41 OO(pHK II CoIY+); B, MC41 00; C, 
MC4100(pBR322); D, BzB2101(pCoIA-CA31 ColA' ); E, MC4100(pGOB18 Mcc24\ 
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Ammonium Sulphate Precipitation. 
Ammonium sulphate was added to varying saturations to induced culture supernatants 
(Methods 2.9.4) and the precipitate at each step dissolved in 200f.l150mM KH2P04 (PH 
7.0). A 1Of.l1 aliquot from each Mcc24 extraction was placed onto a lawn of MC4100 
and inhibition of growth seen for all fractions. Microcin 24 extracts prepared using 
ammonium sulphate at 50% and 60% saturation gave the best inhibition. Activity 
dropped off sharply in fractions from saturations 60%. Analysis of the fractions by 
SDS-PAGE showed that the 25%, 40%,50% and 60% saturation fractions contained 15 
protein bands of molecular weights between 14 - 90 kDa. 
Ion Exchange Chromatography. 
Microcin 24-containing supernatants were dialysed against 50mM HEPES pH 7.6 (SP 
column) or 20mM Tris-HCI pH 8.2 (Q column). The 1ml ion exchange columns 
(Pharmacia) were prepared (Methods 2;9.7) and the samples applied to the columns. 
After the application, washing and elution steps the eluate was collected, precipitated 
(Methods 2.9.3) and the precipitate dissolved in 100111 of buffer. A 101l1 aliquot was 
placed onto a lawn ofMC4100 to assay for antimicrobial activity. Faint activity was 
seen in the SP column application fraction and very strong activity was seen in the Q 
column elution fraction. All of the fractions were analysed by SDS-PAGE in a 10% 
acrylamide gel. The elution fraction (Q column) was found to contain 4 proteins of 
molecular weights 45 kDa, 94 kDa, 98 kDa and 100kDa. 
Extraction through Nitrocellulose Filters. 
Extraction through nitrocellulose filters (Methods 2.9.5) was found to be an excellent 
method of Mcc24 extraction. After removal of the protein from the filters and 
dissolving the protein in buffer, a lOf.l1 aliquot was found to retain antimicrobial 
activity. SDS-PAGE in a 10% acrylamide gel showed that this fraction contained 10 
proteins of molecular weights between 14 - 90 kDa. 
Once it was confirmed that Mcc24 was in fact a microcin, bulk extraction was 
performed by growing MC41 OO(pGOB 18) in M63 medium for 6 hours (Methods 2.9.2). 
Dissolving the final precipitate in 111000th the original volume produced extracts with 
activity as high as 128 A.U./ml (Figure 35A). Bacterial growth in the clearing zones 
during critical dilution tests occurred. To ensure that these colonies were not 
contaminants, the colonies were purified and tested for Mcc24 activity and immunity 
using the patch and cross streak tests. No zones of inhibition were produced by these 
colonies, but they were resistant to Mcc24 indicating they were spontaneous MC4100 
mutants, resistant to Mcc24. SDS-P AGE maximised for small proteins showed that 
many proteins were present in the extract, including a band at the expected 7.75 kDa 
(Figure 35B). Testing for microcin activity after SDS-PAGE (Methods 2.10.2) failed to 
show any inhibition of the MC4100 lawn, unlike ColV which has been shown to retain 
activity in acrylarnide gels (Fath et al., 1994). 
3.4.3 EFFECT OF PROTEINASE OR RNASE TREATMENT ON MCC 24. 
To confirm that Mcc24 was a proteinaceous bacteriocin and did not contain a RNA 
component, activity of MC4100(pGOB 18) was tested in the presence of proteinase K 
and RNase A (Methods 2.10.4). It was, found that the presence of proteinase K inhibited 
MC41 OO(pGOB 18) from killing a lawn ofMC4100, however the presence of RNase A 
had no effect on Mcc24 activity. 
3.4.4 EFFECT OF CHLOROFORM ON MICROCIN 24 ACTIVITY. 
Previously it had been shown that chloroforming transport mutants failed to restore 
Mcc24 activity (Results 3.1.2). To confirm that chloroform did not affect Mcc24, 
MC41 OO(pGOB 18) was mixed with chloroform and the supernatant assayed for 
microcin activity (Methods 2.10.3). Cqloroform was found to have no effect on the 
antimicrobial activity ofMcc24 present in the supernatant. 
3.4.5 TIME SERIES 
In order to determine the time required for Mcc24 to reduce the viability of a culture of 
a sensitive bacterium, a time series experiment was undertaken (Methods 2.10.5). 
Microcin extract was prepared and found to have an activity of 128 A.U./ml. After two 
hours incubation, it was found that the concentration of the sensitive cells was reduced 
by half (Figure 36). 
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Figure 35. Extraction of microcin 24 using nitrocellulose filters. A. Estimation of microcin titre by 
critical dilution. Halos: A, Mcc24 extract undiluted; B-E, Mcc24 dilutions 1116, 1/8, 1/4, 112 
respectively; F-I, Mcc24 dilutions 1/256, I1l28, 1/64, I132 respectively; J, 0.1 M Phosphate Buffer pH 
7.4. B. SDS-PAGE of Mcc24 extract. The Mcc24 extract was analysed by SDS-PAGE in a 18% 
acrylamide gel maximised for small proteins and the protein bands were visualised by silver staining. 
Lanes: I, BioRad Broad Range molecular weight standard; 2, Microcin 24 extract. Arrow indicates 
putative Mcc24 band. 
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Figure 36. Time series of microcin 24 activity. An exponential culture of MC41 00 was grown to an 
OD600 of 0.12. A series of six tubes containing 50~1 of cells and an equal volume ofMcc24 extract were 
each incubated for varying times. The viable cell count was determined and plotted against time. 
3.4.6 THE ANTIBIOTIC EFFECT OF MCC24 ON SENSITIVE CELLS. 
Disruption of the proton motive force. 
One of the primary mechanisms by which microcins inhibit the growth of sensitive cells 
is through disruption of the proton motive force (Table1). The uptake of amino acids is 
an active process and is very sensitive to disruptions in the proton motive force. By 
using radioactively labelled amino acids it is possible to measure the rate of their uptake 
in cells treated with microcin extracts in order to determine if the microcin affects the 
proton motive force of the cell (Pugsley and Oudega, 1987). 
In order to determine whether Mcc24 affects sensitive cell by disrupting the 
proton motive force, microcin extracts were prepared from M63 medium (Methods 
2.9.2) and the titre determined to be 128 AU./ml. The amino acid uptake assay was 
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performed using MC4100 and a MC4100 Mcc24 resistant strain (Mcc24R)without 
Mcc24 and then with Mcc24 added 5 min prior to the addition of 35S_ 
methionine/cysteine. Uptake of amino acids by MC4100 (Mcc24R) was found to be less 
than that observed for MC41 00 (Figure 37). 
The reduced uptake of amino acids by MC4100(Mcc24R) suggested that 
spontaneous resistance to Mcc24 might affect cysteine or methionine uptake. This was 
tested by generating spontaneous Mcc24R mutants from cys- or me{ parental strains 
(Methods 2.3.4) and testing the mutants for the ability to grow on M63 agar plates 
supplemented with cysteine (20J..tg/ml) or methionine (20J..tg/ml). Mcc24 resistant 
strains of E. coli JM246 (cys) and N3002 (cys-) were found to grow on M63 agar 
supplemented with cysteine M63 but no growth was observed using M63 agar. Mcc24 
resistant mutants of E. coli LE392 (me{) and K802 (men appeared to have reduced 
growth on M63+methionine compared to the parental strain, with neither growing on 
M63 agar. The twoK802 Mcc24R mutants were also ColV sensitive, however LE392 
Mcc24R # 1 was ColV resistant. In order to quantify the difference in growth between 
met- parental and Mcc24R strains, the experiment was repeated using Iml of overnight 
culture washed in Ix M63 salts. Serial dilutions of the mutant and parental strains were 
found to grow equally well on M63 agar+methionine with neither growing on M63 
agar, indicating that there was no real difference in growth. 
Nuclease activity assay. 
Nuclease activity is mechanism by which some E type colicins inhibit cell growth (Toba 
et aI., 1988), however no microcins have been found which function in this manner 
(Table 1). As a matter of interest Mcc24 extracts were prepared from 
MC4100(pGOBI8) and MC4100(pGOBI81::mini-TnlOtet mtfS) #2 (Mcc24-, Results 
3.11.2) as described in Methods 2.9.5. Nuclease activity of both extracts was tested on 
A HindUI cut DNA and uncut pBR322 (Methods 2.10.8). The boiling and rapid cooling 
described in the method resulted in all the DNA becoming single stranded, producing 
the smearing observed in gel electrophoreses (Figure 38). Nuclease activity was found 
in the MC4100(pGOB18) extract, resulting in the linear and circular DNA being 
degraded over time, suggesting that Mcc24 functions as an endonuclease activity 
(Figure 38). 
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Figure 37. Effect of microcin 24 on amino acid uptake. Cultures of MC41 00 and MC41 00 (Mcc24R) 
were grown to an OD6ooofO.15-0.2, washed and resuspended in M63 medium + Cm (25Jlglml). Aliquots 
of Iml were incubated with Mcc24 extract for 5 minutes prior to the addition oeSS-methionine!cysteine. 
Controls did not contain any Mcc24 extract. Samples (I 02JlI) were taken at 30sec, Imin, 2.5min, 5min 
and 10min intervals and 2111 used to determine the cell concentration ofthe sample. The cpm of the cell 
fraction was determined using a Wallac 1410 Liquid Scintillation Counter and plotted as a percentage of 
the total cpm (cells + supernatant) against time. Treatments: 1, MC41 00; 2, MC4100+Mcc24; 3, 
MC4IOO (Mcc24R); 4, MC4IOO (Mcc24R) + Mcc24. 
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Figure 38. Nu clease activity test using microcin 24+ an d microcin 24- ext racts. Protein extracts with 
Mcc24 ac tivity (Mcc24 +) and without activity (Mcc24-) were produced from MC4 100(pGOB IS) and 
MC4100(pGOBI81::mini-TnI0 #2, mtfS-) respectively. Samples were analysed by gel electrophoresis in 
a 0.6% agarose gel. A. Activity test lIsing Ie Hindl][ cut DNA and Mcc24+ extract. Lanes: I, A HindIII 
standard; 2, Ie HindI!! without Mcc24' extract; 3, Mcc24 ' extract; 4-10 ,), Hil1dIli cut DNA incubated 
with Mcc24 ' extract for 5, 10, 15,30,60.90 and 120 minutes respectively. B. Activity test using Ie 
HindIII cut DNA and Mcc24- extract. Lanes: I. A Hind!I1 standard ; 2, A HindII! without Mcc24- ex tract; 
3, Mcc24- extract; 4-S, A Hind III cut DNA in cubated with Mcc24- extract for 5, 10, 15, 30 and 60 
minutes respectively. C. Activity test using uncut pBR322. Lanes: I , A HindII! standard ; 2, pBR322 
linearised with EcoR.I; 3, pBR322 without Mcc24+ ex tract; 4, Mcc24 ~ extract; 5-S, uncut pBR322 DNA 
incubated with Mcc24+ for 5, 10, 15 and 30 mininutes respectively; 9, Mcc4- ex tract ; 10-14 Ullcut 
pBR322 DNA incubated with Mcc24- extract for 5, 10, ! 5, 30 and 60 min utes respectively. 
3.5 PROTEINS INVOLVED IN THE EXPRESSION, REGULATION AND 
ACTIVITY OF MICROCIN 24. 
3.5.1 EFFECT OF TOLC ON MICROCIN 24 EXPORT. 
Tol C had previously been shown to be involved in the export of Col V (Gilson et al., 
1990). Since the export ofMcc24 utilises proteins homologous to CvaAB as shown by 
trans-complementation (Results 3.1.3), it was ofinterest to detelmine if TolC was also 
involved in Mcc24 export. 
The plasmid pGOB 18 was e1ectroporated into TolC mutant strains which had 
previously been used to assay the effects ofTolC on ColV secretion and were 
designated "tight" (E.coli GC7459) and "leaky"(E.coli GC7442) (Gilson et al., 1990). 
TransfOlmants were assayed for microcin production using the patch and overlay test 
(Methods 2.3.3). Export of Mcc24 was absent in both TolC mutants and chloroforming 
failed to restore microcin activity. The'presence ofpGOB18 in both strains was 
confirmed by plasmid extraction and restriction analysis. 
To determine if TolC was involved in the translocation of Mcc24 into sensitive 
cells, the patch test was performed using the "tight" and "leaky" TolC mutants as lawns. 
Both mutants were found to be Mcc24 sensitive. 
3.5.2 EFFECT OF TONB ON MICROCIN 24 ACTIVITY. 
TonB is another outer membrane protein that has been previously found to have a role 
in microcin import (pugsley et al., 1986; Chehade and Braun, 1988; Salomon and 
Farias, 1995). E. coli BzB 1192 (tonB-) was found to be sensitive to Mcc24 when used as 
a lawn in the patch test. Electroporation ofpGOB18 into E. coli BzB1192 produced 
transformants which all produced Mcc24 to the same level as MC41 OO(pGOB 18). 
3.5.3 CHARACTERISATION OF THE MICROCIN 24 RECEPTOR ON 
SENSITIVE CELLS. 
Pugsley and Oudega (1987) have produced a set of E. coli strains which contain 
mutations in the major microcin or colicin receptor genes. By using these strains as 
lawns in the patch test (Methods 2.3.3), it is possible to detelmine the receptor on 
sensitive cells responsible for Mcc24 binding. 
Chapter 3. Results. 126 
Various strains producing Mcc24, ColV and other colic ins or microcins were 
spotted onto lawns of the indicator strains (Table 7). One strain, PAP710 (semA::Tn5) 
was found to be resistant to Mcc24. The SemA protein is responsible for sensitivity to 
MccE492 (Pugsley et al., 1986), therefore activity ofMC4100(pGOB18) against K. 
pneumoniae RYC472 (MccE492+) was confirmed by using RYC492 as a lawn in the 
patch test. MC4100(pGOB18) produced the same sized halo on RYC472 as on 
MC4100. 
Table 7. Activity of microcin 24 against E. coli receptor mutants. 
Strain Genotype Mcc 24a Mcc24b Mcc E492 
Activi!y 
Col V ColA ColEl MC4100 
BzBIOl3 fepA + + + + + + 
BzBI030 butB + + + + 
BzB1190 tsx + + + + + + 
PAP308 ompF + + + + + 
PAPl402 ompR::TnS + + + + + 
PAP702 ompA + + + + + 
PAP 7 10 semA::TnS small small + + + 
opaque opaque 
MC4100 2mm lmm 2mm 2mm Imm Imm 
Strains: Mcc24', MC4l00(pGOB18); Mcc24b, 2424(p24-2); MccE492, RYC472; ColV, MC4100(pHK-
11); ColA, BzB2101(pCoIA-CA31); ColEI, BzB2104(pColEI-K53). Production or absence of a halo is 
designated "+" and "-" respectively. 
3.5.4 REGULATION OF MICROCIN 24 EXPRESSION. 
Regulation by Fur. 
The Fur repressor is a known regulator of gene expression in response to the iron status 
of the cellular environment and has been found to be regulate ColV expression 
(Chehade and Braun, 1988). In light of the similarities between the ColV and Mcc24 
genetic systems, and the identification of a Fur box upstream of mtjI (Figure 24) it was 
of interest to determine the degree of Fur regulation in the expression of Mcc24. 
Regulation by Fur was tested by electroporating E. coli GC4468 (fur +) and E. 
coli GC4468 (!J.fur) strains with parental microcin plasmids p24-2(Mcc24+) and pCoIV-
K30 (CoIV+). These plasmids were used instead of recombinant plasmids in order to 
negate any effect plasmid copy number might have on gene expression. Transformants 
were selected directly for microcin production, purified and grown overnight in LB 
broth. A 1 fll aliquot of overnight culture was spotted onto a lawn of MC4l 00 on M63, 
LB and LB+2,2' -dipyridyl plates, incubated overnight and the halo size taken as a 
measure of Fur regulated microcin expression. The expression of ColV increased 
greatly when on plates with limited iron supply (M63 and LB+2,2' -dipyridyl), however 
the expression of Mcc24 increased only slightly in response to iron limitation (Figure 
39). 
Regulation by as and the possible involvement of mdbA. 
The synthesis of microcins is known to occur when the cells enter stationary phase 
(Kolter and Moreno, 1993). Previously it had been found that the stationary phase 
sigma factor, as encoded by the rpaS gene, was involved in the regulation of MccC7 
production, and that derepression of an rpaS mutation could occur in an hns' 
background (Moreno et al., 1992). 
In order to determine if as had a role in Mcc24 regulation, various plasmids were 
electroporated into E. cali ZB3(rpaS ") and microcin production tested using the patch 
test at 37°C and 30°C and compared to that observed in a MC4I00(rpaS+) background. 
The constructs pGOB 18 and pLOB813/pHKl1-1 were both tested inorder to negate any 
effect of copy number since pGOB 18 (pBR322 based) had a high copy number and 
pLOB813 (pACYCI84 based) had a low copy number. No expression of Mcc24 
occurred when pLOB813 was in the ZB3 background and expression from 
ZB3(pGOB 18) was significantly reduced to that observed from MC41 OO(pGOB 18) 
Cfable 8). 
To test if mdbA was also involved in rpaS regulated Mcc24 production by 
functioning in a similar manner to H-NS, pLOB813::mini-TnlOtet insertion #1 was also 
tested in both ZB3 and MC41 00 backgrounds. The insertion point of this mutation had 
previously been determined by DNA sequencing to be after base 248 in the mdbA gene, 
producing a Mcc24', Mcc24 immune phenotype when complemented with pHKlI-l 
(Results 3.11.1). Expression of Mcc24 was found to be absent in both backgrounds, 
however at 30°C a very slight clearing was observed (Table 8). 
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Figure 39. Regulation of microcin 24 expression by the Fur repressor .. Plates: I, LB plate. 2, 
LB+2,2'-dipyridyl plate. 3, MA plate.Strains: A, CSH26(pCoIY-K30::Tn/O CoIY-); B, W3110(p24-
2::Tn/O #24 Mcc24'); C, GC4468ju/(pCoIY-K30::Tn/O CoIY+); D, GC4468 Nur(pCoIY-K30 ::Tn/O 
CoIY+); E, GC4468jur' ( p24-2::TnIO #24 Mcc24+); F, GC4468 t..}IIr( p24-2::Tn/O #24Mcc24+); G, 
GC4468 t..fi"·; H, GC4468 ju/; I, MC41 00. 
F 
Table 8. Effect of rpoS on microcin 24 expression. 
Strain 
MC4100 
ZB3 
MC4 10 0 
ZB3 
Plasmids 
pGOB18 
pLOB813/pHKll-l 
pLOB813 no.lIpHKll-l 
pGOB18 
pLOB813/pHKll-l 
pLOB813 no.lIpHKll-l 
Temperature(°C) 
37 
4mm 
3mm 
3mm 
30 
5mm 
3mm 
0.5mm 
opaque clearing 
3mm 
0.5mm 
opaque clearing 
Size of microcin halo on MC41 00 lawn measured in mm from edge of colony to the edge of the clearing 
zone. Lack ofmicrocin production denoted "-": 
3.6 THE ROLE OF MCC24 IN DETERMINING THE VIRULENCE OF E. 
COLI. 
The role that colicins and microcins play in the ecology of E. coli is thought to be one of 
defending the ecological niche of the producing strain against invading E. coli (Braun et 
al.,1994) or to enhance the chance of faecal to oral transmission (Pugsley, 1984b). 
Resent evidence that ColV is directly cytotoxic to chicken embryos (Wooley et ai., 
1994), suggests a more direct role for microcins in determining the virulence of E. coli 
strains. 
To address this question two techniques were employed: a) testing Mcc24 
activity against medically important bacteria; b) testing Mcc24 activity for toxicity 
against chicken embryos by expressing various recombinant Mcc24 encoding plasmids 
in MC4100, and analysing these strains using the embryo lethality assay. 
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3.6.1 ACTIVITY OF MCC24 AGINST MEDICALLY IMPORTANT BACTERIAL 
STRAINS. 
The activity ofMcc24 against a number of medically important gram-positive and 
gram-negative bacteria was tested using the patch test. The plates were incubated at the 
appropriate temperature for the lawn bacteria and antibiotic activity checked after 6 and 
16 hours. Mcc24 activity was found to be directed against gram-negative enteric 
bacteria strains (Table 9). 
3.6.2 THE EFFECT OF MCC24 EXPRESSION ONE. COLI VIRULENCE 
USING THE EMBRYO LETHALITY ASSAY. 
Strains of MC41 00 harbouring the recombinant plasmid pGOB 18 encoding the Mcc24 
genes and mutant derivatives of this plasmid were sent to Prof. R.E. Wooley (University 
of Georgia) for trials using the embryo lethality assay (Wooley et al., 1994). E. coli 
MC41 00 harbouring the plasmids was not found to be virulent for the embryos (Table 
10) and the embryos harvested on day six were found to be normal in appearance and of 
similar weights (R.E. Wooley, personal communication). 
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Table 9. Activity of microcin 24 against medically important bacterial strains. 
Morphology 2 3 4 5 6 7 A B C D E 
Controls 
E.coliMC4100 bacilli 5 5 5 5 5 5 2 3 5 
Salmonella 
typhimurium L T2 bacilli 5 3 5 5 5 
HosQital Strains 
Gram positive 
Bacillus cerus bacilli 
C. diphtheriae bacilli na na na na na na na na na na na na 
Listeria monocytogenes bacilli 
Staphylococcus aureus cocci 
OX " 
BORSA " 
~ Lactamase + " 
ORSA " 
MRSA " 
Staphylococcus 
epidermidis cocci 
Streptococcus A cocci na na na na na na na na na na na na 
Streptococcus B cocci 
Streptococcus faecalis cocci 
Gram Negative 
Aeromonas hydrophila bacilli 
Enterobacter bacilli 2 1 4 4 4 1 3 4 
Escherichia coli bacilli 4 4 5 5 5 4 4 4 
Hemophilus injluenzae bacilli na na na na na na na na na na na na 
Klebsiella >I< bacilli 
Neisseria meningitidis cocci na na na na na na na na na na na na 
Proteus mirabilis bacilli 
Pseudomonas 
aeruginosa bacilli 
Salmonella typhimurium bacilli 5 5 5 5 5 
Serratia marcescens bacilli 
Shi gell a jlexneri bacilli 5 5 5 5 5 
Shigella sonnei bacilli 5 5 5 5 5 
Yersinia enterocolitica bacilli 2 2 
Yeast 
Candida albicans 
Strains: 1, Ecolf 2424(p24-12 Mcc24+); 2, Ecolf 2424(P24-2 Mcc24+); 3, Ecoli MC41 OO(pGOB34 
Mcc24+);4, Ecoli MC4100(pGOB342 Mcc24+); 5, E.coli 71-18(pGOB420 Mcc24+); 6, E.coli 2687, 
MccJ+; 7, E.coli ZKI26(pJCI0 MccJ+). Controls: A, MC4100; B, 71-18; C,ZK126; D, ZK126(pCoIY. 
K30 ColY+); ZKI26(pHKIl ColV+). Colicin activity (edge of colony to edge of halo): " no activity; 
1, <O.5mro; 2, O.5-1.0mm; 3, LO-2.5mm; 4,2.5-5.0mm; 5, >5.0mm; na, results not available because lawn 
did not grow. >1<, Mcc24 is known to be active against Klebsiella pneumonia RYC472 (Results 3.5.3). 
Table 10. The effect ofmicrocin 24 expression on the virulence of E. coli MC4100 
using the embryo lethality assay. 
Strains Cfu/ml Embryo Mean embryo Bacterial titre post-
inoculated deaths (120) weight (gm) inoculation(LoglO cfu/ml) 
MC4100 
Group 1 356 0 20.3 7.43 
Group 2 3560 0 16.7 7.48 
MC4100(pBR322) 
Group 1 406 2 19.6 8.04 
Group 2 4066 5 19.4 8.40 
MC4100(pGOB18) 
Group 1 190 19.2 7.08 
Group 2 1900 20.0 7.41 
MC41 OO(pGOB 181: :mini-
TnlO #2) 
Group 1 330 0 20.2 7.85 
Group 2 3300 0 19.5 8.30 
MC4100(pGOBl81) 365 
Group 1 3650 0 18.4 8.32 
Group 2 0 18.9 7.53 
PBS 0 17.1 none 
Uninoculated controls 0 20.6 none 
Colony forming units (cfu) of strains in O.1ml phosphate buffered saline (PBS) were inoculated into the 
allantoic cavity of 12-day old SPF embryos. Twenty embryos were inoculated per group. The number of 
embryo deaths was recorded over a six day period and the mean embryo weight for each group 
determined. At six days post-inoculation the bacterial titre within the allantoic fluid was determined. 
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CHAPTER 4. 
DISCUSSION. 
Bacteriocin production is a common phenomenon in a variety of bacterial species. 
Within the Enterobacteriaceae, the production of colic ins and microcins has been 
frequently observed among natural populations (pugsley, 1984b; Riley and Gordon, 
1992; O'Brien et al., 1996) and provides some of the most substantial evidence for a 
significant ecological advantage provided by these bacteriocins. To date only ColV has 
been found to have a role in pathogenicity, either by an association with virulence 
factors (Waters and Crosa, 1991) or directly through a cytotoxic effect (Wooley et al., 
1994). 
Of the known microcins, only CoIV, MccB 17 and MccC7 have been studied in 
detail. The analysis of these microcins.has indicated that this class of bacteriocin is 
more similar to the antibiotics produced by gram-positive bacteria than to colicins 
(Kolter and Moreno, 1992). Because of the paucity in the number ofmicrocins analysed 
in detail, the evolutionary significance of these bacteriocins cannot be conclusively 
traced. Therefore further studies of novel microcins are needed in order to present a 
clearer picture of bacteriocin evolution and significance. The results presented in this 
thesis provide another example of a novel microcin, Mcc24, and contribute to the 
existing knowledge of this class of bacteriocin. 
4.1 ESTABLISHMENT OF COLICIN 24 AS A TRUE MICROCIN, 
MICROCIN 24. 
Previous classification of the antibiotic activity produced by E. coli 2424 based on the 
criteria used by Arsensio et al. (1976) for distinguishing between colicins and 
microcins, had determined that this activity was a colicin since diffusion through 
cellophane was not observed (O'Brien and Mahanty, 1994). SDS-PAGE analysis 
identified a protein of approximately 38kDa which was thought to be colicin 24 
(O'Brien, 1992). 
Prior to the DNA sequencing of the bacteriocin encoding region, all expression 
assays and SDS-PAGE gels were performed to maximise analysis based on the previous 
classification of this bacteriocin as colicin 24. However, when the CvaAB transport 
system was shown to export the activity encoded by pGO B 18 (Results 3.1.3), there was 
a suggestion that this activity might be a microcin, since CvaAB is known to export 
another microcin, ColV (Gilson et al., 1990). Subsequently, DNA sequencing failed to 
detect an open reading frame of sufficient size to encode a 38kDa protein within the 
structural region (Figure 25) as determined by trans-complementation (Figure 18), 
further indicating that the inhibitory activity had been wrongly classified. The 
possibility did exist however, that a colicin-sized molecule could be exported by an 
ABC transport system since CvaAB has been shown to facilitate the export of larger 
proteins (Fath et al., 1991). In order to resolve the problems in classification of colicin 
24, the cellophane test was repeated and showed that the activity encoded by pGOB18 
was able to diffuse through the cellophane membrane (Figure 34). Once diffusibility 
through cellophane had been established, extraction and SDS-PAGE of the activity 
confirmed the presence of a peptide band corresponding to the 7. 7kDa predicted by 
DNA sequencing (Figure 35). The proteinaceous nature of Mcc24 was confirmed by 
treatment with proteinase K, which inhibited the antibiotic activity (Results 3.4.3). As a 
result of the experimental evidence, the activity encoded by pGOB18 was re-named 
microcin 24 (Mcc24). 
The reclassification ofbacteriocins is not uncommon. For example, after 
detailed genetic analysis, ColV has also been identified as a microcin (Fath et al., 1992). 
Previously in our laboratory it had been observed that the properties of cellophane 
change over time or after different sterilisation methods, which may account for some 
incorrect classifications. Different E. coli strains were also found to have different 
growth rates on cellophane, necessitating the use of the correct strain to harbor the 
plasmids in order to get sufficient expression of the microcin during the assay. The 
cellophane test therefore allows only a tentative classification of a novel bacteriocin and 
confirmation ofthis classification requires further genetic analysis. 
4.2 GENETIC ORGANISATION OF THE MICROCIN 24 ENCODING 
REGION. 
As described in the introduction, there are differences between the organisation of the 
operons encoding rnicrocins resident in natural plasmids. The four ColV genes which 
form two converging operons (Figure 3) represent the simplest arrangement of genes for 
the production of peptide antibiotics. Microcins B 17 and C7 have a more complex 
genetic system (Figures 4 and 7 respectively) which reflects the high degree of 
modification that occurs in the formation of these microcins. 
In the case of Mcc24, several lines of evidence were combined in order to 
compare the Mcc24 genetic region with known systems and this evidence indicates that 
the Mcc24 genetic organisation has some similarities to that of CoIV. First, the creation 
of various deletion derivatives from the original clone pGOB34 (O'Brien and Mahanty, 
1994), identified important restriction sites and helped to define distinct genetic regions 
important in Mcc24 production. The EcoRI site joining the two EcoRI fragments was 
shown to be crucial for Mcc24 production since separating the fragments resulted in the 
loss of production (pGOB421 and pGOB423, Figure 10). However pGOB423 still 
conferred Mcc24 immunity. 
It was hoped to determine gene boundaries and promoter locations within 
pGOB18 using mini-TnlOlacZmutagenesis (Results 3.1.2). However, all of the Mcc24-
insertions fell within the 3.44kb EcoRI-BamHI fragment and Mcc24RED insertions were 
located in the 2kb Sau3AI-EcoRI fragment suggesting that the latter fragment might be 
a structural or regulatory encoding region (Figure 13). By determining the ~­
galactosidase activity for each insertion, it was possible to show that the light blue 
phenotype observed for several insertions was the result of negligible activity, since 
Miller, (1972), defined full activity as 1000 Miller units and activity of approximately 1 
Miller unit as negligible. Significant ~-galactosidase activity was only observed when 
lacZ was transcribed left to right (Figure 13), suggesting that two or three promoters 
may exist within this region and transcribe in the same direction. Gilson et ai. (1987) 
had previously been able to create mutations within the ColV encoding region and 
identify insertions within the transport genes. However, this technique failed to identify 
a transport encoding region for Mcc24 and will be discussed later (Discussion 4.3.1). 
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Previous analysis of ColV has shown that lysing cells by exposing them to 
chloroform vapour chloroform, is a useful technique for determining mutations in 
transport genes (Gilson et ai., 1987). This technique was not successful when analysing 
mutations in pGOB18, therefore the identification of functional units involved in Mcc24 
production was obtained through DNA sequencing and trans-complementation. The 
gene of interest was sequenced using a iacZ primer and the sequence was compared to 
known sequences using the BLAST server. Sequence similarity comparisons to the 
ColV transporters CvaA and CvaB (Figure 14) identified a possible function for the 
gene disrupted by mini-Tnl 0 insertion which could be confirmed by trans-
complementation. Gilson et ai. (1987) had already established that trans-
complementation between genes cloned into compatible plasmids can be used to 
elucidate gene function. Utilising this property, it was possible to show that insertions 
pGOB 18::mini-TnlO insertions #9, 14 and 18 were in transport genes since the loss of 
function could be replaced by CvaAB (Results 3.1.3, Figure 15). 
Trans-complementation not only allowed gene functions to be determined, but 
was also of use in defining the boundaries between the Mcc24 genes. If a deletion 
derivative contained only the structural gene(s), complementation with CvaAB would 
restore the lost export function whereas no complementation would be observed 
between CvaAB and derivatives containing only the transport genes. This technique 
identifed pGOB 181 and pGOB423 as encoding the Mcc24 structural and immunity 
genes (Results 3.1.5; Figure 17). The boundary between the two transport genes (1 and 
2) was also determined to within 50bp by complementation (Figure 18). Of interest was 
the failure to obtain complementation between pGOB421/pL Y21 and 
pLOB4211pGOB181. This indicated that a small portion of the transport genes 
encoding the promoter may be disrupted by the EcoRI site located between pGOB421 
and pGOB423. As a result, pGOB421 and pLOB421 would encode incomplete 
transport genes. The sequence data from pGOB18::mini-TnlO #18 (Figure 14) 
identified a putative promoter in the first 50bp of the sequence, confirming that location 
of the promoter for the transport genes. 
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The final confirmation of the physical map for the Mcc24 encoding region was 
obtained by DNA sequencing (Results 3.2; Figure 25) and identified three operons, 
mdbA, mtftlmtjS and mtfAlmtjB (Results 3.2.3). Although the genetic organisation of 
the Mcc24 encoding region most closely resembles that of CoIV, the transcription of the 
Mcc24 operons in the same direction, and the identification of another open reading 
frame, mdbA located upstream of mtft, indicates significant differences between the 
ColV and Mcc24 genetic systems. Microcins B 17, C7 and the bacteriocins produced by 
gram-positive bacteria have a more complex genetic arrangement than Mcc24 (Moreno 
et al., 1992, Gonzales-Pastor et al., 1995 and Jack et al., 1995 respectively) which 
suggests that Mcc24 does not undergo the high degree of modification experienced by 
these bacteriocins. 
Intergenic regions. 
An interesting feature of the ColV genetic region is a 169bp inter genic region between 
cvaC and cvaB (Gilson et al., 1990). The RNA encoded by this region can be folded 
into a highly stable structure, the significance of which is not known (Fath et al., 1992). 
The genetic region encoding MccH47 also contains a large 3kb intergenic region 
between the mchA and mchB genes which does not appear to affect MccH47 production, 
even though a 43.5kDa protein is encoded by this region (Gaggero et al., 1993). A 
447bp intergenic region is located between the stop codon for mtjS and the transcription 
initiation codon for mtfA (Figure 24), however there is no evidence to suggest that this 
region is involved in Mcc24 expression. One insertional mutation within this region, 
pGOBI8::mini-Tnl0 #R3 (Figure 13), did result in a reduction in Mcc24 expression. 
This reduction could be due to the polar effect of the mini-Tn10 insertion disrupting the 
transcription of the mtjS gene rather than affecting a regulatory mechanism. ISla 
insertions are known to have polar effects, disrupting gene expression (lida et al., 1983). 
A second intergenic region of 243bp exists between the end of mdbA and the start of 
mtft. The only insertional mutations within this region are located within the PI 
promoter (Results 3.3.2) and so it is not thought that this intergenic region has a role in 
Mcc24 regulation except for the fact that the PI promoter is located within this region. 
4.3 MICROCIN 24 PRODUCTION, EXPORT AND ACTIVITY. 
4.3.1 THE STRUCTURAL GENE ENCODING MICROCIN 24. 
Identification of mtjS and its protein product MtfS. 
Through complementation, mutagenesis and protein analysis it was possible to confirm 
that the open reading frame identified through DNA sequencing as mtjS, was the 
structural gene encoding Mcc24. By growing MC4100(T14/pHK22-6) on LB + 2,2'-
dipyridyl in order to allow a limited amount of cell growth, it was possible to visualise a 
small amount of Mcc24 production (Figure 30) identifYing mtjS as the structural gene 
since no other open reading frames were encoded by this deletion. Insertional mutations 
within mtjS all produced a Mcc24- Imm+ phenotype (Result 3.3.2), except insertions 
pLOB813: :mini-Tnl 0 # 2 and #3 (Figure 31). An effect of copy number on Mcc24 
expressi on had previously been· noted when analysing the gene mdbA (Discussion 
4.3.4), and so it is possible that the reduced copy number ofpLOB813 compared to 
pGOB 181 resulted in the production of Mcc24 below the sensitivity limits of the patch 
test. These insertions also produced a poor growing phenotype which again would 
further reduce levels of Mcc24. Confirmation that mtjS encoded a protein was obtained 
by expressing the gene in minicells. The protein band of approximately 7.5kDa which 
was visualised (Figure 33, lane 2) is thought to be Mcc24 and is comparable to the 
protein band observed after extraction ofMcc24 from culture supemantants (Figure 
35B). The nucleotide sequence of mtjS showed that the open reading frame consisted of 
270bp, encoding a putative 9.42kDa (90 a.a.) protein (Figure 25). The disparity 
between the predicted and observed size of the protein, suggests that Mcc24 is the 
mature form of a post-translational modified precursor. Modification of the primary 
translation product is a common feature of peptide antibiotic biosynthesis in both gram-
negative and gram-positive bacteria (Kolter and Moreno, 1992) and can range from 
cleavage of a leader sequence as seen for ColV (Fath et ai., 1994) to substantial amino 
acid modifications like that observed for MccB 17 (Y orgey et ai., 1993). It is therefore 
possible, based on previous research, that Mcc24 is subjected to post-translational 
processing or modification. 
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Analysis of the mtfS DNA sequence and comparison to known peptide antibiotics. 
The nucleotide sequence of mtfS did not show significant identity with protein 
sequences contained in the BLAST data base (Appendix 6). However upon close 
inspection of the sequence, a leader peptide was identified (Figure 27). This leader 
sequence was found to have significant similarity to the double glycine leader sequence 
identified in nonQlanthionine containing antibiotics and the Group All lantibiotics 
produced by gram-positive bacteria (de Vos et al., 1995; Jack et al., 1995), and ColV 
which is the only bacteriocin produced by gram-negative bacteria which is currently in 
this group (Fath et aZ., 1994; Havarstein et al., 1994). Gilson et aZ. (1990) has identified 
the glycine residues at positions 14 and 38 as being critical for the export of CoIV. 
Point mutations of Gly 14 to Asn and Gly38 to Arg produced a leaky phenotype, 
however Gly 14 to Asp resulted in an export deficient phenotype. Further analysis by 
Zhang et al., (1995), has shown that the leader containing the Gly 14 to Asn mutation is 
not processed, whereas the Gly 14 to Asp mutation is incorrectly processed. The 
characteristic features that are present in double glycine leader sequences can all be 
identified within the MtfS leader sequence (Figure 27 and 29C). These features are: the 
conserved hydrophobicity and charged residues, a general hydrophilic nature especially 
in the N-terminus and GA, GS or GG at positions -2 and-l 
Leader sequences are required for efficient export of the bacteriocin out of the 
cell, unlike the leader for MccB 17 which is characteristic of the lantibiotic leader 
sequences and is required for maintaining protein solubility (Kolter and Moreno, 1992; 
Yorgey et ai., 1993). Export of the bacteriocin and removal of the leader sequence is 
mediated by the ABC transporter, which has a 100-150 amino acid N-terminal extension 
that contains the proteolytic domain (Havarstein et ai., 1995). The export ofMtfS by 
the ABC transporters MtfAB and CvaAB (Results 3.1.3), suggests that the MtfS leader 
peptide identified by DNA sequencing is functional, since the normal substrate for 
CvaAB, ColV, is also known to contain a double glycine leader sequence (Fath et aZ., 
1994). By analysing the export of Col V, Zhang et al.(1995) have shown that CvaB is 
sufficient for the processing of pre-ColV and that in the absence of CvaA and CvaB, 
pre-ColV is unstable in the celL Protein analysis of MtfS and pre-MtfS using minicells 
has also shown that in the presence ofMtfA and MtfB, pre-MtfS can be identified 
(Figure 33, lane 2) and the size ofpre-MtfS corresponds to the 9.42kDa predicted by 
nucleotide sequencing. In the absence of the transport proteins however, there does not 
appear to be any pre-MtfS (Figure 33, lane 3) suggesting that like pre-CoIV, pre-MtfS is 
unstable in the absence of the exporters. 
As mentioned earlier, one difference observed between secretion of ColV and 
Mcc24 is that the release of Mcc24 in transport deficient mutants cannot be restored by 
lysing the cell with chloroform. The activity of ColV however can be restored (Gilson 
et al., 1987), even though the levels of activity are reduced due to the instability of 
internal ColV in export deficient strains (Fath et al., 1992; Zhang et al., 1995). Three 
possibilities exist which may explain this difference. Firstly it is possible that 
chloroform affected the activity of Mcc24. However, this was shown not to be the case 
(Results 3.4.4). The second possibility is that pre-MtfS is inactive, thereby preventing 
the formation of a halo upon lysis, since activation of the toxin requires removal of the 
leader sequence during export. Evidence for this possibility comes from the generation 
of immunity mutants in the presence of ABC transporters (Results 3.3.2), since the 
Imm- phenotype is not lethal to the producing cells. In contrast to this, Zhang et al. 
(1995) have shown that ColV is only toxic when presented to the hmer membrane from 
the periplasmic side, indicating the function of ColV in disrupting the membrane 
potential. This suggests that for ColV, the possession of a leader peptide does not affect 
it's toxic activity since ColV cannot insert into the inner membrane from the 
cytoplasmic side. This difference between ColV and Mcc24 may reflect an inherent 
difference in their mechanism of activity. In the third scenario, the possession of a 
leader sequence could make pre-MtfS so unstable that it is degraded rapidly. The 
absence of pre-MtfS in export deficient derivatives supports this hypothesis (Figure 33, 
lane 3). The distinction between the last two alternatives awaits confirmation. 
Analysing the mode of action of Microcin 24. 
Determining how a peptide antibiotic inhibits the growth of sensitive bacteria is the 
major goal in the study of peptide antibiotics. The mode of action is also reflected in 
the physical characteristics of the bacteriocin. It was necessary to first extract and 
purify the peptide in sufficient quantities prior to testing its biological activity. The 
purification of non-Ianthionine containing bacteriocins, although yielding highly 
purified molecules, has resulted in low yields of approximately 20% (Jack et at., 1995). 
The purification of active ColV had been facilitated by TCA precipitation from induced 
culture supernatant's (Fath et al., 1994) however, this procedure was not successful 
when applied to Mcc24 purification (results not shown). Once it was confirmed that 
Mcc24 was a microcin, the correct conditions for expression were achieved by growing 
the culture in M63 medium and the bacteriocin extracted from the supernatant using 
nitrocellulose filters, a crude method previously demonstrated to be successful in some 
instances (Pugsley and Oudega, 1987). Although these extracts were not pure, the high 
activity demonstrated using the critical dilution test (Figure 35A) and by the reduction 
in the viable cell count of a sensitive culture within one hour of exposure to the 
microcin (Figure 36), did allow for further investigation into the activity ofMcc24. The 
reduction in Mcc24 activity after 60 minutes during the viable cell count was thought to 
be due to the toxin being consumed during the incubation period. 
One of the most common mechanisms by which peptide antibiotics are known to 
inhibit bacterial growth is through disrupting the membrane potential of the target cells. 
This can be monitored by following the uptake of radioactivly labelled amino acids, a 
process which requires an intact membrane potential and is sensitive to disruptions in 
the inner membrane. The lantibiotics Pep5, nisin and subtilin, all form voltage-
dependent channels in the inner membrane causing a rapid efflux of amino acids within 
thirty seconds after the addition ofthe lantibiotic to sensitive cells (Sahl and Brandis, 
1983; Ruhr and Sahl, 1985; SchUler et al., 1989; Sahl, 1994). The microcins ColV, 
MccD 140 and MccE492 have also been found to affect membrane potential resulting in 
the inhibition of amino acid transport (Duro et at., 1979; Yang and Konisky, 1984; de 
Lorenzo and Pugsley, 1985). In contrast however, Mcc24 did not significantly affect 
amino acid uptake into Mcc24 sensitive and Mcc24 resistant cells (Results 3.4.6). 
Hydropathy analysis of MtfS (Figure 29C) also does not predict any large hydrophobic 
domains potentially associated with insertion into the inner membrane, as found with 
other bacteriocins which insert into membranes, such as ColV (Fath et at., 1992). Of 
interest was the observation that a Mcc24R mutant ofLE392(me{) was also ColV 
resistant (Results 3.4.6). The significance of this is not known, but may suggest a 
common pathway for Mcc24 and ColV uptake which has yet to be identified. 
Nuclease activity is another mechanism by which a number of colicins have 
been shown to inhibit the growth of sensitive cells, however no microcins to date have 
been identified with this mode of action. Endodeoxyribonuclease activity is displayed 
by colicins E2, E7, E8 and E9 and all share significant protein similarities (Toba et al., 
1988). Colicins £3, E4, E6 and Cloacin DF13 all possess endoribonuclease activity and 
share extensive protein identity (de Graaf and Oudega, 1986), but not with the 
endodeoxyribonuclease colicins (Cole et at., 1985). The lack of sequence identity 
between MtfS and the nuclease colicins (Results 3.2.3) was at first, not unexpected. 
However, extracts ofMcc24 were found to degrade both linear and covalently closed 
plasmid DNA (Figure 38) indicating DNase activity. The absence of nuclease activity 
in extracts prepared from MC4100 harbouring pGOB181::mini-TnlO #2 (mt/S), 
confirmed that this activity was Mcc24 (Figure 38). The method outlined (Methods 
2.10.8) reduces the double stranded DNA to single stranded DNA by boiling the sample 
after exposure to Mcc24 and quickly cooling it on ice. This results in the DNA smears 
observed in Figure 38, rather than discrete DNA fragments obtained in other studies 
using colicins with nuclease activity. Even though this method does not indicate 
discrete digestion of the DNA, DNase activity is still observed since the size of the 
DNA fragments within the smears are reduced over time. 
4.3.2 IMMUNITY TO MICROCIN 24. 
An important component of bacteriocin encoding systems is the specific immunity that 
protects strains from the bacteriocin they produce. ColV is unique among microcins in 
that only one gene, cvi, is sufficient to encode immunity to ColV (Fath et at., 1992; 
Zhang et al., 1995). However, for MccB17 and MccC7, several genes, including those 
involved in microcin transport, are responsible for immunity (Garrido, et al., 1988; 
r. Gonzales-Pastor et al., 1995). Baquero et al. (1995) have also identified a chromosomal 
gene sbmC, which confers resistance to MccB 17 when cloned into a high copy number 
vector. For the bacteriocins Pep5 and nisin produced by gram-positive bacteria, full 
immunity has been found to require expression of both the immunity and structural 
genes (Jack et aI., 1995). Immunity to Mcc24.appears to be encoded by one gene mtft. 
The immunity encoded by this gene was confirmed by the creation of deletion 
derivatives which encoded immunity (Figures 10, 12 and 30) and through the generation 
of insertional mutations which abolished Mcc24 immunity (Table 6). Minicell analysis 
also confinned the predicted size ofMtfI (11.43kDa, Figure 25), since a protein band at 
approximately 11.5kDa was identified and was found to be absent in an mtfI mutant 
(Figure 33, lanes 2 and 5). 
Both ColV and Mcc24 appear to be unique among peptide bacteriocins in that 
the immunity and structural genes form an operon in which the immunity gene is 
transcribed first. For microcins B 17 and C7, the specific immunity gene is located 
downstream of the structural gene (Figure 4 and Figure 7) and for MccH47 which is 
chromosomally encoded, the immunity gene is located upstream of the mchB gene 
within the 3kb intergenic region (Lavifia and Gaggero, 1992). The difference in genetic 
organisation may reflect the limited degree of post-translational modification for ColV 
and Mcc24, which would result in an active molecule being fonned almost immediately. 
The producing cells in the case of ColV and Mcc24 must have immunity to the 
microcins before the structural gene is translated. In contrast, the other microcins are 
subjected to a high degree of post-translational modification prior to the active microcin 
being generated and also utilise export as a second mechanism of immunity, allowing 
sufficient time delay for the immunity protein to be produced. 
The actual mechanisms by which immunity is conferred on the bacteriocin-
producing strain are of great interest and vary depending on the mode of action of the 
bacteriocin. The immunity proteins which act against either pore-fonning colicins or 
some bacteriocins produced by gram-positive bacteria are located in the inner membrane 
and prevent pore fonnation (G6li and Lazdunski, 1992; Jack et al., 1995) as seen with 
Cvi, which functions to block the activity of exogenous ColV at the periplasmic side of 
the inner membrane (Zhang et al., 1995). A different mechanism of immunity exists for 
colicins with nuclease activity, where the immunity protein binds directly to the C-
terminal catalytic domain of the colicin, thereby preventing activity (Jakes and 
Lazdunski, 1992; Wallis et al., 1994). Specific mechanisms also exist such as McbG 
which provides specific immunity to endogenous MccB 1 7 by preventing the steps 
leading to cell death after the inhibition of DNA synthesis (Herrero et al., 1986; Garrido 
et al., 1988) and MccE and MccF which provide immunity against MccC7 by 
acetylation of the antibiotic target site and sequestering MccC7 in the periplasm, 
respectively (Gonzales-Pastor et al., 1995). Two models can be proposed that account 
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for how Mtfl provides immunity to the Mcc24 producing cell. In the first model, Mtfl 
binds to either the target site for Mcc24 action or to Mcc24 itself, thereby inhibiting 
activity. This model would be consistent with the mechanism of immunity to other 
bacteriocins which function as nucleases. However, for Mcc24, immunity is not 
required to protect against endogenous microcin. Mtfl has not been found to have 
sequence identity to the other nuclease immunity proteins which are all known to 
possess commonality in their amino acid sequence (de Graaf and Oudega, 1986) and 
may discount this mechanism of activity. Another possibility is that Mtfl blocks or 
sequesters MtfS at the inner membrane, thereby preventing entry of the toxin into the 
cells, a mechanism observed for MccB 17 and MccC7 immunity (Baquero et aZ., 1995; 
Gonzales-Pastor et aI., 1995). Evidence supporting this model comes from the 
hydropathy analysis ofMtfl which shows three hydrophobic regions (Figure 29B). 
These domains could be indicative of integral membrane domains and may imply that 
Mtfl is associated with the inner membrane and function to block or sequester active 
Mcc24. 
4.3.3 EXPORT OF MICROCIN 24. 
The mechanism by which pep tides are exported across membranes, and in particular the 
double membrane of gram-negative bacteria, has become an intense area of study. A 
common feature of double glycine leader peptide-containing peptides such as the 
lantibiotics subtilin and epiderrnin and the microcins B 17 and C7 is that they are all 
exported in an energy dependent fashion by an ABC transporter complex (Garrido et aZ., 
1988; Fath et aZ., 1994; HAvarstein et aZ., 1994; Gonzales-Pastor et aZ., 1995; HAvarstein 
et aZ., 1995). The first indication that Mcc24 was also exported by an ABC transport 
complex came from DNA sequence comparisons and trans-complementation 
experiments using the ColV transporters CvaA and CvaB with pGOB18::mini-TnlOlac 
insertions and various deletion derivatives (Results 3.1.3 and 3.1.5). Of interest, was the 
finding that complementation between the ColV and Mcc24 export systems was 
reciprocal, even though there was a slight reduction in ColV export using the Mcc24 
exporters, as seen in Figure 19B and C, where plate B shows ColV production on a 
Mcc24R lawn, and plate C shows Mcc24 production on a ColVR lawn. No 
complementation was found between the S. entomphila chitinase transporter and the 
Mcc24 transporters (Results 3.1.3), even though complementation between CvaAB and 
the S. entomphila chitinase transporter is known to occur (Shum, 1992). F ath et al. 
(1991) have previously shown that trans-complementation between different ABC 
transporters does occur. However, complementation is not necessarily reciprocal, 
presumably because of different specificities in export signals within each export 
system. This may also explain the differences in complementation observed between 
CvaAB, the Mcc24 transporters and the S. entomphila chitinase transporter. The 
reduced export of ColV when using the Mcc24 exporters may be due to differences in 
the leader sequences which, though similar (Figure 27), may have sufficient differences 
to reduce substrate recognition by the export apparatus. 
The genes and their protein products involved in the export of Mcc24, have been 
found to have a very high degree of similarity in size and function to the CvaA and 
CvaB proteins required for ColV export. The predicted size of MtfA, 414 amino acids 
long (47kDa, Figure 25), is comparable to CvaA (47kDa) (Gilson et al., 1990) and 
MtfA also has 71 % identity and 86% positive identity to CvaA over the entire length of 
the protein (Appendix 6). This sequence similarity along with the complementation 
(Results 3.1.6 and3.2.4) identifies MtfA as a member of the MFP protein family which 
includes CvaA (Skvirsky et al., 1995). The hydropathy profile of MtfA (Figure 29D) 
also follows the recognised pattern for MFP proteins with a N-terminal hydrophobic 
segment which may anchor the protein to the cytoplasmic membrane, a hydrophilic 
central region which spans the peri plasm and a hydrophobic C-terminal region which 
forms a highly conserved outer-membrane domain (Dinh et al., 1994). An interesting 
feature of the cvaA gene is an internal in-frame methionine codon which produces the 
truncated CvaA * protein (27kDa) (Gilson et al., 1990). Analysis of the mifA gene 
products using minicells has identified a protein band at approximately 47kDa (Figure 
16, lane 2) which is missing in the mifA- mutants pGOB18::mini-TnlOlac #18 and 9 
(Figure 16, lanes 3 and 4) and is thought to be MtfA. However unlike cvaA, no 
truncated form of MtfA was visible (Figure 16, lane 2) even though an internal ATG 
codon exists in the DNA sequence between bases 2341-2343 (Figure 24) which could 
give rise to a 27kDa protein. This suggests that unlike CvaA, there is only one form of 
MtfA present within the cell. 
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The mifB gene is predicted to encode a 707 amino acid protein (79kDa, Figure 
25) which has been found to have 73% identity and 87% positive similarity to CvaB as 
well as a high degree of similarity to other ABC transporters (Appendix 6), indicating 
that MtfB is a member of the ABC transporter family of proteins. Confirmation of the 
predicted size of MtfB was not possible using minicell analysis, however CvaB and 
HylB have also not been visualised by SDS-PAGE because of the low levels of protein 
expression and the difficulty in characterising complex integral membrane proteins 
(Fath et al., 1992). The region of strongest similarity among ABC transporters is the 
200 amino acid ATP-binding domain (Higgins et al., 1986), comprising the two Walker 
motifs A and B (Walker et al., 1982) and a linker peptide (Koronakis et ai., 1995). 
These features have all been identified within MtfB (Figures 24 and 28) and are located 
within the region of highest similarity to known ABC transporters as determined using 
the BLAST server (Appendix 6). Although the binding of ATP by MtfB has not been 
determined experimentally, trans-complementation between MtfAB and CvaAB 
(Results 3.1.3 and 3.1.6) suggests that the two systems are homologous and predicts that 
MtfB must bind ATP, since the export of ColV is dependent on the hydrolysis of ATP 
by CvaB. ABC transporters which export peptides with a double glycine leader 
sequence, are also thought to encode a proteolytic domain in their N-terminal region 
which is responsible for cleavage of the leader sequence (Havarstein et al., 1995). MtfB 
is of a similar size to that of other double glycine peptide transporters and shares a high 
degree of identity to CvaB within this N-terminal region, suggesting that MtfB also 
contains a proteolytic domain that cleaves the leader sequence from pre-MtfS during 
export. Like CvaAB which have been found to be required for the processing of pre-
ColV during export (Zhang et al., 1995), MtfAB also appears to be required for pre-
MtfS stabilisation and processing, since pre-MtfS is inactive in mtfAB deficient strains 
(Results 3.1.2) and is absent from the protein profiles of minicells in a mtfAB deficient 
background (Figure 33, lane 3). 
Another similarity between the ColV and Mcc24 export systems is the 
requirement for ToIC, which was previously found to be necessary for the export of (X-
hemolysin and ColV across the outer-membrane (Wandersman and Delepelaire, 1990; 
Gilson et al., 1990). TolC was also found to be required for the secretion of Mcc24 
however, unlike the secretion of ColV which is termed "leaky" in some tolC mutations 
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(Gilson et al., 1990), the expression of Mcc24 from the tolC -strains was absent even 
after exposure to chloroform vapour (Results 3.5.1). This suggests that there are subtle 
differences in the export of ColV and Mcc24 as previously suggested by 
complementation, and that activation of Mcc24 requires the export process to be 
completed. 
4.3.4 REGULATION OF MICROCIN 24 EXPRESSION. 
Promoters controlling Microcin 24 expression. 
Putative regulatory promoter elements controlling of the expression of the Mcc24 genes 
were identified from the DNA sequence information (Figure 24) and the functionality of 
these elements was confirmed by mutagenesis and trans-complementation. The 
promoter P mdb, is thought to regulate the expression of mdbA, and has sequences similar 
to those required for transcription using Eas. This may provide a mechanism by which 
Mcc24 expression is growth-phase regulated since mdbA is required for the production 
of Mcc24. The expression of mtfllmtfS is controlled by the PI promoter located 
upstream of the mtfl gene (Figure 24 and 25). Sequences with a high degree of 
similarity to a 7o-dependent promoters are found within the PI DNA sequence suggesting 
that transcription from this promoter is mediated by the Ea70 holoenzyme. Mutations 
within this region significantly reduced the production ofMcc24 and abolished 
immunity to Mcc24 as seen with pGOBl8 mini-TnlO insertions #R5 and R7 (Figure 13) 
which are located within the -35 region of the promoter (Table 5) and mini-TnlO 
insertions into pLOB813 and pGOB181 within this promoter (Results 3.3.2), which 
even on a low copy number plasmid still retain some Mcc24 expression (Table 6). The 
low level expression ofMcc24 in the PI promoter mutants indicates that a second 
promoter, P2 which contains sequences with significant similarity to the a
70
_ and a s_ 
dependent promoter sequences, may function to produce low levels of Mcc24 (Figure 
25). This was confirmed by the observation that the deletion derivative T14 was still 
able to produce some Mcc24 even in the absence of PI (Figure 30), suggesting thatP2 
maybe responsible for low level transcription of mtfS before the full transcription of 
mtfS is initiated from PI in response to environmental signals. Another promoter which 
also has sequences similar to those observed in both a70_ and as -dependent promoters is 
thought to regulate expression of the transport genes. As previously mentioned, the 
absence of this promoter resulted in lack of trans-complementation between pGOB421 
or pLOB421 and pL Y21. It is possible that transcription from P2 and P AB is mediated 
by both E0'7o and EO's since the binding of both holoenzymes to similar DNA sequences 
has been previously demonstrated (Tanaka et al., 1993). 
In comparison to the genetic arrangement of other microcins, the four promoters 
controlling Mcc24 expression are unique. The regulated expression of the MccB 17 and 
MccC7 encoding regions is mainly controlled by a single promoter, P mcb and P mcc 
respectively (Moreno et al., 1992). Also among the majority ofmicrocins, for example 
ColV (Gilson et al., 1990), MccC7 (Gonzales-Pastor et al., 1995), and MccH47 
(Gaggero et at., 1993), the direction of transcription of the genes involved in microcin 
production can vary. However, for MccB17 (Moreno et al., 1992) and Mcc24, all the 
genes are transcribed in the same direction. The MccB 17 encoding region also has a 
promoter within the main operon, a situation found in Mcc24 where the P2 promoter 
occurs within the mifllmtfS operon. 
The role of mdbA. 
The gene mdbA, which was located upstream ofthe Mcc24 genes (Figure 24 and 25), is 
unique to the Mcc24 system since no other microcins are known to be positively 
regulated by a cis-acting element. Trans-complementation between pLOB813::mini-
TnlO #1 and pHK11-1 (cvaAB\ has shown that mdbA is required for the expression of 
Mcc24 since this insertion abolishes Mcc24 activity but retains immunity to Mcc24 
whereas pLOB813/pHKll-1 expresses Mcc24 fully (Results 3.3.2) This contrasts with 
pGOBI8::mini-TnlOlac #R2 (Results 3.1.2), where the insert is located between bases 
352 and 353 (Table 5) producing a slightly reduced Mcc24 halo. By using E.coli 
ZK762, a strain carrying the plasmid copy number reducing mutation pcnB (Lopilato et 
ai., 1986), as the host strain for this plasmid, it has been possible to show that reducing 
the copy number the plasmid results in negligible expression of Mcc24 (M. Kamiya, 
personal communication). however). This suggests that the expression originally 
observed was a result of the high copy number ofpGOB18, a pBR322 derivative. 
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Protein sequence comparisons and proposed mechanism of activity. 
Interestingly, comparisons of the protein encoded by mdbA to known protein sequences 
using the BLASTX data base identified a significant region of identity between amino 
acids 15 to 86 of MdbA and other H-NS and H-NS-like proteins (Results 3.2.4). The 
first 90 amino acids of H-NS, the region with similarity to MdbA, has previously been 
shown to have 22-29% identity to structural protein such as myosin, resulting in the 
speculation that this region is involved in the oligomerisation ofH-NS along the DNA 
(Ussery et at., 1994). The hydropathy profile ofMdbA (Figure 29A) shows that 
residues 43-86 form a highly hydrophilic domain, suggesting that MdbA functions as a 
homodimer and that this N-terminal domain is involved in protein-protein interaction 
between the MdbA monomers. Mutational analysis has shown that this domain is 
important, since pLOB813::mini-TnlO #1 and pGOB18::mini-TnlOtac #R2, insert 
within the codons for amino acids 52 and 87 respectively, disrupting this putative 
dimer-forming domain of MdbA. Evidence that MdbA functions as a dimer is seen in 
the minicell analysis, where the MdbA protein was confirmed as a 19.94kDa protein 
(Figure 16, lanes 2-8; Figure 33, lanes 2-5) which is absent in the mdbA insertion mutant 
(Figure 16, lane 9; Figure 33, lane 6). Also visualised in Figure 16 (lanes 2-8) and 
Figure 33 (lanes 2-5) is a 40kDa protein which is not present in lanes 9 and 6 
respectively, and is thought to be a dimeric forms of MdbA. Figure 33 (lanes 2-5) also 
shows a 44kDa protein which is thought to represent an isomer of the 40kDa dimeric 
MdbA, since different species ofH-NS have been identified by Spassky et at. (1984) 
and exist in varying ratios depending on growth conditions. The 44kDa protein oberved 
in figure 16 (lanes 2-8) is also present in lane 9 (mdbA-) and therefore cannot be MdbA. 
The identification of this protein has yet to be determined. 
Recently, H-NS has not only been seen as a component ofthe bacterial nucleoid 
(Drlica and Rouviese-Yaniv, 1987), but has also been implicated in gene regulation 
through altering DNA topology (Hulton et al., 1990). The highly conserved amino acid 
sequence of approximately 135 residues, which is not too dissimilar to the size of MdbA 
(171 residues, Figure 25), confirms the ubiquitous nature of this protein (Ussery et at., 
1994). However, unlike typical DNA binding proteins which have a helix-turn-helix 
motif (Pabo and Sauer, 1984; Brennan and Mathews, 1989), H-NS utilises a stretch of 
positively charged amino acids toward the C-terminus ofthe protein which are thought 
to be involved in DNA binding (Ussery et ai., 1994) and binds to DNA at regions 
containing curved DNA sequences (Zuber et ai., 1994). These curved DNA sequences 
are typified by having a rich AT content (Crothers et al., 1990). Regions with a high 
AT content can also be found along the nucleotide sequence ofpGOB18 (Figure 24), 
especially upstream of the mtfS and mtfA genes. The significance of these regions in 
relation to MdbA binding has yet to be determined, however it is tempting to speculate 
that MdbA acts in a similar fashion to H-NS and binds to these AT rich regions. MdbA 
binding would therefore regulate the expression ofMtfS and also the expression of the 
transport genes which have been implicated in the post-translational modification and 
stabilisation ofpre-MtfS (Discussion 4.3.3). 
The regulation ofmicrocin expression by H-NS has been previously determined 
for MccB17 and MccC7, however unlike Mcc24 which is positively regulated by 
MdbA, H-NS functioned as a repressor-in the case ofMccB17 and MccC7 (Moreno et 
aZ., 1992). Positive regulation by the DNA binding protein, IHF has been demonstrated 
for MccB 17 synthesis (Moreno et aZ., 1992). Of interest, is the observation that the 
expression of MccC7 is de-repressed in an rpoS background when a hns mutation was 
introduced. In an attempt to identify a similar function for MdbA, pLOB813::mini-
Tn} 0 #1 (mdbA") was expressed in E. coli ZB3 (rpoS) (Results 3.5.4). The results were 
not conclusive, possibly because of hns encoded in the chromosome which may have 
interfered with the assay by substituting for MdbA. By performing the assay at 30°C in 
order to allow gene expression before the cells reached stationary phase, a faint clearing 
zone was observed (Table 8). However, this experiment needs to be repeated before any 
conclusions can be drawn suggesting a similar mechanism of activity between MdbA 
and H-NS. MdbA also has sequence identity to the E. coli StpA protein, which is an H-
NS-like protein implicated in H-NS-independent gene regulation through binding RNA 
(Zhang et aZ., 1996). Several mechanisms can be suggested by which MdbA could 
activate Mcc24 expression. Activation of Mcc24 could occur directly through MdbA 
binding the DNA or RNA encoding Mcc24, changing the configuration ofthe template 
into a transcriptionally or translationally competent state. MdbA may also 
repress/activate the transcription or translation of a chromosomally encoded repressor or 
activator, through binding to the DNA or mRNA templates encoding this, as yet, 
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undetermined molecule. The exact mechanism of MdbA regulation awaits experimental 
investigation. 
A significant finding in this study is that the gene encoding MdbA is located on 
the same plasmid as the Mcc24 genes. If MdbA does function as a H-NS-like molecule, 
this would be the first report of such a protein being encoded on a plasmid, since all 
other H-NS-like proteins are chromosomally encoded (Drlica and Rouviere-Yaniv, 
1987; Ussery et al., 1994). The regulatory proteins involved in the biosynthesis of 
microcins B 17, C7 and ColV are also encoded on the chromosome (Moreno et al., 1992; 
Chehade and Braun, 1988). MdbA therefore represents a new class of microcin 
regulatory protein which is encoded as a Cis-acting element, affecting the transcription 
and/or the translation of closely linked genes. 
RegUlation at stationary phase. 
One ofthe interesting aspects of microqin expression is the induction of synthesis when 
the producing cells enter stationary phase. Both MccB 17 and MccC7 are growth-phase 
dependent, however only MccC7 is regulated by rpoS (Diaz-Guerro et al., 1989), which 
encodes (i the stationary phase sigma factor (Loewen and Hengge-Aronis, 1994). The 
expression of MccB17 from P mcb is a 70 -dependent, utilising "gear-box" promoter 
sequences for transcription (Bohannon et al., 1991). Like that of MccC7, the expression 
ofMcc24 is dependent on rpoS, since Mcc24 expression was repressed in an rpoS-
background, however the effect was only observable when the genes encoding Mcc24 
were present on a low copy plasmid such as pACYC184 (Results 3.5.4). As previously 
mentioned, DNA sequencing has identified promoter sequences with identity to as and 
a
70 
consensus sequences however, no gearbox sequences have been identified (Figure 
24). 
As part of a global regulatory system, other transcription factors have been 
found to act independently or in combinations to affect the transcription of cl-
dependent genes. This may also be the case with Mcc24 expression since putative 
consensus sequences for as are located within P mdb and may result in the production of 
MdbA during stationary phase and subsequent induction ofMcc24 biosynthesis. Barth 
et al. (1995) have previously identified H-NS as a component of the rpoS regulatory 
network. In this study, the similarities between H-NS and MdbA may indicate that 
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MdbA is also part of this network. Of the three classes defined for as -dependent genes 
with respect to H-NS (Barth et al., 1995), the expression ofMccC7 fits into the type two 
model in which the genes are more strongly expressed in an hns rpo5r background than 
in an rpo5r background alone. The expression of Mcc24 appears to fit into the type 
three model in which gene expression is weakly increased in an hns- mutant during 
exponential growth, with H-NS acting as a positive activator for stationary phase growth 
as well as additional factors besides as. In this scenario, MdbA would replace H-NS as 
the positive activator. Another mechanism by which Mcc24 expression is controlled 
may be through the regulation of the transport genes mtfA and mtfB, as discussed 
previously (Discussion 4.3.3). Consensus sequences for as binding can be found within 
the mtfA promoter, therefore expression of the transport genes may be induced during 
stationary phase resulting in the processing of the unstable pre-MtfS. The P2 promoter 
of mtfS also has as consensus sequences which would be required to link the 
transcription of mtfS and mtfAR As previously mentioned, the promoter sequences for 
PI' P2 and P AB may also bind a 70 however, the lack of well defined promoter sequences 
within as-dependent promoters can be compensated for by DNA bending (Espinosa-
Urgel and Tormo, 1993). The AT rich regions located upstream of the mtfS and mtfA 
genes may indicate that these promoters preferentially bind as, resulting in stationary 
phase dependent expression from Pi> P2 and P AB' These regions may also be the sites of 
interactions between MdbA and as since both H-NS -like proteins and as preferentially 
bind to curved DNA sequences. 
Regulation by the Fur repressor. 
Superimposed upon the regulation of Mcc24 expression by MdbA and as is another 
global regulatory protein, the Fur repressor, which links gene expression to iron 
limitation in the environment. A putative Fur-box within the -35 promoter region of the 
PI promoter was identified by DNA sequencing and shares significant identity to the 
Fur-box consensus sequence (Figure 26), suggesting that :Fur represses the transcription 
of both mtfl and mtfS from this promoter. 
Included among the virulence genes regulated by Fur or Fur homologues, are the 
genes encoding the shiga-like toxin (Calderwood and Mekalanos, 1987), the shiga toxin, 
diptheria toxin and the P. aeruginosa exotoxin A (Litwin and Calderwood, 1993), as 
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well as ColV (Chehade and Braun, 1988). The Fur-box regulating ColV expression, 
151-GA T AA TCA TTATC-171 is, like that of Mcc24, located upstream of the microcin 
immunity gene cvi (Gilson et ai., 1990), and although shorter than the consensus 
sequence, it still contains the dyad repeat. Fur regulated expression of ColV is very 
strong, with expression in the presence of iron being significantly reduced and 
derepression occurring in iron limiting conditions or in b.fur strains (Figure 39). The 
increase in Mcc24 expression in similar conditions was only slight compared to the 
expression of Mcc24 on LB media (Figure 39), suggesting that Fur has a minor role in 
regulating Mcc24 expression. Compan and Touati (1993) have shown that the 
expression of manganese superoxide dismutase in E coli is Fur regulated, however Fur 
is involved in fine tuning expression to environmental signals and functions in 
conjunction with other regulatory molecules. Fur regulated expression of Mcc24 may 
also function to fine tune the expression of Mcc24 as part of a further global regulatory 
mechanism, possibly involving MdbA and as. 
4.3.5 MICROCIN 24 UPTAKE INTO SENSITIVE CELLS. 
In order for microcins and colicins to be taken up by their target cells, they must first 
bind to an outer-membrane receptor and then be translocated across the outer and inner 
membranes by a second protein (Pugsley, 1984a). Both colicins and microcins have 
been shown to utilise the same receptors and translocation machinery, for example 
Colla, Ib and ColV all use Cir for a receptor and TonB as part of the translocation 
machinery (Pugsley, 1984a; Chehade and Braun, 1988). By using the microcin and 
colicin resistant or tolerant E coli strains in the colicin reference collection (Pugsley and 
Oudega, 1987), it was possible to identify the gene encoding the outer-membrane 
receptor for Mcc24 binding as sernA (Table 7). The only previously reported function 
for sernA was as the gene encoding the receptor for MccE492 (Pugsley et ai., 1986). No 
cross immunity was found between K pneurnoniae RYC472(MccE492+) and E coli 
MC4100(pGOB18 Mcc24+) indicating that they were in fact different microcins 
(Results 3.5.3), Uptake ofMccE492 is mediated by TonB and ExbB, however Mcc24 
activity was still found against strains carrying a tonB mutation (Results 3.5.2). 
Although MccE492 and Mcc24 share the same outer-membrane receptors, differences in 
their translocation appear to exist. This has also been demonstrated for MccB 17 and 
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MccC7 which share the same outer-membrane receptor OmpF (Liu, 1994; Gonzales-
Pastor et al., 1995), but utilise different inner-membrane proteins for translocation. The 
inner-membrane protein for MccC7 translocation has yet to be identified (GonzaIes-
Pastor et al., 1995). Differences in the target site between Mcc24 and MccE492 may be 
responsible for the utilisation of different translocation proteins because MccE492 
depolarises the cell membrane and would not require entry into the cytoplasm (de 
Lorenzo and Pugsley, 1985), unlike Mcc24 which appears to have nuclease activity 
(Results 3.4.6). 
4.3.6 THE PROPOSED MODEL FOR THE BIOLOGICAL ACTIVITY OF 
MICROCIN 24. 
The results presented in this thesis have allowed a model to be proposed for the 
biological activity of Mcc24 (Figure 40). 
4.4 SIGNIFICANCE OF MICROCIN 24 PRODUCTION. 
The role of bacteriocin production in determining the virulence of E. coli is an important 
area of investigation in bacterial ecology. ColV is the only microcin which has been 
directly associated with virulence in E. coli (Smith, 1974; Smith and Huggins, 1976; 
Wooley et al., 1994). An attempt to repeat the experiment of Wooley et al. (1994) 
using E. coli strains harbouring Mcc24 producing plasmid derivatives did not show any 
effect on the mortality rates of chicken embryos (Table 10). A significant difference 
between the original experiment using pHK11 and this trial lies in the origin of the 
parental Mcc plasmids pCoIV-K30 (CoIV) and p24-2 (Mcc24). The plasmid pHKl1 is 
derived from pCoIV-K30, a plasmid first extracted from E.coli K30, a chicken isolate 
however, pGOB18 is derived from p24-2 harboured by E. coli 2424, a human 
uropathogenic strain (O'Brien and Mahanty, 1994). Colicin V production has also been 
found to be significantly higher among E. coli isolates of animal origin than among E. 
coli isolates of human origin (Smith, 1974; Smith and Huggins, 1976). The difference 
in the origins of the microcin plasmids may affect the sensitivity of the assay in 
determining the direct toxicity of the bacteriocins. The chicken embryo lethality assay 
may be appropriate in assessing the significance ofbacteriocins encoded by plasmids 
from E. coli of avian origin, however this assay may not be appropriate for microcins 
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encoded by plasmids from E. coli derived from human sources. To assess the 
sensitivity of the embryo lethality assay to bacteriocins produced by bacterial strains 
isolated from different organisms, it would be necessary to compare ColV derivatives 
from both human and animal sources. 
Outer membrane 
Periplasmic space 
Inner membrane 
? 
t Post-translational I modification 
-.!::.-------J ---. C~ 
Primary translation 
product 
Figure 40. A suggested model for the biological activity of microcin 24. Negative regulation by the 
Fur repressor and positive regulation by ri and MdbA is denoted "-" and "+" respectively. Proteins or 
pathways not yet determined are denoted "7". Two possible mechanisms for immunity to Mcc24 are 
shown. In the fIrst, MtfI prevents MtfS from entering the cell. The alternative is that MtfI prevents the 
nuclease activity ofMtfS by binding to the cellular target of the toxin (DNA) or binding to the active site 
of MtfS. 
4.5 CONCLUSION. 
The study presented in this thesis represents the first analysis of Mcc24 and the genes 
involved in the production of this novel microcin. The identification of the genes 
involved in Mcc24 production, immunity, transport and regulation and their protein 
products, forms the basis for more in-depth analysis of the Mcc24 system and the 
interaction between the various components which make up this system. The exact 
mechanism by which a number of the proteins involved in Mcc24 production and 
activity function, although suggested, awaits further elucidation. 
Four general areas of research into the molecular biology of Mcc24 require 
further investigation. The first area of study involves the mechanisms by which MdbA 
regulates the expression of Mcc24, in order to determine whether MdbA functions in a 
similar manner to H-NS. It would also be of interest to investigate whether MdbA 
mediated regulation was involved in the crS -dependent expression of Mcc24. Any 
investigation into the regulation of Mcc24 expression would also require the 
experimental confirmation of the putative promoter sequences identified by DNA 
sequencing in order to determine whether growth-phase dependent expression of Mcc24 
was mediated by crS or cr 70, and to identify structural motifs involved in the regulation. 
The specific role of the leader peptide in the production of Mcc24 is another area 
for future investigation. Whether the leader peptide of pre-MtfS has a role in regulating 
the activity of Mcc24 within the producing cell has yet to be fully determined. Also the 
mechanisms of post-translational modification and the role of the ABC transport 
complex comprising MtfA, MtfB and TolC in this process awaits further elucidation. 
Exploring the differences between the pre-MtfS and pre-ColV export signals in order to 
help understand the specific nature ofthe export signals and how they influence 
transport using MtfAB and CvaAB would also be of interest. 
The third area of investigation would be to elucidate the exact mechanism by 
which Mcc24 induces DNA degradation in sensitive cells. Associated with this would 
be analysis into how MtfI mediates the specific immunity to Mcc24. 
Defining the role of Mcc24 in the virulence of E. coli forms the last area of 
interest. It would first be necessary to determine what other virulence factors are 
located on the plasmid p24-2. An assessment of the embryo lethality assay using ColV 
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plasmids derived from E. coli of human and avian origins would be of interest in order 
to investigate the appropriateness of this system in determining the toxicity of a 
microcin. Further investigations into the physical properties of Mcc24 are also required 
to determine whether this toxin remains active within the intestine or bladder. 
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APPENDIX 1. BUFFERS AND SOLUTIONS. 
O.SMEDTA. 
18.612g EDTA 
Distilled water to 100mi pH 8.0. 
SmMEDTA. 
1ml O.5MEDTA 
Distilled water to 100ml pH 8.0. 
2M NaOH. 
8g NaOH 
Distilled water to 100ml. 
SDS 
Distilled water to 500ml. 
SOx TAE. 
242g 
100mI 
57.1ml 
Trizma Base 
0.5MEDTApH 8.0 
Glacial acetic acid 
Distilled water to llitre pH 8.0. 
Ix TAE. 
40ml 50x TAE 
Distilled water to 2 litres. 
0.5M EDTA 
5mM EDTA 
2M NaOH 
10% SDS 
2M Tris-acetate 
0.05M EDTA 
Ix TAE 
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TIOEI (TE). 
10mM 
ImM 
lOxTBE. 
12l.1g 
51.35g 
3.72g 
Appendix 1. Buffers and Solutions. 
Tris-HCI pH 8.0 
EDTApH8.0 
Trizma base 
Boric acid 
EDT A Na22H20 
Distilled water to 1 litre pH 8.0. 
sse SOLUTIONS. 
20xSSC. 
350.6g NaCl 
1M Tris 
0.83M Borate 
10mM EDTA 
3M NaCI 
I 76.4g Na3Citrate 0.3M Na3Citrate 
Distilled water to 2litres, pH 7.0. Adjust pH with HCl. 
2xSSC. 
100ml 20x SSC 
distilled water to I litre. 
O.lxSSC. 
5ml 2xSSC 
distilled water to 100m!' 
LOADING BUFFER FOR AGAROSE GELS. 
30% 
0.25% 
0.25% 
Glycerol 
Bromophenol blue 
Xylene cyanol 
2x 
O.Ix 
SSC 
SSC 
RNaseA to a final concentration of 10ug/ml was added when required. 
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5x LIGATION BUFFER (STICKY-END, BRL). 
250mM Tris-HCI pH 7.6 
50mM MgC12 
5mM ATP 
5mM OTT 
25 %(w/v) PEG-8000 
ALKALINE EXTRACTION OF DNA. 
Solution I. 
50mM 
10mM 
25mM 
2mg/ml 
Solution II. 
1% 
0.2M 
Solution III. 
3M 
Glucose 
EOTA 
Tris HCI pH 8.0 
Lysozyme 
SOS 
NaOH 
NaAcetate pH 4.8 
LARGE SCALE PLASMID PREPARATION. 
Solution I. 
1% Glucose 
25mM Tris-HCl pH 8.0 
10mM EOTA 
Solution II. 
0.2% NaOH 
1% SDS 
Solution III. 
5M KAcetate 
5MLiCI. 
21.2g LiCI 
Distilled water to 100ml. 
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5M LiCI 
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2.5M NaC/120%PEG. 
14.61g NaCl 
20ml Polyethylene glycol 
Distilled water to 100mL 
DEPHOSPHORYLATION USING CIP. 
0.12g Tris-HCI 
2.5M NaCl 
20% PEG 
10mM Tris-HCl 
Distilled water to 100m!' Adjust to pH 8.3 with HCl. 
ELECTROPORATION. 
10ml 100% Glycerol 
Distilled water to 100m!' 
ELECTROPORATION OF LIGATED DNA. 
9.814g KAcetate 
Distilled water to 100mi. Adjust to pH 8.0 with 
PREPARATION OF COMPETENT CELLS. 
Solution L 
10mM NaCI 
Solution IL 
100mM CaC12 
MEASURING B-GALACTOSIDASE ACTIVITY. 
lxA medium. 
10.5g K2HP04 
4.5g KH4P04 
1.0g (NH4)2S04 
O.5g NaCitrate.2H20 
Distilled water to 11. Autoclave. 
10% Glycerol 
1M KAacetate 
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ZBuffer. 
0.06M 
0.04M 
O.OIM 
O.OOlM 
0.05M 
Appendix 1. Buffers and Solutions. 
Na2HP04·7H20 
NaH2P04·H20 
KCl 
MgS04·7H20 
p-mercaptoethanol 
pH 7. Do not autoclave. 
1M Na2C03. 
105.99g 
Distilled water to llitre. Do not autoclave. 
SDS-P AGE PROTEIN GEL STOCK SOLUTIONS. 
Monomer Solution (30%T 2. 7%CBis): 
58.4g Acrylimide 
1.6g Bis 
Distilled Water to 200ml. 
Resolving Gel Buffer. 
36.3g Tris-Hel 
Distilled water to 200ml. 
Adjust to pH 8.8 with HC!. 
Stacking Gel Buffer. 
3.0g Tris-Hel 
Distilled water to 50ml. 
Adjust to pH 6.8 with Hel. 
Initiator. 
0.5g Ammonium persulphate (APS) 
Distilled water to 5ml. 
183 
30% Acrilimide 
7% Bis 
1.5M Tris-HCI 
0.5M Tris-Hel 
10% Ammonium 
persulphate 
Appendices. Appendix 1. Buffers and Solutions. 
Resolving Gel Overlay. 
25mI 1.5M TrisHCI 
l.Omi 10% SDS 
Distilled water to 100ml pH 8.8. 
2x Treatment Buffer. 
2.5ml 0.5M Tris-HCI 
4.0ml 10% SDS 
2.0ml Glycerol 
l.Omi 2-mercaptoethanol 
Distilled water to 10mI pH 6.8. 
Tank Buffer. 
12g Tris-HCI 
57.6g 
40ml 
Glycine 
10% SDS 
Distilled water to 4litres pH 8.3. 
Stain Stock. 
2.0g Coomassie Blue R-250 
Distilled water upto 200mi. Stir and filter. 
Stain. 
62.5ml Stain stock 
250ml 100% Methanol 
50ml 100% Acetic acid 
Distilled water to 500ml. 
Destaining Solution 1. 
500ml 100% Methanol 
100mI 100% Acetic acid 
Distilled water to 1 litre. 
184 
0.375M Tris-HCI 
0.1% SDS 
0.125M Tris-HCI 
4% SDS 
20% Glycerol 
10% 2-mercaptoethaol 
0.025M Tris-HCI 
0.192M Glycine 
0.1% SDS 
1% Coomassie 
brilliant blue R-250 
0.125% Coomassie 
brilliant blue R-250 
50% 
10% 
50% 
10% 
Methanol 
Acetic acid 
Methanol 
Acetic acid 
Appendices. 
Destaillillg Solution 2. 
500ml 
700ml 
Appendix 1. Buffers and Solutions. 
100% Methanol 
100% Acetic acid 
5% 
7% 
Distilled water to 10 litres. 
SDS-PAGE Protein Gel Recipes -1.5mm tflick slab gel. 
Separating Gel 
Uniform Gradient 10%-20% 
15% 10% 20% 
30%T2.7%C 15.00mI 5.00mI 1O.00ml 
Separating Gel 
Buffer 7.50mI 3.75ml 3.75ml 
Stacking Gel 
Buffer 
10%SDS 0.30ml O.I50mI O.150mI 
Distilled water 7.00mI 6.00ml l.OOml 
1O%APS 0.10ml 0.05ml 0.05ml 
TEMED O.025mI 0.OI25ml O.0125ml 
Total volume 30.00ml I5.00ml I5.00mI 
Degas fIrst four components prior to adding 10% APS and TEMED. 
Methanol 
Acetic acid 
Stacking Gel 
4%T2.7%C 
1.33ml 
2.50mI 
l.OOmi 
6.l0mI 
0.05ml 
O.025ml 
1O.00ml 
185 
Pour a layer of water-saturated butanolover the separating gel to aid polymerisation. Remove and rinse 
before stacking gel is poured. 
SILVER STAINING. 
Wash 1. 
500ml 
100ml 
100% Methanol Stock 
100% Acetic acid Stock 
Distilled water to 1 litre. 
Wash 2. 
80ml 25% Glutaraldehyde Stock 
Distilled water to 200mL 
50% 
10% 
10% 
Methanol 
Acetic acid 
Glutaraldehyde 
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NaOHStock. 
9ml 1M NaOH 0.36% NaOH 
Distilled water to 100m!' 
Aqueous Silver Nitrate Stock. 
O.2g Silver Nitrate crystals per ml Distilled water. 
Developer Solution. 
10mI 100% Ethanol 
2.5mI 1 % Citric acid 
0.25ml 38% Formaldehyde Stock Solution 
Distilled water to 1 litre. 
Fixer Solution. 
50ml 100% Acetic acid 
Distilled water to 1 litre. 
Staining Solution. 
Add in order with stirring. 
15.3mI 0.36% NaOH 
5% 
Concentrated NH40H. Added dropwise. 
Silver Nitrate Stock. Added dropwise. 
Acetic acid 
1.03ml 
3.0ml 
55.0ml 100% Ethanol. Added slowly with a Pasteur pipette. 
If at anytime the solution went brown while adding Silver Nitrate or 
Ethanol, 
the solution was carefully back titrated with concentrated NH40H until 
clear. 
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SDS-PAGE STOCK SOLUTIONS FOR RESOLUTION OF LOW MOLECULAR 
WEIGHT PROTEINS (Thomas and Kornberg, 1978). 
Separating Gel Buffer. 
72.7g Tris-Hel 3M Tris-Hel 
Distilled water to 200ml 
Adjust to pH 8.8 with Hei. 
Separating Gel AcrylamidelBis Solution. 
75ml 40% Acrylamide stock 30% Acrylamide 
7.5m! 2% Bisacrylamide stock 0.15% Bisacrylamide 
Distilled water to 100mi. 
Stacking Gel Buffer. 
6g Tris-Hel 0.5M Tris-Hel 
Distilled water to 100m! 
Adjust to pH 6.8 with Hei. 
Stacking Gel AcrylamidelBis Solution. 
2.5mI 40% Acrylamide solution 10% Acrylamide 
2.5ml 2% Bisacrylamide 0.5% Bisacrylamide 
Distilled water to 10mi. 
5x Stock Tank Buffer. 
30.2g Tris-Hel 50mM Tris-Hel 
144g Glycine 0.38M Glycine 
50ml 10% SDS 0.1% SDS 
Distilled water to 1 litre. 
Predying Solution. 
400ml 100% Methanol 40% Methanol 
100ml 100% Acetic Acid 10% Acetic acid 
30ml 100% Glycerol 3% Glycerol 
Distilled water to 11itre. 
Appendices. Appendix 1. Buffers and Solutions. 
SDS-PA GE Protein Gel Recipes. 
Solution 
Acrylamide:Bis (30%:0.15) 
Acrylamide:Bis (10%:0.5%) 
Tris-HCI 3M pH8.8 
Tris-HCI 0.5M pH 6.8 
Distilled Water 
TEMED 
10% Ammonium persulphate 
Separating gel 
30ml 
12.5ml 
6.25ml 
O.Olml 
0.5ml 
Degas mixture of first four components prior to adding add 10% SDS and 
10% APS prior to pouring gel. 
PREPARATION AND LABELLIN<;; OF MINI-CELLS. 
20% SucroselM63. 
20g Sucrose 20% 
Ix M63 salts to 100mI. 
BSGBuffer. 
8.5g NaCl 8.5gll 
O.3g KH2P04 0.3g/l 
0.6g Na2HP04 0.6g/l 
O.lg Gelatin O.Ig/l 
Distilled water to 1 litre pH 704. Adjust pH with KOH. 
Storage Buffer. 
0.7g Na2HP04 7g/1 
O.3g KH2P04 O.3g/l 
OAg NaCI 4g/1 
O.OIg MgS04 O.lg/l 
Distilled water to 100mI. 
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Stacking gel 
6ml 
4.8ml 
·8.8ml 
O.OIml 
O.2mI 
Sucrose 
NaCl 
KH2P04 
Na2HP04 
Gelatin 
Na2HP04 
KH2P04 
NaCl 
MgS04 
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MAXICELLS. 
Oo4g Glucose 004% Glucose 
Ix M63 salts to lOOmi. 
AMMONIUM SULPHATE PRECIPITATION. 
6.8g 
Distilled water to 1 litre. 
BULK PREPARATION OF MICROCIN 24 BY NITROCELLOLOSE 
EXTRACTION. 
Stock Solutions. 
l.l4g Na2HP04 
Distilled water to 100ml. 
l.S6g NaH2P04 
Distilled water to 100ml. 
Phosphate Buffer (Wash Buffer). 
7704ml 0.IMNa2HP04 
22.6ml O.1M NaH2P04 
pH 7.4. 
Elution Buffer. 
Iml Triton X-lOO 
1ml O.SMEDTA 
Wash buffer to 100ml. 
GEL FILTRATION. 
Buffer. 
6.8g 
O.IM Na2HP04 
O.IM NaH2P04 
O.IM Phosphate 
0.1M Phosphate 
1% Triton 
SmM EDTA 
SOmM KH2P04 
Distilled water to 1 litre, pH 6.S. Adjust pH with KOH. 
Column. 
lSg Sephadex G-100 12-1Sx Volume 
Soaked in excess buffer for 24 hours. 
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Column Wasil. 
8g NaOH 
Distilled water to 1 litre. 
Column Storage. 
0.02g Sodium Azide 
Buffer to 100ml. 
ION EXCHANGE CHROMATOGRAPHY. 
Start Buffers. 
11.92g HEPES 
O.2M NaOH 
0.02% Sodium Azide 
50mM HEPES 
Distilled water to 1 litre. Adjust to pH 7.6 with NaOH. Use with SP column. 
2.42g Tris-HCI 20mM Tris-HCl 
Distilled water to 1 litre. Adjust to pH 8.2 with HCL Use with Q column. 
Elution Buffer. 
5.84g NaCI 1M NaCI 
Start buffer to 100mL 
Storage Buffers. 
20ml 
6.67ml 
100% Ethanol 
3M NaAcetate pH 4.3 
Distilled water to 100m!' Use with SP column. 
20ml 100% Ethanol 
Distilled water to 100m!' Use with Q column. 
NUCLEASE ACTIVITY ASSAY. 
Stock solutions. 
121.1g Tris-HCI 
Distilled water to 1 litre. Adjust to pH 8.0 with HC!. 
20% Ethanol 
O.2M NaAcetate 
20% Ethanol 
1M Tris-HCI 
29.22g NaCI 5M NaCI 
Distilled water to 100ml. 
24.65g 1M 
Distilled water to 100m!' 
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Reaction Buffer. 
2ml 1M Tris-HCl pH 8.0 20mM Tris-HCl 
1.6ml 5MNaCl 80mM NaCl 
1.0ml 1M MgS04 20mM MgS04 
Distilled water to 10mI. 
Dilution Buffer. 
1.25ml Glycerol 12.5% Glycerol 
lOO1l1 0.5MEDTA 5mM EDTA 
lOOll1 20% SDS 0.2% SDS 
O.OOlg Bromophenol Blue 0.01% Bromophenol Blue 
Distilled water to 10mI. 
H-TOPAGAR. 
109 
8g 
8g 
APPENDIX 2. MEDIA. 
Bacto-tryptone 
NaCI 
Agar 
Distilled water to 1 litre. 
LURIA-BERT ANI MEDIA (LB). 
109 
5g 
5g 
Bacto-tryptone 
Yeast extract 
NaCl 
Distilled water to llitre pH 7.0 - 7.4. 
LBAGAR. 
As above plus 
15g Agar 
20g Agar 
2xYTMEDIA. 
109 Bacto-tryptone 
1 Og Yeast extract 
5g NaCI 
Distilled water to l1itre. 
1% 
0.8% 
0.8% 
1% 
0.5% 
0.5% 
1.5% 
2.0% 
1% 
1% 
0.5% 
Tryptone 
NaCI 
Agar 
Tryptone 
Yeast extract 
NaCl 
Agar 
Agar 
Tryptone 
Yeast extract 
NaCl 
SOC (Electroporation media). 
2g Bact-tryptone 2% Typtone 
0.5g Yeast extract 0.5% Yeast Extract 
200ml 5MNaCI 10mM NaCI 
250ml 1MKCI 2.5mM KCI 
1ml 1M MgCl2 10mM MgCl2 
10ml 0.1 MMgS04 10mM MgS04 
2ml 1M Glucose 20mM Glucose 
Distilled water to 100 ml. 
SUPER BROTH. 
16g Bact -Tryptone 1.6% Tryptone 
109 Yeast Extract 1.0% Yeast Extract 
2.5g NaCI 0.25% NaCI 
Distilled water to 1 litre: 
TBMM. 
109 Bacto-tryptone 1% Tryptone 
5g NaCI 0.5% NaCI 
Distilled water to 980ml. 
Autoclave. 
Add from sterile stock: 
10ml 20% Maltose 0.2% Maltose 
12.5ml 20% MgS04 10mM MgS04 
100MI 1% Thiamine 1Mg/mi Thiamine 
TRYPTONE AGAR. 
109 Bacto-tryptone 1% Tryptone 
8g NaCI 0.8% NaCI 
20g Agar 2% Agar 
Distilled water to 1 litre. 
Appendices. 
M63MEDIA. 
Ix M63 SALTS 
13.6g 
2g 
0.5mg 
Appendix 2. Media. 
KH2P04 
(NH4)2S04 
FeS04·7H20 
Distilled water to 1 litre and autoclave. 
Add/ litre: 
Iml 
0.5ml 
10ml 
20% MgS04 
1 % Thiamine-HCI 
20% Glucose 
M63 / MINIMAL AGAR (MA). 
40g Agar 
Distilled water to I litre and autoclave. 
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O.lM KH2P04 
0.0l5M (N~hS04 
1.8xlO-6M FeS04·7H20 
0.02% MgS04 
0.0005% Thiamine-HCl 
0.2% Glucose 
2% Agar 
Add to I litre Ix M63 salts. When cooled sufficiently add MgS04, 
Thiamine 
and Glucose 
AMINO ACID SUPPLEMENTS FOR MINIMAL MEDIA (Rodriguez and Tait, 
1983). 
Amino acid 
L-arginine 
L-asparagine 
L-aspartic acid 
L-cysteine 
glycine 
L-glutamine 
L-giutamic acid 
L-histidine (free base) 
L-isoleucine 
L-Ieucine 
L-Iysine 
I-methionine 
L-pheny lalanine 
L-proline 
L-serine 
L-threonine 
L-tryptophane 
L-tyrosine 
L-valine 
100x stock solution (mg/ml) 
2 
2* 
10* 
2* 
2 
2 
10 
2 
3 
3 
3 
2 
5 in O.OlN Hel 
2 
37.5 
20 
2* 
3 * in lOmM NaOH 
10 
*. Filter sterilise. All others may be autoclaved. Amino acids dissolved in 
double distilled water unless stated. 
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APPENDIX 3. PRIMERS USED FOR DIDEOXYNUCLEOTIDE SEQUENCING. 
Primer Sequence (5'-3't Reference 
T7 -TAATACGACTCACTATAGGG- Chen and Seeburg, 1985 
T3 -ATTAACCCTCACTAAAGGGA- Chen and Seeburg, 1985 
Sp6 -GATTTAGGTGACACTATAG- Chen and Seeburg, 1985 
BamHlcw -CACTATCGACTACGCGATCA- Wallace, 1981 
BamHlccw -ATGCGTCCGGCGTAGA- Wallace, 1981 
Mini-Tnl OlacZ' -ACGACGTTGTAAAACGACGG- This study 
Mini-TnlOtetA -AAGGCACCTTTGGTCACCAA- This study 
MKBGALl -AAGGGCGATCGGTGCGGGCCTCTTC- M. Kennedy 
813 T32 186-TTTTGAGCAGTTGCTCGAAA-205 This study 
PrimerR5 838-TAATAAGTTAACAAGAATGA-857 This study 
813 K70b 1120-TCTCTCATA TACATCTCCTG-1139 This study 
851 K5b 2879-TCCGGGATAGGTCTGCA TIT -2898 This study 
851 K5ab 2700~TTATTTCTTCTGGAATAATT-2719 This study 
851 T22 2241-AACTACACTACAGACACTGG-2260 This study 
851 T22a 2388-CATAAACAAAGACCAGTT AA-2407 This study 
a. Nucleotide numbers relate to coding strand. 
b. Complementary strand primers. 
APPENDIX 4. PLASMIDS CREATED FOR SEQUENCING. 
The pUC18 fragment in pGA185 and pGA851 corresponds to bases 5'-3690-3740-3' of 
pBR322. 
Restriction Enzymes: B, BamHI; E, EeoRI; P, Pst!; R, EeoRV; S, San; Sa, Sau3AI; 
A. pDELTAl (7.995 kb, Deletion FactoryTM system, BRL). 
SstI 
BglI 
Transposon End 
Bss}ll 
KpnI 
pDELTA1 
7995 bp 
Multiple Cloning Site (MCS). . ............. SftI ...... . 
End 
kan 
• MCS I 
HindIII 
5'-TTCCCAGTCACGACGITGTAAAACGACGGCCAGTGAAITCCCGGGCCATGGAGGCCACGCGTGCGGCCGC 
EcoRI" Slnaf 1VcoI Miui NotI 
GGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGGCGTAATCATGGTCATAGCTGTITCCT-3' 
BamHI '-x"haf Sail Pstl SphI . Hit/1m! 
B. pG~18S (17.258 kb) 
o "Ikb 
I I 
Kpol soeS lean loeZ' tet strA BOll ~ {pol t.......4.....--_~ ~t----GtJf=441===1----F' ~ ~ cos + 
Sp6 T7 
E P S Sa R E R P PP R S Sa S I ____  ____ ~~~----.!~I--~I------I~I!~!-----I~I----~!~!~~ 
pBR322 ~ 
3'~TAGCCTCCTGGCTTCCTCGATTGGCGAAAAAACGTGTTGTACCCCCTAG-
5' 
Sal/3AI pUC18 BamBI 
C. pG~8S1 (11.361 kb) 
o lkb 
I I 
E R P PP R SSa S 
~I ~I!~I ____ ~I!~ __ .I~I~~ 
I 
pUC18 
Appendices. Appendix 4. Plasmids. 
D. pGSK813 (5.113 kb). 
o lkb 
I I 
E SSa R E 
b ~ I 
pBluescript SK M13+ I 
pBR322 
E. pGL\813 (10.24 kb) 
o lkb 
I I 
Kpnl socB kan locZ' tet 00 :rOll ~ ~Kpnl ~~--~ ~I---cos + ~ 
Sp6 /~ T7 
"'E S Sa RES'" 1r I ~ 
pBR322 
5' -GAATTCCCGGGCCATGGAGGCCACGCGTGCGGCCGcrJGATCCTCTAGAGTCGAC-3' 
"EcoRI BamHI 
DuplicationofpDELTAl MCS. 
Sall* 
199 
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APPENDIX 5. RESTRICTION ENZYME SITES IN pGOB18 SEQUENCE. 
ENZYME SEQUENCE CUTTING POSITION TOTAL 
NAME 
A luI AG!CT 217636642 1328 1535 1687228825843678 12 
4609 4929 4933 
ApaI GGGCC!C 1244 
A val C!YCGRG 33555038 2 
Bgll GCCNNNN!NGGC 3247 
BstBI TT!CGAA 3602 
BstEII G!GTNACC 2488 
EcoRI G!AATTC 1908 
EcoRV GAT!ATC 617218222124784 4 
HaeII RGCGC!Y 50465217 2 
HaeIII GG!CC 7501242202628042826286731003219 14 
3241 35543748456046955082 
Hpall CICGG 54136318335 1337 1727 1904 26632864 25 
2895 2954 3180 3480 3532 355635903632 
38784021 45444581 4668469047565058 
KpnI GGTAC!C 27474780 2 
MspI CICGG 54136318335 1337 1727 190426632864 25 
28952954 31803480353235563590 3632 
38784021454445814668469047565058 
NdeI CA!TATG 1332 
NheI G!CTAGC 4929 
PstI CTGCA!G 2562 3737 3892 3 
RsaI GT!AC 68560697 1522 1981 2055214322792745 18 
30223269363839684047419447294747 
4778 
Sail G!TCGAC 5053 
Sau3AI !GATC 1 716 1180 1192 1611 3260333333713476 13 
371937404788 5264 
TaqI T!CGA 201 518 1021 218423003228360237434860 11 
50395054 
XhoI C!TCGAG 5038 
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APPENDIX 6: BLAST SERVER SEQUENCE SIMILARITY COMPARISONS. 
1. MdbA. 
Sequences producing High-scoring Segment Pairs; Reading High 
Frame Score PIN) N 
gilll97456 (U47048) microcin DNA binding pro ... +l 
spIP300l7ISTPA_ECOLI DNA-BINDING PROTEIN STPA. >pirl IJ ... +l 
sp P08936 HNS ECOLI DNA-BINDING PROTEIN H-NS (HISTONE ... +l 
PirllS23868 - gene h-ns protein - Escherichia c ... +l 
pirl S03772 DNA-binding protein H-NS - Escher ... +l 
spIPl8955IHNS_SERMA DNA-BINDING PROTEIN H-NS (HISTONE ... +l 
IPl88l8IHNS_PROVU DNA-BINDING PROTEIN H-NS (HISTONE ... +l 
l54220 (M3789l) histone HI-like protein '" +l 
sp PI7428!HNS_SALTY DNA-BINDING PROTEIN H-NS (HISTONE ... +l 
sp P4384l HNS HAEIN DNA-BINDING PROTEIN H-NS HOMOLOG .... +l 
gi 47036 (Xl3l31) kcpA gene product (AA 1 ... +1 
pdbllHNRI H-Ns (Dna-Binding Domain) (Nmr, M ... +3 
gi 212879 (K02113) vitellogenin [Gallus gal ... -3 
sp P02845IvIT2_CHICK VITELLOGENIN II PRECURSOR (CONTAI ... 3 
gi 212881 (MI8060) vitellogenin [Gallus gal ... -3 
sp P40552IYIBl_YEAST HYPOTHETICAL 26.3 KD PROTEIN IN B ... -3 
gi 1197667 (U46857) vitellogenin [Anolis pul ... -3 
P42505IHVRA_RHOCA TRANS-ACTING REGULATORY PROTEIN H ... +3 
1197665 (U46856) vitellogenin [Anolis pul ... -3 
sp P32323IAGAl_YEAST A-AGGLUTININ ATTACHMENT SUBUNIT P ... -3 
pirllpQ0759 polyprotein turnip mosaic virus ... +1 
gil295671 (LI1275) selected as a weak suppr ... -3 
splp325831SR40_YEAST SUPRESSOR PROTEIN SRP40. >pirl IS3 ... -3 
spIP28738IKINH_MOUSE KINES IN HEAVY CHAIN. >pirl IS37711 ... +1 
gil516516 (U06698) neuronal kinesin heavy c ... +1 
prfl12113194A H ATPase inhibitor [Solanum tuber ... +1 
1459202 (U07055) vitellogenin 1 [Fundulus ... -3 
1 I
S34257 hypothetical protein 4 - Escheric ... +3 
pir A48347 coat protein turnip mosaic viru ... +1 
gil940016 (U25663) coat protein [Turnip mos ... +1 
pirlls11689 coat protein - turnip mosaic viru ... +l 
gil62047 (X52804) coat protein [Turnip yel ... +l 
splp40442IYIQ9_YEAST HYPOTHETICAL 99.7 KD PROTEIN IN S ... -3 
pirllC61615 sericin MG-2 - greater wax moth ( ... -3 
pirlls21499 coat protein - turnip mosaic virus +1 
gil535078 (X65978) coat protein [Turnip mos ... +l 
pirlls48795 troponin Thuman >gi1587434 (X7 ... +1 
gil1200154 (X95759) glycogen (starch) syntha ... +1 
sp P02567IMYSD_CAEEL MYOSIN HEAVY CHAIN D (MHC D). >pi ... +1 
pirllpQ0757 polyprotein - turnip mosaic virus ... +l 
spIPl4328ISP96_DICDI SPORE COAT PROTEIN SP96. >pirl Iso ... -3 
pirlls47179 hypothetical protein - common tob ... +1 
pirllA33513 hypothetical protein B human T- ... +1 
gil746442 (U23455) No definition line found ... +l 
pirlls5l329 coat protein - turnip mosaic viru ... +1 
gi 669069 (Z4824l) C32A3.2 [Caenorhabditis ... +1 
gi l072358 (Z68108) T05AlO.3 [Caenorhabditis ... +1 
sp P425681AF9 HUMAN AF-9 PROTEIN. >gi1306449 (Ll3744) ... -3 
sp Q02224 CENE HUMAN CENTROMERIC PROTEIN E (CENP-E PRO ... +1 
sp P266861sR55=DROME SERINE-ARGININE PROTEIN 55 (SRP55 ... -3 
gi 1072217 (U40946) coded for by C. elegans +1 
sp Pll837INIMA_EMENI G2-SPECIFIC PROTEIN KINASE. >pirl ... +1 
P40480IYIL2_YEAST HYPOTHETICAL l23.6 KD PROTEIN IN ... +1 
171959 (LOI992) myosin-like protein [Sac ... +l 
sp Q02455IMLPl_YEAST MYOSIN-LIKE PROTEIN MLPI. >pirl Is ... +1 
gi 144666 (M37402) [Plasmid ColA, complete +1 
SpIPOll54IPOPI_BOVIN POSTERIOR PITUITARY PEPTIDE. >pir ... +3 
gi ll03869 (U39815) surface coat glycoprotei ... -3 
pirlls28974 vitellogenin precursor silver 1 ... 3 
pirllJQl168 polyprotein - turnip mosaic virus ... +1 
IpI9649ITMPB_TREPA TREPONEMAL MEMBRANE PROTEIN B PRE ... +1 
i I C43592 outer membrane protein TmpB - Tre ... +1 
Q02597IpOLG_TUMVQ GENOME POLYPROTEIN (CONTAINS: N-T ... +1 
P30427IPLEC_RAT PLECTIN. >pirl IS21876 plectin - r ... +1 
452945 (S67069) autoantigen {Clone Rl} [ ... +1 
437639 (L04l59) [Plasmodium falciparum 3 ... +1 
Q01565 I GSQD_ERWCH GENERAL SECRETION PATHWAY PROTEIN ... -3 
PI3816IGARP_PLAFF GLUTAMIC ACID-RICH PROTEIN. >pirl ... +l 
544939 (S68736) myosin heavy chain, MHC ... +l 
sp P45387IHAP_HAEIN ADHESION AND PENETRATION PROTEIN ... +l 
gi 940233 (U32574) myosin heavy chain [Oryc ... +1 
Probability 
855 2.le-lB 
169 9.5e-36 
l55 l.7e-3l 
l55 3.3e-3l 
l49 1.le-30 
l5l 1.4e-29 
157 7.2e-28 
157 1.5e-24 
157 1. 5e-24 
l14 1.2e-21 
Il0 1.ge-2l 
76 3.0e-06 
88 0.0043 
88 0.0057 
88 0.0057 
8l 0.044 
79 0.071 
77 0.082 
77 0.l4 
77 0.18 
76 0.23 
75 0.30 
75 0.30 
75 0.33 
75 0.33 
66 0.33 
75 0.33 
64 0.35 
74 0.38 
74 0.39 
74 0.39 
74 0.39 
74 0.42 
72 0.59 
72 0.59 
72 0.59 
71 0.65 
72 0.66 
72 0.66 
71 0.73 
71 0.75 
54 0.78 
61 0.79 
59 0.8l 
70 0.82 
70 0.83 
70 0.84 
70 0.85 
70 0.88 
62 0.91 
69 0.92 
49 0.94 
69 0.94 
69 0.94 
69 0.94 
67 0.97 
38 0.97 
67 0.98 
68 0.98 
68 0.98 
64 0.98 
64 0.98 
68 0.98 
71 0.998 
66 0.999 
66 0.9991 
66 0.9993 
66 0.9993 
66 0.9994 
66 0.9995 
66 0.9995 
l 
2 
3 
3 
3 
3 
3 
2 
2 
2 
3 
2 
1 
1 
l 
1 
1 
l 
1 
1 
l 
1 
1 
1 
1 
l 
1 
2 
1 
l 
1 
1 
1 
1 
l 
1 
1 
1 
1 
1 
1 
3 
2 
l 
1 
l 
1 
1 
l 
2 
1 
3 
1 
1 
1 
1 
2 
l 
1 
1 
2 
2 
l 
2 
1 
l 
1 
1 
1 
l 
1 
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prf 1I1819485A CENP-E protein [Homo sapiens] +1 66 0.9996 1 
spIQ06666IT2_MOUSE OCTAPEPTIDE-REPEAT PROTEIN T2. >g ... +1 60 0.9996 2 
pir II A35419 neutrophil protein - pig (fragmen ... -3 65 0.9999 1 
gi1155172 (L08499) nitrogen regulator 1 [Vi. .. +1 65 0.99991 1 
sp PI9906INTRB_VIBAL NITROGEN REGULATION PROTEIN NTRB. +1 65 0.99991 1 
pir II JL0114 ntrB protein Vibrio +1 65 0.99991 1 
pir I I S33068 myosin II heavy chain - +1 65 0.99995 1 
gi 111067 (X65591) myosin II heavy +1 65 0.99995 1 
gil1197456 (U47048) microcin DNA binding protein [Escherichia colil Length = 171 
Plus Strand HSPs: Score = 855 (393.3 bits), Expect = 2.1e-113, P = 2.1e-113 
Identities = 171/171 (100%), Positives = 171/171 (100%), Frame +1 
Query: 1 MSELTKEDEYGI ISRTMMNIRSLRVFARE IDFEQLLEMQEKLNVVIEERREDAEREAAER 
MSELTKEDEYGIISRTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDAEREAAER 
Sbjct: 1 MSELTKEDEYGIISRTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDAEREAAER 
Query: 181 AERERKRQELLQLIAGEGFSPEELLGLSEEAPKSRKKTLPKPRLNISLKKMVKRNTGLVV 
AERERKRQELLQLIAGEGFSPEELLGLSEEAPKSRKKTLPKPRLNISLKKMVKRNTGLVV 
Sbjct: 61 AERERKRQELLQLIAGEGFSPEELLGLSEEAPKSRKKTLPKPRLNISLKKMVKRNTGLVV 
Query: 361 DVRQNQLLKHWQVVVLLMSFSSRNDSTALLFSGGLYPLKHTCQPILYKCYV 513 
DVRQNQLLKHWQVVVLLMSFSSRNDSTALLFSGGLYPLKHTCQPILYKCYV 
Sbjct: 121 DVRQNQLLKHWQVVVLLMSFSSRNDSTALLFSGGLYPLKHTCQPILYKCYV 171 
>spIP30017ISTPA_ECOLI DNA-BINDING PROTEIN STPA. >pir11JH0774 stpA protein -
Escherichia coli >gi143008 (X69210) H-NS-like protein [Escherichia 
coli1 >gi1469172 (U07823) H-NSB [Escherichia coli]. Length = 134 
180 
60 
360 
120 
Plus Strand HSPs: Score = 169 (77.7 bits), Expect = 9.5e-36, Sum P(2) = 9.5e-36 
Identities = 36/80 (45%), Positives = 52/80 (65%), Frame = +1 
Query: 34 IISRTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDAEREAAERAERERKRQELL 213 
++ +++ NIR+LRARE +'L EM EK VV +ERRE+ E++ E AER+ K L 
Sbjct: 3 VMLQSLNNIRTLRAMAREFSIDVLEEMLEKFRVVTKERREEEEQQQRELAERQEKISTWL 62 
Query: 
Sbjct: 
214 QLIAGEGFSPEELLGLSEEA 273 
+L+ +G +PEELLG S A 
63 ELMKADGINPEELLGNSSAA 82 
Score = 42 (19.3 bits), Expect 4.8e-13, Sum P(2) = 4.8e-13 
Identities 16/59 (27%), positives = 26/59 (44%), Frame +1 
Query: 130 VVIEERREDAEREAAERAERERKRQELLQLIAGEGFSPEELLGLSEEAPKSRKKTLPKP 306 
V E R E+ +++ +E+ L + A E L S AP++ KK P+P 
Sbjct: 36 VTKERREEEEQQQRELAERQEKISTWLELMKADGINPEELLGNSSAAAPRAGKKRQPRP 94 
>splp08936IHNS_ECOLI DNA-BINDING PROTEIN H-NS (HISTONE-LIKE PROTEIN HLP-II) 
(PROTEIN HI) (PROTEIN Bl). >splp0912oIHNS_SHIFL DNA-BINDING PROTEIN 
H-NS (PATHOGENESIS PROTEIN KCPA). >pirl IS09325 DNA-binding protein 
drdx - Escherichia coli >pirl IS00903 DNA-binding protein H-NS -
Escherichia coli >Pirl IS23789 histone-like protein H-NS 
Escherichia coli >pir S24755 DNA-binding protein H-NS - Shigella 
flexneri >pirl IS28633 DNA-binding protein H-NS - Escherichia coli 
>gi141736 (X07688) hns gene (AA 1-137) [Escherichia coli] >gi142027 
(X59940) histone-like protein H-NS [Escherichia coli] >gi142183 
(X57231) DNA-binding protein OsmZ [H-NS (H1a)] [Escherichia colil 
>gi147070 (X66848) pid:g47070 [Shigella flexneri] >prf111607341A 
drdX gene [Escherichia coli] Length = 137 
Plus Strand HSPs: Score = 155 (71.3 bits), Expect 1.7e-31, Sum P(3) = 1.7e-31 
Identities = 34/71 (47%), positives = 44/71 (61%), Frame +1 
Query: 43 RTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDAEREAAERAERERKRQELLQLI 222 
+ + NIR+LR ARE E L EM EKL VV+ ERRE+ AAE ER RK Q+ +++ 
Sbjct: 6 KILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEESAAAAEVEERTRKLQQYREML 65 
Query: 223 AGEGFSPEELL 255 
+G P ELL 
Sbjct: 66 IADGIDPNELL 76 
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>pirl IS23868 gene h-ns protein - Escherichia coli >gi143078 (X67326) H-ns[Escherichia 
coli) 
Length = 135 
Plus Strand HSPs: Score = 155 (71.3 bits), Expect = 3.3e-31, Sum P(3) 3.3e-31 
Identities 34/71 (47%), Positives 44/71 (61%), Frame = +1 
Query: 43 RTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDAEREAAERAERERKRQELLQLI 222 
+ + NIR+LR ARE E L EM EKL VV+ ERRE+ AAE ER RK Q+ +++ 
Sbjct: 6 KILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEESAAAAEVEERTRKLQQYREML 65 
Query: 223 AGEGFSPEELL 255 
+G P ELL 
Sbjct: 66 IADGIDPNELL 76 
>pirl IS03772 DNA-binding protein H-NS Escherichia coli Length 136 
plus Strand HSPs: Score 149 (68.5 bits), Expect 1.le-30, Sum P(3) = 1.le-30 
Identities = 33/71 (46%), Positives = 43/71 (60%), Frame +1 
Query: 43 RTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDAEREAAERAERERKRQELLQLI 222 
+ + NIR+LR ARE E L M EKL VV+ ERRE+ AAE ER RK Q+ +++ 
Sbjct: 5 KILNNIRTLRAQARECTLETLERMLEKLEVVVNERREEESAAAAEVEERTRKIQQYREML 64 
Query: 223 AGEGFSPEELL 255 
+G P ELL 
Sbjct: 65 IADGIDPNELL 75 
Ip18955IHNS_SERMA DNA-BINDING PROTEIN H-NS (HISTONE-LIKE PROTEIN HLP-II). 
1 IS02775 DNA-binding protein H-NS - Serratia marcescens Length = 135 
Strand HSPs: Score = 151 (69.5 bits), Expect = 1.4e-29, Sum P(3) 1.4e-29 
Identities 33/71 (46%), Positives 44/71 (61%), Frame = +1 
Query: 
Sbjct: 
Query: 
Sbjct: 
43 RTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDARREAAERAERERKRQELLQLI 222 
+ + NIR+LR ARE E L EM EKL VV+ ERRE+ + AR ER RK Q+ +++ 
6 KILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEDSQAQAEIEERTRKLQQYREML 65 
223 AGEGFSpEELL 255 
+G P ELL 
66 IADGIDPNELL 76 
>spIP18818IHNs_pROVU DNA-BINDING PROTEIN H-NS (HISTONE-LIKE PROTEIN HLP-II). 
>pirl IS02776 DNA-binding protein H-NS - proteus vulgaris Length = 134 
plus Strand HSPs: Score 157 (72.2 bits), Expect 7.2e-28, Sum P(3) = 7.2e-28 
Identities = 35/88 (39%), Positives = 51/88 (57%), Frame +1 
Query: 43 RTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDAEREAAERAERERKRQELLQLI 222 
+ + NIR+LR ARE E L EM EKL VV+ ERRE+ + AE ER++K Q+ +L+ 
Sbjct: 6 KILNNIRTLRAQARETSLETLEEMLEKLEVVVNERREEEQAMQAEIEERQQKLQKYRELL 65 
Query: 
Sbjct: 
223 AGEGFSPEELLGLSEEAPKSRKKTLPKp 306 
+G P +LL + + R K +P 
66 IADGIDPTDLLEAAGASKTGRAKRAARP 93 
1154220 (M37891) histone H1-like protein (H-NS) [Salmonella typhimuriuml Length 137 
Strand HSPs: Score = 157 (72.2 bits), Expect 1.5e-24, Sum p(2) = 1.5e-24 
Identities = 36/82 (43%), positives 46/82 (56%), Frame = +1 
Query: 43 RTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDAEREAAERAERERKRQELLQLI 
+ + NIR+LR ARE E L EM EKL VV+ ERRE+ AAE ER RK Q+ +++ 
Sbjct: 6 KILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEESAAAAEVEERTRKLQQYREML 
Query: 223 AGEGFSPEELLGLSEEAPKSRK 288 
+G P ELL A K 
Sbjct: 66 IADGIDPNELLNSMAAAKSGTK 87 
>Splp17428IHNS_SALTY DNA-BINDING PROTEIN H-NS (HISTONE-LIKE PROTEIN HLP-II) 
(PROTEIN HI) (PROTEIN B1). >pirl IS10155 DNA-binding protein H-NS -
Salmonella typhimurium.>giI47736 (X14375) H-NS protein (AA 1-137) 
[Salmonella typhimuriuml Length 137 
222 
65 
plus Strand HSPs: Score 157 (72.2 bits), Expect 1.5e-24, Sum P(2) = 1.5e-24 
Identities = 36/82 (43%), positives = 46/82 (56%), Frame +1 
Query: 43 RTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDAEREAAERAERERKRQELLQLI 222 
+ + NIR+LR ARE E L EM EKL VV+ ERRE+ AAE ER RK Q+ +++ 
Sbjct: 6 KILNNIRTLRAQARECTLETLEEMLEKLEVVVNERREEESAAAAEVEERTRKLQQYREML 65 
Query: 223 AGEGFSPEELLGLSEEAPKSRK 288 
+G P ELL A K 
Sbjct: 66 IADGIDPNELLNSMAAAKSGTK 87 
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>splp43841IHNS~HAEIN DNA-BINDING PROTEIN H-NS HOMOLOG. >pirl ID64131 DNA-binding 
protein H-NS (hns) homolog - Haemophilus influenzae (strain Rd K,v20) 
>gi11007825 (L46217) DNA-binding protein H-NS (Haemophilus influenzae] 
>gi11205819 (U00085) DNA-binding protein H-NS [Haemophilus influenzae] 
11221730 (U32779) DNA-binding protein [Haemophilus influenzae] Length 134. 
strand HSPs: Score ~ 114 (52.4 bits), Expect 1.2e-21, Sum P(2) ~ 1.2e-21 
Identities = 26/70 (37%), positives ~ 37/70 (52%), Frame = +1 
Query: 43 RTMMNIRSLRVFAREIDFEQLLEMQEKLNVVIEERREDAEREAAERAERERKRQELLQLI 222 
R + N+RSLR RE+ EQ EKL IEE+R + ER+ + + +L+ 
Sbjct: 6 RGLTNLRSLRAAVRELTLEQAENALEKLQTAIEEKRANEAELIKAETERKERLAKYKELM 65 
Query: 223 AGEGFSPEEL 252 
EG +PEEL 
Sbjct: 66 EKEGITPEEL 75 
>gi147036 (X13131) kcpA gene product (AA 1 - 109) [Shigella flexneril Length = 109 
plus strand HSPs: Score 110 (50.6 bits), Expect 1.ge-21, Sum P(3) 1.ge-21 
Identities = 23/48 (47%), positives 30/48 (62%), Frame ~ +1 
Query: 112 MQEKLNVVIEERREDAEREAAERAERERKRQELLQLIAGEGFSPEELL 255 
M EKL VV+ ERRE+ AAE ER RK Q+ +++ +G P ELL 
Sbjct: 1 MLEKLEVVVNERREEESAAAAEVEERTRKLQQYREMLIADGIDPNELL 48 
2. Mtfl. 
Sequences producing High-scoring Segment Pairs: 
gi 11197457 
Ip24884INU5M~ASCSU 
II B26696 
pir 11A35349 
gi 11109903 
pir II S43955 
gil1022918 
sp p24499IATP6~TRYBB 
gil343544 
gil786217 
Ip384591YM16_MARPO 
1992700 
pir II S34960 
gi1501027 
pir II E22845 
gi1662891 
pirllA27507 
pirllS55409 
splp09045INU1M~LOCMI 
pir llC30010 
g i 1758171 
gi 1872064 
pir II B21124 
gil436923 
SPP39109IYCFI~YEAST 
pir II S51863 
gil336843 
pat lusI5429921 17 
Ip15583 I NU5M_LEITA 
II S51910 
gi 11171589 
High 
Score 
+1 
+3 
+1 
+1 
+2 
+3 
+1 
Probability 
peN) N 
495 2.7e-63 
42 lo5e-05 
52 2.0e-05 
55 0.0015 
37 0.0017 
44 0.016 
55 0.021 
46 0.28 
46 0.29 
41 0.31 
41 0.33 
57 0.41 
51 0.45 
54 0.47 
49 0.78 
42 0.80 
44 0.95 
37 0.95 
44 0.98 
44 0.992 
46 0.992 
41 0.992 
62 0.995 
52 0.997 
46 0.998 
46 0.998 
39 0.998 
45 0.998 
61 0.9993 
47 0.9998 
42 0.9998 
>gi11197457 (U47048) microcin 24 immunity protein [Escherichia coli] Length 93 
Plus Strand HSPs: Score = 495 (227.7 bits), Expect ~ 2.7e-63, P 2.7e-63 
Identities = 93/93 (100%), Positives = 93/93 (100%), Frame +1 
Query: 
Sbjct: 
Query: 
Sbjct: 
1 MSFLNFAFSPVFFSIMACYFIV>VRNKRNEFVCNRLLSIIIISFLICFIYP>VLNYKIEVKY 180 
MSFLNFAFSPVFFSlMACYFIV>VRNKRNEFVCNRLLSIIIISFLICFIYP>VLNYKIEVKY 
1 MSFLNFAFSPVFFSlMACYFIVWRNKRNEFVCNRLLSIIIISFLICFIYPWLNYKIEVKY 60 
181 YIFEQFYLFCFLSSLVAVVINLIVYFILYRRCI 279 
YIFEQFYLFCFLSSLVAVVINLIVYFILYRRCI 
61 YIFEQFYLFCFLSSLVAVVINLIVYFILYRRCI 93 
204 
1 
4 
3 
3 
4 
3 
2 
3 
3 
3 
3 
2 
3 
2 
2 
3 
3 
3 
3 
3 
2 
3 
1 
2 
3 
3 
3 
3 
1 
2 
3 
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>sp1P24884 I NUSM_ASCSU NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 5. 
Score 41 (18.9 bits), Expect = 1.Se-OS, Sum P(4) 1.Se-OS 
Identities = 8/19 (42%), positives 12/19 (63%), Frame = +1 
Query: 181 YIFEQFYLFCFLSSLVAVV 237 
Y F FC+LSSL+ ++ 
Sbjct: 155 YYFLSLSFFCWLSSLMLLL 173 
Score 40 (18.4 bits), Expect = 6.9, Sum P(3) = 1.0 
Identities 8/17 (47%), Positives 9/17 (52%), Frame +1 
Query: 
Sbjct: 
10 LNFAFSPVFFSIMACYF 60 
L F FS F + AC F 
350 LEFFFSNFFMVVFACMF 366 
Score = 38 (17.5 bits), Expect loSe-OS, Sum P(4) loSe-OS 
Identities = S/17 (47%), Positives = 12/17 (70%), Frame = +1 
Query: 
Sbjct: 
229 AVVINLIVYFILYRRCI 279 
+VVI L+++F L CI 
516 SVVIVLVLFFFLVWGCI 532 
Score = 34 (15.6 bits), Expect 0.00033, Sum P(4) = 0.00033 
Identities 6/11 (54%), positives = 8/11 (72%), Frame = +1 
Query: 
Sbjct: 
196 FYLFCFLSSLV 228 
F+LF F SS + 
141 FFLFVFFSSTI 151 
Score = 34 (15.6 bits), Expect = 3.0, Sum P(3) 0.95 
Identities 7/19 (36%), Positives = 12/19 (63%), Frame +1 
Query: 91 VCNRLLSIIIISFLICFIY 147 
V LS++++ F r FI+ 
Sbjct: 399 VVMNFLSLLLVLFSIFFIW 417 
Score = 33 (15.2 bits), Expect = 1.Se-05, Sum P(4) = 1.5e-05 
Identities 8/14 (57%), positives 9/14 (64%), Frame +1 
Query: 7 FLNFAFSPVFFSIM 48 
FL+F S F SIM 
Sbjct: 37 FLSFKISVYFNSIM 50 
Score 32 (14.7 bits), Expect = 1.5e-OS, Sum P(4) 1.Se-OS 
Identities = 6/29 (20%), Positives 16/29 (55%), Frame +1 
Query: 
Sbjct: 
103 LLSIIIISFLICFIYPWLNYKIEVKYYIF 189 
L+ +++ ++ F +L+ ++ YY F 
53 LILLLVTISVLVFSTYYLSGELNFNYYYF 81 
>pirl IB26696 hypothetical protein 1 (CYb-COII intergenic region) - Sauroleishmania 
tarentolae mitochondrion (S8C6) (fragment) 
205 
>gi1S962S6 (M10126) NH2 terminus uncertain [Sauroleishmania tarentolael Length 443 
plus Strand HSPs: Score = 52 (23.9 bits), Expect = 2.0e-05, Sum P(3) = 2.0e-OS 
Query: 
Sbjct: 
Identities 10/33 (30%), positives lS/33 (54%), Frame +1 
166 IEVKYYIFEQFYLFCFLSSLVAVVINLIVYFIL 264 
I K YIF + F + SL +++ ++ YF + 
276 ISTKNYIFYMYLNFHLIYSLSLIILIILYYFFI 30S 
Score 45 (20.7 bits), Expect = 2.0e-OS, Sum P(3) = 2.0e-OS 
Identities = 9/15 (60%), Positives 10/15 (66%), Frame = +1 
Query: 
Sbjct: 
103 LLSIIIISFLICFIY 147 
L HI LICFIY 
216 LFCFILIILLICFIY 230 
Score = 37 (17.0 bits), Expect = 2.0e-OS, Sum P(3) 2.0e-OS 
Identities 9/21 (42%), Positives 12/21 (57%), Frame = +1 
Query: 7 FLNFAFSPVFFSIMACYFIVW 69 
FLNF VF 1+ Y I++ 
Sbjct: 71 FLNFDTRFVFMIIIMQYIIIF 91 
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Score = 33 (15.2 bits), Expect = 1.3, Sum P(3) = 0.73 
Identities = 6/26 (23%), Positives 15/26 (57%), Frame +1 
Query: 
Sbjct: 
190 EQFYLFCFLSSLVAVVINLIVYFILY 267 
+ + + +L+ + ++LI+ ILY 
279 KNYIFYMYLNFHLIYSLSLIILIILY 304 
206 
>pirl IA35349 H+-transporting ATP synthase (EC 3.6.1.34) protein 6 - Trypanosoma brucei 
mitochondrion (SGC6) Length = 214 
Plus Strand HSPs: Score 55 (25.3 bits), Expect = 0.0015, Sum P(3) = 0.0015 
Identities = 10/29 (34%), positives 18/29 (62%), Frame = +1 
Query: 
Sbjct: 
178 YYIFEQFYLFCFLSSLVAVVINLIVYFIL 264 
Y+IF F+L+CFL + + ++ FI+ 
166 YFIFVFFFLWCFLLLIYFIYFCVLFLFII 194 
Score = 36 (16.6 bits), Expect 0.0015, Sum P(3) 0.0015 
Identities 8/38 (21%), Positives = 17/38 (44%), Frame = +1 
Query: 31 VFFSIMACYFIVWRNKRNEFVCNRLLSIIIISFLICFI 144 
+ F + C+ + N V + + + I L+CF+ 
Sbjct: 94 IAFLFLFCFLCDFFLFNNLLVGDSFMDVFFIRPLLCFL 131 
Score = 32 (14.7 bits), Expect = 0.011, Sum P(3) 0.011 
Identities 7/17 (41%), positives = 8/17 (47%), Frame = +1 
Query: 
Sbjct: 
3. MtfS. 
94 CNRLLSIIIISFLICFI 144 
C L I FL CF+ 
87 CIVFLLYIAFLFLFCFL 103 
Sequences producing High-scoring Segment Pairs: Reading High Probability 
Frame Score peN) N 
gil1197458 (U47048) microcin 24 precursor [E ... +1 
sp P04052 I RPB1_DROME DNA-DIRECTED RNA POLYMERASE II LA ... +2 
pirllS24066 protein-tyrosine kinase (EC 2.7.1 ... +1 
splp355901TIE1_HUMAN TYROSINE-PROTEIN KINASE RECEPTOR +1 
spIQ06805ITIE1_BOVIN TYROSINE-PROTEIN KINASE RECEPTOR ... +1 
pir11A36734 bacillopeptidase F (EC 3.4.21.-) ... +1 
gi 1139531 (D44498) 90k-protease (bacillopep ... +1 
P36329IpOLS_EEVV3 STRUCTURAL POLYPROTEIN (CONTAINS: ... -1 
554636 (L00930) polyprotein [Venezuelan .. . 1 
sp P09592IpOLS_EEVVT STRUCTURAL POLYPROTEIN (CONTAINS: ... 1 
pir VHWVVT structural polyprotein Venezuel ... -1 
gil 
SPIP42345IFRAP_HUMAN 
splP42346 FRAP_RAT 
pirlls45340 
prf 12014422A 
pir IS37671 
pir S36152 
pir S41525 
splp056741 pOLS_EEVV8 
splp36332IpOLS_EEVVP 
p ir 11A38096 
pir llA41736 
gil29470 
pirllA41793 
gi 306708 
sp p42659 I DPP6_BOVIN 
sp P42658 DPP6 HUMAN 
sp P22567IARGA_PSEAE 
gi 993017 
gi 993016 
pir II A27598 
Splp08148 I GP63_LEIMA 
P10264 GAG2 HUMAN 
1196427 
gi 190164 
sp P25054IAPC_HUMAN 
pir 11B39658 
gil887448 
pir lls55202 
gi 300249 
gi 1049102 
644882 
817954 
(X89453) pid:e188462 [Rattus norv ... -2 
FKBP-RAPAMYCIN ASSOCIATED PROTEIN ... +2 
FKBP-RAPAMYCIN ASSOCIATED PROTEIN ... +2 
FKBP-rapamycin-associated protein .. . +2 
FKBP-rapamycin-associated protein ... +2 
bat2 protein - human >gi129375 (Z ... -2 
bat2 protein - human -2 
major ring-forming surface protei ... +1 
STRUCTURAL POLYPROTEIN (CONTAINS: ... 1 
STRUCTURAL POLYPROTEIN (CONTAINS: ... -1 
heparan sulfate proteoglycan HSPG ... +1 
heparan sulfate proteoglycan prec ... +1 
(X62515) Human basement membrane ... +1 
dipeptidyl aminopeptidase-like pr ... +1 
(M96860) dipeptidyl aminopeptidas ... +1 
DIPEPTIDYL PEPTIDASE IV LIKE PROT ... +1 
DIPEPTIDYL PEPTIDASE IV LIKE PROT ... +1 
AMINO-ACID ACETYLTRANSFERASE (N-A... +3 
(X87246) alternative start codon '" -1 
(X87246) alternative start codon ... -1 
major surface antigen precursor - ... +1 
LEISHMANOLYSIN PRECURSOR (CELL SU ... +1 
RETROVIRUS-RELATED GAG POLYPROTEI ... +1 
(M14123) gag 2 protein [Homo sapi ... +1 
(M73548) polyposis locus-encoded '" -1 
ADENOMATOUS POLYPOSIS COLI PROTEI ... -1 
polyposis coli protein DP2.5 - hu ... -1 
(X72791) pid:e185416 [Human endog ... +1 
hypothetical protein YJR83.24 - y ... -1 
(S60312) DMR-N9 {C-terminal} [mic ... -1 
(U31777) atrophin-1 [Rattus norve ... -2 
(D45419) HCF [Mesocricetus auratus] 
(Z38011) pid:g817954 [Mus musculus] 
+1 
-1 
394 2.7e-49 
37 0.0046 
44 0.0083 
44 0.0083 
44 0.015 
46 0.030 
46 0.030 
42 0.032 
42 0.034 
42 0.056 
42 0.056 
37 0.067 
38 0.085 
38 0.085 
38 0.085 
38 0.085 
41 0.15 
41 0.15 
36 0.16 
42 0.27 
42 0.27 
40 0.41 
40 0.41 
40 0.41 
37 0.61 
37 0.61 
37 0.66 
37 0.66 
36 0.70 
41 0.73 
41 0.73 
36 0.82 
36 0.82 
46 0.83 
46 0.85 
47 0.85 
47 0.86 
47 0.86 
46 0.95 
62 0.97 
48 0.97 
37 0.97 
39 0.98 
48 0.98 
1 
4 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
2 
2 
2 
2 
2 
2 
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2 
3 
3 
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P03186ITEGU_EBV LARGE TEGUMENT PROTEIN. >pirl IQQB ... +3 39 0.996 
290623 (L04599) envelope glycoprotein [V ... -1 38 0.999 
291946 (L12398) dopamine receptor D4 [Ho ... +3 36 0.999 
191992 (M88127) APC [Mus musculus] -1 47 0.9993 
gi 915326 (U23851) atrophin-1 [Homo sapiens] -3 35 0.9998 
pir II S5 0832 DRPLA protein human -3 35 0.9998 
gil862330 (D31840) DRPLA product [Homo ... -3 35 0.9998 
IIA53689 transcription ITF2 rat ( ... +1 45 0.9998 
IS41735 cholesterol esterase - yeast (Can ... 2 36 0.9999 
gi 157018 (L06475) brain-specific homeobox ... +1 60 0.9999 
sp P359141HMGL HUMAN HYDROXYMETHYLGLUTARYL-COA LYASE P ... +1 49 0.99990 
sp P32947 LIP3_CANRU LIPASE 3 PRECURSOR. >pi r 11JN0551 ... -2 36 0.99993 
gi 1212992 (X90568) Protein sequence and ann ... +1 42 0.99994 
>gi11197458 (U47048) microcin 24 precursor [Escherichia coli] Length = 90 
Plus Strand HSPs: Score = 394 (181.2 bits), Expect = 2.7e-49, P = 2.7e-49 
Identities = 74/74 (100%), positives = 74/74 (100%), Frame +1 
Query: 
Sbjct: 
Query: 
Sbjct: 
1 AGDPLADPNSQIVRQIMSNAAWGPPLVPERFRGMAVGAAGGVTQTVLQGAAAHMPVNVPI 180 
AGDPLADPNSQIVRQIMSNAAWGPPLVPERFRGMAVGAAGGVTQTVLQGAAAHMPVNVPI 
17 AGDPLADPNSQIVRQIMSNAAWGPPLVPERFRGMAVGAAGGVTQTVLQGAAAHMPVNVPI 76 
181 PKVPMGPSWNGSKG 222 
PKVPMGPSWNGSKG 
77 PKVPMGPSWNGSKG 90 
>splp04052 I RPBl_DROME DNA-DIRECTED RNA POLYMERASE II LARGEST SUBUNIT. 
>pirl IRNFF2L DNA-directed RNA polymerase (EC 2.7.7.6) II 215K chain 
207 
3 
3 
3 
2 
3 
3 
3 
2 
3 
1 
2 
3 
3 
- fruit fly (Drosophila melanogaster) >gi1158332 (M27431) RNA polymerase II [Drosophila 
melanogaster] Length = 1896 
Plus Strand HSPs: 
Score = 34 (15.6 bits), Expect = 0.0046, Sum P(4) = 0.0046 
Identities 6/11 (54%), positives 8/11 (72%), Frame = +1 
Query: 190 PMGPSWNGSKG 222 
P PS++GS G 
Sbjct: 1765 PPSPSYDGSPG 1775 
Score = 31 (14.3 bits), Expect = 0.0046, Sum P(4) = 0.0046 
Identities 5/9 (55%), positives = 7/9 (77%), Frame = +1 
Query: 
Sbjct: 
4 GDPLADPNS 30 
GD +ADP + 
682 GDTIADPQT 690 
>pirl IS24066 protein-tyrosine kinase (EC 2.7.1.112) Tie - human >gi1512414 (A16753) tie 
receptor tyrosine kinase gene product [Homo sapiens] 
lusI544786018 Sequence 8 from patent US 5447860 Length = 1138 
Strand HSPs: Score = 44 (20.2 bits), Expect = 0.0083, Sum P(3) 0.0083 
Identities = 7/10 (70%), Positives = 9/10 (90%), Frame = +1 
Query: 
Sbjct: 
61 AWGPPLVPER 90 
AWGPPL+ E+ 
56 AWGPPLLLEK 65 
Score 35 (16.1 bits), Expect = 0.0083, Sum P(3) = 0.0083 
Identities = 6/10 (60%), positives = 8/10 (80%), Frame +1 
Query: 166 VNVPIPKVPM 195 
VNV +P VP+ 
Sbjct: 441 VNVKVPPVPL 450 
>SpIP35590 ITIE1_HUMAN TYROSINE-PROTEIN KINASE RECEPTOR TIE-1 PRECURSOR. 
>gi 396815 (X60957) receptor tyrosine kinase [Homo sapiens] Length = 1138 
plus Strand HSPs: Score = 44 (20.2 bits), Expect = 0.0083, Sum P(3) = 0.0083 
Identities 7/10 (70%), positives = 9/10 (90%), Frame = +1 
Query: 
Sbjct: 
61 AWGPPLVPER 90 
AWGPPL+ E+ 
56 AWGPPLLLEK 65 
Score 35 (16.1 bits), Expect = 0.0083, Sum P(3) = 0.0083 
identities = 6/10 (60%), positives 8/10 (80%), Frame +1 
Query: 
Sbjct: 
166 VNVPIPKVPM 195 
VNV +P VP+ 
441 VNVKVPPVPL 450 
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>spIQ06805ITIE1_BOVIN TYROSINE-PROTEIN KINASE RECEPTOR TIE-1 PRECURSOR. 
>pirl IS32690 protein-tyrosine kinase (EC 2.7.1.112) Tie-1 precursor - bovine 
>gi1296576 (X71423) receptor tyrosine kinase [Bas taurus] Length 1136 
Plus Strand HSPs: Score 44 (20.2 bits), Expect = 0.015, Sum P(3) 0.015 
Identities 7/10 (70%), positives = 9/10 (90%), Frame = +1 
Query: 
Sbjct: 
61 AWGPPLVPER 90 
AWGPPL+ E+ 
56 AWGPPLLLEK 65 
Score 34 (15.6 bits), Expect = 0.015, Sum P(3) = 0.015 
Identities = 5/10 (50%). Positives 8/10 (80%), Frame +1 
Query: 
Sbjct: 
166 VNVPIPKVPM 195 
+NV +P VP+ 
439 INVKVPPVPL 448 
>pirl IA36734 bacillopeptidase F (EC 3.4.21.-) precursor - Bacillus subtilis 
>gi1143308 (M29035) bacillopeptidase F [Bacillus subtilisl Length = 1433 
Plus Strand HSPs: Score 46 (21.2 bits), Expect = 0.031, Sum P(3) 0.030 
Identities 8/27 (29%), positives = 13/27 (48%), Frame = +1 
Query: 19 DPNSQIVRQIMSNAAWGPPLVPERFRG 99 
D +V I + W P + E++RG 
Sbjct: 217 DGTGTVVASIDTGVEWNHPALKEKYRG 243 
>gi11139531 (D44498) 90k-protease (bacillopeptidase F) 
Plus Strand HSPs: Score = 46 (21.2 bits), Expect 
Identities = 8/27 (29%), positives 
Query: 19 DPNSQIVRQIMSNAAWGPPLVPERFRG 99 
D +V I + W P + E++RG 
Sbjct: 217 DGTGTVVASIDTGVEWNHPALKEKYRG 243 
[Bacillus subtilisl Length 
0.031, Sum P(3) 0.030 
13/27 (48%), Frame +1 
208 
1433 
>splp42345IFRAP_HUMAN FKEP-RAPAMYCINASSOCIATED PROTEIN (FRAP) (RAPAMYCIN TARGET 
PROTEIN). >gi1508482 (L34075) FKBP-rapamycin associated protein [Homo sapiens] Length 
2549 
Plus Strand HSPs: 
Score 36 (16.6 bits), Expect = 0.089, Sum P(3) = 0.085 
Identities 5/16 (31%), Positives = 10/16 (62%), Frame +1 
Query: 
Sbjct: 
7 DPLADPNSQIVRQIMS 54 
DP DPN ++ +++ 
785 DPDPDPNPGVINNVLA 800 
>spIP42346IFRAP_RAT FKBP-RAPAMYCIN ASSOCIATED PROTEIN (FRAP) (RAPAMYCIN TARGET PROTEIN). 
>pirl IA54837 rapamycin/FKBP12 target 1 - rat 
>gi1511229 (Ul1681) rapamycin and FKBP12 target-1 protein [Rattus norvegicus] 
>gi1561858 (L37085) rapamycin target [Rattus norvegicus] Length = 2549 
Plus Strand HSPs: 
Score = 36 (16.6 bits), Expect 0.089, Sum P(3) 0.085 
Identities 5/16 (31%), positives = 10/16 (62%), Frame +1 
>pirl IS45340 FKBP-rapamycin-associated protein (FRAP) human Length 2549 
Plus Strand HSPs: 
Score 36 (16.6 bits), Expect = 0.089, Sum P(3) = 0.085 
Identities 5/16 (31%), positives 10/16 (62%), Frame +1 
Query: 
Sbjct: 
7 DPLADPNSQIVRQIMS 54 
DP DPN ++ +++ 
785 DPDPDPNPGVINNVLA 800 
>prfl 12014422A FKBP-rapamycin-associated protein [Homo sapiens] Length 2549 
Plus Strand HSPs: 
Score 36 (16.6 bits), Expect = 0.089, Sum P(3) = 0.085 
Identities 5/16 (31%), positives = 10/16 (62%), Frame +1 
Query; 
Sbjct: 
7 DPLADPNSQIVRQIMS 54 
DP DPN ++ +++ 
785 DPDPDPNPGVINNVLA 800 
5. MtfA 
Sequences producing High-scoring Segment Pairs: Reading High Probability 
Frame Score PIN) N 
gil1197459 (U47048) MtfA [Escherichia coli] +1 
sp P22519 CVAA ECOLI COLICIN V SECRETION PROTEIN CVAA .... +1 
sp P09986 HLY4_ECOLI HEMOLYSIN D, CHROMOSOMAL. >pirl IL ... +1 
SplP06739 HLYD ECOLI HEMOLYSIN D, PLASMID. >pirl IS1005 ... +1 
sp P18790 LKTD=ACTAC LKTD PROTEIN. >piri IS11215 lktD p ... +1 
gnliPIDle152894 (X86087) EHEC-hlyD product [ ... +1 
I
P16534 ILKTD_PASHA LKTD PROTEIN. >pirl B32051 leukot ... +1 
150515 (M24197) leukotoxin (LktD) [Paste ... +1 
pirllD30169 hypothetical 54.7K protein Past ... +1 
splp44812IYIIU_HAEIN HYPOTHETICAL PROTEIN HI0668. >pir ... +1 
gil141822 (M65808) hemolysin determinant [A ... +1 
PirllS18856 *ClyI-D protein Actinobacillus ... +1 
pirl S48045 xIIID protein - Actinobacillus pl ... +1 
sp Q08633IRTXD_ACTPL RTX TOXIN-III OPERON PROTEIN RTXD ... +1 
P26761IHLYD_ACTPL HEMOLYSIN SECRETION PROTEIN APPD ... +1 
805105 (U22021) P120 [Mycoplasma hominisl +1 
gi 457620 (L12148) pllktD [Pasteurella haem ... +1 
gi 1208411 (D38539) CeTMIII [Caenorhabditis ... +1 
sp Q09712IYA35_SCHPO HYPOTHETICAL 48.8 KD PROTEIN C18B ... -1 
gi 298680 (S57152) placenta growth factor 2 ... +3 
gi 633814 (S72960) placenta growth factor 2 ... +3 
gi 1139568 (D49826) serratia marcescens LipB ... +1 
gil695621 (Z48542) SppE [Lactobacillus sake] +1 
gi 733567 (U23452) No definition line found ... +1 
gi 1046031 (U39715) protein V [Mycoplasma ge ... +1 
gi 1150766 (U42409) myosin heavy chain [Dict ... +1 
sp P32716IYJCR_ECOLI HYPOTHETICAL 36.9 KD PROTEIN IN F ... +1 
gi 599857 (Z46867) accessory factor for ABC ... +1 
gi 1212983 (X95654) polypeptide of 976 aa [H ... +1 
gi 806511 (D50474) fast skeletal muscle myo ... +1 
gi 694116 (U21056) polyprotein [Yellow feve ... +1 
gi 829367 (U17066) polyprotein precursor [Y ... +1 
gi 1065509 (U40419) C27F2.6 gene product [Ca ... -3 
sp Q03030IDCOA_SALTY OXALOACETATE DECARBOXYLASE ALPHA ... +1 
gi 805101 (U22019) P120 [Mycoplasma hominisl +1 
sp Q02224ICENE_HUMAN CENTROMERIC PROTEIN E (CENP-E PRO ... +1 
prfll1819485A CENP-E protein [Homo sapiens] +1 
gil806513 (D50475) fast skeletal muscle myo ... +1 
pirllS54487 Bul1p protein (YM8156.17c) - yeas ... +1 
gi 773190 (D50083) the BULl gene product [S ... +1 
gi 895907 (X88901) respiration deficiency s ... +1 
gi 1177653 (X92557) biotin carboxylase and b ... +1 
sp P09490ITPMO_DROME TROPOMYOSIN I, MUSCLE EMBRYONIC I ... +1 
pirllS05515 myosin heavy chain, skeletal musc ... +1 
splp033141pOLG_YEFV1 GENOME POLYPROTEIN (CONTAINS: CAP ... +1 
gil694114 (U21055) polyprotein [Yellow feve ... +1 
pirllC35815 myosin heavy chain 3, muscle fr ... +1 
pirllD35815 myosin heavy chain 4, mUSCle - fr ... +1 
Ip11154IpYC1_YEAST PYRUVATE CARBOXYLASE 1 (PYRUVIC C ... +1 
I IA35815 myosin heavy chain 1, muscle - fr ... +1 pir B35815 myosin heavy chain 2, muscle - fr ... +1 
gil1208409 (D38539) CeTMI [Caenorhabditis el ... +1 
gil1208413 (D38540) CeTMI [Caenorhabditis el ... +1 
11197459 (U47048) MtfA [Escherichia coli] Length = 414 
2120 
1599 
97 
87 
81 
64 
84 
84 
84 
58 
71 
71 
70 
69 
62 
71 
75 
77 
59 
59 
59 
59 
61 
52 
73 
75 
64 
70 
48 
74 
59 
59 
54 
58 
64 
58 
58 
74 
56 
56 
56 
63 
69 
69 
57 
57 
56 
56 
62 
56 
56 
58 
58 
1.1e-287 
7.3e-216 
1.4e-10 
3.3e-09 
1. ge- 07 
4.8e-05 
0.00024 
0.00024 
0.00024 
0.00061 
0.022 
0.022 
0.023 
0.032 
0.033 
0.27 
0.41 
0.43 
0.52 
0.84 
0.84 
0.89 
0.91 
0.92 
0.92 
0.93 
0.94 
0.96 
0.96 
0.97 
0.98 
0.98 
0.98 
0.99 
0.99 
0.997 
0.997 
0.998 
0.9992 
0.9993 
0.9993 
0.9996 
0.9996 
0.9998 
0.9998 
0.9998 
0.9998 
0.9998 
0.9999 
0.9999 
0.9999 
0.99995 
0.99995 
1 
1 
4 
4 
4 
4 
3 
3 
3 
2 
3 
3 
2 
2 
4 
2 
2 
1 
2 
2 
2 
3 
3 
4 
1 
2 
2 
2 
4 
2 
3 
3 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
1 
1 
3 
3 
2 
2 
2 
2 
2 
2 
2 
Strand HSPs: Score = 2120 (971.0 bits), Expect = 1.le-287, P = 1.1e-287 
Identities = 414/414 (100%), Positives = 414/414 (100%), Frame +1 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
1 MKWCGRAVLLPGIPPWLVISVSVFFFISFIVFVMEGTYTRRINVEGEITTWPRPVNVYSG 180 
MKWCGRAVLLPGIPPWLVISVSVFFFISFIVFVMEGTYTRRINVEGEITTWPRPVNVYSG 
1 MKWCGRAVLLPGIPPWLVISVSVFFFISFIVFVMEGTYTRRINVEGEITTWPRPVNVYSG 60 
181 VQGVVIKQFVTEGQRIKKGDPIYLIDVSKSTSSGVVGDNKRRDIEKQLSRIGDIISRLEE 360 
VQGVVIKQFVTEGQRIKKGDPIYLIDVSKSTSSGVVGDNKRRDIEKQLSRIGDIISRLEE 
61 VQGVVIKQFVTEGQRIKKGDPIYLIDVSKSTSSGVVGDNKRRDIEKQLSRIGDIISRLEE 120 
361 NKKTTLQTLEKQRIQYYSAFERSTEILRRAEEGVKIMKSNMDNYKQYQTKGLINKDQLTN 540 
NKKTTLQTLEKQRIQYYSAFERSTEILRRAEEGVKIMKSNMDNYKQYQTKGLINKDQLTN 
121 NKKTTLQTLEKQRIQYYSAFERSTEILRRAEEGVKIMKSNMDNYKQYQTKGLINKDQLTN 180 
541 QIALYYQQQNNILSLSTQNEQNLLQVTSLESQMQTLAAEFDNRIYQVELQRYELQKELVD 720 
QIALYYQQQNNILSLSTQNEQNLLQVTSLESQMQTLAAEFDNRIYQVELQRYELQKELVD 
181 QIALYYQQQNNILSLSTQNEQNLLQVTSLESQMQTLAAEFDNRIYQVELQRYELQKELVD 240 
Appendices. Appendix 6. Sequence similarity comparisons. 
Query: 721 TDAGRDI I lRALSDGKIDSLSVTPGQMVSVGDSLLQI IPEEIKNYHLIVWVPNNAI PYIS 900 
TDAGRDlllRALSDGKIDSLSVTPGQMVSVGDSLLQIIPEEIKNYHLIVWVPNNAIPYIS 
Sbjct: 241 TDAGRDI I lRALSDGKIDSLSVTPGQMVSVGDSLLQI IPEEIKNYHLIVWVPNNAIPYIS 300 
Query: 901 VGDNVNVRYEAFPPGKFGQFTAKIMLISRTPASAQEMQTYPGAPRNNTGVSVPYYKIVLN 1080 
VGDNVNVRYEAFPPGKFGQFTAKIMLISRTPASAQEMQTYPGAPRNNTGVSVPYYKIVLN 
Sbjct: 301 VGDNVNVRYEAFPPGKFGQFTAKIMLISRTPASAQEMQTYPGAPRNNTGVSVPYYKIVLN 360 
Query: 1081 PEQQTIEYGEKKMPLENGMKAQSTLFLEKRKIYQWMLSPFYNMKYSAVGPVNEQ 1242 
PEQQTIEYGEKKMPLENGMKAQSTLFLEKRKIYQWMLSPFYNMKYSAVGPVNEQ 
Sbjct: 361 PEQQTIEYGEKKMPLENGMKAQSTLFLEKRKIYQWMLSPFYNMKYSAVGPVNEQ 414 
>Splp22519IcvAA_ECOLI COLICIN V SECRETION PROTEIN CVAA. >pirl IIKEC5A colicin V 
secretion protein cvaA Escherichia coli plasmid ColV >gi141175 
(X57524) cvaA protein[Escherichia coli] Length; 413 
plus Strand HSPs: Score 1599 (732.4 bits), Expect = 7.3e-216, P 7.3e-216 
Identities 294/413 (71%), positives 358/413 (86%), Frame = +1 
Query: 1 MKWCGRAVLLPGIPPWLVISVSVFFFISFIVFVMEGTYTRRINVEGEITTWPRPVNVYSG 180 
MKW GRA+LLPGIP WL++ S+ F +F++F++ GTY+RR+NV GE+TTWPR VN+YSG 
Sbjct: 1 MKWQGRAILLPGIPLWLIMLGSIVFITAFLMFIIVGTYSRRVNVSGEVTTWPRAVNIYSG 60 
Query: 181 VQGVVIKQFVTEGQRIKKGDPIYLIDVSKSTSSGVVGDNKRRDIEKQLSRIGDIISRLEE 360 
VQG V++QFV EGQ IKKGDP+YLID+SKST +G+V DN RRDIE QL R+ +IISRLEE 
Sbjct: 61 VQGFVVRQFVHEGQLIKKGDPVYLIDISKSTRNGIVTDNHRRDIENQLVRVDNIISRLEE 120 
Query: 361 NKKTTLQTLEKQRIQYYSAFERSTEI LRRAEEGVKIMKSNMDNYKQYQTKGLINKDQLTN 540 
+KK TL TLEKQR+QY AF RS++I++RAEEG+KIMK+NM+NY+ YQ+KGLINKDQLTN 
Sbjct: 121 SKKITLDTLEKQRLQYTDAFRRSSDIIQRAEEGIKIMKNNMENYRYYQSKGLINKDQLTN 180 
Query: 541 QIALYYQQQNNILSLSTQNEQNLLQVTSLESQMQTLAAEFDNRIYQVELQRYELQKELVD 720 
Q+ALYYQQQNN+LSLS QNEQN LQ+T+LESQ+QT AA+FDNRIYQ+ELQR ELQKELV+ 
Sbjct: 1B1 QVALYYQQQNNLLSLSGQNEQNALQITTLESQIQTQAADFDNRIYQMELQRLELQKELVN 240 
Query: 721 TDAGRDIIIRALSDGKIDSLSVTPGQMVSVGDSLLQIIPEEIKNYHLIVWVPNNAIPYIS 900 
TD +IIIRALSDGK+DSLSVT GQMV+ GDSLLQ+IPE I+NY+LI+WVPN+A+PYIS 
Sbjct: 241 TDVEGEIIIRALSDGKVDSLSVTVGQMVNTGDSLLQVIPENIENYYLILWVPNDAVPYIS 300 
Query: 901 VGDNVNVRYEAFPPGKFGQFTAKIMLISRTPASAQEMQTYPGAPRNNTGVSVPYYKIVLN lOBO 
GD VN+RYEAFP KFGQF+A + ISRTPAS QEM TY GAP+N G SVP+YK++ 
Sbjct: 301 AGDKVNIRYEAFPSEKFGQFSATVKTISRTPASTQEMLTYKGAPQNTPGASVPWYKVIAT 360 
Query: 1081 PEQQTIEYGEKKMPLENGMKAQSTLFLEKRKIYQWMLSPFYNMKYSAVGPVNE 1239 
PE+Q I Y EK +PLENGMKA+STLFLEKR+IYQWMLSPFY+MK+SA GP+N+ 
Sbjct: 361 PEKQIIRYDEKYLPLENGMKAESTLFLEKRRIYQWMLSPFYDMKHSATGPIND 413 
>splp09986IHLY4_ECOLI HEMOLYSIN D, CHROMOSOMAL. I ILEECD hemolysin secretion 
protein hlyD - Escherichia coli >gi11463B1 (M10133 chromosomalhemolysin D (hlyD) 
[Escherichia coliJ Length 478 
Plus strand HSPs: Score 97 (44.4 bits), Expect = 1.4e-10, Sum P(4) = 1.4e-10 
Identities 26/90 (28%), positives 40/90 (44%), Frame = +1 
Query: 742 IIRALSDGKIDSLSVTPGQMVSVGDSLLQIIPEEIKNYHLIVWVPNNAIPYISVGDNVNV 
+IRA GK+ LV V L +1 E + V N I +I+VG N + 
Sbjct: 329 VlRAPVSGKVQQLKVHTEGGVVTTAETLMVIVPEDDTLEVTALVQNKDIGFINVGQNAII 
Query: 922 RYEAFPPGKFGQFTAKIMLISRTPASAQEM 1011 
+ EAFP ++G K+ 1+ Q++ 
Sbjct: 389 KVEAFPYTRYGYLVGKVKNINLDAIEDQKL 418 
Score 68 (31.1 bits), Expect 1.4e-10, Sum P(4) = 1.4e 10 
Identities = 11/45 (24%), positives = 25/45 (55%), Frame +1 
Query: 1063 YKIVLNPEQQTIEYGEKKMPLENGMKAQSTLFLEKRKIYQWMLSP 1197 
+ ++++ E+ + G K +PL +GM + + R + ++LSP 
Sbjct: 422 FNVIVSVEENDLSTGNKHIPLSSGMAVTAEIKTGMRSVISYLLSP 466 
Score = 47 (21.5 bits), Expect = 1.4e-10, Sum P(4) = 1.4e-l0 
Identities 15/66 (22%), Positives = 27/66 (40%), Frame +1 
Query: 43 PWLVISVSVFFFISFIVFVMEGTYTRRINVEGEITTWPRPVNVYSGVQGVVIKQFVTEGQ 
P LV + F + + + G G++T R + +V + V EG+ 
Sbjct: 57 PRLVAYFIMGFLVIAFILSVLGQVEIVATANGKLTLSGRSKEIKPIENSIVKEIIVKEGE 
Query: 223 RIKKGD 240 
++KGD 
Sbjct: 117 SVRKGD 122 
921 
388 
222 
116 
210 
Appendices. Appendix 6. Sequence similarity comparisons. 
Score 45 (20.6 bits), Expect = 0.96, Sum P(2) 0.62 
Identities = 11/37 (29%), positives = 20/37 (54%), Frame +1 
Query: 
Sbjct: 
721 TDAGRDIIIRALSDGKIDSLSVTPGQMVSVGDSLLQI 831 
T +GR 1+ + + + + V G+ V GD LL++ 
91 TLSGRSKEIKPIENSIVKEIIVKEGESVRKGDVLLKL 127 
Score = 37 (16.9 bits), Expect 1.4e-10, Sum P(4) = 1.4e-10 
Identities = 9/32 (28%), positives 16/32 (50%), Frame = +1 
Query: 
Sbjct: 
613 QVTSLESQMQTLAAEFDNRIYQVELQRYELQK 708 
+ +L++Q L A + YQ+ + EL K 
133 EADTLKTQSSLLQARLEQIRYQILSRSIELNK 164 
Score 37 (16.9 bits), Expect = 1.4e-10, Sum P(4) = 1.4e-10 
Identities = 9/38 (23%), Positives 22/38 (57%), Frame = +1 
Query: 
Sbjct: 
586 STQNEQNLLQVTSLESQMQTLAAEFDNRIYQVELQRYE 699 
S ++Q + + LE + + + A + R+Y+ +L++ E 
242 SLLHKQAIAKHAVLEQENKYVEAANELRVYKSQLEQIE 279 
Score = 37 (16.9 bits), Expect 1.4e-10, Sum P(4) = 1.4e-10 
Identities = 9/38 (23%), positives 21/38 (55%), Frame = +1 
Query: 607 LLQVTSLESQMQTLAAEFDNRIYQVELQRYELQKELVD 720 
LL++T+L ++ TL + ++E RY++ ++ 
Sbjct: 124 LLKLTALGAEADTLKTQSSLLQARLEQIRYQILSRSIE 161 
211 
>splp06739IHLYD_ECOLI HEMOLYSIN 
protein hlyD - Escherichia coli 
hemolysin D [Plasmid pHly152] 
478 
D, PLASMID. >pirl IS10058 hemolysin secretion 
pHly152 >gi1150684 (M14107) 
1 1208296D hemolysin hlyD [Escherichia coli] Length 
Plus Strand HSPs: Score 87 (39.8 bits), Expect = 3.3e-09, Sum P(4) 3.3e-09 
Identities 24/81 (29%), positives = 36/81 (44%), Frame = +1 
Query: 742 IIRALSDGKIDSLSVTPGQMVSVGDSLLQIIPEEIKNYHLIVWVPNNAIPYISVGDNVNV 
+IRA K+ LV V L +1 E + V N I +I+VG N + 
Sbjct: 329 VIRAPVSVKVQQLKVHTEGGVVTTAETLMVIVPEDDTLEVTALVQNKDIGFINVGQNAII 
Query: 922 RYEAFPPGKFGQFTAKIMLIS 984 
+ EAFP ++G K+ 1+ 
sbjct : 389 KVEAFPYTRYGYLVGKVKNIN 409 
Score = 69 (31.6 bits) I Expect 3.3e-09, Sum P(4) = 3.3e-09 
Identities = 11/45 (24%), positives = 25/45 (55%), Frame +1 
Query: 1063 YKIVLNPEQQTIEYGEKKMPLENGMKAQSTLFLEKRKIYQWMLSP 1197 
+ ++++ E+ + G K +PL +GM + + R + ++LSP 
sbjct: 422 FNVIISIEENCLSTGNKNIPLSSGMAVTAEIKTGMRSVISYLLSP 466 
Score = 48 (22.0 bits), Expect = 0.28, Sum P(2) 0.25 
Identities = 11/37 (29%), Positives = 20/37 (54%), Frame +1 
Query: 
Sbjct: 
721 TDAGRDIIIRALSDGKIDSLSVTPGQMVSVGDSLLQI 831 
T +GR 1+ + + + + V G+ V GD LL++ 
91 THSGRSKEIKPIENSIVKEIIVKEGESVRKGDVLLKL 127 
Score = 47 (21.5 bits), Expect = 3.3e-09, Sum P(4) 3.3e-09 
Identities 23/127 (18%), Positives = 48/127 (37%), Frame = +1 
921 
388 
Query: 43 PWLVISVSVFFFISFIVFVMEGTYTRRINVEGEITTWPRPVNVYSGVQGVVIKQFVTEGQ 222 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
P LV + F + + + G G++T R + +V + V EG+ 
57 PRLVAYFIMGFLVIAFILSVLGQVEIVATANGKLTHSGRSKEIKPIENSIVKEIIVKEGE 116 
223 RIKKGDPIYLIDVSKSTSSGVVGDNKRRDIEKQLSRIGDIISRLEENKKTTLQTLEKQRI 402 
++KGD + + + + + + + +R + +E NK L+ ++ 
117 SVRKGDVLLKLTALGAEADTLKTQSSLLQARLEQTRYQILSRSIELNKLPELKLPDEPYF 176 
403 QYYSAFE 423 
Q S E 
177 QNVSEEE 183 
Appendices. Appendix 6. Sequence similarity comparisons. 
Score 39 (17.9 bits), Expect 2.6e-07, Sum P(3) 2.6e-07 
Identities = 9/32 (28~), positives 16/32 (50~). Frame = +1 
Query: 
Sbjct: 
613 QVTSLESQMQTLAAEFDNRIYQVELQRYELQK 708 
+ +L++Q L A + YQ+ + EL K 
133 EADTLKTQSSLLQARLEQTRYQILSRSIELNK 164 
Score 39 (17.9 bits), Expect 2.6e-07, Sum P(3) 2.6e-07 
Identities = 9/38 (23%). Positives = 21/38 (55~), Frame = +1 
Query: 607 LLQVTSLESQMQTLAAEFDNRIYQVELQRYELQKELVD 720 
LL++T+L ++ TL + ++E RY++ ++ 
Sbjct: 124 LLKLTALGAEADTLKTQSSLLQARLEQTRYQILSRSIE 161 
Score = 36 (16.6 bits). Expect 8.4e-05, Sum P(4) = 8.4e-05 
Identities 7/14 (SO~), positives = 11/14 (78%), Frame +3 
Query: 1152 FISGKEENIPVDAI 1193 
++ GK +NI +DAI 
Sbjct: 400 YLVGKVKNINLDAI 413 
Score = 36 (16.5 bits), Expect = 3.3e-09, Sum P(4) = 3.3e-09 
Identities 9/38 (23%). positives = 22/38 (57~), Frame = +1 
Query: 
Sbjct: 
586 STQNEQNLLQVTSLESQMQTLAAEFDNRIYQVELQRYE 699 
S ++Q + + LE + + + A + R+Y+ +L++ E 
242 SLLHKQAIAKHAVLEQENKYVEAVNELRVYKSQLEQIE 279 
212 
Appendices. Appendix 6. Sequence similarity comparisons. 
6. Mtm 
Sequences producing High-scoring Segment Pairs: Reading High Probability 
Frame Score peN) N 
gil1197460 (U47048) MtfB [Escherichia coli] +1 
sp P22520ICVAB ECOLI COLICIN V SECRETION ATP-BINDING P ... +1 
SplP18770 CYAB-BORPE CYCLOLYSIN SECRETION ATP-BINDING ... +1 
sp P23702ILKTB=ACTAC LEUKOTOXIN SECRETION ATP-BINDING ... +1 
gnliPIDle150185 (X86087) EHEC-hlyB gene product [ ... +1 
splp16532ILKTB_PASHA LEUKOTOXIN SECRETION ATP-BINDING ... +1 
pirllC30169 hypothetical 79.6K protein (lktA ... +1 
splp26760IHLYB_ACTPL HAEMOLYSIN SECRETION ATP-BINDING ... +1 
gil457619 (L12148) pllktB [Pasteurella haem ... +1 
pirlls51785 RTX toxin apxIIIB - Actinobacillu ... +1 
IQ04473IRTXB_ACTPL RTX TOXIN-III OPERON PROTEIN RTXB. +1 
1
150514 (M24197) leukotoxin (LktB) [Paste ... +1 
gi 505571 (X68595) secretion protein B [Act ... +1 
PirllA40366 hemolysin secretion protein appB ... +1 
pir S51777 xIIIB protein - Actinobacillus pl ... +1 
splp10089IHLY2_ECOLI HAEMOLYSIN SECRETION ATP-BINDING +1 
pirllA42255 hemolysin secretion protein hlyB +1 
spIP08716IHLYB_ECOLI HAEMOLYSIN SECRETION ATP-BINDING +1 
splp11599 HLYB_PROVU HAEMOLYSIN SECRETION ATP-BINDING +1 
pirllLEECB hemolysin secretion protein hlyB +1 
gi 599856 (Z46867) ABC exporter [Lactobacil ... +1 
gi 695620 (Z48542) SppT [Lactobacillus sake] +1 
gi 972714 (L47121) ATP-dependent translocat ... +1 
sp Q03727IcOMA_STRPN TRANSPORT ATP-BINDING PROTEIN COM ... +1 
pirllA39203 comA protein Streptococcus pneu ... +1 
sp 1 Q005641 LCNC_LACLA LACTOCOCCIN A TRANSPORT ATP-BINDI ... +1 
pirllA41464 hemolysin secretion protein CylB ... +1 
gil703126 (L40491) leucocin A trans locator ... +1 
pirlls52205 mesI protein - Leuconostoc mesent ... +1 
P36497IPEDD_PEDAC PEDIOCIN PA-1 TRANSPORT ATP-BINDI ... +1 
1013631 Sequence 4 from Patent US 4837306 ... +1 
sp P21449 MDR2_CRIGR MULTIDRUG RESISTANCE PROTEIN 2 (P ... +1 
sp P214391MDR3_HUMAN MULTIDRUG RESISTANCE PROTEIN 3 (P ... +1 
sp P06795IMDR1_MOUSE MULTIDRUG RESISTANCE PROTEIN 1 (P ... +1 
sp P45861 YWJA BACSU HYPOTHETICAL ABC TRANSPORTER IN A ... +1 
sp P432451MDR1_RAT MULTIDRUG RESISTANCE PROTEIN 1 (P ... +1 
gi 425476 (L26287) SMDR2 [Schistosoma mansoni] +1 
pirllc38696 multidrug resistance protein (clo ... +1 
IQ00449IMDR4_DROME MULTIDRUG RESISTANCE PROTEIN HOMO ... +1 
IIDVHY1C multidrug resistance protein 1 - ... +1 
sp P21448IMDR1_CRIGR MULTIDRUG RESISTANCE PROTEIN 1 (P ... +1 
gi 1065701 (Z67882) F22E10.4 [Caenorhabditis ... +1 
sp P214471MDR3 MOUSE MULTIDRUG RESISTANCE PROTEIN 3 (P ... +1 
sp Q08201 MDR2-RAT MULTI DRUG RESISTANCE PROTEIN 2 (P ... +1 
sp P23174 MDR3_CRIGR MULTIDRUG RESISTANCE PROTEIN 3 (P ... +1 
pirllDVMS1A multidrug resistance protein 1a - ... +1 
Ip21440IMDR2_MOUSE MULTIDRUG RESISTANCE PROTEIN 2 (P ... +1 
1 1A35671 multidrug resistance protein 1a +1 
splp18768ICHVA_AGRTU BETA-(1-->2)GLUCAN EXPORT ATP-BIN ... +1 
gil159363 (L01572) P-glycoprotein [Leishman ... +1 
splp081831MDR1_HUMAN MULTIDRUG RESISTANCE PROTEIN 1 (P ... +1 
PirllA34914 multidrug resistance protein 1 - '" +1 
pir S30327 multidrug resistance protein 1 - .. , +1 
P44407IMSBA_HAEIN PROBABLE TRANSPORT ATP-BINDING PR ... +1 
1139567 (D49826) Serratia marcescens LipB ... +1 
gi 1065700 (Z67882) F22E10.3 [Caenorhabditis ... +1 
sp P27299IMSBA_ECOLI PROBABLE TRANSPORT ATP-BINDING PR ... +1 
PirllA42150 P-glycoprotein atpgp1 Arabidops ... +1 
pir IS25577 mt2 protein rat +1 
pirl S38400 TAP2 protein rat >gi1407477 (X7 ... +1 
sp P363721TAP2_RAT ANTIGEN PEPTIDE TRANSPORTER 2 (AP ... +1 
gi 393116 (L23922) P-glycoprotein 5 [Entamo ... +1 
sp P23596IPRTD_ERWCH PROTEASES SECRETION ATP-BINDING P ... +1 
P22638IHETA_ANASP HETEROCYST DIFFERENTIATION ATP-BI ... +1 
387688 (M90969) ATP-binding protein [Lac ... +1 
gi 290801 (L17003) member of super-family 0 ... +1 
sp Q06034IMDR1_LEIEN MULTIDRUG RESISTANCE PROTEIN 1 (P ... +1 
gi 762882 (L25849) glycoprotein P [Rattus n ... +1 
pirlls25576 mt2 protein rat >pirl IS38401 TA ... +1 
pirllS21740 probable transport protein mt2 - ... +1 
gil833699 (U17608) multidrug resistance pro ... +1 
gi 1065698 (Z67882) F22E10.1 [Caenorhabditis ... +1 
pirlls21957 P-glycoprotein pgp1 - Arabidopsis ... +1 
gil405076 (U01056) P-glycoprotein 6 [Entamo ... +1 
3587 
2693 
383 
365 
358 
377 
377 
365 
378 
378 
378 
375 
348 
355 
367 
367 
367 
367 
362 
367 
278 
297 
251 
234 
233 
250 
191 
259 
162 
216 
366 
352 
364 
346 
330 
356 
385 
351 
348 
351 
351 
381 
348 
343 
349 
345 
350 
345 
327 
350 
348 
348 
243 
201 
199 
363 
198 
361 
344 
344 
344 
229 
182 
360 
250 
166 
341 
198 
348 
348 
341 
358 
361 
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0.0 
0.0 
2.7e-83 
5.4e-82 
1.2e-81 
2.4e-81 
2.4e-S1 
3.3e-81 
1.3e-SO 
3.7e-79 
3.7e-79 
7.Se-79 
9.6e-79 
2.1e-78 
1.0e-77 
1.ge-77 
2.7e-77 
2.7e-77 
1.4e-76 
7.4e-76 
2.0e-74 
6.1e-74 
3.4e-67 
1.1e-66 
1.5e-66 
1.1e-64 
4.0e-63 
8.4e-61 
2.7e-5S 
5.6e-52 
4.6e-50 
4.2e-47 
7.6e-47 
1.2e-46 
1.4e-46 
4.3e-46 
6.8e-46 
1.4e-45 
1.4e-45 
1. ge-45 
1. ge-45 
3.7e-45 
4.ge-45 
4.ge-45 
5.0e-45 
8.3e-45 
1.3e-44 
1. 3e-44 
2.4e-44 
3.ge-44 
4.7e-44 
4.7e-44 
1.5e-43 
4.5e-43 
8.7e-43 
1. 3e-42 
2.3e-42 
2.6e-42 
2.6e-42 
2.6e-42 
2.6e-42 
2.7e-42 
3.1e-42 
3.4e-42 
6.3e-42 
9.ge-42 
1.1e-41 
1.2e-41 
1.3e-41 
1.3e-41 
1. 8e-41 
2.3e-41 
2.6e-41 
3.3e-41 
1 
1 
5 
5 
4 
3 
3 
3 
3 
3 
3 
4 
3 
4 
3 
3 
3 
3 
3 
3 
5 
4 
5 
4 
4 
4 
5 
4 
5 
5 
2 
5 
3 
4 
4 
4 
3 
3 
3 
3 
3 
2 
3 
3 
3 
3 
3 
3 
4 
3 
3 
3 
4 
4 
4 
2 
5 
4 
3 
3 
3 
4 
6 
2 
3 
5 
3 
3 
3 
3 
4 
3 
3 
4 
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gi 1065699 
gb 1013621 
gi 159372 
gi 1236092 
gi 
sp 
sp 
gi 
sp 
576813 
P187671NDVA RHIME 
P37608 LCN3_LACLA 
1001774 
P36619 PMD1 SCHPO 
gi 
pirlls30328 
gi 1236101 
1016270 
576812 
790373 
1051314 
MDR1 CAEEL 
1051318 
P34713IMDR3_CAEEL 
P36371 TAP2 MOUSE 
860725 
sp Q02592IHMTl_SCHPO 
pir11S53971 
spIP40416IATM1_YEAST 
Appendix 6. Sequence similarity comparisons. 
(Z67882) F22E10.2 [Caenorhabditis ... +1 
Sequence 3 from Patent US 4837306 ... +1 
(L06062) multi drug resistance P- ... +1 
(Z70265) C05A9.1 [Caenorhabditis ... +1 
(M25792) P-glycoprotein [Cricetul ... +1 
BETA-(1-->2)GLUCAN EXPORT ATP-BIN ... +1 
LACTICIN 481/LACTOCOCCIN TRANSPOR ... +1 
(D64004) hypothetical protein [sy ... +1 
LEPTOMYCIN B RESISTANCE PROTEIN P ... +1 
(Z50189) ExsA [Rhizobium meliloti) +1 
multidrug resistance protein 2 - ... +1 
(Z70268) T21E8.1 [Caenorhabditis ... +1 
(U35123) p-glycoprotein [Urechis ... +1 
(M25792) P-glycoprotein (Cricetul ... +1 
(Z49126) DH11.3 [Caenorhabditis e ... +1 
(Z66562) F42E11.1 [Caenorhabditis ... +1 
MULTIDRUG RESISTANCE PROTEIN 1 (P ... +1 
MDL2 PROTEIN. >pirl IS42682 MDL2 p ... +1 
(Z70268) T21E8.2 [Caenorhabditis ... +1 
(Z66562) ZK455.7 [Caenorhabditis ... +1 
MULTIDRUG RESISTANCE PROTEIN 3 (P ... +1 
ANTIGEN PEPTIDE TRANSPORTER 2 (AP ... +1 
(L42939) major histocompatibility ... +1 
HEAVY METAL TOLERANCE PROTEIN PRE ... +1 
Atm1p protein (YM9952.03c) - yeas ... +1 
MITOCHONDRIAL TRANSPORTER ATM1 PR ... +1 
11197460 (U47048) MtfB (Escherichia coli] Length = 707 
355 
192 
350 
343 
193 
302 
116 
300 
226 
338 
240 
327 
207 
193 
335 
335 
333 
197 
327 
327 
327 
339 
334 
327 
309 
309 
Strand HSPs: Score = 3587 (1650.0 bits), Expect = 0.0, P 0.0 
7.6e-41 
8.7e-41 
2.0e-40 
2.7e-40 
4.0e-40 
1.2e-39 
1. 5e-39 
1. ge-39 
5.1e-39 
5.7e-39 
7.0e-39 
3.0e-38 
3.6e-38 
5.8e-38 
6.7e-38 
8.2e-38 
1.5e-37 
2.1e-37 
4.3e-37 
5.5e-37 
1.4e-36 
2.8e-36 
2.8e-36 
3.7e-36 
2.5e-35 
2.5e-35 
3 
3 
2 
3 
3 
4 
7 
3 
4 
2 
3 
3 
3 
4 
3 
3 
4 
4 
3 
3 
3 
2 
2 
3 
3 
3 
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Identities = 707/707 (100%), Positives = 707/707 (100%), Frame +1 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
Query: 
Sbjct: 
1 MNNNATSPLNTLLNKLEIGLRRRIPVVHQTESSECGLACLSMICGHYGRHIDLSTLRRQF 180 
MNNNATSPLNTLLNKLEIGLRRRIPVVHQTESSECGLACLSMICGHYGRHIDLSTLRRQF 
1 MNNNATSPLNTLLNKLEIGLRRRIPVVHQTESSECGLACLSMICGHYGRHIDLSTLRRQF 60 
181 NLSALGTTLAGITEIGSQLGMETRAFSLDLNELSVLKLPCILHWEFSHFVVLVSVRKNHF 360 
NLSALGTTLAGITEIGSQLGMETRAFSLDLNELSVLKLPCILHWEFSHFVVLVSVRKNHF 
61 NLSALGTTLAGITEIGSQLGMETRAFSLDLNELSVLKLPCILHWEFSHFVVLVSVRKNHF 120 
361 VLHDPARGRRTVGLAEMSQCFTGVALEVWPGTEFVQETMKNRVVLRTLFRSIYGLRSTLT 540 
VLHDPARGRRTVGLAEMSQCFTGVALEVWPGTEFVQETMKNRVVLRTLFRSIYGLRSTLT 
121 VLHDPARGRRTVGLAEMSQCFTGVALEVWPGTEFVQETMKNRVVLRTLFRSIYGLRSTLT 180 
541 KIFCFSLVIEAVGLVIPVGTQLVMDHAIPAGDRGLLSLICVGLMFFILLRTAVSMIRSWS 720 
KIFCFSLVIEAVGLVIPVGTQLVMDHAIPAGDRGLLSLICVGLMFFILLRTAVSMIRSWS 
181 KIFCFSLVIEAVGLVIPVGTQLVMDHAIPAGDRGLLSLICVGLMFFILLRTAVSMIRSWS 240 
721 SLVMETLINVQWQSGLHRHLLQLPLAYFERRKMGDIQSRFSSLDTLRTTFTTSVVGAIMD 900 
SLVMETLINVQWQSGLHRHLLQLPLAYFERRKMGDIQSRFSSLDTLRTTFTTSVVGAIMD 
241 SLVMETLINVQWQSGLHRHLLQLPLAYFERRKMGDIQSRFSSLDTLRTTFTTSVVGAIMD 300 
901 SIMVSGVLAMLVLYGGWLTTIVLGFTIIYVLIRLLTYNYYRQLSEESLIREARASSYFME 1080 
SIMVSGVLAMLVLYGGWLTTIVLGFTIIYVLIRLLTYNYYRQLSEESLIREARASSYFME 
301 SIMVSGVLAMLVLYGGWLTTIVLGFTIIYVLIRLLTYNYYRQLSEESLIREARASSYFME 360 
1081 TLYGIATIKMQGMGERRGRHWLNLKIDAINTGIRLARMDMLFSGINTFVAACDQVVILWL 1260 
TLYGIATIKMQGMGERRGRHWLNLKIDAINTGIRLARMDMLFSGINTFVAACDQVVILWL 
361 TLYGIATIKMQGMGERRGRHWLNLKIDAINTGIRLARMDMLFSGINTFVAACDQVVILWL 420 
1261 GTSLVIDNQMTIGMFVAFGVFRGQFSDRVGSLTNFLLQLRMMSLHNERIADIAMNEREAR 1440 
GTSLVIDNQMTIGMFVAFGVFRGQFSDRVGSLTNFLLQLRMMSLHNERIADIAMNEREAR 
421 GTSLVIDNQMTIGMFVAFGVFRGQFSDRVGSLTNFLLQLRMMSLHNERIADIAMNEREAR 480 
1441 KPDTAMKADMYPVALETQDLSFRYDSQSAPVFSNLNISIKPGESVAITGASGSGKTTLMK 1620 
KPDTAMKADMYPVALETQDLSFRYDSQSAPVFSNLNISIKPGESVAITGASGSGKTTLMK 
481 KPDTAMKADMYPVALETQDLSFRYDSQSAPVFSNLNISIKPGESVAITGASGSGKTTLMK 540 
1621 VLCGLLVPESGRVMIDGTDIRSLGVNNYHKIISCVMQDDRLFSGSIRENICGFTENIDEA 1800 
VLCGLLVPESGRVMIDGTDIRSLGVNNYHKIISCVMQDDRLFSGSIRENICGFTENIDEA 
541 VLCGLLVPESGRVMIDGTDIRSLGVNNYHKIISCVMQDDRLFSGSIRENICGFTENIDEA 600 
1801 WMVECARASFIHDVIIKMPMGYDTLIGELGEGLSGGQKQRIFIARALYRRPGILFMDEAT 1980 
WMVECARASFIHDVIIKMPMGYDTLIGELGEGLSGGQKQRIFIARALYRRPGILFMDEAT 
601 WMVECARASFIHDVIIKMPMGYDTLIGELGEGLSGGQKQRIFIARALYRRPGILFMDEAT 660 
1981 SALDTESEYYVNQAIKQLNITRIIIAHRETTVKSADRIILLEAPARI 2121 
SALDTESEYYVNQAIKQLNITRIIIAHRETTVKSADRIILLEAPARI 
661 SALDTESEYYVNQAIKQLNITRIIIAHRETTVKSADRIILLEAPARI 707 
Appendices. Appendix 6. Sequence similarity comparisons. 
>Splp22520ICVAB_ECOLI COLICIN V SECRETION ATP-BINDING PROTEIN CVAB. 
>pirl IIKEC5B colicin V secretion protein cvaB Escherichia coli 
plasmid ColV >gi141176 (X57524) cvaB protein [Escherichia coli] Length = 698 
plus Strand HSPs: Score = 2693 (1238.8 bits), Expect = 0.0, P 0.0 
Identities = 507/688 (73%), positives = 601/688 (87%), Frame +1 
Query: 34 LLNKLEIGLRRRIPVVHQTESSECGLACLSMICGHYGRHIDLSTLRRQFNLSALGTTLAG 213 
++N L++ +RR+PV+HQTE++ECGLACL+MICGH+G++IDL LRR+FNLSA G TLAG 
Sbjct: 9 IINLLDLRWQRRVPVIHQTETAECGLACLAMICGHFGKNIDLIYLRRKFNLSARGATLAG 68 
Query: 214 ITEIGSQLGMETRAFSLDLNELSVLKLPCILHWEFSHFVVLVSVRKNHFVLHDPARGRRT 393 
I I QLGM TRA SL+L+EL VLK PCILHW+FSHFVVLVSV++N +VLHDPARG R 
Sbjct: 69 INGIAEQLGMATRALSLELDELRVLKTPCILHWDFSHFVVLVSVKRNRYVLHDPARGIRY 128 
Query: 394 VGLAEMSQCFTGVALEVWPGTEFVQETMKNRVVLRTLFRSIYGLRSTLTKIFCFSLV1EA 573 
+ EMS+ FTGVALEVWPG+EF ET++ R+ LR+L SIYG++ TL KIFC S+VIEA 
Sbjct: 129 1SREEMSRYFTGVALEVWPGSEFQSETLQTRISLRSLINSIYGIKRTLAK1FCLSVVIEA 188 
Query: 574 VGLV1PVGTQLVMDHAIPAGDRGLLSL1CVGLMFFILLRTAVSMIRSWSSLVMETLINVQ 753 
+ L++PVGTQLVMDHAIPAGDRGLL+LI LMFFILL+ A S +R+WSSLVM TLINVQ 
Sbjct: 189 INLLMPVGTQLVMDHAIPAGDRGLLTLISAALMFF1LLKAATSTLRAWSSLVMSTLINVQ 248 
Query: 754 WQSGLHRHLLQLPLAYFERRKMGD1QSRFSSLDTLRTTFTTSVVGAIMDSIMVSGVLAML 933 
WQSGL HLL+LPLA+FERRK+GDIQSRF SLDTLR TFTTSV+G IMDSIMV GV M+ 
Sbjct: 249 WQSGLFDHLLRLPLAFFERRKLGDIQSRFDSLDTLRATFTTSVIGF1MDS1MVVGVCVMM 308 
Query: 934 VLYGGWLTTIVLGFTIIYVLIRLLTYNYYRQLSEESLIREARASSYFMETLYGIATIKMQ 1113 
+LYGG+LT IVL FT IY+ IRL+TY YRQ+SEE L+REARA+SYFMETLYGIAT+K+Q 
sbjct: 309 LLYGGYLTWIVLCFTTIYIFIRLVTYGNYRQISEECLVREARAASYFMETLYGIATVKIQ 368 
Query: 1114 GMGERRGRHWLNLKIDAINTGIRLARMDMLFSGINTFVAACDQVVILWLGTSLVIDNQMT 1293 
GM RG HWLN+KIDAIN+GI+L RMD+LF GINTFV ACDQ+VILWLG LVIDNQMT 
Sbjct: 369 GMVGIRGAHWLNMKIDAINSGIKLTRMDLLFGGINTFVTACDQIVILWLGAGLVIDNQMT 428 
Query: 1294 IGMFVAFGVFRGQFSDRVGSLTNFLLQLRMMSLHNERIADIAMNEREARKPDTAMKADMY 1473 
1GMFVAF FRGQFS+RV SLT+FLLQLR+MSLHNERIADIA++E+E +KP+ + ADM 
Sbjct: 429 IGMFVAFSSFRGQFSERVASLTSFLLQLRIMSLHNER1AD1ALHEKEEKKPE1E1VADMG 488 
Query: 1474 PVALETQDLSFRYDSQSAPVFSNLN1SIKPGESVAITGASGSGKTTLMKVLCGLLVPESG 1653 
P++LET LS+RYDSQSAP+FS L++S+ PGESVAITGASG+GKTTLMKVLCGL P+SG 
Sbjct: 489 P1SLETNGLSYRYDSQSAP1FSALSLSVAPGESVAITGASGAGKTTLMKVLCGLFEPDSG 548 
Query: 1654 RVM1DGTDIRSLGVNNYHKI1SCVMQDDRLFSGS1REN1CGFTENIDEAWMVECARASFI 1833 
RV+1+G DIR +G+NNYH++I+CVMQDDRLFSGSIRENICGF E +DE WMVECARAS I 
sbjct: 549 RVLING1D1RQ1GINNYHRMIACVMQDDRLFSGS1RENICGFAEEMDEEWMVECARASHI 608 
Query: 1834 HDV11KMPMGYDTLIGELGEGLSGGQKQRIFIARALYRRPGILFMDEATSALDTESEYYV 2013 
HDV1+ MPMGY+TL1GELGEGLSGGQKQRIFIARALYR+PGILFMDEATSALD+ESE++V 
sbjct: 609 HDVIMNMPMGYETLIGELGEGLSGGQKQRIF1ARALYRKPG1LFMDEATSALDSESEHFV 668 
Query: 2014 NQAIKQLN1TR111AHRETTVKSADR11 2097 
N A1K +NITR+IIAHRETT+++ DR+1 
Sbjct: 669 NVAIKNMNITRVIIAHRETTLRTVDRVI 696 
>splp18770ICYAB_BORPE CYCLOLYSIN SECRETION ATP-BINDING PROTEIN CYAB. 
215 
>pirl I BVBRCB cyaB protein - Bordetella pertussis >gi139733 (X14199) cyaB gene product 
[Bordetella pertussis] Length = 712 
plus Strand HSPs: Score = 383 (176.2 bits), Expect 2.7e-83, Sum P(5) = 2.7e-83 
Identities = 80/192 (41%), Positives = 121/192 (63%), Frame +1 
Query: 1480 ALETQDLSFRYDSQSAPVFSNLNISIKPGESVAITGASGSGKTTLMKVLCGLLVPESGRV 1659 
++E +SFRY +A N+++ I pGE V + G SGSGK+TL +++ + V + GRV 
Sbjct: 470 SIELDRVSFRYRPDAADALRNVSLRIAPGEVVGVVGRSGSGKSTLTRLIQRMFVADRGRV 529 
Query: 1660 MIDGTDIRSLGVNNYHKIISCVMQDDRLFSGSIRENICGFTENIDEAWMVECARASFIHD 1839 
+IDG DI + + + + V+Q+ LF+ S+R+NI +V AR + H+ 
Sbjct: 530 LIDGHDIG1VDSASLRRQLGVVLQESTLFNRSVRDNIALTRPGASMHEVVAAARLAGAHE 589 
Query: 1840 VIIKMPMGYDTLIGELGEGLSGGQKQRIF1ARALYRRPGILFMDEATSALDTESEYYVNQ 2019 
I ++P GYDT++GE G GLSGGQ+QRI IARAL RP +L +DEATSALD ESE+ + + 
Sbjct: 590 FICQLPEGYDTMLGENGVGLSGGQRQR1GIARAL1HRPRVLILDEATSALDYESEHIIQR 649 
Query: 2020 AIKQLNITR111 2055 
++ + R +1 
Sbjct: 650 NMRD1CDGRTV1 661 
Appendices. Appendix 6. Sequence similarity comparisons. 
Score = 248 (114.1 bits), Expect = 2.7e-83 
Identities 62/226 (27%), positives 
Sum P(5) = 2.7e-83 
(50%), Frame = +1 
Query: 526 RSTLTKIFCFSLVIEAVGLVIPVGTQLVMDHAIPAGDRGLLSLICVGLMFFILLRTAVSM 705 
R + ++ SLV++ + L+ P+ Q+VMD + L++I VG + IL ++ 
Sbjct: 155 RHLIGEVLLISLVLQFISLLTPLFFQVVMDKVLVNNAMETLNVITVGFLAAILFEALLTG 214 
Query: 706 IRSWSSLVMETLINVQWQSGLHRHLLQLPLAYFERRKMGDIQSRFSSLDTLRTTFTTSVV 885 
IR++ + ++V+ + L+ HLL+LPLAYF+ R++GD +R L+ +R T + V 
Sbjct: 215 IRTYLFAHTSSKLDVELGARLYAHLLRLPLAYFQARRVGDSVARVRELEHIRAFLTGNAV 274 
Query: 886 GAIMDSIMVSGVLAMLVLYGGWLTTIVLGFTIIYVLIRLLTYNYYRQLSEESLIREARAS 1065 
++D + +A++ Y LT +VL Y L+ L+ R+ R A 
Sbjct: 275 TVLLDVVFSVVFIAVMFFYSVKLTLVVLAALPCYFLLSLVLTPVLRRRLHVKFNRGAENQ 334 
Query: 1066 SYFMETLYGIATIKMQGMGERRGRHWLNLKIDAINTGIRLARMDML 1203 
++ +ET+ GI T+K + + R+W + G+ +A + ML 
Sbjct: 335 AFLVETVSGIDTVKSLAVEPQWQRNWDRQLAGYVAAGLSVANVAML 380 
Score 64 
Identities 
(29.4 bits), Expect 2.7e-83, Sum P(5) = 2.7e-83 
13/22 (59%), positives 18/22 (81%), Frame +1 
Query: 2041 TRIIIAHRETTVKSADRIILLE 2106 
T IIIAHR + V+ ADRI+++E 
Sbjct: 659 TVIIIAHRLSAVRCADRIVVME 680 
Score 58 (26.7 bits), Expect = 2.7e-83, Sum P(5) = 2.7e-83 
Identities = 18/81 (22%), positives 31/81 (38%), Frame +1 
Query: 1285 QMTIGMFVAFGVFRGQFSDRVGSLTNFLLQLRMMSLHNERIADIAMNEREARKPDTAMKA 1464 
+MT+G VAF + G + V L + + +R+ DI E + A 
Sbjct: 407 RMTVGELVAFNMLSGHVTQPVIRLAQLWNDFQQTGVSMQRLGDILNCRTEVAGDKAQLPA 466 
Query: 1465 DMYPVALETQDLSFRYDSQSA'1527 
+ L+ +R D+ A 
Sbjct: 467 LRGSIELDRVSFRYRPDAADA 487 
Score 55 (25.3 bits), Expect 2.7e-83, Sum P(5) = 2.7e-83 
Identities 12/36 (33%), positives = 17/36 (47%), Frame +1 
Query: 73 PVVHQTESSECGLACLSMICGHYGRHIDLSTLRRQF 180 
PV + GL CL M+ ++G D LR +F 
Sbjct: 4 PVAQCASVPDSGLLCLVMLARYHGLAADPEQLRHEF 39 
IP23702ILKTB_ACTAC LEUKOTOXIN SECRETION ATP-BINDING PROTEIN LKTB. 
I 
IS12601 lktB protein - Actinobacillus actinomycetemcomitans 
>pir IA61378 leukotoxin expression protein B - Actinobacillus actinomycetemcomitans 
138647 (X53955) LKTB [Haemophilus actinomycetemcomitans] Length = 707 
Strand HSPs: Score = 365 (167.9 bits), Expect = 5.4e-82, Sum P(5) = 5.4e-82 
Identities 77/188 (40%), positives 114/188 (60%), Frame +1 
Query: 1492 QDLSFRYDSQSAPVFSNLNISIKPGESVAITGASGSGKTTLMKVLCGLLVPESGRVMIDG 1671 
+++ FRY S + +N+N+ I GE + I G SGSGK+TL K++ +PE G+V+IDG 
Sbjct: 471 RNIKFRYKPDSPMILNNINLDISQGEVIGIVGRSGSGKSTLTKLIQRFYIPEQGQVLIDG 530 
Query; 1672 TDIRSLGVNNYHKIISCVMQDDRLFSGSIRENICGFTENIDEAWMVECARASFIHDVIIK 1851 
D+ N + + V+QD+ L + SIRENI + ++ A+ + HD I + 
Sbjct: 531 HDLALADPNWLRRQVGVVLQDNVLLNRSIRENIALTNPGMPMEKVIAAAKLAGAHDFISE 590 
Query: 1852 MPMGYDTLIGELGEGLSGGQKQRIFIARALYRRPGILFMDEATSALDTESEYYVNQAIKQ 2031 
+ GY+T++GE G GLSGGQ+QRI IARAL P IL DEATSALD ESE + + + 
Sbjct: 591 LREGYNTVVGEQGAGLSGGQRQRIAIARALVNNPRILIFDEATSALDYESENIIMHNMHK 650 
Query: 2032 LNITRIII 2055 
+ R ++ 
Sbjct: 651 ICQNRTVL 658 
Score = 216 (99.4 bits), Expect = 5.4e-82, Sum P(5) 5.4e-82 
Identities = 55/206 (26%), Positives = 98/206 (47%), Frame = +1 
Query: 526 RSTLTKIFCFSLVIEAVGLVIPVGTQLVMDHAIPAGDRGLLSLICVGLMFFILLRTAVSM 705 
R + S+ ++ L+ P+ Q+VMD + L++I V L +L + 
sbjct: 151 RKIFIETLIVSIFLQIFALITPLFFQVVMDKVLVHRGFSTLNVITVALAIVVLFEIILGG 210 
Query: 706 IRSWSSLVMETLINVQWQSGLHRHLLQLPLAYFERRKMGDIQSRFSSLDTLRTTFTTSVV 885 
+R++ + I+V+ + L RHLL LP++YFE R++GD +R LD +R T + 
Sbjct: 211 LRTYVFAHSTSRIDVELGARLFRHLLALPISYFEARRVGDTVARVRELDQIRNFLTGQAL 270 
216 
Appendices. Appendix 6. Sequence similarity comparisons. 
Query: 886 GAIMDSIMVSGVLAMLVLYGGWLTTIVLGFTIIYVLIRLLTYNYYRQLSEESLIREARAS 1065 
+I+D + A++ Y LT +VLG YV+ + R+ ++ R A 
Sbjct: 271 TSILDLLFSFIFFAVMWYYSPKLTLVVLGSLPCYVIWSVFISPILRRRLDDKFARNADNQ 330 
Query: 1066 SYFMETLYGIATIKMQGMGERRGRHW 1143 
S+ +E++ I TIK + + W 
Sbjct: 331 SFLVESVTAINTlKAMAISPQMTNIW 356 
Score = 94 (43.2 bits), Expect 5.4e-82, Sum P(5) 5.4e-82 
Identities = 25/104 (24%), positives 43/104 (41%), Frame = +1 
Query: 1243 VVILWLGTSLVIDNQMTIGMFVAFGVFRGQFSDRVGSLTNFLLQLRMMSLHNERIADIAM 1422 
V+ LWLG LVI ++IG +AF + GQ V L + + + R+ D+ 
Sbjct: 390 VINLWLGAHLVISGDLSIGQLIAFNMLAGQIISPVIRLAQIWQDFQQVGISVTRLGDVLN 449 
Query: 1423 NEREARKPDTAMKADMYPVALETQDLSFRYDSQSAPVFSNLNIS 1554 
+ E ++ ++ ++ DS NL+IS 
Sbjct: 450 SPTENNTASVSLPEIQGEISFRNIKFRYKPDSPMILNNINLDIS 493 
Score = 73 (33.6 bits), Expect 5.4e-82, Sum P(5) = 5.4e-82 
Identities 15/24 (62%), Positives 21/24 (87%), Frame = +1 
Query: 2035 NITRIIIAHRETTVKSADRIILLE 2106 
N T +IIAHR +TVK+ADRII+++ 
Sbjct: 654 NRTVLIIAHRLSTVKNADRIIVMD 677 
Score 51 (23.5 bits), Expect 5.4e-82, Sum P(5) = 5.4e-82 
Identities 13/85 (15%), Positives = 36/85 (42%), Frame = +1 
Query: 91 ESSECGLACLSMICGHYGRHIDLSTLRRQFNLSALGTTLAGITEIGSQLGMETRAFSLDL 
+++ L L ++ ++ 1+ ++ +F++ G LG++ R + + 
Sbjct: 5 KNTNLALQALEVLAQYHNISINPEEIKHKFDIDGHGLNQTKWLLAAKSLGLKVRTANKTV 
Query: 271 NELSVLKLPCILHWEFSHFVVLVSV 345 
+ L L LP + + +L+ + 
Sbjct: 65 DRLPFLHLPALAWRDDGEHFILLKI 89 
270 
64 
>gnl1PIDle150185 (X860S7) EHEC-hlyB gene product [Escherichia coli] Length = 706 
Plus Strand HSPs: Score 35S (164.7 bits), Expect = 1.2e-Sl, Sum P(4) = 1.2e-81 
Identities = 77/191 (40%), positives = 117/191 (61%), Frame = +1 
Query: 1483 LETQDLSFRYDSQSAPVFSNLNISIKPGESVAITGASGSGKTTLMKVLCGLLVPESGRVM 1662 
+E +++ FRY S + +N+N+ I G+ + I G SGSGK+TL K+L +PE+G+++ 
Sbjct: 468 IEFKNVRFRYSSDGNVILNNINLYISKGDVIGIVGRSGSGKSTLTKLLQRFYIPETGQIL 527 
Query: 1663 IDGTDIRSLGVNNYHKIISCVMQDDRLFSGSIRENICGFTENIDEAWMVECARASFIHDV 1842 
IDG D+ + I V+Q++ L + SI +NI + + +E AR + HD 
Sbjct: 528 IDGHDLSLADPEWLRRQIGVVLQENILLNRSIIDNITLASPAVSMEQAlEAARLAGAHDF 587 
Query: 1843 IIKMPMGYDTLIGELGEGLSGGQKQRIFIARALYRRPGILFMDEATSALDTESEYYVNQA 2022 
I ++ GY+T++GE G GLSGGQ+QRI IARAL P IL DEATSALD ESE + + 
Sbjct: 588 IRELKEGYNTIVGEQGVGLSGGQRQRIAIARALVTNPRILIFDEATSALDYESENIIMKN 647 
Query: 2023 IKQLNITRIII 2055 
+ ++ R +1 
Sbjct: 648 MSRICKNRTVI 658 
Score 279 (128.3 bits), Expect = 1.2e-81, Sum P(4) 1.2e-81 
Identities 73/302 (24%), positives = 138/302 (45%), Frame = +1 
Query: 511 SIYGLRSTLTKIFCFSLVIEAVGLVIPVGTQLVMDHAIPAGDRGLLSLICVGLMFFILLR 690 
S+ R L ++ S 1+ + L+ P+ Q+VMD + L++I + + IL 
Sbjct: 146 SVVKYRRILLEVLTVSAFIQFLALITPLFFQVVMDKVLVHRGFSTLNIITIAFIIVILFE 205 
Query: 691 TAVSMIRSWSSLVMETLINVQWQSGLHRHLLQLPLAYFERRKMGDIQSRFSSLDTLRTTF 870 
++ R++ + I+V+ + L RHLL LP++YFE R++G+ +R LD +R 
Sbjct: 206 VILTGARTYIFSHTTSRIDVELGAKLFRHLLALPVSYFENRRVGETVARVRELDQIRNFL 265 
Query: 871 TTSVVGAIMDSIMVSGVLAMLVLYGGWLTTIVLGFTIIYVLIRLLTYNYYRQLSEESLIR 1050 
T + +++D ++ Y LT ++L YV+ L R+ ++ +R 
Sbjct: 266 TGQALTSVLDLFFSVIFFCVMWYYSPQLTLVILLSLPCYVIWSLFISPLLRRRLDDKFLR 325 
Query: 1051 EARASSYFMETLYGIATIKMQGMGERRGRHWLNLKIDAINTGIRLARMDMLFSGINTFVA 1230 
A ++ +ET+ I TIK + + W + + R+ + M + 
Sbjct: 326 NAENQAFLVETVTAINTIKSMAVSPQMIATWDKQLAGYVASSFRVNLVAMTGQQGIQLIQ 385 
Query: 1231 ACDQVVILWLGTSLVIDNQMTIGMFVAFGVFRGQFSDRVGSLTNFLLQLRMMSLHNERIA 1410 
V+ LW+G LVI +++IG +AF + GQ V L + + + + ER+ 
Sbjct: 386 KSVMVISLWMGAHLVISGEISIGQLIAFNMLAGQVIAPVIRLAHLWQDFQQVGISVERLG 445 
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Appendices. Appendix 6. Sequence similarity comparisons. 
Query: 1411 DI 1416 
D+ 
Sbjct: 446 DV 447 
Score = 70 (32.2 bits), Expect = 1.2e-81, Sum P(4) = 1.2e-81 
Identities = 15/24 (62%), positives = 21/24 (87%), Frame = +1 
Query: 2035 NITRIIIAHRETTVKSADRIILLE 2106 
N T IIIAHR +TVK+A+RII+++ 
Sbjct: 654 NRTVIIIAHRLSTVKNANRIIVMD 677 
Score = 60 (27.6 bits), Expect = 1.2e-81, Sum P(4) = 1.2e-81 
Identities 15/87 (17%), Positives = 37/87 (42%), Frame = +1 
Query: 94 SSECGLACLSMICGHYGRHIDLSTLRRQFNLSALGTTLAGITEIGSQLGMETRAFSLDLN 273 
SS L L ++ ++ ++ T+R Q+N + +G++ + + 
Sbjct: 6 SSHNSLYALILLAQYHNITVNAETIRHQYNTHTQDFGVTEWLLAAKSIGLKAKYVEKHFS 65 
Query: 274 ELSVLKLPCILHWEFSHFVVLVSVRKN 354 
LS++ LP ++ + +L + K+ 
Sbjct: 66 RLSIISLPALIWRDDGKHYILSRITKD 92 
Score = 37 (17.0 bits), Expect = 2.8e-43, Sum P(3) = 2.8e-43 
Identities = 7/19 (36%), positives = 11/19 (57%), Frame = +1 
Query: 
Sbjct: 
256 FSLDLNELSVLKLPCILHW 312 
+S L + +L LPC + W 
289 YSPQLTLVILLSLPCYVIW 307 
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